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I. Summary 
 
The presented research focuses on viral and cellular determinants of the Hepatitis C Virus (HCV) 
replication. In particular, a novel minus strand replication system was developed to study distinct aspects of 
the HCV minus strand synthesis initiation. The system enabled a revision of state-of-the-art requirements for 
the HCV antigenome synthesis when uncoupled from possibly overlapping functions in viral translation 
and/or plus strand synthesis. So far mainly addressing the genome RNA sequence and structural elements 
prerequisites, the system displays a universal potential for investigation of replication of other plus strand 
RNA virus genomes. 
HCV is a positive-sense single-stranded RNA virus that infects human hepatocytes and causes both 
acute and chronic hepatitis. The challenge of elimination of HCV as a public health threat is largely 
complicated by absence of an efficient vaccine and by rapid emergence of virus quasispecies resistant to the 
existing treatment. Therefore, novel approaches are required for further understanding of molecular 
mechanisms of the HCV life cycle. Development of the autonomous replicon and full-length HCV cell 
culture systems has enabled a substantial breakthrough in understanding of the HCV translation and 
replication. However, these systems allow analysis of cis-elements and trans-acting factors required for 
genome replication only in presence of both genomic ends. Thus, it remains unclear, whether an element 
identified in the annotated HCV genome exerts its function when physically present on the plus or the minus 
strand, or on both. Additionally, given an entangled nature of viral RNA and protein synthesis, a number of 
overlapping cis-elements cannot be assigned to a specific step of the viral life cycle. To overcome the above 
limitations, the minus strand replication system was designed to specifically focus on prerequisites for the 
HCV antigenome production. 
The system, which represents a set of replication constructs assembled in agreement with the current 
knowledge on the HCV replication, uncouples to various extents the HCV minus strand synthesis from the 
plus strand synthesis and translation, thereby empowering diversified applications. The very 5’-end of the 
annotated HCV genome constituted by the stem-loop (SL) I and II domains was confirmed to be essential for 
the minus strand synthesis initiation at the genomic 3’-end. The positive regulation of the antigenome 
production was found to extend up to inclusion of the SL III domain; however, enabling of functional 
translation initiation from the HCV internal ribosome entry site (IRES) resulted in a profound negative effect 
on RNA replication. The latter observation has encouraged in-depth analysis of a balance between the HCV 
genome translation and replication that suggested an importance of the genomic RNA ends communication. 
Yet lacking an experimental confirmation, a possible circularization of the HCV RNA for efficient 
replication is supported by the importance of long-range RNA-RNA interactions between cis-elements, 
which were addressed by mutational analysis. Along with validation of the previously reported regulatory 
RNA elements, a comprehensive screening for cis-acting replication elements within the protein-coding 
sequence was undertaken. In addition to addressing the genome sequence and structure determinants, the 
minus strand replication system was utilized to examine a regulation of the HCV RNA synthesis by selected 
cellular factors. A positive role of the most of the liver-specific microRNA-122 (miR-122) binding sites on 
efficiency of the HCV minus strand synthesis initiation was demonstrated.  
In conclusion, an assay system for the specific analysis of requirements for the HCV minus strand 
RNA synthesis was developed. Uncoupling of the HCV minus and plus strand replication from each other 
and from translation enabled a dissection of essential cis-elements and assignment of their functions 
specifically to antigenome synthesis. Ultimately, the versatility of the system enables further characterization 
of regulatory trans-factors and investigation of the interplay of molecular processes during the HCV life 
cycle as well as of other RNA viruses.   
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II. Zusammenfassung 
 
Diese Arbeit befasst sich mit viralen und zellulären Voraussetzungen der Hepatitis-C-Virus (HCV) 
Replikation. Ein neuartiges Minusstrang-Replikationssystem wurde entwickelt, um spezifische Aspekte der 
Initiation der Minusstrangsynthese zu untersuchen. Dieses System ermöglicht eine genaue Betrachtung der 
Voraussetzungen für die HCV Antigenom-Synthese, wenn diese nicht mit potentiell überlappenden Funktionen 
der Positiv-Strang-Synthese und/oder der viralen Translation gekoppelt ist. Dadurch besteht ein hohes Potential, 
dieses System als Modell für Untersuchungen der Replikation anderer Positivstrang-RNA-Viren Genomen zu 
verwenden, da es hauptsächlich die Erfordernisse der RNA-Genomsequenz sowie strukturelle Elemente 
einbezieht. 
HCV ist ein einzelsträngiges RNA-Virus positiver Polarität, welches menschliche Hepatozyten infiziert 
und sowohl akute als auch chronische Hepatitis verursacht. Die Herausforderung der Bekämpfung von HCV als 
Gefahr für die öffentliche Gesundheit wird durch das Fehlen eines wirksamen Impfstoffs und das schnelle 
Auftreten von Virus-Quasispezies, die gegen die bestehende Behandlung resistent sind, erheblich erschwert. 
Daher sind neue Ansätze erforderlich, um die molekularen Mechanismen des HCV-Lebenszyklus besser zu 
verstehen. Die Entwicklung autonomer Replikon- und HCV-Zellkultursysteme mit Genomen in voller Länge 
ermöglichte einen wesentlichen Durchbruch beim Verständnis der HCV Translation und Replikation. Allerdings 
ermöglichen diese Systeme die Analyse von cis-Elementen und trans-wirkenden Faktoren, welche auf die 
Genomreplikation nur in Gegenwart beider Genomenden wirken. Somit bleibt unklar, ob ein Element, welches im 
HCV-Genom identifiziert wurde, seine Funktion ausübt, wenn es physikalisch auf dem Plusstrang oder auf dem 
Minusstrang, oder auf beiden liegt. Angesichts der komplexen Natur der viralen RNA- und Proteinsynthese 
können überlappendende cis-Elemente nicht einem spezifischen Schritt des viralen Lebenszyklus zugeordnet 
werden. Um diese Einschränkungen zu überwinden, wurde ein Minusstrang-Replikationssystem entwickelt, um 
speziell die Voraussetzungen für die HCV-Antigenom-Produktion zu untersuchen. 
Dieses System, welches eine Reihe verschiedener Replikationskonstrukte beinhaltet, die in Überein-
stimmung mit dem aktuellen Verständnis der HCV-Replikation zusammengestellt wurden, entkoppelt die HCV-
Minusstrangsynthese von der Plusstrangsynthese und der Translation, wodurch vielfältige 
Anwendungsmöglichkeiten bestehen. Das 5’-Ende des HCV-Genoms, welches aus den Stem-Loop (SL) I- und II-
Domänen besteht, wurde als essentiell für die Initiation der Minusstrangsynthese am genomischen 3’-Ende 
bestätigt. Die Region, die für den positive Einfluss auf die Antigenom-Produktion verantwortlich ist, schließt die 
SL III-Domäne mit ein, jedoch führte die Einführung funktioneller Translationsinitiation durch die HCV interne 
ribosomale Eintrittsstelle (IRES) zu einem negativen Effekt auf die RNA-Replikation. Aufgrund dieser 
Beobachtung wurde eine eingehende Analyse des Gleichgewichts zwischen HCV-Genom-Translation und -
Replikation durchgeführt, welche eine Interaktion zwischen den beiden genomischen RNA-Enden nahelegt. 
Obwohl bisher nicht experimentell bestätigt, spricht viel dafür, dass das HCV-Genom zirkularisiert, um effizient 
zu replizieren. Die Signifikanz der vorhergesagten RNA-RNA-Interaktion zwischen cis-Elementen über weite 
Distanzen wurde durch eine Mutationsanalyse überprüft. Neben zuvor beschriebenen regulatorischen RNA-
Elementen wurde zusätzlich eine umfassende Suche nach cis-aktiven Replikationselementen innerhalb der 
Protein-kodierenden Sequenz durchgeführt. Zusätzlich zur Untersuchung der Genomsequenz und von 
Strukturelementen wurde das Minusstrang-Replikationssystem verwendet, um eine Regulation der HCV-RNA-
Synthese durch ausgewählte zelluläre Faktoren zu untersuchen. Eine wichtige Rolle der meisten Bindesstellen der 
leberspezifischen microRNA-122 (miR-122) auf die Effizienz der HCV Minusstrangsynthese-Initiation wurde 
gezeigt. 
Zusammenfassend wurde in dieser Arbeit ein experimentelles System für die Analyse von spezifischen 
Anforderungen für die HCV-Minusstrang-RNA-Synthese entwickelt. Die Entkoppelung der HCV-Minus- und 
Plusstrangreplikation voneinander und von der viralen Translation ermöglichte eine präzise Analyse wichtiger cis-
Elemente und ihrer spezifischen Funktionen bei der Antigenomsynthese. Letztlich ermöglicht die Vielseitigkeit 
dieses Systems eine Charakterisierung von regulatorischen trans-Faktoren und die Untersuchung des 
Zusammenspiels molekularer Prozesse während des HCV-Lebenszyklus sowie bei anderen RNA-Viren. 
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1. Introduction 
1.1 General information on Hepatitis C Virus 
1.1.1 HCV history  
HCV existence was first fully recognized in 1975 (Feinstone et al. 1975) as an unidentified infectious 
agent causing the so-called non-A/non-B (NANB) transfusion-associated hepatitis. In 1989 an experimental 
chimpanzee model was applied for the study of NANB hepatitis that allowed demonstrating the 
transmissible, viral nature of the agent. Via a blind immunoscreening approach using high-titer samples, a 
cDNA clone encoding an antigen specific for NANBH-infected patients was isolated (Choo et al. 1989). 
Sharing the properties with Togaviridae and Flaviviridae, such as a 10 kb RNA genome with a positive 
polarity with respect to the encoded antigen, the novel infection agent was designated as Hepatitis C Virus 
(HCV). Simultaneously, a cDNA clone from plasma of patients chronically infected with NANBH was 
derived with a characterization of a different viral epitope (Maéno et al. 1990). 
This progress has rapidly led to a development of a serological assay improving the diagnostics of 
HCV and blood-donor screening (Kuo et al. 1989). In a short period of time the nucleotide sequence of HCV 
full-length genome was arranged from multiple overlapping cDNA clones. A single ORF encoding a 
polyprotein of 3011 amino acids and its main domains were described and homology to other members of 
the Flaviviridae family was postulated (Choo et al. 1991). HCV was later classified as a separate genus 
Hepacivirus within the Flaviviridae family and as a very distant relative of the Flavivirus genus and the 
Pestivirus genus (Robertson et al. 1998).  
Conducted in 1993 a vast phylogenetic analysis of partial HCV sequences from a worldwide range of 
clinical isolates enabled a classification into 6 genotypes (nucleotide sequence differs by 30–35 %) including 
a various number of subtypes (20-25 % sequence difference; designated a, b, etc.) (Simmonds et al. 1993; 
Simmonds et al. 2005). In 1997 a consensus sequence of the genotype 1a (strain H77) was determined and 
lead to a generation of the first infectious molecular cDNA clones (Kolykhalov et al. 1997; Yanagi et al. 
1997). Following the classification verification by the analysis of full-length sequences, a genotype 7 was 
newly discovered and affiliated (Murphy et al. 2015) resuming the existence of 7 major genotypes and 
67 subtypes (Smith et al. 2014; Tarr et al. 2015). Genotype 1 and 3 are the most prevalent worldwide as well 
as in Europe (mostly subtypes 1a, 1b and 3a) (Bukh 2016), however a higher risk of progressive liver 
disorder is associated with genotype 3 (Smith et al. 2014).  
In May 2016 the World Health Assembly on viral hepatitis proposed to eliminate viral hepatitis as a 
public health threat by 2030. The elimination is defined as a 90 % reduction in new chronic infections and a 
65 % reduction in mortality comparing to the 2015 statistics. According to the WHO report from 2018, 
71 million people globally have chronic hepatitis C infection (WHO 2018), comparing to 130-150 million 
people in 2016 (WHO 2016), with yearly 399 000 death cases, from hepatitis C-related liver diseases 
(cirrhosis, hepatocellular carcinoma and liver failure), comparing to former 0.7 million death rates (Lozano 
et al. 2012). Therefore, the Hepatitis C elimination still remains to be a great challenge (WHO 2018). 
1.1.2 HCV genome, virology and life cycle overview 
The genome organization of HCV RNA is similar to that of the other members of the Flaviviridae 
family and is represented by a positive-sense single-stranded RNA composed of a 9.6 kb long open reading 
frame (ORF) flanked by two untranslated regions (UTRs) at its 5’- and 3’- ends. The ORF encodes a 
polyprotein precursor of about 3000 amino acids that is cleaved co- and post- translationally into three 
structural and seven non-structural (NS) proteins by host or viral proteases (Fig. 1.1.1). The structural 
proteins – Core and envelope glycoproteins E1 and E2 – are involved in viral particle formation. The non-
structural proteins include the p7 viroporin, the NS2 protease, the NS3-4A complex with protease and 
NTPase/RNA helicase activities, the NS4B and NS5A proteins, and the NS5B RNA-dependent RNA 
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polymerase (RdRp) that enable viral processing, replication and assembly (Moradpour et al. 2007; 
Moradpour and Penin 2013). Translation from an alternative ―core +1‖ reading frame results in a production 
of the F protein of various sizes with yet unclear function (Branch et al. 2005).  
 
The highly structured 5’- and 3’- UTRs play predominant roles in HCV translation and replication. In 
the 5’UTR stem-loops (SL) II to IV constitute the major part of the IRES, whereas SL I and II are essential 
for replication (Friebe et al. 2001) and harbor the two vital microRNA-122 (miR-122) binding sites 
contributing considerably to both processes (Jopling et al. 2005; Henke et al. 2008). The 3’UTR is composed 
of a variable region with two stem-loop structures, a 30-90 nt long polyU/UC tract and an almost invariant 
98-nt X-tail (Fig. 1.1.2). All elements to a different extent facilitate initiation and regulation of the minus 
strand synthesis (Friebe and Bartenschlager 2002), as does an additional cis-acting replication element 
(CRE) 5BSL3.2 within the NS5B coding region that is engaged in a kissing-loop interaction with SL2 
(Friebe et al. 2005). 
 
Although HCV is related to the broadly investigated Flaviviruses, the morphology of its virions 
remains poorly characterized due to their unusual low buoyant density. Their enveloped nature was validated 
by chloroform inactivation followed by infection of chimpanzees (Houghton 2009), whereas gel filtration 
and electron microscopy studies identified the mature particles to be 50-80 nm in diameter 
(Wakita et al. 2005). An infectious virion contains a spherical nucleocapsid of about 30 nm in diameter that 
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is formed by the Core protein and serves to contain supposedly a single copy of the HCV genomic RNA. The 
capsid is surrounded by a lipid-containing host cell derived double-layered lipid envelope supplemented with 
anchored E1 and E2 viral glycoproteins which are involved in entry of the HCV into hepatocytes via a 
number of host cell receptors (Moradpour et al. 2007; Dubuisson and Cosset 2014). Besides its primary 
target cells – hepatocytes - HCV was also reported to infect B cells, dendritic cells and some other cell types 
using CD81, the LDL receptor (LDLR), scavenger receptor class B type I (SR-BI), heparan sulfate 
proteoglycan (HSPG) and claudin-1 (Zeisel et al. 2013). HCV circulates in various forms in the infected host 
and can be associated with low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL), or 
with cholesterol esters accounting for almost half of the total HCV lipids (Merz et al. 2011).  
In more detail, the HCV life cycle (Fig. 1.1.3) starts when the primary infection HCV particles are 
transported by the blood stream and access hepatocytes by entering the space of Disse through fenestrae 
between hepatic endothelial cells. The predominant transmission mode during ongoing HCV infection is a 
direct cell-to-cell spread. First interactions with attachment factors and receptors on the cell surface are 
conducted by both the lipoprotein components and the viral envelope glycoproteins. Docking of the virions 
due to ApoE interaction with HSPG, SR-BI or LDLR is then followed by the tetraspanin CD81 interaction 
with the a core of the E2 protein. CD81 acts in association with a co-receptor Claudin-1 (CLDN1) and 
primes the HCV envelope proteins for low pH-dependent fusion (Bartosch et al. 2003b; Zeisel et al. 2013; 
Dubuisson and Cosset 2014). The viral particles internalize via a clathrin-dependent endocytosis (Blanchard 
et al. 2006) and occur in early endosomes to undergo an endosomal membrane fusion. In turn, that leads to 
the HCV genome release into the cytosol where both translation and replication take place (Lindenbach and 
Rice 2013; Zeisel et al. 2013; Dubuisson and Cosset 2014).  
 
HCV RNA translation is entirely dependent on the cellular translation machinery as well as on a 
number of non-canonical RNA-binding proteins that are not involved in the regulation of cap-dependent 
eukaryotic translation initiation (Niepmann 2013). A distinct tertiary structure of the HCV IRES mediates 
direct binding and positioning of the 40S ribosomal subunit resulting in the 80S initiation complex assembly 
assisted by the eukaryotic initiation factor 3 (eIF3) (the detailed mechanism of HCV translation is elucidated 
in 1.2.2). After translation and polyprotein processing by cellular and viral proteases (Fig. 1.1.1) the HCV 
proteins remain associated with the endoplasmic reticulum (ER), where on site the replication machinery is 
arranged by non-structural proteins NS3/4A, NS4B, NS5A, and NS5B (the detailed mechanism of HCV 
replication is described in 1.3). In brief, NS4B protein mediates vesicular membrane alterations resulting in 
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formation of a so-called membranous web with double- or multi- membrane vesicles (DMVs/MMVs) that 
play a role of replication factories. The viral RNA-dependent RNA polymerase (RdRp) NS5B initiates 
synthesis of minus strand intermediates that in turn serve as a template for multiple copies of genomic plus 
strands. Nascent RNA genomes can either re-enter a new translation/replication round or can be assembled 
into infectious virions (Lohmann 2013). A number of host factors (e.g. RNA-binding proteins, miR-122 and 
lipoproteins) are involved in regulation of different steps of HCV replication. Lipid droplets (LDs) are 
located in proximity of the membrane vesicles in close association with the HCV Core and NS5A and are 
currently hypothesized to coordinate viral RNA synthesis and virion morphogenesis through the physical 
association of replication and assembly sites (Miyanari et al. 2007).  
Typically for the Flaviviridae family, HCV particle assembly requires engagement of the viral 
non-structural proteins and is coupled with lipid metabolism. HCV assembly is conducted by a coordinated 
action of the envelope E1-E2 glycoprotein complex and LD-associated Core protein. Posttranslationally 
retained in the ER, E1-E2 heterodimers migrate to the virion assembly site via interaction with NS2 and p7. 
The C-terminal domain of NS5A is responsible for the switch from replication to assembly due to an 
interaction with the LD-bound Core protein. Other viral proteins such as NS3/4A enzyme complex, NS4B 
and NS5B along with host factors are also implicated in the assembly process. Virions presumably form by 
budding and exit the cell through the secretory pathway. In addition to producing extracellular virus 
particles, HCV has been reported to directly infect neighboring cells without releasing detectable virus 
particles (Lindenbach 2013). 
1.1.3 HCV cell culture systems 
Despite the rapid progress in characterization of HCV genome and polyprotein organization, a 
generation of an experimental cell culture system appeared to be a major challenge. In fact, clinical isolates 
of HCV failed to induce productive infection in cell culture: infections were originally reported in continuous 
human T and B cell lines, but remained inefficient and often irreproducible (Lohmann and Bartenschlager 
2014). Although a fully permissive cell culture system was developed only in 2005 (Lindenbach et al. 2005; 
Wakita et al. 2005; Zhong et al. 2005), a few auxiliary in vitro model systems have been successfully applied 
by then for the investigation of individual steps of the HCV life cycle.    
The primary step towards the generation of recombinant experimental systems was creation of 
infectious molecular cDNA clones for the genotype 1a in 1997 (Kolykhalov et al. 1997; Yanagi et al. 1997). 
An ability of an intrahepato-injected RNA transcript to infect chimpanzees defined the genetic elements’ 
prerequisites for the further design of HCV replicons. In 1999 Lohmann and co-workers defined the minimal 
viral sequence required for the virus replication in human cells to be constituted by the 5’UTR, NS3-NS5B 
and the 3’UTR (strain Con1, genotype 1b) (Fig. 1.1.4). Representing a selectable bicistronic construct, where 
an antibiotic resistance gene was driven from the HCV IRES and the non-structural proteins - from the 
Encephalomyocarditis Virus (EMCV) IRES, these subgenomic replicons were capable of self-replication in 
HuH-7 hepatoma cell lines (Lohmann et al. 1999) (Fig. 1.1.5, B). The relatively low initial levels of 
replication were improved by adaptive mutations of the replicating HCV RNA and by increased host cell 
permissiveness (Lohmann et al. 2001). Therefore, selection for viral genomes with replication-enhancing
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mutations (REMs) and for permissive clones of a human hepatoma cell line with subsequent curing of the 
cells with interferon (IFN) lead to the generation of the highly permissive HuH-7.5 cells (Blight et al. 2002; 
Zhong et al. 2005). This clone appeared to be highly permissive for HCV RNA due to a single point 
mutation in Retinoic Acid Inducible Gene I (RIG-I) resulting in defective IFN signaling and therefore 
enhanced production and spread in cell culture (Sumpter et al. 2005).  
 
Another important in vitro system addressing the mechanism of the HCV attachment and entry is the 
pseudoparticle system (HCVpp; Fig. 1.1.5, A). Designed in 2003, it is represented by defective retroviral 
particles presenting the HCV E1-E2 glycoproteins on their surface (Bartosch et al. 2003a). Such 
pseudoparticles are generated in HEK 293T cells by co-transfection of three expression plasmids encoding 
E1/E2, retroviral Gag-Pol proteins and a retroviral provirus with a reporter gene. Upon entry into susceptible 
cells, followed by processing and integration of proviral RNA, the expression level of a reporter gene allows 
quantitative evaluation of the HCV entry. The HCVpp model system was an indispensable tool for 
investigation of E1-E2-mediated HCV entry and for identification of receptors and attachment factors (Ziesel 
et al. 2013). 
Commonly, an infection with patient-derived HCV isolates is inefficient in cell culture due to the lack 
of a key host factor SEC14L2 that permits replication of different HCV genotypes without a need for 
adaptive mutations (Saeed et al. 2015). The only exception so far was a genotype 2a strain from a Japanese 
patient with fulminant hepatitis (Kato et al. 2001), termed JFH1, that within a subgenomic replicon could 
replicate in original HuH-7 cells without a requirement for cell culture adaptive mutations (Kato et al. 2003). 
This unique strain has eventually paved the way for the first cell culture infectious HCV system (HCVcc; 
Fig. 1.1.5, D). Described independently by three research groups (Lindenbach et al. 2005; Wakita et al. 2005; 
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Zhong et al. 2005) a recombinant genotype 2a HCV genome was capable of replication and infectious virus 
assembly in HuH-7.5 cells. Combination of the original JFH1 NS3-NS5B region with the Core-NS2 region 
from another genotype 2a isolate - J6 - resulted in intragenomic chimeras - JFH1/J6 (genotype breakpoint is 
between NS2 and NS3) (Lindenbach et al. 2006) or Jc1 (genotype breakpoint is within NS2) (Pietschmann et 
al. 2006) – characterized by enhanced replication, spread and particle production. Further on, chimeric HCV 
genomes (encoding structural proteins of a genotype of interest and non-structural proteins from the JFH1 
with certain adaptive mutations) were developed for all 7 genotypes (Gottwein et al. 2009).  
In order to overcome the difficulties with adaptation of different isolates in cell culture, an alternative 
trans-complemented particle system (HCVTCP; Fig. 1.1.5, C) was engineered. This approach requires a JFH1 
subgenomic replicon providing non-structural proteins to be transfected into so-called packaging cell lines. 
The trans-complemented assembly module can be derived from any HCV isolate to elucidate isolate-specific 
mode of viral entry and replication dissected from assembly, however being capable of a single-round 
infection only (Steinmann et al. 2008).  
A development of in vitro cell culture systems - the HCVcc system on the first place - enabled 
studying of all aspects of the HCV life cycle in vitro and so far remains to be the most widely used 
experimental system in the field. However, the generation of cell systems permissive to HCV replication 
in vitro appeared to be a challenge for many years. Nowadays, the most permissive cell line for efficient 
replication in vitro is the HuH-7 human hepatoma cell line and its derivatives, in particular HuH-7.5 cells 
(Blight et al. 2002). One of the major limitations of such experimental systems is a non-polarity of 
HuH-7-based cultures in comparison to highly polarized hepatocytes in the liver. HepG2 cells, in contrast, 
polarize in culture, but require ectopic expression of human CD81 and miR-122 to become fully permissive 
(Steinmann and Pietschmann 2013). Recently primary hepatocyte cell culture models have become available 
to shed light on the role of host genetics in HCV infection (Ploss et al. 2010). Nevertheless, investigation of 
many aspects of the HCV infection still remains limited by the existing models.  
1.2 HCV translation 
1.2.1 Canonical versus IRES-mediated translation initiation 
The eukaryotic translation initiation on cellular mRNA is a complex, strictly regulated process that 
involves a large number of participants, such as nine eukaryotic initiation factors (eIF), 40S and 60S 
ribosomal subunits, Met-tRNAi and other auxiliary factors. 
The canonical translation (Fig. 1.2.1) typically begins with the 5’cap (m7G) recognition by eIF4E 
followed by recruitment of the scaffold protein eIF4G, which in turn mediates unwinding of the 5’-terminal 
region of the mRNA by eIF4A, eIF4B and eIF4F in order to prepare it for ribosomal attachment. Interaction 
of the poly(A)-binding protein (PABP) bound to the poly(A) tail at the 3’-end with eIF4G directs mRNA 
circularization. The subsequent recruitment of the 43S preinitiation complex is mainly driven by interaction 
between eIF4G and eIF3. The 43S complex itself is comprised of the 40S subunit, the eIF2/GTP/Met-tRNAi 
ternary complex, eIF3, eIF1, eIF1A and eIF5 and serves for scanning of the mRNA downstream the cap to 
locate an initiation codon (which is usually the first AUG triplet in an optimal context GCC(A/G)CCAUGG) 
(Kozak 1987). Establishment of a stable codon-anticodon base-pairing is mediated by conformational 
changes of the ribosomal complex resulting in a ―closed‖ conformation locked onto the mRNA (the 48S 
initiation complex). These events lead to a displacement of eIF1, permitting eIF5-mediated hydrolysis of 
eIF2-bound GTP and Pi release. Association of the 60S subunit to the 48S complex and eIF5B-mediated 
displacement of eIF2/GDP and other factors (eIF1, eIF3, eIF4B, eIF4F and eIF5) ultimately yield an 
elongation-competent 80S ribosome (Pestova and Kolupaeva 2002; Altmann and Linder 2010; Jackson et al. 
2010; Voigts-Hoffmann et al. 2012).  
Viruses, being naturally not capable of encoding their own translation machinery, have developed a 
range of peculiar mechanisms driven by specific genomic RNA sequences. In the absence of canonical 
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signals for ribosome recruitment virus appear to be concurrently and entirely dependent on their hosts for the 
required components and have to achieve an advantageous customized mode of action as well as to 
circumvent immune surveillance mechanisms.  
The first mechanism of a non-canonical cap-independent translation initiation was disclosed in 1988 
for Poliovirus (PV) and Encephalomyocarditis Virus (EMCV) RNA referring to as an internal translation 
initiation mechanism promoted by uniquely structured 5’UTR RNA sequence termed internal ribosome entry 
site (IRES) (Jang et al. 1988; Pelletier and Sonenberg 1988). This discovery rapidly led to identification of a 
vast number of other examples of IRES-mediated translation initiation in both viral and cellular mRNAs 
(Kieft 2008). Moreover, to further compact their genomes and maximize coding capacity, viruses were found 
to manipulate host ribosomes to shift reading frames and translate overlapping open reading frames (Kerr 
and Jan 2016). Potential cellular IRESs share little structural similarity to each other and their underlying 
mechanism remains largely unknown, however, believed to bear resemblance to the one of Picornaviruses 
(Jackson et al. 2010). 
An immediate in-depth detailing of the IRES structure and function was of high importance for a 
number of pathogenic viruses such as Hepatitis A Virus (HAV) (Glass and Summers 1992), HCV 
(Tsukiyama-Kohara et al. 1992), Foot-and-Mouth Disease Virus (FMDV) (Kuhn et al. 1990), HIV 
(Buck et al. 2001) and many others. Currently, viral IRESs are classified into four types according to their 
secondary structure and interaction with eIFs and the 40S subunit (Fig. 1.2.2). Initiation on Type 1 
(Poliovirus, Rhinovirus) and 2 (EMCV, FMDV) IRESs involves most of the canonical eIFs, Met-tRNAi and 
additional IRES trans-acting factors (ITAFs) and starts downstream of the IRES. In contrast, Type 4 IRES 
(Cricket Paralysis Virus; CrPV) is capable of binding directly to the 40S subunits independently of any 
auxiliary proteins: the IRES domain occupies the P-site and there mimics codon-anticodon base-pairing 
(Wilson et al. 2000). The HCV IRES represents a typical example of the Type 3 IRES; it binds to the 40S 
ribosomal subunit and requires fewer canonical factors (eIF2; eIF3 and Met-tRNAi) than Type 1 and 2 IRESs 
(Tsukiyama-Kohara et al. 1992). 
1.2.2 IRES-mediated translation initiation in HCV 
1.2.2.1 HCV IRES structure  
Following a functional identification of the HCV IRES in 1992 (Tsukiyama-Kohara et al. 1992), 
multiple approaches enabled a rapid identification of its secondary structure. It was shown to consist of three 
main structural domains II-IV comprising ∼340 nucleotides that adopt a tertiary fold under physiological salt 
conditions (Kieft et al. 1999) (Fig. 1.2.3). The 5’- and 3’- boundaries of the HCV IRES have been mapped 
using dicistronic reporter assays that located it to the residues 40 to 372 of the genomic 5’UTR overlapping 
with the start codon (342-344) and a part of the Core-coding region (Lukavsky 2009). SL I of the 5’UTR is 
not involved in translation, while the apical part of the SL II is engaged in a close contact with the 40S 
subunit inducing conformational changes (Spahn et al. 2001) important for ribosomal translocation (Filbin 
and Kieft 2011). The larger domain III consists of branching hairpin stem–loops (IIIabcdef) organized in 
3- and 4-way junctions. The latter structure at the basal part of the domain III is referred to as the core of the 
HCV IRES with a double pseudoknot (IIIf). This region of the IRES is highly conserved both in structure 
and primary sequence and serves for binding of the platform of the 40S small ribosomal subunit 
(Spahn et al. 2001; Joseph et al. 2014) and AUG positioning at the 40S (Berry et al. 2010). The middle IIId 
subdomain interacts with the 18S rRNA, consequently playing an anchoring role for ribosome recruitment 
(Boehringer et al. 2005). The 4-way junction domain IIIabc, together with loops IIIa and IIIb, is essential for 
an interaction with eIF3 and recruitment of Met-tRNAi–eIF2 (Fraser and Doudna 2007). The affinity of this 
binding is highly enhanced once the 40S is already bound to the IRES (Siridechadilok et al. 2005). The 
domain IV is represented by a small stem–loop structure and a highly conserved downstream coding 
sequence (Khawaja et al. 2015) and provides the AUG initiation codon for interaction with the ternary 
complex (Ji et al. 2004).   
1. Introduction 
 
19 
 
 
 
1.2.2.2 Model of HCV IRES translation initiation  
The HCV IRES mediated translation initiation is remarkably different from canonical eukaryotic 
mRNA translation in two major aspects: 7-methyl guanosine 5’-cap recognition and scanning are not 
required for the 48S complex formation and only a subset of four canonical eIFs is sufficient 
(Kieft et al. 2001; Otto and Piglisi 2004). Instead, in a biphasic way of association, at first, the high-affinity 
interaction of the structured IRES element with the 40S subunit takes place followed by the second slow 
phase. The current binding model is based on the IRES flexibility and involves repositioning of the domain 
II (Fuchs et al. 2015) that further plays a role in tRNA recruitment and the transition to elongation (Kieft et 
al. 2001; Lukavsky 2009). Moreover, ribosomal toeprinting has demonstrated the direct positioning of the 
initiation codon in the mRNA binding cleft of the 40S ribosomal subunit upon its recruitment to the 
pseudoknot (Berry et al. 2010); therefore, no initiation factors or ribosome scanning are needed at this step. 
Next, the positioning is followed by the binding of eukaryotic translation initiation factor 3 (eIF3) and the 
eIF2/GTP/Met-tRNAi ternary complex that stabilizes the pre-initiation translation complex assembly 
(Ji et al. 2004). In the resulting 48S complex the tRNA is positioned in the P site of the 40S subunit and 
base-paired to the initiation codon. Subsequent eIF5-catalyzed GTP hydrolysis leads to a release of the 
initiator tRNA and eIF2 dissociation. The second GTP hydrolysis step involving the initiation factor eIF5B 
promotes association of the 60S ribosomal subunit to form the 80S initiation complex capable of directing 
viral protein synthesis (Ji et al. 2004; Fraser and Doudna 2007; Khawaja et al. 2015) (Fig. 1.2.4). Upon 
cellular response to viral infection, the activity of eIF2 can be reduced via eIF2𝛼 subunit phosphorylation in 
order to inhibit viral protein synthesis. Under these stress conditions the HCV IRES can use eIF2-
independent pathways to generate the 80S ribosomes. One of the possibilities is to utilize an initiator tRNA-
binding protein eIF2A that under stress conditions directly interacts with the domain IIId of the HCV IRES 
committing the recruitment of Met-tRNAi to the P site of the 40S (Kim et al. 2011). Similarly, eIF2D protein 
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was reported to facilitate Met-tRNAi assembly with the 40S under stress conditions (Dmitriev et al. 2010). 
Alternatively, IF2-like protein eIF5B may assist in this initiator tRNA recruitment process and/or the 
subsequent 60S ribosome-joining step (Terenin et al. 2008).  
1.2.3 Modulation of HCV translation initiation 
The ability to initiate translation in the absence of many of the canonical initiation factors reflects the 
significance both of the IRES tertiary structure and primary nucleotide sequence that in part makes the IRES 
sensitive to mutations or inhibitors targeting the key binding sites. A number of studies have demonstrated an 
importance of the conservation and specificity of domains II-IV that are used at particular steps for 
interactions with the cellular translational machinery.  
A high-affinity interaction with the 40S small ribosomal subunit requires binding surfaces formed by 
4-way junctions between domains IIIabc and domains IIIef with the crucial importance of domain IIId 
(Kieft et al. 2001; Spahn et al. 2001; Joseph et al. 2014). However, neither deletion of the domains II and IV 
interacting with the 40S subunit nor deletion of the domain IIIb (part of the eIF3 binding site) affect the 40S 
binding affinity (Kieft et al. 2001; Otto and Piglisi 2004). Incorporated in a 3-way junction, domain IIId 
contains a hairpin loop (5’- 264UUGGGU269 -3’). The GGG triplet in its apical loop was found to be 
indispensable for the recruitment of the 40S (Lukavsky et al. 2000; Kieft et al. 2001). RNA aptamers with a 
consensus loop sequence of ACCCA, which is complementary to the apical loop of domain IIId, abrogated 
the binging of the 40S (Kikuchi et al. 2005). In particular, a GGG to CCC mutation in the IIId loop at 
positions 266–268 was demonstrated to reduce the 40S binding affinity by 25-fold (Kieft et al. 2001; 
Ji et al. 2004). Moreover, the deletion of the domain IIId or mutations in the IIId apical loop cause a low 
binding capability towards eIF2A, thus affecting translation activity under stress conditions 
(Kim et al. 2011). Crucial importance of a tetraloop (5’- GA[U/C]A -3’) within the domain IIIe was also 
pointed out in several studies. Any deletions or mutations in the IIIe tetraloop strongly reduce both the 40S 
binding affinity and translational activity (Psaridi et al. 1999). 
After the IRES association with the 40S ribosomal subunit, eIF3 mediates ternary complex binding 
and Met-tRNAi positioning in the P site. The binding affinity of eIF3 to the entire HCV IRES equals the one 
to an isolated domain IIIabc (Kieft et al. 2001), indicating that the 4-way helical junction IIIabc serves as a 
binding platform for eIF3. Deletions of both domains IIIabc and domain IIIb alone were demonstrated to 
strongly impair eIF3 binding and to obstruct translation initiation at the IRES-40S complex stage. In the 
absence of the IIIb region this effect is mainly achieved due to a lowered thermodynamic stability of 
complexes with eIF3 and of eIF2 with the 48S complex and the deposition of Met-tRNAi to the AUG 
binding site (Ji et al. 2004; Otto and Piglisi 2004). Domain IIIb consists of an apical loop and an internal 
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loop of variable sequence that is nevertheless characterized by a conserved three-dimensional secondary 
structure. Structural studies indicated that the secondary structure of the IIIb rather than conservation of 
individual bases is recognized by eIF3, and its recruitment depends on interactions within the properly folded 
IIIabc junction (Collier et al. 2002; Lukavsky 2009).  
Another reported target for a disruption of the HCV IRES translation is subdomain IIb. It is 
constituted by an apical loop and a loop E motif characterized by a high degree of sequence conservation 
(Lukavsky et al. 2003). Chemical probing experiments underline an importance of intact domain IIb for the 
IRES-40S complex arrangement at the AUG start codon. Mutations in the apical loop of domain IIb, 
disturbing an interaction with rpS5, affect the 40S subunit conformation in a way that the most of mutant-
bound ribosomes stall at the start site. Nonetheless, it does not lead to a complete abrogation of the 
translation-competent 80S complex formation. Since the ribosome samples conformations, an ability to 
translocate can be occasionally acquired allowing for the functional 80S ribosome formation (Filbin and 
Kieft 2011; Filbin et al. 2013). 
1.3 HCV replication: state-of-the-art 
1.3.1 Models for HCV replication study 
The establishment of functional HCV replicons in cell culture (Lohmann et al. 1999) had an 
indispensible impact on the beginning of the era of in vitro studies on HCV RNA replication. Previously 
available infectious cDNA clones (Kolykhalov et al. 1997; Yanagi et al. 1997) suffered from a number of 
shortcomings such as the low efficiency in cell culture and the need for a controversial chimpanzee model. 
The novel approach was based on the transfection of cloned viral consensus genome sequences constructed 
of the HCV 5’UTR, NS3-NS5B and the 3’UTR derived from total liver RNA isolated from a chronically 
HCV-infected patient (genotype 1b). In order to select only for the replicon-containing cells, a neomycin 
phosphotransferase (neo) gene was included in replicon constructs in a bicistronic manner under control of 
the HCV-IRES (Fig. 1.1.4). Following transfection into the HuH-7 cells, neomycin selection and validation 
of replicon population, several autonomously replicating HCV RNA clones were isolated. Corresponding 
mutated constructs with an in-frame deletion of the NS5B polymerase active site served as a negative control 
(Lohmann et al. 1999). However, only a small number of efficiently replicating clones was consistently 
obtained that indicated a gain of adaptive mutations. Indeed, in the later studies these replication-enhancing 
mutations (REMs) were identified within nearly every HCV non-structural protein (but neither in 5’- nor in 
3’- UTRs), although the level of adaptation was very variable. The most adaptive mutation in the study - 
2884Gly in NS5B - was found to be conserved in all replicons derived from one cell line 
(Lohmann et al. 2001).  
The further characterization of conserved mutations and their combinations revealed a dual adaptation 
nature. The mutations in NS4B, NS5A and NS5B were found to be highly adaptive, but incompatible with 
each other, whereas mutations within the N-terminus of NS3 displayed only a low or no effect on HCV 
replication efficiency, however cooperatively increased replication efficiency when combined with highly 
adaptive mutations and each other (Lohmann et al. 2003). A cluster of REMs, in particular an amino acid 
substitution Ser2204Ile, was found within NS5A, however an outstanding replication facilitation was 
observed only in about 10 % of transfected HuH-7 cells (Blight et al. 2000; Lohmann et al. 2003) that 
highlighted an importance of host cell environment. Significant variations in HuH-7 cells permissiveness 
were noted even among individual passages of the same stock, speculating on variations in the abundance 
and/or activity of cellular factors engaged in the HCV RNA replication (Lohmann et al. 2003). Suggesting a 
cellular environment maintaining a persistent replicon to be optimal, removal of the replicon from such 
adapted cells would create a perfect host cell for transient replication assays.  
Consequently, several HuH-7 lines harboring subgenomic HCV replicons were cured of the HCV 
RNA by prolonged treatment with IFN-α: two of the clones (HuH -7.5 and -7.8) harbored replicons without 
any REMs and one contained a substitution Ser2204Ile (HuH-7.4). After a complete elimination of HCV 
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replicons and re-electroporation with HCV RNA, the first two clones demonstrated a significantly higher 
number of G-418 resistant colonies than the parental HuH-7 cells and the HuH-7.4 clone. The HuH-7.5 line 
appeared to be the most permissive of those tested, although curing of other replicon-containing cells did not 
always result in highly permissive lines (Blight et al. 2002). Further investigation of IFN-treated cells 
revealed that a mutational inactivation of RIG-I mediated cellular permissiveness to HCV replication. RIG-I 
is an interferon-inducible cellular RNA helicase that serves as a receptor to transduce signals to activate 
innate antiviral defenses. Upon HCV infection the helicase domain of RIG-I binds structured genomic RNA 
and dsRNA and activates interferon regulatory factor 3 (IRF3), thereby inducing interferon production and 
expression of IFN-stimulated genes (ISGs) in cells. This pathway was found to be defect in cells selected for 
permissiveness for the HCV RNA replication (Stumpler et al. 2005). 
From the early 2000s, even before an establishment of the first cell culture infectious HCV system in 
2005, replicon systems provided a valuable platform for identification of the role of HCV genome segments 
and proteins essential for RNA replication as well as of virus-host interactions and candidate therapeutic 
agents and direct-acting antivirals (DAAs) (Bartenschlager et al. 2013). Already the first replicons defined 
that the components of the replication module (NS3-NS5B), unlike the assembly module (C-NS2), were 
sufficient for their autonomous replication in the cell culture (Lohmann et al. 1999).  
1.3.2 Cis-acting RNA elements 
Enabled by the use of the HCV replicon system, a comprehensive mapping of the HCV 5’- and 3’- 
UTRs revealed basic requirements for the efficient RNA replication (Fig. 1.3.1), in particular for the 
initiation of minus strand synthesis. With regard to the 5’-end, a 40-nt deletion of the very 5’-terminus 
entirely abrogated replication, however only to a certain extent affected translation. The first 125 nt were 
found to be sufficient for the HCV RNA replication with a significant improvement of the efficiency when 
further 5’-end sequences (up to the complete 5’UTR) were introduced (Friebe et al. 2001). At the 3’-end the 
variable region and polyU/UC tract were found to be conditionally essential for replication: a complete 
deletion of the variable region was tolerated and resulted only in reduced replication efficiency, whereas at 
least a 26-nt homouridine stretch was required. Remarkably, neither point mutations nor stem-loop deletions 
within the X-tail were viable, proposing its crucial importance for efficient RNA replication (Friebe and 
Bartenschlager 2002). Intolerance to mutations in the latter region (Yi and Lemon 2003a) and a strong 
preference for the uridine residue at the very 3’-end (Yi and Lemon 2003b) indicated the significance of both 
structure and sequence of the X-tail in the HCV replication.  
Identified in a number of previous studies, six highly structured RNA elements in the NS5B region 
were challenged by site-directed mutagenesis of a subgenomic HCV replicon to determine their role in 
replication (You et al. 2004). When the mutagenesis strategy was disrupting the predicted RNA secondary
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structures (retaining the amino acid sequence of NS5B) solely mutations in 5BSL3.2 (Fig. 1.3.1) caused 
replication abrogation. This structural element embedded in a cruciform-like structure was defined to act as a 
cis-acting replication element (CRE) (designated variously as SL3.2, SL-V or lately SL9266). Further 
in-depth analysis verified an importance of both loops and the upper stem in replicon viability 
(You et al. 2004, Friebe et al. 2005). Separation of a genetic role of the 5BSL3.2 element from its role in 
replication, performed by translocation to the variable region in the 3’UTR, allowed rescuing the efficient 
replication and demonstrated an importance of the secondary structure rather than the primary sequence. 
Additionally, a complementarity between CACAGC motif within the apical loop of the 5BSL3.2 and the 
loop sequence in the SL2 within the X-tail provided genetic evidence for a mid-range kissing-loop 
interaction: abrogation of RNA replication by mismatches in the loops was rescued when complementarity 
was restored (Friebe et al. 2005). The subterminal 8-nt bulge at the 5BSL3.2 was discovered to establish two 
additional long-range interactions: one with the apical loop of the SL9110 located upstream the 5BSL3.2 
(so-called Alt sequence), shown to be likewise crucial for replication (Diviney et al. 2008), and another 
interaction with the apical loop of the subdomain IIId of the IRES (Shetty et al. 2013) (see Fig. 1.3.2). Due to 
a mutually exclusive nature of these long-range interactions, the 5BSL3.2 was hypothesized to serve as a 
molecular switch between translation and replication (Diviney et al. 2008; Tuplin et al. 2012; Shetty et al. 
2013). Intriguingly, the 5BSL3.2 element was shown to inhibit IRES-dependent, but not cap-dependent 
translation, in particular deletion of the domain 5BSL3.2 was associated with at least 5-fold increase in the 
IRES activity (Romero-López et al. 2012). These results are in agreement with a complex interplay between 
the IRES SL IIId, SL9110, bulge or loop of the 5BSL3.2 and SL2, since mutually exclusive RNA-RNA 
interactions are formed (see Fig. 1.3.2). Consistently with the enhancement of the HCV translation by the 
3’UTR only in cis (Ito et al. 1998), the 5BSL3.2 regulatory activity of the IRES function was as well only 
achieved in the presence of the 3’UTR in cis (Romero-López et al. 2012). Conversely, more complex model 
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suggests that structural rearrangements between open and closed conformation of the 5BSL3.2 element 
enhance and reduce the HCV translation, respectively (Tuplin et al. 2015), sustaining its function as a 
molecular switch (Fig. 1.3.2). The study demonstrated that both inactivation of the apical loop of the 
5BSL3.2 and the apical loop of the 3’UTR SL2 by LNA antisense oligonucleotides interferes with 
translation. It emphasizes stimulatory function of the 5BSL3.2(loop)-SL2 ―kissing-loop‖ interaction that 
comprises the closed conformation of the 5BSL3.2 (Tuplin et al. 2015). Nevertheless, neither mutagenesis 
nor biophysical methods have yet confirmed the formation of the 5BSL3.2 element cruciform and dynamic 
nature of the long-range RNA-RNA interactions in vivo (Romero-López and Berzal-Herranz 2017). 
More detailed understanding of the cis-elements’ intercommunication was obtained using SHAPE 
(selective 2’-hydroxyl acylation and primer extension) analysis that enables mapping of both local and long-
range interactions in RNA molecule. An intricate interplay of long-range RNA-RNA interactions was 
proposed to operate between IRES, 5BSL3.2 and 3’UTR. The existence of the complexes 
SL9110-5BSL3.2-SL2 and IIId-5BSL3.2 was verified by several techniques in replication-competent RNA 
transcripts. Tertiary conformations of the IRES (domains IIIb, IIId and IV), the 5BSL3.2 and the X-tail of the 
3’UTR were found capable of mutual regulation and reorganization regardless viral or cellular proteins 
(Romero-López et al. 2012; Tuplin et al. 2012; Romero-López et al. 2014).  
With regard to the structure of the X-tail, a previously predicted co-existence of two stable 
conformations (Ivanyi-Nagy et al. 2006) seems to play a key role in switching between different functions 
during the HCV life cycle. In more detail, both predicted conformations retain the SL1 domain as a site of 
the primer-dependent minus strand synthesis initiation, whereas the upstream sequence forms either two 
canonical stem-loops 2 and 3 (Blight and Rice 1997) (Fig. 1.1.3) or a single stem-loop exposing a so-called 
dimerization linkage sequence (DLS) (Fig. 1.3.1). Located within an apical loop of this alternative stem-
loop, the DLS region is a palindromic RNA motif that was proposed to enable formation of genomic RNA 
homodimers in the presence of the Core protein in vitro (Shetty et al. 2010).  
The IRES and the 5BSL3.2 element were shown to perform a structural reorganization within the 
X-tail by switching to the two stem-loops conformation containing the DLS motif that in turn might be 
related to the switch between viral replication and genomic dimerization (Romero-López et al. 2014). A 
homodimer form may in turn be an intermediate conformation facilitating a switch between a process of 
genome replication and encapsidation. Indeed, viruses often establish a dynamic network of conserved 
interactions between functional genomic RNA domains to implement regulation of different steps of viral 
life cycle with the minimal requisite for proteins (Shi and Suzuki 2018).  
For instance, direct RNA-RNA interactions between the 5’- and 3’- ends of some Flaviviruses (such as 
Dengue virus and Yellow fever virus) induce genome circularization mediating initiation of the RNA 
replication (Villordo and Gamarnik 2009). In contrast, circularization in Poliovirus requires RNA-protein-
RNA interactions fulfilled by PCBP2 and PABP proteins bound to the 5’- and 3’- genomic ends, respectively 
(Herold and Andino 2001). Any definite proof whether a circularization of the HCV genome takes place 
and/or regulates RNA synthesis remains missing, however, indirect evidence and computational predictions 
allow to take it into account when speculating on a possible model of HCV replication (discussed below).    
1.3.3 Viral and cellular determinants 
Translated directly in the cytoplasm, HCV genome gives rise to a polyprotein that is processed by 
viral and cellular proteases into structural and non-structural proteins (detailed in 1.1.2). While the HCV 
translation fully relies on the host cell machinery, the viral replication complex is formed by encoded 
NS3-NS5B viral proteins. Embedded into the ER, multiple copies of the NS proteins induce typical for 
Flaviviruses intracellular membrane rearrangements that form vesicle-like structures referred to as 
―membranous web‖. Combined immunofluorescence analysis of the HCV NS proteins and metabolic 
labeling of newly synthesized viral RNA demonstrated their co-localization, therefore postulating the 
membranous web as a ―replication factory‖ (Gosert et al. 2003) (Fig. 1.3.3).   
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1.3.3.1 Viral components of the HCV replication complex  
In contrast to well-characterized individual NS3-NS5B proteins, the molecular architecture of the 
replication complex remains unclear. The multifunctional NS3 protein requires the co-factor NS4A 
anchoring the heterodimer in the membrane and mediating its activities: the N-terminal serine protease 
domain of the NS3 catalyzes processing of the downstream polyprotein and the C-terminal RNA 
helicase/NTPase domain is essential for RNA replication (Beran et al. 2009). NS4B is an integral membrane 
protein that induces formation of the membranous web via oligomerization and interaction with other NS 
proteins and viral RNA (Paul et al. 2011). Anchored by its N-terminus, serine phosphoprotein NS5A 
associates in homodimers to implement its multiple activities: the domains 1 and 2 are primarily involved in 
phosphorylation-dependent modulation of the HCV RNA replication, whereas the domain 3 serves viral 
assembly (Ross-Thriepland and Harris 2015). The viral RNA-dependent RNA polymerase (RdRp) NS5B is 
anchored by its C-terminal tail and harbors features that are canonical for all RdRp subdomains: fingers, 
palm and thumb of a right hand (Moradpour et al. 2004; Bartenschlager et al. 2010; Moradpour and 
Penin 2013). Recently revised mutation rate of the HCV replicase in vivo was computed to reach on average 
2.5*10
-5
 that is 1.3 nucleotides per each round of replication (Ribeiro et al. 2012).  
The formation of a functional replication complex has various cis- and trans- requirements for the NS 
HCV components. In transient complementation studies, a co-transfection of helper and various mutant 
replicon RNAs identified that trans-complementation was limited to certain lethal NS5A mutations, however 
only an expression of the minimal coding sequence of NS3 to NS5A, and not NS5A alone, from a helper 
RNA rescued a defective replicon RNA (Appel et al. 2005). Moreover, replacement of the HCV 5’- or 3’- 
UTRs by the sequences from heterologous genotypes dramatically impaired efficiency of the HCV plus or 
minus strand synthesis, respectively. In particular, a combination of the NS3 helicase, NS5A and NS5B with 
the homologous 5’UTR was required as well as a combination of the homologous X-tail and NS5B 
polymerase (Binder et al. 2007). Interestingly, requirements for the virion assembly appeared somewhat 
different from the ones for replication: trans-expression of NS5A alone was sufficient to complement 
defective mutations indicating an existence of a minor virion assembly pathway that bypasses the need for 
RNA replication (Herod et al. 2014). Further identified, strict requirements for the HCV NS3 
helicase/NTPase activities in cis suggest its role in recruitment of the RNA template for replication. 
Complementation group analysis, conducted in the same study, identified that the NS3-NS4A and NS4B 
activities are coordinated, while the RdRp activity is dependent on the complete set of the upstream 
NS3-NS5A genes. Although NS5B can perform binding and polymerase activity when provided in trans, its 
expression is required in cis underlining a structural role in replication complex assembly (Kazakov et al. 
2015). Common for other members of the Flaviviridae family, examples of cis-preferences represent a 
mechanism for genome quality control. 
1.3.3.2 Organization of the HCV replication site 
Biogenesis of the membranous web is induced by a coordinated action of the HCV non-structural 
proteins together with several host factors. The three dimensional organization of HCV-altered membranes 
was found to resemble those of Corona- or Picorna- viruses, rather than those of the related Flaviviruses (e.g. 
Dengue virus), adopting double- or multi- membrane configuration (Fig. 1.3.3). An electron tomography and 
3D-reconstruction analysis identified that, in contrast to Dengue virus, the predominant membrane species - 
double-membrane vesicles (DMVs) – are on average 150 nm in diameter and about a half of them is 
connected by a neck to the ER membrane (Romero-Brey et al. 2012). The narrow connection to cytoplasm 
on the one hand allows an access of metabolites (e.g. NTPs) and an egress of newly synthesized RNA; on the 
other hand it provides an environment protective from cellular proteases, nucleases and receptors of innate 
immunity (Lohmann 2013; Chatel-Chaix and Bartenschlager 2014).  
Morphologically the membranous web is a cytoplasmic accumulation of highly heterogeneous 
membranous vesicles that are embedded into an amorphous matrix (Fig. 1.3.3). Formerly, NS4B was 
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believed to play a primary role in a biogenesis of the web: its oligomerization induces analogous membrane 
alterations independently of the other NS proteins (Egger et al. 2002, Paul et al. 2013). Although also 
NS3-NS4A and NS5B may to a certain extent induce a formation of single membrane vesicles, NS5A is 
essential for the biogenesis of DMVs (Romero-Brey et al. 2012). Several host factors are the major 
contributors to the membrane reorganization. Interaction of NS5A and NS5B with phosphatidylinositol-4-
kinase IIIα (PI4KIIIα) induces its lipid kinase activity and results in intra-vesicle accumulation of 
phosphatidylinositol-4-phosphate (PI4P) essential for normal morphology of the membranous web (Reiss et 
al. 2013). Cyclophilin A (CypA) induces conformational changes in NS5A through its peptidyl-prolyl 
cis-trans isomerase activity facilitating the recruitment of NS5B into the replication complex (Chatel-Chaix 
and Bartenschlager 2014). Formation of the HCV replication sites demands increased levels of lipids to 
perform membrane proliferations. In contrast to intact ER membranes, DMVs are enriched in cholesterol and 
sphingolipids and therefore dependent on cellular lipid-binding proteins, for example, vesicle-associated 
membrane proteins A and B (VAPA and VAPB) that are engaged in sphingolipid metabolism and vesicle 
transport (Paul et al. 2013; Li et al. 2015). In ultrastructural studies, lipid droplets (LDs) were found to be 
abandoned in proximity of the membranous web and play a central role in the HCV RNA replication and 
assembly coordination (Miyanari et al. 2007). Overall, the membranous web represents a balanced 
environment and its isolated nature favors both higher local concentration of components and physical 
separation of different steps of the viral life cycle. 
1.3.4 Mechanism and regulation of the HCV RNA synthesis 
1.3.4.1 Current model of minus strand synthesis initiation 
The HCV RdRp NS5B is a key enzyme for the minus and plus strand viral RNA synthesis. The crystal 
structure of the NS5B replicase demonstrated that its catalytic domain has a closed conformation 
accommodating only a single-stranded RNA template and nucleotides for de novo initiation (Simister et al. 
2009). A recombinant HCV RdRp was shown to be capable of copy-back and primer-dependent as well as of 
primer-independent de novo synthesis initiation in vitro (Luo et al. 2000; Zhong et al. 2000). Under special 
conditions the enzyme was functional on poly(C) and poly(U) homopolymeric templates, indicating that 
specific cis-elements are dispensable (Luo et al. 2000). Nonetheless, these in vitro experiments required very 
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high nucleotide concentrations, not supplied in vivo, suggesting that in vivo replication by the NS5B 
replicase is promoted by auxiliary factors.  
In vivo the NS5B polymerase is anchored into membranes by the highly hydrophobic C-terminal 
transmembrane helix connected by a 40-nt linker to the catalytic core (Moradpour and Penin 2013). A 
catalytic cleft is situated between the fingertips and the linker interacting with a beta flap of the thumb 
domain and incurs a closed initiation conformation. This orientation of the beta flap and the linker restricts 
an access to the active site in order to ensure a selective and precise positioning of a 3’-end of genomic RNA 
together with incoming nucleotides along the finger RNA-binding cleft (Harrus et al. 2010). Several amino 
acid motifs within the NS5B polymerase were identified to be crucial for its activity. Most of single 
substitutions within those motifs were demonstrated to significantly reduce or inactivate the enzymatic 
activity; in particular, changes of the absolutely conserved aspartic acid residue within motif C at position 
318 completely abolished the RdRp activity (reflects a well-known GND mutation) (Lohmann et al. 1997).   
The de novo initiation starts upon binding of the first two priming nucleotides to the 3’-end and 
dinucleotide primer synthesis; this process is slow and demands high nucleotide concentrations. At the 
second - rate-limiting - step the dinucleotide serves as a primer for an accommodation of the third nucleotide 
that requires high GTP concentration and conformational reorganization of the polymerase structure. The 
latter is mediated by removal of the linker allowing the fingertips to directly contact the thumb; as a result, 
the catalytic core assumes an open conformation allowing an accommodation of the double-stranded RNA 
and egress of the elongating product (Harrus et al. 2010; Lohmann 2013). After a switch to an efficient 
elongation, relatively low nucleotide concentrations are sufficient for a processive synthesis of the entire 
HCV genome (Jin et al. 2012). The termination of the HCV RNA synthesis is achieved simply when the 
polymerase reaches the end of the template. After completion of synthesis the minus strand serves as a 
template for production of multiple copies of nascent plus strands.  
While synthesis of the plus strand clearly occurs from an ideal (with a single-stranded overhang) 
template for de novo initiation, the initiation process for the minus strand still raises a number of questions. 
The 3’-end of the plus strand forming a strong stem structure (Blight and Rice 1997) represents, at least from 
the first sight, an unsuitable template for de novo initiation. Furthermore, the uridine is a strongly favorable 
residue at the very 3’-end in vivo (Yi and Lemon 2003b), whereas in vitro the polymerase demonstrates a 
preference for poly(C) templates (Lohmann et al. 1997). At last, proceeding in the opposite direction protein 
synthesis has to be prevented during ongoing replication. The above mentioned undeniably suggests a 
contribution of other viral and cellular determinants for the initiation and regulation of the minus strand 
synthesis.  
1.3.4.2 Plus strand HCV RNA synthesis 
The exact sequence and dynamics of HCV RNA synthesis following virus internalization and 
translation vary in the available cell culture replication models due to differences in cell permissiveness and 
viral isolates. The data obtained in a single-step growth in vitro system using a highly infectious variant of 
the JFH1 isolate, presented the first minus strands to be generated 4 and 6 h post transfection or infection, 
respectively, and to reach the maximum at 24-48 h. The HCV minus strand synthesis is limited by the 
number of replication sites where the genomic RNA is thought to be retained in a double-stranded 
intermediate form (Targett-Adams et al. 2008). Meanwhile, plus strand production is retarded; therefore the 
ratio between the strands is about 1:1. The production of the plus strands is boosted after 24-48 hours and 
leads to the ratio of 10:1 plus strands to minus strands (Keum et al. 2012).  
As for the minus strand initiation discussed above, the plus strand RNA synthesis is performed by the 
NS5B polymerase and initiated de novo at the 3’-end of the minus strand (Luo et al. 2000). Numerous cis-
signals on the HCV genome appeared to be genotype-specific in regulation of RNA synthesis: intergenotypic 
replicon chimeras harboring a 5’UTR of a heterologous HCV genotype manifested an impaired plus strand 
synthesis. Additionally this approach identified that the helicase NS3, NS5A, and NS5B are essential 
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components of an initiation complex for genomic RNA synthesis (Binder et al. 2007). A combination of 
computational and experimental analysis allowed visualization of the secondary structure of the 3’-end of the 
minus strand and revealed the lack of resemblance to the antisense sequence of the 5’UTR due to different 
G:U base pairs. The proposed domain I contains the first 220 nt and folds into five stable stem-loops, 
whereas the domain II (corresponding to the HCV IRES pseudoknot) adopts a varying secondary structures 
(Schuster et al. 2002; Smith et al. 2002) (Fig. 1.3.4). The minimal region sufficient for the plus strand 
synthesis initiation was identified by a genetic mapping of replicon constructs and constituts the first 125 nt 
of the 3’-end (comprising SL-I’ SL-IIz’), however, an optimal replication required 341 nt (Friebe et al. 2001; 
Kim et al. 2002). As it was confirmed later, SL-IIy’ is crucial for the efficient replication while subdomains 
SL-IIIa’, SL-IIIb’, SL-IIIcdef’ and SL-IV’ serve auxiliary functions. Interestingly, folding of the required 
subdomains appeared to be more important than the underlying primary sequence (Friebe and Bartenschlager 
2009).  
 
Partially contrary requirements were derived by biochemical in vitro approaches. Various RNA 
fragments of the 3’-end of the HCV minus strand and their mutated variants were challenged in vitro in the 
presence of viral polymerase. The study demonstrated the high significance of the SL-I’, whereas 
modifications into the SL-IIz’ rather improved the RNA synthesis efficiency (Astier-Gin et al. 2005). Further 
in vitro analysis revealed that modifications into the SL IIIb’ reduce RNA synthesis catalyzed by 
recombinant NS5B. In the minigenome system, its intact secondary structure appeared to be required for the 
efficient HCV minus strand RNA synthesis from the 3’-end by the viral replication complex 
(Mahias et al. 2010), in contrast to the genetic studies (Friebe and Bartenschlager 2009). Eventually, it 
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remains elusive whether miR-122 target sites located within SL-IIz’ on the minus strand (complementary to 
the SL I-II) (Fig. 1.3.4) play a role in the plus strand genome replication. 
1.3.4.3 Role of microRNA-122 and other host factors 
Taking advantage of development of the fully permissive cell culture system (Lindenbach et al. 2005; 
Wakita et al. 2005; Zhong et al. 2005), transcriptomic and proteomic approaches enabled a comprehensive 
screening for host factors engaged at different stages of the HCV life cycle in vitro. Numerous cellular 
proteins take part in the formation of the membranous web and therefore indirectly regulate HCV replication, 
whereas others act directly on the genomic RNA. In a study using a sequence-specific biotinylated peptide 
nucleic acid (PNA)-neamine conjugate targeted to specifically capture the HCV genomic RNA in situ, 83 
cellular factors associated with the viral genome were identified (Upadhyay et al. 2013). Multiple studies 
utilizing a systematic siRNA screening empowered assessment of candidate host factors’ effects on viral 
fitness. For instance, inhibition of the HCV replication through silencing of the components of the RNAi 
pathway (Drosha, DGCR8, Dicer, TRBP, and Ago 1–4) was a leap forward in understanding of the 
previously suggested role of miR-122 in HCV RNA synthesis (Jopling et al. 2005; Randall et al. 2007; 
Wilson et al. 2011; Zhang et al. 2012).  
In addition to the host factors described above - PI4KIIIα (Reiss et al. 2013), CypA (Chatel-Chaix and 
Bartenschlager 2014), VAPA/VAPB (Paul et al. 2013; Li et al. 2015) and LDs (Miyanari et al. 2007) - vital 
for the replication site organization (see 1.3.3.2), there is a number of other regulatory cellular determinants. 
Modulation proteins directly binding to the HCV RNA commonly contain multiple RNA-binding motifs and 
predominantly act at the 5’- and/or 3’- UTRs. Among those, Lupus antigen (La) (Ali et al. 2000; Mondal et 
al. 2008) and Poly(rC) binding protein 2 (PCBP2) (Wang et al. 2011; Masaki et al. 2015), were reported to 
oligomerize upon binding to the 5’- and 3’- UTRs, respectively, and act as chaperones for stabilization of the 
HCV RNA secondary and tertiary structures. Some members of the hnRNP group, such as the 
polypyrimidine tract-binding protein (PTB) and hnRNP C, were reported to take part in initiation and/or 
regulation of the HCV replication upon their binding to the 3’UTR (Gontarek et al. 1999). Stabilization of 
the secondary structure of stem-loops 2 and 3 by PTB is suggested to shift the equilibrium to the three stem-
loops conformation of the X-tail (Fig. 1.3.1). Since both PTB and PCBP2 proteins bind with different 
affinities to the 5’- and 3’- UTRs they were hypothesized to mediate long-range interaction of the genomic 
ends that may promote the HCV RNA circularization (Shetty et al. 2013). An ability of La protein to interact 
with both of them may contribute to the same effect upon a protein bridge formation (Spangberg et al. 1999; 
Fontanes et al. 2009).  
Known as a regulator of alternative splicing, EWSR1 protein upon HCV infection colocalizes with 
replication sites and interacts with the 5BSL3.2 structure, preferentially in the absence of the kissing 
interaction. This interaction appeared to be required for the HCV replication, but not for initial translation, 
suggesting the EWSR1 function in switching between open and closed conformations of the 5BSL3.2 
element (Oakland et al. 2013). Next, generally localized to the nucleus, cellular proteins of the dsRBM 
family (NF90, NF110, NF45 and RNA helicase A) were found to accumulate in the cytoplasmic viral 
replication sites and promote HCV genome circularization (Isken et al. 2007). Moreover, exhibiting a 
substrate-selective RNA chaperone activity, a complex NF90-NF45 was shown to stimulate the initiation of 
HCV RNA synthesis (Schmidt et al. 2017). At last, it was recently discovered that a cDNA SEC14L2 (for 
tocopherol-associated protein 1, TAP1) is essential for the efficient HCV replication. Promoting HCV 
infection by enhancing vitamin E-mediated protection against lipid peroxidation, it enables RNA replication 
of all HCV genotypes in culture system without a need for adaptive mutations (Saeed et al. 2015). 
The most remarkable host factor modulating almost all stages of the HCV life cycle is microRNA-122 
(miR-122). Generally, microRNA (miRNA) duplexes are the post-translational down-regulators of 
eukaryotic gene expression that - in association with a miRNA-induced silencing complex (miRISC) - 
repress translation of target mRNA and promote its degradation upon binding to the 3’UTR (Fabian and 
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Sonenberg 2012). In contrast, miR-122 directly binds to both the 5’- and 3’- UTRs of the HCV genome and 
displays a positive effect on viral translation (Henke et al. 2008), replication (Jopling et al. 2005) and 
stability (Shimakami et al. 2012a). Unlike in other tissues, miR-122 is highly abundant in the liver, 
constituting over 70 % of the total miRNA pool that comprises about 66 000 copies per cell in adult 
hepatocytes (Lagos-Quintana et al. 2002; Jopling 2012). Encoded in a single genomic locus on human 
chromosome 18, it is transcribed by RNA polymerase II as pri-miRNA and undergoes a processing by 
Drosha into pre-miRNA followed by a cytoplasmic cleavage by Dicer, resulting in the 22 bp mature miRNA 
duplex with extremely conserved sequence (Kim et al. 2009). In hepatocytes miR-122 regulates the 
expression of many genes involved in fatty acid and cholesterol metabolism and displays a profound tumor 
suppressor activity (Tsai et al. 2012). 
A number of conserved miR-122 binding sites were identified within the HCV genomic RNA 
(Fig. 1.3.5). Historically, the two tandem binding sites - S1 and S2 - were identified at the HCV 5’-end 
upstream of the IRES and reported to promote HCV replication (Jopling et al. 2005; Jopling et al. 2008). 
Subsequently, additional miR-122 binding consensus sequences were revealed: the conserved S3 site located 
in the otherwise variable region of the HCV 3’UTR and three sites – 5B.1-3 – within the NS5B coding 
region; their functions remain to be clarified (Nasheri et al. 2011; Gerresheim et al. 2017).  
Binding of miR-122 to its target sequence occurs in a following manner. Upon association with 
argonaute proteins (mainly, Ago2) in the cytoplasm, mature miR-122 duplexes are unwound and one of the 
strands (the ―passenger‖ strand) is discarded. The ―guide‖ strand induces formation of the miRISC complex 
where it is positioned to expose its ―seed‖ sequence (GGAGUGU at positions 2-8 of the miR-122) for 
interaction with a target RNA. An auxiliary binding region (UGGUGUU at positions 14-20 of the miR-122) 
contributes to base-pairing to various extents (Jopling et al. 2008; Shimakami et al. 2012b; 
Masaki et al. 2015) (Fig. 1.3.5). 
 
Effects of miR-122 binding at the HCV 5’UTR are well investigated. In association with Ago2, 
miR-122 was proven to protect the viral genome from 5’-exonuclease activity of the host mRNA decay 
machinery, substituting the need for the 5’-capping (Shimakami et al. 2012a). Similarly to the degradation of 
cellular uncapped mRNAs, the HCV RNA decay is mediated by the cellular 5’-3’ exoribonuclease Xrn1 
(Li et al. 2013). In addition, miR-122 was demonstrated to protect HCV RNA from degradation by the 
nuclear exoribonuclease Xrn2, playing rather a minor role in HCV genome decay (Sedano and Sarnow 
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2014). Notably, the S1 and S2 miR-122 binding sites seem to contribute more to RNA stability and 
translation stimulation, respectively, but always in a cooperative fashion (Thibault et al. 2015; 
Nieder-Röhrmann et al. 2017). Indirectly, increased stability of the HCV genome also impacts viral 
translation and replication.  
A direct dose-dependent effect of miR-122 binding at the HCV 5’UTR on translation was 
demonstrated in several studies. Complementation of miR-122 in non-liver cells (lacking endogenous 
miR-122) was able to rescue translation of the HCV reporter RNA independently of the viral RNA 
replication (Henke et al. 2008). The enhancement of infectious virus production was observed when mutated 
S1 and/or S2 sites were addressed together with compensating miR-122 variants with an impact on both 
translation and replication (Jangra and Lemon 2010). Ago2-knockdown and co-localization data allowed 
proposing that miR-122 fulfills its functions at the HCV 5’UTR within an Ago2-containing miRNP complex 
(Roberts et al. 2011; Wilson et al. 2011; Conrad et al. 2013). 
Similarly, stimulation of the HCV replication was revealed to be an effect of direct interaction of 
miR-122 with the genomic RNA. Severely impaired production of autonomous replicons upon sequestration 
of endogenous miR-122 or genetic modifications within target sequences was rescued by corresponding 
compensatory miR-122 variants (Jopling et al. 2005). Sequestration of miR-122 in vivo had a suppressive 
effect on the HCV viremia, paving the way to a promising treatment approach using anti-sense locked 
nucleic acids (LNA), e.g. Miravirsen (Lanford et al. 2010; Janssen et al. 2013). The phase 2 of the clinical 
trials on HCV-infected individuals reflected a significant decrease of HCV RNA up to non-detectable level 
after four-week therapy (Jansen et al. 2013).  
The HCV RNA itself was discovered to exert a ―sponge‖ effect, resulting in functional de-repression 
of host mRNAs that are normally targeted by miR-122 (Luna et al. 2015). Only few studies attempted so far 
to elucidate a role of the miR-122 binding sites at the 3’-end of the HCV genome. High-affinity binding of 
miR-122 to these sites was found to be cooperative and result in negative impact on overall HCV production, 
most likely through translation repression (Nasheri et al. 2011). Recently demonstrated, a dependence of 
miR-122/Ago2 binding affinity on local HCV RNA structure may suggest a link between these complexes 
and the current function of the viral RNA, such as translation or replication. Moreover, in opposition to the 
latter study, miR-122 binding to the 5B.2 site had a positive effect on overall genome replication 
(Gerresheim et al. 2017). Proposed association of miR-122/Ago2 complexes at the characterized binding 
sites within the HCV coding region and the 3’-end may support a previous assumption that highly structured 
nature of these regions serve to pause active translation by the ribosome (Xu et al. 2001). Thus, it is still of 
high priority to investigate relative contributions of each site to translation, replication and infectious virus 
production. 
1.3.4.4 HCV replication versus translation: possible models 
Many processes of the HCV life cycle are tightly associated with each other and regulated by the same 
set of viral and cellular factors. Ribosomes proceeding from 5’ to 3’ end during translation inevitably collide 
with the RNA replicase complex assembled at the 3’-end of the genomic RNA. In order to uncouple those 
processes, the virus may employ one or more molecular switches at both RNA and protein levels. Although 
the exact mechanism regulating a transition from translation to replication in the HCV life cycle is not 
defined yet, a number of clues as well as validated interactions allow proposing possible models.    
Since liver-specific miR-122 is a key host factor modulating HCV translation, replication and stability, 
several studies suggest it to play a central role in altering translation versus replication. As described above, 
miR-122 was demonstrated to recruit Ago2 protein to the 5’UTR S1 and S2 sites and therefore stimulate 
IRES-mediated translation (Roberts et al. 2011; Wilson et al. 2011; Conrad et al. 2013; Nieder-Röhrmann et 
al. 2017) and protect the genomic RNA from Xrn1-mediated degradation (Shimakami et al. 2012a; Li et al. 
2013). In Xrn1-depleted cells introduction of exogenous miR-122 enhances HCV replication. In the context 
of mutated binding sites, corresponding miR-122 mutant variants, however, fail to restore the replication rate 
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(Li et al. 2013). This indicates a complex function of miR-122 also in other processes tightly linked to RNA 
synthesis. Previously, it was shown for Flaviviruses that ongoing protein translation is not required for RNA 
synthesis when essential viral proteins were produced in abundance (Westaway et al. 1999). Interestingly, a 
replication stimulation effect of miR-122 was found to be dependent on active protein translation 
(Masaki et al. 2015). In the experiment cellular protein synthesis in Xrn1-depleted cells was blocked by 
treatment with either cycloheximide (that freezes ribosomes on viral RNA) or puromycin (that releases 
translating ribosomes from viral RNA). As a result, puromycin treatment led to a short-term stimulation of 
the RNA replication. Under these conditions miR-122 did not demonstrate its stimulating effect on 
replication, suggesting that it acts similarly and thus redundantly to puromycin, serving a switch from 
translation to replication by a non-additive increase of available templates for RNA synthesis. Supposedly, 
miR-122 may serve to reduce the circularized state of the viral genome by displacing PCBP2 (see below) 
from the genome RNA, and therefore freeing 3’UTR sequences for interactions with the replication complex 
(Masaki et al. 2015). 
In addition to miR-122, the HCV 5’UTR serves as a binding platform for several cellular proteins, 
including PCBP2. This factor was reported to facilitate both translation and replication and to mediate HCV 
RNA circularization upon binding to the 5’- and 3’- UTRs (Wang et al. 2011). Another study demonstrated 
that PCBP2 competes with miR-122 for binding to the HCV 5’UTR since a major PCBP2 binding site 
overlaps one of the two functional miR-122 binding sites (Li et al. 2014). Taking this into account, 
replacement of PCPB2 at the HCV 5’UTR by miR-122 was hypothesized to promote an opening of a 
circularized form and to conduct a switch from translation to replication (Masaki et al. 2015). Indeed, 
depletion of PCPB2 from the cells resulted in reduction of translation efficiency, but not replication, and 
both processes under this condition were not responsive to supplementation of miR-122 (Masaki et al. 2015). 
Besides PCPB2 oligomerization, a circular form can be stabilized by the PCPB2-La-PTB protein bridge 
(Fontanes et al. 2009; Shetty et al. 2013). Alternatively, retention of the 40S ribosomal subunits at the HCV 
3’UTR enhances translation re-initiation and maintains the circularized form of the genomic RNA that favors 
a multi-round translation and prevents an assembly of the replicase complex (Bai et al. 2013). Once 
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established by any means, the circularized form of the HCV RNA is maintained and regulated via IRES-
5BSL3.2-3’UTR long-range interactions (see 1.3.2). Confirmed by SHAPE analysis, rearrangement of these 
contacts may mutually regulate interactions of the HCV genomic RNA with cellular factors, therefore tuning 
protein synthesis versus RNA synthesis. 
Taken all together, the following model of the switch between HCV translation and replication can be 
suggested (Shetty et al. 2013; Romero-López et al. 2014). After viral internalization and release of the HCV 
genome into the cytoplasm, cellular RNA-binding proteins PTB and PCPB2 occupy its 5’- and 3’- UTRs, 
respectively, (Fig. 1.3.6, II). At this stage the three stem-loops conformation of the HCV X-tail (Fig. 1.3.6, I, 
Conformation 1) is stabilized by PTB, thus favoring 5BSL3.2(loop)-SL2 and IIId-5BSL3.2(bulge) RNA-
RNA interactions. The latter long-range interaction as well as the assembly of the PCPB2-La-PTB protein 
bridge brings the HCV 5’UTR in closer proximity of the 3’UTR (Fig. 1.3.6, III and IV). Engagement of the 
40S ribosomal subunits disrupts the contact IIId-5BSL3.2(bulge) due to a higher affinity of the 40S subunit 
to the IRES. Thus, the translation machinery is assembling at the HCV IRES and the SL9110-
5BSL3.2(bulge) RNA-RNA interaction takes place (Fig. 1.3.6, V). Protein synthesis initiation and the HCV 
polyprotein processing result in accumulation of viral non-structural proteins that induce cellar 
membranealterations and membranous web formation. Accumulating viral protease cleaves PCPB2 and PTB 
(Fontanes et al. 2009; Wang et al. 2011), leading to disintegration of the protein bridge and linearization of 
the HCV genome (Fig. 1.3.6, VI). Accumulating Core protein competes with the 40S for interaction with the 
IRES IIId subdomain, therefore slowing down the translation (Shimoike et al. 2006). In the absence of PTB, 
a stable kissing-loop interactions SL9110-5BSL3.2(bulge) and 5BSL3.2(loop)-SL2 are established and 
provide a suitable platform for replicase complex assembly and the HCV minus strand synthesis initiation 
(Fig. 1.3.6, VII). Accumulation of newly synthesized genomic plus strand RNAs shifts the equilibrium 
towards the two stem-loops conformation of the X-tail (Fig. 1.3.6, I, Conformation 2) that exposes the DLS 
motif and favors genome dimerization while disrupting the 5BSL3.2(loop)-SL2 interaction. This 
conformation slows down the HCV replication and promotes genome packaging in the presence of the Core 
chaperone protein. Nearly all stages are modulated by miR-122 action. Importantly, within the Ago2 
complex miR-122 protects the 5’-end from Xrn1 degradation when the genome is present in linearized from 
and not shielded by the protein complexes. Decreasing the fraction of viral RNAs engaged in translation and 
proportionally increasing the fraction available for replication, miR-122 promotes a switch from protein to 
viral RNA synthesis acting at the 5’- and possibly at the 3’- genomic ends. Many aspects of the HCV 
replication remain elusive and require experimental validation. It is only clear that regulation of the HCV 
replication is an intricate interplay between cellular proteins and viral RNA that reciprocally and indivisibly 
tune the engagement of the RNA in protein translation versus viral RNA synthesis. 
The most recent model (Tuplin et al. 2015; Romero-López and Berzal-Herranz 2017) implies the 
5BSL3.2 element as a molecular switch and a number of mutually exclusive long-range RNA-RNA and 
protein-RNA interactions it is engaged in – to balance HCV translation and replication (Fig. 1.3.7). 
The5BSL3.2 represents a core of a complex pseudoknot structure formed by dynamic long-range RNA-RNA 
contacts involving structural elements of the HCV IRES, 5BSL3.2 and the 3’UTR (Tuplin et al. 2012). As 
described above, the three stem-loops configuration of the HCV 3’UTR enables 5BSL3.2(loop)-SL2 
interaction and is referred to as a closed conformation (see Fig. 1.3.2, i), whereas the two stem-loops X-tail 
form – to as an open conformation (see Fig. 1.3.2, ii) that favors genome dimerization (Ivanyi-Nagy et al. 
2006). Following endocytosis of HCV virions, the genomic RNA is released to the cytoplasm and associates 
at the ER. At this stage the HCV IRES, and in particular SL IIId, are engaged in interactions with assembling 
ribosome, that favors a closed conformation of the 5BSL3.2 pseudoknot (contacts SL9110-5BSL3.2(bulge) 
and 5BSL3.2(loop)- SL2); see Fig. 1.3.7, ―Translation‖). Polyprotein translation and its processing, as 
described above, results in accumulation of the viral replication proteins at the 3’-end of the genome as well 
as of cellular 5BSL3.2-binding proteins. The latter disrupts the former RNA-RNA contacts and facilitates the 
open conformation, in which 5BSL3.2(bulge) interacts with domain IIId that in turn brings the genomic ends 
into a close proximity (see Fig. 1.3.7, ―Replication‖). A dynamic shift to the IIId-5BSL3.2(bulge) contact 
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now prevents the ribosome recruitment to the IRES, therefore conducting a switch from viral translation to 
replication. During accumulation of the HCV genomic RNA thermodynamic equilibrium balances formation 
of open and closed conformations providing a possibility for new rounds of HCV translation (see Fig. 1.3.7, 
―Viral genome accumulation‖). On the late stages of replication genome dimerization becomes more 
thermodynamically probable and, mediated by a contact of DLS elements between two genomic RNAs in 
open conformation of the 5BSL3.2 pseudoknot, it facilities both – further replication and shuffling for 
encapsidation (see Fig. 1.3.7, ―Dimerization‖).  
Both models virtually propose an analogous mechanistic view on the regulation of encountering 
intracellular stages of the HCV propagation. Evidently, a certain feedback mechanism enables a switch from 
translation, after sufficient amounts of non-structural proteins have been produced, to replication or when 
sufficient amounts of genomic RNA require relocation - for packaging. Proposed as such molecular sensors, 
miR-122 or 5BSL3.2 pseudoknot, inevitably function cooperatively and implicate a complex network of 
cellular factors.  
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1.4 Aims of the work  
The life cycle of the HCV in vitro and especially in vivo is certainly more complex than we currently 
picture it. Virus RNA replication is inevitably linked to polyprotein synthesis and processing, to 
membranous web formation and to the cis/trans interplay of cis-elements with viral and cellular factors. 
Existing in vitro models are often incapable of addressing specific interactions of a cis-element or a host 
factor serving multiple and overlapping functions at different stages of the HCV life cycle.   
Although, the autonomous replicon system and full-length HCV cell culture system have been 
indispensable for HCV studies, the presence of both 5’- and 3’- genomic ends limits their capacity to assign 
the exact determinants for each individual step of the HCV life cycle. Assessment of replication efficiency 
via an overall viral genome amplification or virus production does not provide details on whether a 
cis-element identified within the annotated HCV genome exerts its function through physical presence on the 
plus or the minus strand HCV RNA. If a sequence or structure of an element appears vital at one or 
numerous overlapping steps of the virus life cycle, mutations within this element may completely abolish 
RNA synthesis and/or generation of virus progeny. Thus, mutational analysis attempted in such systems is 
restricted by retention of efficient translation, minus strand RNA synthesis and plus strand RNA synthesis. 
Various regions within the HCV genome are known to play direct or indirect roles in multiple molecular 
processes during virus propagation. In particular, sequences within the HCV 5’- and 3’- UTRs were proven 
to engage at virtually every step, including replication of the plus and the minus strand as well as translation. 
Similar complications are encountered in attempt to dissect functions of a certain viral or cellular 
trans-acting factor contributing in several ways to the HCV viral cycle. It can be illustrated by entangled 
miR-122 interactions with the HCV RNA that contribute to the HCV genome translation, stability and 
replication upon binding to the target sites at both the 5’- and 3’- ends. Lastly, accumulating reports on 
cis-elements, other than the 5BSL3.2 element, located within the HCV protein-coding region and acting via 
long-range RNA-RNA interaction, require assignment of their functions to distinct steps of the viral life 
cycle. 
The goal of the present doctoral work is to overcome the above mentioned limitations and to develop a 
novel minus strand replication system to dissect the requirements for the HCV minus and plus strand RNA 
synthesis. The system aims at uncoupling overlapping functions of cis-elements in viral replication from 
each other and from possible functions in translation initiation and other steps of the viral life cycle. The 
main focus of the current work is the analysis of minus strand RNA synthesis uncoupled from all other steps. 
In particular, revisiting the state-of-the-art requirements for the HCV antigenome synthesis initiation, aims at 
dissection of the essential cis-elements and clarification of their functions, also in scope of the interplay with 
plus strand RNA synthesis, translation and miR-122 function.  
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2. Materials and methods 
2.1 Materials  
2.1.1 Bacterial strains and cell lines 
Strain Company Genotype 
One Shot® TOP10 Chemically 
Competent E. coli 
Thermo 
Scientific 
F- mcrA Δ( mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 Δ lacX74 recA1 araD139 
Δ(araleu)7697 galU galK rpsL 
(StrR) endA1 nupG 
The strain is highly transformable and ideal for stable replication of high-copy plasmids. Along with 
the usage of commercial stocks, self-made chemically competent E.coli TOP10 was also applied for 
transformations. 
Cell line Source Origin 
HeLa 
Ralf Bartenschlager laboratory;  
Charles M. Rice laboratory 
Human negroid cervix epitheloid carcinoma cells 
HuH-7.5 Human hepatocellular carcinoma cells 
HuH-7.5 is a derivative of HuH-7 cells generated after removal of the HCV replicon by IFN treatment 
(Blight et al. 2002). This clone appeared to be highly permissive for the HCV RNA due to a single point 
mutation in the dsRNA sensor retinoic acid inducible gene I (RIG-I) (Sumpter et al. 2005); the HuH-7.5 cell 
line was generated by Zhong and co-workers (Zhong et al. 2005). 
2.1.2 Materials for bacterial growth and cell culture 
2.1.2.1 Materials for bacterial growth  
Material Company 
LB-Broth (Lennox) Roth 
Agar-Agar, Kobe I Roth 
SOC Outgrowth Medium NEB 
Ampicillin sodium salt Roth 
Glass spatula Sigma 
2.1.2.2 Materials for cell culture 
Material Company 
Dulbecco’s Modified Eagle’s Medium (DMEM) Thermo Scientific 
100 x Penicillin-streptomycin solution (Pen/Strep; 10 000 U/ml 
penicillin and 10 000 μg/ml streptomycin) 
Thermo Scientific 
Fetal Bovine Serum (FBS) Thermo Scientific 
0.5 % Trypsin-EDTA (10 x; 5 g/l Trypsin, 2 g/l EDTA) Thermo Scientific 
Dimethyl Sulfoxide (DMSO) Roth 
Roti-Stock 10 x Phosphate buffered saline (PBS) Roth 
Lipofectamine 2000 Thermo Scientific 
2.1.3 Enzymes 
2.1.3.1 Restriction endonucleases 
Enzyme Units/µl Buffer Recognition sequence Company 
AflII 20 CutSmart C↓TTAAG NEB 
AgeI-HF 20 CutSmart A↓CCGGT NEB 
AscI 10 CutSmart GG↓CGCGCC NEB 
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BamHI-HF 20 CutSmart G↓GATCC NEB 
BbvCI 2 CutSmart CC↓TCAGC NEB 
BsrGI 20 CutSmart T↓GTACA NEB 
EcoRI-HF 20 CutSmart G↓AATTC NEB 
EcoRV-HF 20 CutSmart GAT↓ATC NEB 
FseI 2 CutSmart GGCCGG↓CC NEB 
HindIII-HF 20 CutSmart A↓AGCTT NEB 
MluI-HF 20 CutSmart A↓CGCGT NEB 
MscI 5 CutSmart TGG↓CCA NEB 
NotI-HF 20 CutSmart GC↓GGCCGC NEB 
NsiI-HF 20 CutSmart ATGCA↓T NEB 
SapI 10 CutSmart GCTCTTC(N)↓ NEB 
SbfI-HF 20 CutSmart CCTGCA↓GG NEB 
XbaI 20 CutSmart T↓CTAGA NEB 
2.1.3.2 Modifying enzymes 
Enzyme Units/µl Company 
Antarctic Phosphatase (supplied with 10 x Antarctic 
Phosphatase reaction buffer) 
5 NEB 
DNase I (RNase-free) (supplied with 10 x DNase I reaction 
buffer) 
2 NEB 
T4 DNA Ligase (supplied with 10 x T4 DNA Ligase buffer) 400 NEB 
One Taq DNA Polymerase (supplied with 5 x OneTaq 
standard reaction buffer) 
5 NEB 
Proteinase K 0.8 NEB 
RNase A (10 mg/ml)  Thermo Scientific 
SP6 RNA polymerase (supplied with 10 x RNAPol reaction 
buffer) 
20 NEB 
T7 RNA polymerase (supplied with 10 x RNAPol reaction 
buffer) 
50 NEB 
2.1.4 Molecular biological consumables  
Consumable Concentration Company 
dNTPs (separate solutions of dATP, dGTP, dCTP and 
dTTP) 
100 mM each Roth 
NTPs (separate solutions of ATP, GTP, CTP and UTP) 100 mM each Roth 
Radioactive [α-³²-P]-UTP (> 400 Ci/mmol, 10 mCi/ml)  Amersham Biosciences 
MgCl2  25 mM NEB 
GeneRuler DNA Ladder Mix  Thermo Scientific 
HyperLadder 1 kb  Bioline 
GeneRuler 50 bp and 100 bp 0.5 µg/µl Thermo Scientific 
5 x DNA Loading Buffer  Bioline 
2 x RNA Loading Dye   NEB 
PageRuler Prestained Protein Ladder (10 to 250 kDa)  Thermo Scientific 
GlycoBlue  15 mg/ml Thermo Scientific 
2.1.5 Antibodies and beads 
Antibody Description Company 
Anti-Hepatitis C Virus 
NS3 antibody [8 G-2] 
A mouse monoclonal antibody to HCV NS3 that 
efficiently reacts towards the JFH-1 strain (genotype 
2a). Utilized in western blot at 1:500 dilution.  
Abcam 
Anti-Hepatitis C Virus 
Core Antigen antibody 
[C7-50] 
A mouse monoclonal antibody to Hepatitis C Virus 
Core Antigen that recognizes an epitope between 
amino acid residues 21-40 of the HCV Core protein 
(conserved among different HCV strains). Used for 
Abcam 
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western blot at 1:1 000 dilution. 
Anti-GAPDH antibody 
A mouse monoclonal antibody to a cytoplasmic 
housekeeping protein GAPDH (Glyceraldehyde-3-
phosphate dehydrogenase). Applied in western blot 
as a loading control at 1:20 000 dilution. 
Sigma 
Anti-mouse-HRP 
antibody and anti-goat-
HRP antibody 
Horseradish peroxidase conjugated secondary 
antibodies that react with primary mouse / goat 
antibodies and allow visualization in presence of the 
HRP substrate. Both used at 1:20 000 - 1:40 000 
dilution. 
Antibodies 
Online 
Anti-PTBP1 antibody 
A goat monoclonal antibody to a Polypyrimidine 
tract-binding protein 1 that was utilized as a positive 
control of binding to the HCV 3’UTR at a working 
concentration 25 μg/ml. 
Abcam 
Anti-FLAG antibody 
A mouse monoclonal antibody to a FLAG epitope 
that was utilized as a negative control of binding to 
the HCV 3’UTR at a working concentration 200 
μg/ml. 
Abcam 
Anti-RARS antibody 
(ab31537) 
A rabbit polyclonal antibody to Arginyl-tRNA 
synthetase. Applied in RNA immunoprecipitation 
assays at a working concentration 25 μg/ml. 
Abcam 
Anti-DARS antibody 
(ab151974) 
A rabbit polyclonal antibody to Aspartyl-tRNA 
synthetase. Applied in RNA immunoprecipitation 
assays at a working concentration 25 μg/ml. 
Abcam 
Anti-QARS antibody 
(ab72957) 
A mouse polyclonal antibody to Glutaminyl-tRNA 
synthetase. Was applied in RNA 
immunoprecipitation assays at a working 
concentration 25 μg/ml. 
Abcam 
Dynabeads Protein G 
magnetic beads 
Recombinant Protein G (~17 kDa) covalently 
coupled to the beads’ surface allows binding to Fc-
region of a wide range of primary antibodies for the 
purposes of immunoprecipitation. 
Thermo 
Scientific 
2.1.6 Kits 
Kit Purpose Company 
GeneJET Gel Extraction Kit 
Purification of DNA fragments from 
agarose gels 
Thermo Scientific 
GeneJET PCR Purification Kit 
Purification and concentration of DNA 
fragments from PCR reactions 
Thermo Scientific 
GeneJET Plasmid Maxiprep 
Kit 
Endotoxin-free plasmid preparation; 
maxi scale 
Thermo Scientific 
GeneJET Plasmid Miniprep 
Kit 
Plasmid preparation; mini scale Thermo Scientific 
GeneJET RNA Cleanup Micro 
Kit 
RNA cleanup and concentration after 
DNase I treatment 
Thermo Scientific 
qScript Flex cDNA Kit 
Reverse transcription of a specific gene 
from total RNA samples 
Quanta Biosciences  
PerfeCTa SYBR Green 
FastMix 
Real-time quantitative PCR Quanta Biosciences  
Qubit quantification assay Kits 
(dsDNA BR, RNA BR) 
Quantification of DNA and RNA 
concentration 
Thermo Scientific 
SuperScript III Reverse 
Transcriptase 
Reverse transcription of a specific gene 
from total RNA samples  
Thermo Scientific 
SuperSignal West Femto 
Chemiluminescent Substrate 
Western blot substrate Thermo Scientific 
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2.1.7 Plasmids 
Map 
Number 
Plasmid name  Source 
6.1.1 pFK-JFH1-J6 C-846_dg_12961 (Jc1) 
Kindly provided by Ralf 
Bartenschlager laboratory 
(Pietschmann et al. 2006) 
6.1.2 pUC18_Plus_strand_backbone_4374 Inserts were chemically 
synthesized and introduced 
into pUC18 vector by 
eurofinsgenomics.eu  
Scrambling is done by 
Yutong Song and Steffen 
Mueller 
6.1.3 pUC18_Minus_strand_backbone_4685 
6.1.4 pUC18_Fragment 1_NS5B_SCR_4157 
6.1.5 pUC18_Fragment 2_NS3-NS5B_SCR_5148 
6.1.6 pUC18_Fragment 3_NS3_SCR_4515 
6.1.7 pUC18_P.s_WT_hp_9899 
Constructed by L. 
Shalamova 
6.1.8 pUC18_P.s_SCR_hp_9899 
6.1.9 pUC18_Minus_strand_F1_6092 
6.1.10 pUC18_Minus_strand_F1_F2_8524 
6.1.11 pUC18_M.s_WT_hp_10334 
6.1.12 pUC18_M.s_SCR_hp_10334 
6.1.13 pUC18_P.s_WT_SL I-II_wt_9968 
6.1.14 pUC18_P.s_WT_SL I-II_S1mS2m_9968 
6.1.15 pUC18_P.s_WT_SL I-III_10182 
6.1.16 pUC18_P.s_WT_SL I-III_IIId mut_10182 
6.1.17 pUC18_P.s_WT_SL I-III_IIIb del_10136 
6.1.18 pUC18_P.s_WT_5’UTR_sinfr_stop_10242 
6.1.19 pUC18_P.s_WT_5’UTR_sinfr_stop_IIId mut_10242 
6.1.20 pUC18_P.s_WT_5’UTR_sinfr_stop_IIIb del_10196 
6.1.21 pUC18_P.s_SCR_SL I-II_wt_9968 
6.1.22 pUC18_P.s_SCR_SL I-II_S1mS2m_9968 
6.1.23 pUC18_P.s_WT_hp_GND_9899 
6.1.24 pUC18_P.s_WT_SL I-II_wt_GND_9968 
6.1.25 pUC18_P.s_WT_SL I-II_wt_5B.2m_9968 
Constructed by N. Dünnes  
6.1.26 pUC18_P.s_WT_SL I-II_wt_5B.3m_9968 
6.1.27 pUC18_P.s_WT_SL I-II_wt_S3m _9968 
6.1.28 pUC18_P.s_WT_SL I-II_S1mS2m_5B.2m_9968 
6.1.29 pUC18_P.s_WT_SL I-II_S1mS2m_5B.3m_9968 
6.1.30 pUC18_P.s_WT_SL I-II_S1mS2m_S3m_9968 
6.1.31 pUC18_P.s_WT_SL I-III_GND_10182 
Constructed by L. 
Shalamova 
6.1.32 pUC18_P.s_WT_5’UTR_sinfr_stop_GND_10242 
6.1.33 pUC18_P.s_WT_SL I-II_wt_8680mut_9968 
6.1.34 pUC18_P.s_WT_SL I-II_wt_9170mut_9968 
6.1.35 pUC18_P.s_WT_5’UTR_Core_10779  
Constructed by G. 
Gerresheim 
6.1.36 pUC18_P.s_WT_5’UTR_Core_GND_10779 
6.1.37 pUC18_P.s_WT_5’UTR_Core_IIIb del_10733 
6.1.38 pHCV-SIN_3235 AG Niepmann plasmid 
collection 6.1.39 pHCV-3’UTR only_3571 
2.1.8 Oligonucleotides and primers 
All DNA and RNA oligonucleotides were supplied by Biomers. Locked nucleic acids (LNA) mixmer 
oligonucleotides were supplied by Exiqon; a ―+‖ indicates a respective LNA residue. 
2.1.8.1 RNA oligonucleotides 
Name  Sequence (5’ - 3’) Source 
miR-122 mat (phos)UGGAGUGUGACAAUGGUGUUUG Conrad et al. 2016 
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miR-122* (phos)AACGCCAUUAUCACACUAAAUA 
miR-122 mat S1m (phos)UGUAGUCUGACAAAGUCGUUUG 
Nieder-Röhrmann et al. 
2017 
miR-122* S1m (phos)AACGACUUUAUCAGACUCAAUA 
miR-122 mat S2m (phos)UGGAUAGUGACAACUGUGUUUG 
miR-122* S2m (phos)AACGCAGUUAUCACUAUAAAUA 
miR-122 mat 5B.2m (phos)UGCUGUGUGACAAUGGUGUUUG 
Gerresheim et al. 2017 
miR-122* 5B.2m (phos)AACGCCAUUAUCACACGAAAUA 
miR-122 mat 5B.3m (phos)UGGUGUCUGACAAUGGUGUUUG 
miR-122* 5B.3m (phos)AACGCCAUUAUCAGACAAAAUA 
miR-122 mat S3m (phos)UGCAGAGUGACAAUGGUGGGUG 
miR-122* S3m  (phos)CCCGCCAUUAUCACUCUAAAUA 
2.1.8.2 DNA oligonucleotides 
Name  Purpose Sequence (5’ - 3’) 
NS5B_minus_RT 
RT primer targeting the NS5B 
sequence in the minus strand 
TGAGGTGTTCTGCGTGG
AC 
NS5A_minus_RT/for 
RT / forward qPCR primer targeting 
the NS5A sequence in the minus 
strand 
GCCTCCCCTTCATCTCTT
GT 
Spinach_minus_RT 
RT primer targeting the Spinach 
sequence in the minus strand 
CCGTCCTTCACCATTTCA
TT 
Spinach_minus_RT_snap 
RT primer targeting the Spinach 
sequence in the minus strand that 
forms a stem (underlined sequence) 
and a loop, unless hybridizes to the 
target 
CTGAATGAAATGCCGTC
CTTCACCATTTCATTCAG 
EMCV_plus_norm_RT 
RT primer targeting the EMCV 
sequence in the plus strand (used for 
normalization) 
CCCCTTGTTGAATACGC
TTG 
NS5B_minus_qPCR_for A pair of qPCR primers for 
quantification of the minus strand 
targeting the NS5B region 
ACATTTTTCACAGCGTG
TCG 
NS5B_minus_qPCR_rev 
GTACCTAGTGTGTGCCG
CTCT 
NS5A_minus_qPCR_rev 
A reverse qPCR primers for 
quantification of the minus strand 
targeting the NS5A region 
GATGGCGGTCTTGTAGT
TCG 
Spinach_minus_qPCR_for A pair of qPCR primers for 
quantification of the minus strand 
targeting the Spinach region 
GGAACTGCTTCCTTCAC
GAC 
Spinach_minus_qPCR_rev 
ACCATATTGCCGTCTTTT
GG 
Spinach_minus_qPCR_rev
2 
An extended reverse qPCR primer 
for quantification of the minus strand 
targeting the Spinach region 
CCACCATATTGCCGTCT
TTTGG 
EMCV_plus_norm_qPCR_
for 
A pair of qPCR primers for 
quantification of the plus strand 
targeting the EMCV region (used for 
normalization) 
AGACCCCTAGGAATGCT
CGT 
EMCV_plus_norm_qPCR_
rev 
CCGTCCTTCACCATTTCA
TT 
NS5B_minus_RT_rev 
Reverse end-point PCR primer 
targeting the NS5B sequence in the 
minus strand 
CGCCCCAAGTTTTCTGA
GGG 
GAPDH_for 
RT / forward qPCR primer targeting 
cellular GAPDH 
GAGTCAACGGATTTGGT
CGT 
GAPDH_rev 
Reverse qPCR primer targeting 
cellular GAPDH 
GATCTCGCTCCTGGAAG
ATG 
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RC_NS5B-3’UTR_SP6_for 
A pair of primers for a PCR template 
generation serving in synthesis of 
control RNA template (HCV minus 
strand) 
ATTTAGGTGACACTATA
GGCGATATCTCTTCAAT
TGG 
RC_ NS5B-3’UTR_rev 
AGTTAGCTATGGAGTGT
ACC 
as-3’UTR_RPA 
(probe 1)_SP6_for 
A pair of primers for a PCR template 
generation used for a short sense 
3’UTR probe synthesis (probe 1) 
ATTTAGGTGACACTATA
GATCTGCAGAGAGACCA
GTTACGG 
as-3’UTR_RPA 
(probe 1)_rev 
GAGGTTACACGGGCTTG
ACG 
as-3’UTR_RPA 
(probe 2)_SP6_for 
A pair of primers for a PCR template 
generation used for a short sense 
3’UTR probe synthesis (probe 2) 
ATTTAGGTGACACTATA
GGTGGCTCCATCTTAGC
CC 
as-3’UTR_RPA 
(probe 2)_rev 
CTCGGAATGTTGCCCAG
C 
sense-
5’UTR_RPA_SP6_for 
A pair of primers for a PCR template 
generation used for antisense 5’UTR 
probe synthesis 
ATTTAGGTGACACTATA
GTGCACGGTCTACGAGA
CCTCC 
sense-5’UTR_RPA_rev 
GCGCCATTCGCCATTCA
GGC 
2.1.8.3 LNA oligonucleotides 
Name  Sequence (5’ - 3’) Source 
anti-miR-122 
LNA/DNA mixmer 
+CCA+TTG+TCA+CAC+TC+C Miravirsen (Janssen et al. 2013) 
2.1.9 Buffers and solutions 
2.1.9.1 Bacterial growth and cell culture solutions 
LB growth medium: in order to obtain 1 l of the medium, 20 g of LB-Broth needs to be dissolved in 
deionized H2O and sterilized by autoclaving. The growth medium is usually supplemented with a selective 
antibiotic (ampicillin) at working concentration 100 µg/ml directly before use. 
2 % Agar-LB plates: for 200 ml stock solutions, 4 g of LB-Broth and 4 g of agar are supplemented 
with deionized H2O; dissolution and sterilization are conducted by autoclaving. If necessary, antibiotic is 
added to a warm solution at working concentration 100 µg/ml prior to pouring dishes. 
Tfb1 solution: 100 mM rubidium chloride, 50 mM manganese chloride (MnCl2-4H2O), 30 mM 
potassium acetate, 10 mM calcium chloride (CaCl2-2H2O), 15 % glycerol; pH is adjusted to 5.8 by 1 M 
acetic acid. The solution is sterilized by filtering and stored at 4°C. 
Tfb2 solution: 10 mM rubidium chloride, 10 mM MOPS, 75 mM calcium chloride (CaCl2-2H2O), 
15 % glycerol; pH is adjusted to 6.5 by 1 M potassium hydroxide. The solution is sterilized by filtering and 
stored at 4°C.   
Complete 10 % DMEM: contains 100 U/ml penicillin, 100 µg/ml streptomycin and 10 % FBS (per 
500 ml: 5 ml Pen/Strep and 50 ml FBS). 
Cryomedium: DMEM that contains 20 % FBS and 10 % DMSO (per 50 ml: 10 ml FBS and 5 ml 
DMSO). 
Cytomix: 120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4/KH2PO4 (pH 7.6), 25 mM HEPES, 2 mM 
EGTA, 5 mM MgCl2, pH 7.6; supplemented by 2 mM ATP and 5 mM reduced glutathione (GSH) before 
use. 
0.5 % Trypsin-EDTA: 10 x stock is diluted 1:10 with sterile 1 x PBS. 
1 x PBS: 10 x PBS stock is diluted 1:10 with deionized H2O and sterilized by autoclaving. 
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2.1.9.2 Gel electrophoresis buffers 
50 x TAE buffer: 2 M Tris (pH 7.6), 1 M acetic acid, 50 mM EDTA.  
10 x TBE buffer: 1 M Tris (pH 7.6), 1 M boric acid, 20 mM EDTA. 
Stacking gel buffer: 1.5 M Tris-HCl, pH 6.8, adjusted with HCl. 
Resolving gel buffer: 1.5 M Tris-HCl, pH 8.8, adjusted with HCl. 
10 x SDS Running buffer: 0.25 M Tris-HCl, 1.92 M glycine, 1 % SDS.  
2 x SDS Sample buffer: 125 mM Tris-HCl (pH 6.8), 20 % glycerol, 20 % ß-Mercaptoethanol, 4 % 
SDS, few grains of bromphenol blue. 
FA loading buffer: 80 % formamide, 10 % glycerol, 50 mM EDTA (pH 7.5), few grains of 
bromphenol blue and xylene cyanol. 
2.1.9.3 Western blot buffers 
NP-40 lysis buffer: 25 mM Tris-HCl (pH 7.5), 150 mM KCl, 2 mM EDTA (pH 7.5), 0.5 mM DTT, 
0.5 % NP-40. 
Anode I buffer: 0.3 M Tris-HCl, 10 % Methanol, pH 10.4, adjusted with HCl. 
Anode II buffer: 25 mM Tris-HCl, 10 % Methanol, pH 10.4, adjusted with HCl. 
Cathode buffer: 25 mM Tris-HCl, 10 % Methanol, pH 9.4, adjusted with HCl. 
10 x TBS buffer: 0.2 M Tris-HCl, 0.15 M NaCl, pH 7.5, adjusted with HCl. 
1 x TBST buffer: 10 x TBS is used to prepare 1 x solution and supplemented with 0.25 % Tween 20.  
Blocking solution: 10 x TBS is used to prepare 1 x TBS(T) solution and supplemented with 10 % of 
dry milk. 
2.1.9.4 IP and RPA buffers 
RNA hybridization buffer: 80 % Formamide, 40 mM Tris-Cl (pH 7.5), 400 mM NaCl, 1 mM EDTA. 
RNase digestion buffer: 10 mM Tris-Cl (pH 7.5), 300 mM NaCl, 5 mM EDTA; supplemented by 
40 μg/ml RNase A directly before use. 
Proteinase K Buffer: 200 mM Tris-Cl (pH 7.5), 300 mM NaCl, 25 mM EDTA, 2 % SDS. 
IP Wash Buffer: 50 mM Tris-Cl (pH 7.5), 300 mM NaCl, 5mM MgCl2, 0.05 % NP-40. 
Fixer solution: 7.5 % acetic acid, 5 % ethanol. 
2.1.10 Chemicals and reagents 
Chemical Company 
Acetic acid Sigma 
Agarose Roth 
Ammonium persulfate (APS) Roth 
Boric acid  Roth 
Bromophenol blue  Roth 
Calcium chloride (CaCl2) Roth 
Chloroform Sigma 
Dimethyl sulfoxide (DMSO) Roth 
Dithiothreitol (DTT) Sigma 
Ethanol (≥99.8 %, p.a.) Roth 
Ethidiumbromide Roth 
Ethylenediaminetetraacetic acid (EDTA) Roth 
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Ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid 
(EGTA) 
Roth 
Formamide Roth 
Glycerol Roth 
Glycine Roth 
Hydrochloric acid min. 32 % (HCl) Roth 
Isoamylalcohol Roth 
Isopropanol Roth 
Magnesium chloride (MgCl2) Roth 
Manganese chloride (MnCl2-4H2O) Sigma 
Methanol Roth 
MOPS (3-(N-morpholino) propanesulfonic acid) Roth 
Nonidet P-40 (NP-40) AppliChem 
Phenol ―Roti Phenol‖ Merck 
Potassium acetate (KOAc) Roth 
Potassium chloride (KCl) Fluka BioChemika 
Potassium hydroxide (KOH) Roth 
Rotiphorese Gel 40 (acrylamide/bisacrylamide 29:1) Roth 
Rubidium chloride (RbCl) Sigma 
Skimmed milk powder EDEKA Krenschker 
Sodium acetate (NaOAc) Roth 
Sodium chloride (NaCl) Roth 
Sodium Dodecyl Sulfate (SDS) Roth 
TEMED (N,N,N’,N’-Tetramethylethylendiamine) Roth 
Tris-hydroxymethylaminomethane (Tris) Roth 
TRIzol reagent Thermo Scientific 
Tween 20 Sigma 
Xylene cyanol  Roth 
β-Mercaptoethanol Sigma 
2.1.11 Laboratory and cell culture plastic 
Consumable Company 
6- and 12- well microplates Sarstedt 
10 cm dishes Sarstedt 
Electroporation cuvettes (4 mm) Sigma 
Eppendorf tubes (1.5 ml, 2 ml; Safe Lock) Sarstedt 
Falcon tubes (15 ml, 50 ml) Sarstedt 
Filter pipette tips (10 μl, 20 µl, 200 μl, 1250 μl) Sarstedt 
qPCR Seal optical clear film VWR 
qPCR Semi-Skirted Plate VWR 
Pipette Tips (10 μl) Sarstedt 
Sterile serological pipettes (5 ml, 10 ml, 25 ml, 50 ml) Greiner 
Tissue culture flasks (25 cm
2
, 75 cm
2
, 175 cm
2
) Sarstedt 
2.1.12 Laboratory equipment 
Equipment Company 
Accublock Digital Dry Bath Labnet 
Autoclave V150  Systec 
B15 petri dish incubator Thermo Scientific 
CB series CO2 Incubator Binder 
Centrifuge 5415 C Eppendorf 
Destamat, bi-destiller Heraeus 
Digital pH-Meter 644 
Knick Elektronische 
Messgeräte 
Duomax 1030 shaker Heidolph 
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ED240 hot-air cabinet Binder 
FastBlot B44 semidry blotting chamber Biometra 
Geiger counter LB 124 Berthold Technologies 
GelDoc XR gel documentation system BioRad 
GenePulser Xcell Bio-Rad 
HA 2448 BS LaminAir lamina flow Heraeus 
Heat-stir US152 magnetic stirrer Stuart 
Heraeus Biofuge Fresco Heraeus 
Herolab UV Transilluminator Herolab 
Julabo 7A water bath Julabo 
Labquake Rotator Thermo Scientific 
Leica DM IL inverted microscope Leica Microsystems 
LKB/BROMMA 2002 Power Supply LabX 
MagnaRack magnetic separation rack Thermo Scientific 
Mastercycler ep Realplex² S Eppendorf 
Micropipettors (0.5 μl to 1000 μl) Gilson 
Pipetboy comfort pipettor Integra Biosciences 
Phosphor Imager Cyclone Plus Perkin Elmer 
Qubit 2.0 Fluorimeter Thermo Scientific 
Sharp R 202 Microwave Sharp 
TProfessional PCR cycler Biometra 
Vortex Genie 2 Scientific Industries 
2.1.13 Tools, software and internet resources 
BioEdit Sequence Alignment Editor version 7.2.0 (Hall 1999) 
Clone Manager Professional Suite version 8 (Small Work Group License) 
Clustal MUSCLE: https://www.ebi.ac.uk/Tools/msa/muscle/ 
Clustal Omega: https://www.ebi.ac.uk/Tools/msa/clustalo/ 
Double Digest Finder by NEB: https://www.neb.com/tools-and-resources/interactive-tools/double-
digest-finder 
OriginPro8 SR4 software, v8.0951, OriginLab Corporation 
Primer3web (v. 4.0.0) (Rozen and Skaletsky 2000; Koressaar and Remm 2007; 
Untergasser et al. 2012): http://bioinfo.ut.ee/primer3/ 
Tm Calculator by NEB: http://tmcalculator.neb.com 
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2.2 Methods 
2.2.1 Microbiological methods 
2.2.1.1 Cultivation of bacteria 
All steps involving bacteria were carried out under sterile conditions using a Bunsen burner. All 
solutions and growth media were sterilized either by filtering or autoclaving (20 min at 120°C, 2 bars). 
Glassware and metal spatulas were disinfected by dry heat sterilization (4 h at 280°C), and only sterile 
plastic consumables were applied. A working surface was disinfected before and after bacteria cultivation 
with 70 % ethanol. Bacteria were predominantly grown under selective antibiotic conditions – 100 µg/ml of 
ampicillin - according to the resistance gene encoded in plasmids used for transformation. Cultivation is 
conducted either on 2 % agar-LB plates or in liquid LB-medium in an incubator or a shaker, respectively; at 
30 or 37°C. 
2.2.1.2 Preparation of competent bacterial cells: rubidium chloride method 
Based on commercially available One Shot TOP10 E.coli cells, additional chemically competent 
bacterial stocks were prepared. TOP10 cells from one vial were plated on an antibiotic-free LB-agar plate 
and incubated overnight at 37°C. Then a starter mini culture was produced by an inoculation of a single 
colony into 10 ml of antibiotic-free growth medium, followed by overnight incubation in 37°C shaker. On 
the next day a mini culture was transferred into 1 l of antibiotic-free LB-medium and grown under the same 
conditions for about 5 h until the cultures OD600 reaches 0.3-0.5. From this point every step is to be 
performed on ice and only ice-cold Tbf1/Tbf2 solutions to be used. The culture is kept on ice for 5 min and 
then centrifuged at 5000 rpm for 10 min at 4°C. Next, cells are gently resuspended in 200 ml (1/5th from 
initial culture volume) of Tfb1 solution and kept on ice for another 5 min. Eventually, cells are spun down at 
5000 rpm for 10 min at 4°C and resuspended in 5 ml (1/20th from initial culture volume) of Tfb2 solution and 
additionally incubated on ice for 15 min. 100, 200 and 500 µl aliquots are dispensed into pre-chilled tubes 
and snap-frozen in liquid nitrogen; storage is at -80°C. In order to characterize a current stock, one vial is 
transformed by pUC19 plasmid and transformation efficiency is estimated according to a formula:  
Number of transformants / DNA [µg] = number of colonies on the plate / (total amount of DNA 
transformed [µg] x a dilution of a culture before plating)  
2.2.1.3 Transformation of competent cells 
For transformation, a plasmid or a ligation reaction is added to 100 µl of competent cells in required 
amount and incubated on ice for 30 min. Transformation is conducted by a heat-shock for 1 min at 42°C 
followed by a cool-down for 2-3 min on ice. Next, cells are carefully mixed into 250 µl of warm SOC 
outgrowth medium and being recovered for 1 h in a 37°C shaker. Transformed cells are plated on ampicillin-
containing agar plates and cultivated as described above.    
2.2.2 Cell culture methods 
2.2.2.1 Passaging of eukaryotic cells  
All steps involving eukaryotic cells were carried out under sterile conditions using a biosafety cabinet 
and certified sterile solutions, growth media and plastic ware. Everything that was taken into the cabinet as 
well as a working surface were disinfected before and after with 70 % ethanol. Cells were maintained in a 
37°C, 5 % CO2 humidified incubator and subcultured every 2-3 days depending on a cell type and on current 
confluence. All the solutions and media for subculturing need to be pre-warmed to room temperature. First 
cells are washed once with 1 x PBS, then a required amount of 0.5 % trypsin-EDTA is applied (3 and 5 ml 
for 75 and 175 cm
2
 flasks, respectively). Culture flasks are kept at 37°C until cells are detached, and then 
trypsin is inactivated by addition of complete DMEM containing 10 % FBS. After resuspension of cells in 
the growth media, they are counted, if necessary, and seeded into new flasks or plates, as desired.   
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2.2.2.2 Thawing and freezing of eukaryotic cells 
In order to create a long-term storage stock of freshly purchased or kindly provided cell lines, 
cryostocks need to be prepared. Every new cell line first is passaged several times in increasing amounts for 
cells adaptation and multiplication until they reach about 90 % confluence. Then all cells are trypsinized, 
resuspended in a small volume of serum-containing DMEM, transferred into a sterile tube and pelleted at 
1000 rpm for 5 min at room temperature. After supernatant removal, cells are gently resuspended in 
cryomedium at a concentration of about 2-4*10
6
 cells per ml; and 1 ml aliquots are transferred into cryotubes 
and snap-frozen in liquid nitrogen; storage is in a liquid nitrogen tank. 
Viability of cells is then tested by thawing one of the vials. For this reason, a vial is briefly thawed in 
37°C water-bath; cells are to be pelleted at 1000 rpm for 5 min, then resuspended in pre-warmed 10 % 
DMEM and placed into a 25 cm
2
 flask containing complete growth medium. This medium needs to be 
exchanged within 4-6 h (after attachment of viable cells) and if necessary from time to time until the cells 
reach confluence of ~90 %.   
2.2.2.3 Counting and seeding of eukaryotic cells 
For all the experiments in which cells had to reach a certain percent of confluence they were counted 
prior seeding. A concentration of cells in a suspension obtained after trypsinization was determined using a 
Neubauer improved hemocytometer. Characteristics of this counting chamber are the following: a depth is 
0.1 mm, a counting grid is 3 mm x 3 mm in size with 9 square subdivisions of 1 x 1 mm
2
 and the central 
square is devided into 25 squares of width 0.2 mm. To calculate a total amount of cells, the number of cells 
in 2-3 bigger squares is counted, and the mean value is multiplied by 10
4
 and by a suspension’s volume 
(in ml). 
For transfection cells are to be seeded one day before, in either 6- or 12- well microplates, at amount 
of 2-2.5*10
5 
and 0.7-0.75*10
5
 cells per well, respectively, that provides 70-90 % cells confluence. 
2.2.2.4 Transfection of eukaryotic cells: Lipofectamine 2000 method 
To perform (co-)transfection of RNA substrates with microRNA or other RNA oligonucleotides, 
Lipofectamine 2000 method was applied. Transfection was only conducted on the cells reached 70-90 % 
confluence; in 6-well microplates for RT-qPCR experiments and in 12-well microplates for protein analysis 
by western blot. The amounts given below correspond to transfection in 6-well format, whereas for 12-well 
format all the amounts should be reduced by 3-fold. 
The day before transfection, cells were trypsinized and seeded into 6-well plates (2.5*10
5
 cells/well). 
In all experiments 0.3 pmol of RNA template per well was transfected; when required, microRNA(s) or LNA 
were co-transfected in various amounts. RNA components and Lipofectamine reagent were first pre-mixed 
in separate tubes (in 100 µl of serum/antibiotic-free DMEM per sample) and then combined and mixed well 
by vortexing for 10 s. Mixtures were incubated at room temperature for 15 min and then transferred 
dropwise on cells; no change of media was conducted. Cells were further incubated at standard conditions, 
usually for 48 h or according to a chosen time-course schedule, until harvesting and total RNA isolation.  
2.2.2.5 Transfection of eukaryotic cells: Electroporation method 
Evaluation of stability of RNA substrates in experimental cells transfected by Lipofectamine 
(see 2.2.2.4) is unflavored since liposomes provide an uneven nucleic acid uptake resulting in differential 
transfection efficiency or/and retention of RNA at the outer cellular surface and gradual release leading to 
artificially extended lifetime values. A more optimal approach is electroporation, which allows precise and 
instant delivery of RNA. Calculation of half-life time of nucleic acid species requires quantification of its 
remaining fraction during an expedient time-course. In the present work stability of RNA templates was 
evaluated within 36 h period. At first, HuH-7.5 cells were trypsinized, pelleted by centrifugation at 1500 rpm 
for 5 min at room temperature, then washed 1-2 times with PBS and resuspended in Cytomix to 10
7
 cells/ml. 
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For the electroporation, 400 µl (4*106 cells) of HuH-7.5 suspension were combined with 1 pmol of the RNA 
of interest, gently mixed by pipetting up and down, transferred into 4 mm cuvettes (Sigma) and then pulsed 
using a GenePulser Xcell (Bio-Rad) with the following conditions: square wave, 270 V, 20 ms. Next, cells 
were carefully resuspended in 12 ml of complete DMEM and seeded in 6- or 12- well plates (2 or 1 ml 
per well, respectively). The input samples, representing a time-point 0 h (in fact, about 30 min post 
electroporation), were directly harvested by Trizol lysis of pelleted cells. In order to remove unviable cells, 
6 h post electroporation growth media exchange was conducted. According to the selected time-course, cells 
were further harvested by Trizol at 6, 16, 24 and 36 h post electroporation; the lysis was followed by total 
RNA isolation (see 2.2.6.1). Remaining fractions of transfected RNA constructs were quantified by 
RT-qPCR (see 2.2.6.3), targeting the EMCV IRES region on plus strands. For individual constructs, mean Ct 
values for each time-point were normalized to a value for the input sample (100 %) and then mean remaining 
fractions (derived from at least three independent experiments) were fitted to exponential decay function 
using OriginPro8 software (ExpDec1 function: y = A1*exp(-x/t)+y0). Half-life values T1/2 were calculated 
from decay curves using a t1 (lifetime) characteristic parameter and its standard error values, as                 
T1/2 = t1*ln(2).    
2.2.3 Basic molecular biological methods 
2.2.3.1 Preparation of plasmid DNA 
Preparation of plasmid DNA was performed according to the following standardized procedure. For 
the primary colony screening, small-scale DNA preparation was applied. Colonies were inoculated and 
transferred into 15 ml Falcon tubes containing 2-2.5 ml of pre-warmed LB medium with an appropriate 
antibiotic (100 µg/ml ampicillin). Afterwards samples were incubated in 30 or 37°C shaker overnight; caps 
of the tubes were loosened. It is important to note that an incubation at 30°C instead of 37°C served to 
reduce activity of bacterial endonucleases and recombination negatively affecting long plasmids (over 10 kb) 
during cultivation. Next day 1 ml of cultures was transferred into Eppendorf tubes and spun down at 
maximum speed for 5 min. Further procedures were conducted using a GeneJET Plasmid Miniprep Kit 
according to the manufacturer’s instructions. The kit enables a convenient SDS/alkaline lysis of pelleted 
bacteria followed by a neutralization step providing optimal high-salt environment for plasmid DNA binding 
and protein/chromosomal DNA precipitation. While cell debris are precipitated and removed by 
centrifugation, the plasmid DNA is bound to the silica-based membrane of the column. Consequent washing 
with ethanol serves to remove contaminants, and plasmid DNA is ultimately eluted by a small volume of 
nuclease-free water. Eventually, integrity of isolated plasmid DNA was verified by restriction analysis 
(see 2.2.3.2) and by agarose gel-electrophoresis (see 2.2.4.1).   
Large-scale DNA preparation served to produce highly concentrated, pure and endonuclease-free 
stocks of a desired plasmid. Usually, one selected small-scale bacterial clone per plasmid was inoculated 
from an overnight mini-culture into a glass flask filled (to maximum 1/3
rd
) with pre-warmed LB medium 
containing an appropriate antibiotic (100 µg/ml ampicillin). Similarly, incubation was conducted overnight 
in a 30 or 37°C bacterial shaker (the incubation temperature mode conforms to the one for the primary 
cultures). Next day the whole amount of a culture was distributed and carefully equilibrated in centrifuge 
flasks, and centrifuged at 5000 rpm for 10 min at 4°C. Further procedures were performed using a GeneJET 
Plasmid Maxiprep Kit according to the manufacturer’s instructions. The principle of the procedure is 
identical to the one of the small-scale plasmid DNA isolation, with addition of the endotoxin-binding step, 
since the large-scale preparation is to be applied to cells. Prior the stock creation, integrity of isolated DNA 
was confirmed by restriction analysis (see 2.2.3.2) and agarose gel-electrophoresis (see 2.2.4.1); plasmid 
DNA concentration was precisely measured using Qubit (see 2.2.3.7).         
2.2.3.2 Restriction endonuclease digest of DNA 
Restriction digest of DNA with endonucleases is an essential method to generate sticky ends for 
ligation procedures as well as an analytical approach for verification of integrity of DNA plasmids: for 
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screening and after a large-scale preparation. Enzymatic reaction is set up according to the manufacturer’s 
instructions that include specific guidelines on a compatible buffer and an enzymatic activity (see 2.1.3.1). 
The volume of a restriction digest reaction is customized depending on the downstream application of a 
product. For an in vitro transcription DNA template preparation, usually 50 µg of plasmid DNA was used for 
the digest with 100 U of EcoRI endonuclease in 200 µl reaction volume for 2 hours at 37°C. For analytical 
purposes smaller amounts of DNA are sufficient: about 1 µg of DNA was digested within 25 µl reaction 
mixture. Larger amounts of DNA fragments are normally used for ligation procedures after subsequent 
gel-extraction (see 2.2.4.2). When a double digest is required, the optimal conditions can be defined at the 
manufacturer’s website (Double Digest Finder). A standard digest procedure is usually carried out at 37°C 
for 1 h, but may significantly vary depending on the selected restriction endonuclease.    
2.2.3.3 The polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) is a commonly known indispensable procedure for in vitro 
amplification of a DNA segment flanked by two defined sequences. Here, PCR was predominantly used for 
cloning purposes, particularly, for site-directed mutagenesis (described in detail in 2.2.5.3). The standard 
PCR procedure is outlined below. The reaction was performed using One Taq DNA Polymerase together 
with a provided OneTaq Standard Reaction Buffer (20 mM Tris-HCl, 22 mM NH4Cl, 22 mM KCl, 1.8 mM 
MgCl2, 0.06 % IGEPAL CA-630, 0.05 % Tween 20; pH 8.9) abiding the manufacturer’s instructions. The 
general composition (for a standard 25 µl reaction is given in brackets) is following: 1 x OneTaq Standard 
Reaction Buffer (5 µl of 5 x stock), 0.2 mM dNTPs (0.5 µl of 10 mM stock), 0.2 µM of each forward and 
reverse primers (0.5 µl of 10 µM stocks), 0.625 U One Taq DNA Polymerase (0.125 µl of 5 U/µl stock), 
<1 µg template DNA (volume is variable); the total volume is adjusted to 25 µl with nuclease-free water. 
When necessary, PCRs can be scaled up to 2 x (50 µl) or 4 x (100 µl) for preparative purposes. The reactions 
were performed using one of the listed thermal cyclers (see 2.1.12) applying the standardized temperature 
profile: initial denaturation – for 2 min at 94°C; 30 cycles of subsequent denaturation (for 15-30 sec 
at 94°C), annealing (for 30 sec at 45-68°C) and elongation (1 min per 1 kb, at 68°C); final extension - for 5 
min at 68°C; hold is at 4°C. The denaturation time should be increased when dealing with templates with a 
high GC-content. The annealing temperatures are to be defined for every primer pair (NEB Tm Calculator 
was used); in case of difficulties, the optimal conditions were determined via a gradient PCR program. The 
number of cycles may vary depending on expected copy number of a target. All PCR products are further 
analyzed by agarose gel-electrophoresis (see 2.2.4.1) before proceeding with a downstream application.          
2.2.3.4 In vitro RNA transcription 
Replication template RNAs for both HCV minus and plus strand synthesis initiation were generated by 
in vitro transcription. Corresponding plasmid DNAs were linearized with EcoRI digest (see 2.2.3.2), 
followed by extraction with phenol and chloroform and precipitation with ethanol (see 2.2.3.5 and 2.2.3.6); 
finally DNAs were dissolved in 50 µl nuclease-free water. DNA concentration was measured by Qubit using 
the dsDNA BR Assay Kit, and completeness of linearization was tested by 1 % agarose gel electrophoresis 
(see 2.2.4.1). 
In vitro transcription for replication constructs generation was performed using T7 RNA polymerase 
with the following modifications to the manufacturer’s protocol: 3.5 mM of each ATP, GTP, CTP and UTP, 
additional 5 mM MgCl2 and 10 mM DTT, 25 ng/µl of linearized plasmid DNA and 1 U/µl of T7 RNA 
polymerase. After 3 h at 37°C, an additional 0.5 U/µl of T7 RNA polymerase was added, and the reaction 
was incubated for another 2 h. Termination of transcription and template DNA removal was conducted by 
addition of 2 U of RNase-free DNase I per 1 µg of template DNA, followed by incubation for 15 min at 
37°C. RNA was further extracted with phenol and chloroform and precipitated with ethanol (see 2.2.3.5 and 
2.2.3.6); finally RNA transcripts were dissolved in RNase-free water. RNA concentration was measured by 
Qubit using RNA BR Assay Kit (see 2.2.3.7), and integrity of transcripts was tested by 1 % agarose gel 
electrophoresis (see 2.2.4.1). 
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For the purposes of radioactively labeled RNA production, in vitro transcription was performed 
according to the standard manufacturer’s protocol with a modification to the concentration of UTP. To 
achieve an efficient incorporation of radio-labeled [α-³²-P]-UTP into a transcribed RNA, the amount of cold 
UTP was reduced to 0.1 mM comparing to a standard 0.5 mM final concentration. It is important to note that 
in vitro transcription of certain RNAs – such as containing the U-rich HCV 3’UTR sequence – requires 
optimization of reaction conditions or a change of radioactively labeled nucleotide in order to ensure a 
generation of a full-length product. For an average sequence the in vitro transcription conditions were as 
following: 1 x T7 RNA polymerase reaction buffer, 0.5 mM of each ATP, GTP and CTP, 0.1 mM of cold 
UTP, 0.5 µM [α-³²-P]-UTP (400 Ci/mmol, 10 mCi/ml), additional 10 mM DTT, 10 ng/µl of DNA template 
and 0.1 U/µl of T7 RNA polymerase. The reaction was carried out at 37°C for 1.5-2 h for T7 RNA 
polymerase as well as for SP6 RNA polymerase that was required in several applications. Subsequent 
removal of DNA template and purification of radioactive RNA transcripts is performed similarly to cold 
transcription products, as mentioned above and in 2.2.3.5 and 2.2.3.6. Verification of RNA integrity and 
concentration estimation was conducted via denaturing polyacrylamide gel electrophoresis (see 2.2.4.4). The 
amount of radioactively labeled RNA was calculated through estimation of percentage of incorporated 
radioactive nucleotides. 
2.2.3.5 Phenol-chloroform extraction 
A procedure of nucleic acids extraction with phenol and chloroform serves to denature and remove 
proteins from an enzymatic reaction (such as restriction digest, DNase I digest or in vitro transcription). In 
order to complete purification and concentrate the sample, the extraction was always followed by ethanol (or 
isopropanol) precipitation. The procedure of nucleic acids separation from a protein fraction is based on a 
formation of two phases – watery and organic. Nucleic acids remain in the watery phase, whereas proteins 
are denatured and trapped in an organic phase. At first, 1.5 volume of phenol is added to 1 volume of an 
aqueous sample of interest. After mixing thoroughly, the sample is centrifuged at maximum speed 
(13 000 rpm) for 5 min at room temperature. The watery phase is then transferred into a clean tube (avoiding 
taking out any of the organic phases) and mixed with 1.5 volume of phenol/chloroform mixture (1:1), and the 
procedure is repeated. Similarly, at the last step the watery phase is mixed with 1.5 volumes of chloroform 
only to remove residual phenol, final centrifugation is performed and eventually the watery phase is 
collected into a clean tube. This multiplicity of steps serves to increase the purity of nucleic acid, however, 
the procedure may be reduced to two steps (omitting the second step).     
2.2.3.6 Precipitation of nucleic acids with ethanol/isopropanol 
The precipitation with ethanol or isopropanol usually comes after phenol-chloroform extraction (see 
2.2.3.5) to both concentrate nucleic acids and remove water-soluble contaminants that remain from the 
previous step (salts, sugars, etc.). The aqueous phase derived at the last step of phenol-chloroform extraction 
is thoroughly mixed with 2.5 volumes of an absolute ethanol (or 1 volume of isopropanol; the highest degree 
of purity). Usually 1/10
th
 volume of 3 M sodium acetate is added to neutralize charges on the nucleic acid, 
however, when a low yield of nucleic acids is expected, 15 µg of GlycoBlue agent can be additionally 
applied as a co-precipitant. For precipitation, samples are incubated at -20°C for at least 1 h; and nucleic acid 
is then recovered by centrifugation at maximum speed (13 000 rpm) for 15 min at 4°C. After removing 
supernatant, pellets are washed 1-2 times with 70 % ethanol and air-dried at 37°C. Pellets are then dissolved 
in a reasonable amount of nuclease-free water and, when necessary, nucleic acid concentration is measured 
according to 2.2.3.7.     
2.2.3.7 Nucleic acid concentration measurement 
All steps involving measurements of nucleic acids concentration were performed using a Qubit 
fluorometric quantification approach. The Qubit 2.0 Fluorimeter together with corresponding assay kits 
allows quantification of both RNA and DNA, in either high-sensitive or broad range. Measurements were 
conducted according to the manufacturer’s instructions: 1 µl of a nucleic acid sample is well-mixed into 
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199 µl of a working solution and incubated for 2 min. Calculation of a final concentration is automatized and 
based on a programmed calibration curve.  
2.2.3.8 Preparation of microRNA duplexes   
Co-transfection of microRNAs – original miR-122 and its mutated versions (see 2.1.8.1) – required 
application of mature imperfect duplexes. All miRNA duplexes were generated from purchased single 
stranded RNA oligonucleotides by annealing equimolar amounts of a guide (mat) and a corresponding 
passenger (*) strands. In mutated duplexes, the sequence was designed to maintain the original mis-pairing to 
assure that the duplex is unwound from the correct end. Annealing was performed in a PCR cycler by a 
steady temperature decrease from 90°C to 4°C (1°C per minute). Generated miR-122, 
miR-122_S1m/S2m/5B.2m/5B.3m/S3m duplexes were then aliquoted and stored at -20°C. 
2.2.3.9 DNA sequencing 
For analysis and verification of DNA segments after cloning or mutagenesis, sequencing service by 
GATC-biotech (and later SeqLab) was applied. Both companies provided primer synthesis service prior to 
sequencing and required only shipment of 50 to 500 ng of DNA sample (sample requirements vary 
depending on the DNA source).  
2.2.4 Gel electrophoresis methods 
2.2.4.1 Agarose gel electrophoresis  
A standard agarose gel electrophoresis procedure was applied for analysis and separation of both RNA 
and DNA. Multiple molecular biological techniques require a size and integrity verification by this method 
during their experimental timeline: visualization of generated PCR products, digested DNA fragments or 
transcribed RNA (see 2.2.3.2-4) – are just some of the applications. Meanwhile, preparative agarose gels 
served to separate DNA fragments for further cloning purposes. 
A concentration of agarose – from 1 to 2 % - was chosen depending on the expected size of the 
fragments to be separated: 1 % gels for the fragments from 0.5 to 10 kb and 2 % - for the 0.1-2 kb range. 
Gels are prepared in 1 x TAE buffer by agarose melting in a microwave oven. Before loading a gel, nucleic 
acid sample is to be mixed with an appropriate – RNA or DNA - loading dye. Standard commercially 
available loading dyes usually contain bromphenol blue and xylene cyanol and allow tracking of the nucleic 
acid migration process. The electrophoresis is performed in 1 x TAE running buffer at 20-25 mA per gel; a 
choice of the current depends on the size of separated fragments and a preferred resolution. A suitable length 
marker is to be loaded on each gel. To stain separated nucleic acids, the gels were soaked in ethidium 
bromide solution (0.5 µg/ml in 1 x TAE buffer) for 20-40 min. Visualization of fragments was carried out 
under UV-light illumination using a GelDoc XR gel documentation system.  
2.2.4.2 Recovery of DNA fragments from agarose gels 
In order to separate certain DNA species from a mixture of fragments, agarose gel electrophoresis 
followed by a gel extraction was conducted. A preparatory procedure was consistent with 2.2.4.1. However, 
to avoid an unwanted DNA damage by UV-light, visualization was conducted using a table transilluminator 
and a protective layer of aluminum foil underneath a gel; an exposure time was reduced to minimum. A 
fragment of interest was defined in accordance with a marker ladder, excised using a blade and transferred 
into a clean tube. Subsequent purification of DNA from a gel slice was carried out with a GeneJET Gel 
Extraction Kit, following the manufacturer’s instructions.    
2.2.4.3 Polyacrylamide gel electrophoresis under non-denaturing conditions 
Analytical non-denaturing polyacrylamide gel electrophoresis (PAGE) was applied as an alternative 
method for shorter DNA fragments separation (below 500 bp; for instance, after RT-PCR, see 2.2.6.2) 
instead of 2 % agarose gel electrophoresis. Electrophoresis was performed under non-denaturing conditions; 
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the concentration of acrylamide was chosen in accordance to the expected size of the fragments to be 
separated: 6 or 8 %. Gels were prepared in 1 x TBE buffer supplemented with an appropriate amount of 
acrylamide solution (from a 40 % stock solution), 0.1 % APS and 0.1 % TEMED just before use. Prior 
loading on a gel, samples were premixed with a loading dye containing bromphenol blue and xylene cyanol 
as well as a suitable length marker to control a migration process. The electrophoresis was performed in 1 x 
TBE running buffer at 20-25 mA per gel; gels were subsequently stained in the ethidium bromide bath 
(0.5 µg/ml in 1 x TBE) for 5-10 min. Visualization of fragments was carried out under UV-light illumination 
using a GelDoc XR gel documentation system. 
2.2.4.4 Polyacrylamide gel electrophoresis under denaturing conditions 
Analytical polyacrylamide gel electrophoresis conducted under denaturing conditions was applied for 
evaluation of in vitro transcribed radio-labeled RNAs integrity (see 2.2.3.4) as well as at final steps of RPA 
and RIP experiments (see 2.2.8 and 2.2.9). Depending on size of expected RNA products, 6-12 % 
polyacrylamide gels supplemented with 50 % Urea, 0.1 % APS, 0.1 % TEMED in 1 x TBE were poured. A 
careful washing of the wells of a gel and a pre-run of electrophoresis at standard conditions (for at least 10 
min) are highly recommended to improve a resolution and a final image quality. Prior loading the samples 
are to be supplemented with 1 (or higher) volume of Formamide-containing loading buffer and denatured for 
2 min at 90°C at the heating block. Electrophoresis is performed at 30 mA per gel for a suitable period of 
time according to expected bromphenol blue and xylene cyanol fronts migration for a chosen acrylamide 
concentration. Eventually radioactively labeled RNA is visualized by autoradiography. For the analysis of 
in vitro transcribed RNA gels were usually wrapped in a plastic foil and exposed directly to Kodak X-ray 
film for about 5 min. In order to conduct a prolonged exposure, gels were usually fixed in fixer solution for 
30-40 min and dried on a gel-drier for 2 h at 80°C. Dehydrated gels were exposed to X-ray film or to a 
PhosphorImager screen for a required period of time to obtain an optimal image. 
2.2.4.5 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
For the separation and analysis of proteins under SDS-denaturing conditions, the discontinuous 
Laemmli polyacrylamide gel system was utilized (Laemmli 1970). Such SDS gels consist of an upper 
stacking gel (usually 5 %) and lower resolving gel (8-12 %); the percentage of acrylamide in a resolving gel 
depends on the size of separated proteins. For visualization of the HCV NS3 protein together with cellular 
GAPDH (as a loading control), 10 % resolving gel was used in the Laemmli system.    
First, a resolving gel solution is to be poured; its composition is the following: 8-12 % 
Acrylamide/bisacrylamide (29:1), 375 mM Tris-HCl (pH 8.8), 0.1 % SDS, 0.1 % APS and 0.1 % TEMED. 
After a complete polymerization of a resolving gel, a stacking gel solution is to be added on top; it has a 
lower pH and consists of: 5 % Acrylamide/bisacrylamide (29:1), 125 mM Tris-HCl (pH 6.8), 0.1 % SDS, 
0.1 % APS and 0.1 % TEMED. Protein-containing samples were diluted 1:4 in 4 x SDS sample buffer and 
denatured by cooking on a dry bath at 95°C for 10 min. After a brief spin-down samples were directly loaded 
on a gel together with a size marker. Electrophoresis was performed using a vertical gel chamber in 1 x SDS 
running buffer, first, at 25 mA per gel for a stacking gel and at 35 mA per gel for a resolving gel; regularly, 
the gels were run until the bromphenol blue dye front exited the gel. After electrophoresis gels were 
immediately applied for the western blot analysis (see 2.2.7).    
2.2.5 Molecular cloning and mutagenesis methods 
A multi-step preparatory cloning procedure was conducted. The DNA templates for transcription were 
meticulously designed in this work and then commercially synthesized in parts by EuroFins and finally 
assembled as follows.  
The minimal template for minus strand synthesis initiation - pUC18_P.s_WT_hp_9899 (designated as 
―hp‖; see 6.1.7) - was assembled in one step from a chemically synthesized backbone plasmid 
(pUC18_Plus_strand_backbone_4374; 6.1.2) and a plasmid encoding the full-length HCV JFH1/J6 genome 
2. Materials and methods 
 
53 
 
(pFK-JFH1-J6 C-846_dg (Jc1)_12961; 6.1.1; Pietschmann et al. 2006). Alternatively, most of the ORF was 
scrambled, i.e. the primary sequence was permutated to disable RNA cis-signals while retaining amino acid 
coding specificity, codon usage and codon pair bias (Song et al. 2012). Scrambled sequence design was done 
by Yutong Song and Steffen Mueller at Stony Brook University (NY, USA). The scrambled version of the 
DNA template encoding for plus strand initiation construct was assembled in three steps using four 
chemically synthesized constructs: a backbone plasmid pUC18_Minus_strand_backbone_4685 (6.1.3) and 
three plasmids containing fragments of scrambled NS3-NS5B sequence (pUC18_Fragment 
1_NS5B_SCR_4157, pUC18_Fragment 2_NS3-NS5B_SCR_5148 and pUC18_Fragment 
3_NS3_SCR_4515; 6.1.4-6). Construction of the template for minus strand synthesis in scrambled context 
(pUC18_P.s_SCR_hp_9899; 6.1.8) and the one for plus strand initiation in wild-type context 
(pUC18_Minus_strand_WT_hp_10334; 6.1.11) was performed by an exchange of backbones/cassettes (also 
see Supplementary materials 6.2.1 and Suppl. Fig. 6.1-6.5). Since the AscI site is located 152 nt upstream of 
the NS5B-3’UTR junction, this exchange site is located downstream of the NS5B miR-122 target sites, but 
directly upstream of the 5BSL3.2 element. Therefore, both resulting minimal constructs (wild-type or 
scrambled) contain the wild-type 5BSL3.2 sequence, but the miR-122 target sites in the NS5B coding region 
are retained only in original constructs.  
The required modifications were introduced into the hp minimal constructs by site-directed 
mutagenesis. The template for minus strand replication initiation was supplemented with partial HCV 5’UTR 
sequences – SL I-II (position 1-117; harboring wild-type or mutated miR-122 sites; mutations are as 
described in Nieder-Röhrmann et al. 2017), SL I-III (position 1-330) or the complete 5’UTR (position 1-376, 
followed by 12 codons of the HCV Core-coding sequence and UGA) – resulting in plasmids 
pUC18_P.s_WT_SL I-II_wt_9968, pUC18_P.s_WT_SL I-II_S1mS2m_9968, pUC18_P.s_WT_SL 
I-III_10182 and pUC18_P.s_WT_5’UTR_sinfr_stop_10242, respectively (6.1.13-15 and 6.1.18). 
Accordingly, the SL I-II sequence was also inserted into the same hp construct with a scrambled context 
(resulting in pUC18_P.s_SCR_SL I-II_wt_9968 and pUC18_P.s_SCR_SL I-II_S1mS2m_9968; 6.1.21-22). 
The constructs with individually mutated cis-elements in the HCV NS5B region - pUC18_P.s_WT_SL 
I-II_8680mut_9968 and pUC18_P.s_WT_SL I-II_9170mut_9968 – were generated by site-directed 
mutagenesis (6.1.33-34). 
The miR-122 binding sites in the HCV NS5B coding region and 3’UTR were mutated within SL I-II 
constructs (6.1.13-14), as in Gerresheim et al. 2017, resulting in plasmids with individually mutated 5B.2m, 
5B.3m or S3m miR-122 binding sites: pUC18_P.s_WT_SL I-II_wt_5B.2m_9968, pUC18_P.s_WT_SL 
I-II_wt_5B.3m_9968, pUC18_P.s_WT_SL I-II_wt_S3m_9968 (6.1.25-27) and pUC18_P.s_WT_SL 
I-II_S1mS2m_5B.2m_9968, pUC18_P.s_WT_SL I-II_S1mS2m_5B.3m_9968, pUC18_P.s_WT_SL 
I-II_S1mS2m_S3m_9968 (6.1.28-30). 
The modifications within the SL III domain - a mutation of GGG to CCC in the apical loop of SL IIId 
and a deletion of the domain SL IIIb – were in turn introduced into the SL I-III or the complete 5’UTR 
constructs by site-directed mutagenesis resulting in plasmids pUC18_P.s_WT_SL I-III_IIId mut_10182, 
pUC18_P.s_WT_SL I-III_IIIb del_10136, pUC18_P.s_WT_5’UTR_sinfr_stop_IIId mut_10242 and 
pUC18_P.s_WT_5’UTR_sinfr_stop_IIIb del_10196 (6.1.16-17 and 6.1.19-20). The constructs including the 
full-length Core-coding sequence downstream the HCV 5’UTR – unmodified or lacking the apical SL IIIb – 
are designated as pUC18_P.s_WT_5’UTR_Core_10779 and pUC18_P.s_WT_5’UTR_Core_IIIb del_10733 
(6.1.35 and 6.1.37). 
The replicase-deficient plasmid variants were generated for the minimal hp and SL I-II, SL I-III, 
5’UTR, 5’UTR-Core constructs (6.1.7 and 6.1.13, 6.1.15, 6.1.18, 6.1.35) by introduction of a GND mutation 
within the NS5B RdRp gene (318D→N; Lohmann et al. 1997) using site-directed mutagenesis resulting in 
plasmids pUC18_P.s_WT_hp_GND_9899, pUC18_P.s_WT_SL I-II_wt_GND_9968, pUC18_P.s_WT_SL 
I-III_GND_10182, pUC18_P.s_WT_5’UTR_sinfr_stop_GND_10242 and pUC18_P.s_WT_5’UTR_Core_ 
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GND_10779 (6.1.23-24, 6.1.33-34 and 6.1.36). These constructs served as negative controls of the minus 
strand synthesis initiation.  
Some of the essential procedures for molecular cloning and mutagenesis, like preparative PCR and 
restriction digest, were already described above (see 2.2.3.2 and 2.2.3.3). The following steps are discussed 
below. Maps and annotations for all plasmids are provided in the Appendix (see 6.1). All cloning procedures 
are detailed in the Supplementary materials (see 6.2.1). 
2.2.5.1 Dephosphorylation of DNA fragments 
A standard cloning procedure engages preparation of the fragments – a vector and an insert - by sticky 
ends generation via a digest with specific restriction endonucleases. This approach, however, engenders 
terminal 5’-phosphate on both fragments that may lead to a self-ligation and re-circularization of a linearized 
vector. To reduce the vector background, a linearized vector is usually dephosphorylated prior ligation. 
Therefore, the gel-purified vector fragment (see 2.2.4.2) is treated with Antarctic Phosphotase according to 
the manufacturer’s instructions. For a standard 20 µl dephosporylation reaction, 5 U of the enzyme per 
1 pmol of DNA ends is applied in 1 x Antarctic Phosphatase reaction buffer; the incubation is carried out at 
37°C for 30 min and followed by the Phosphotase inactivation at 80°C for 2 min. After DNA concentration 
measurement (see 2.2.3.7) the vector fragment can be directly applied for a ligation reaction.  
2.2.5.2 Ligation of DNA fragments 
To complete the formation of a desired plasmid, ligation of a linearized dephosphorylated vector and 
an insert was carried out using T4 DNA Ligase in accordance with the manufacturer’s instructions. A typical 
20 µl reaction mixture contains the following components: 1 x T4 DNA Ligase buffer, 50 ng of vector, a 
3-5-fold molar excess of insert DNA, 1 µl (400 U) T4 Ligase; the reaction volume is adjusted with 
nuclease-free water. Depending on complexity of the ligation strategy, incubation can be performed either 
for 10 min at room temperature or overnight at 16°C. Afterwards, the ligation mixture is directly utilized for 
transformation of competent bacteria cells (see 2.2.1.3). Selection of the clones harboring the construct of 
interest is conducted using various molecular biological approaches: from restriction or PCR analysis (see 
2.2.3.2 and 2.2.3.3) to sequencing of the insert and its flanking regions (see 2.2.3.9).  
2.2.5.3 Site-directed mutagenesis 
In order to introduce a defined mutation – substitution, insertion or deletion – into a plasmid of 
interest, several site-directed mutagenesis approaches were applied. Some mutations can be performed by 
one-step PCR if a restriction site is close to the site to be mutated, whereas most modifications require 
two-step mutagenesis PCR. In the first situation, one of the PCR primers is designed to harbor a mutation 
and a restriction site for further replacement. The opposite primer is chosen in a way that it flanks another 
appropriate restriction site. After the segment of interest is amplified, it is cleaved with the corresponding 
restriction endonucleases, as in the initial plasmid (see 2.2.3.2). The vector and the insert are then purified 
and combined as described above (see 2.2.5.1 and 2.2.5.2). 
The primer extension approach, however, enables introduction of longer modifications or two remote 
mutations at once or if no appropriate restriction site is close to the mutated region. Therefore, mutation-
containing primers are incorporated via independent nested PCRs to eventually combine them in the final 
product. The first PCR requires two types of primers: flanking primers that are complementary to the ends of 
a segment of interest and internal primers that contain the mismatched sequence (either the sequence to be 
mutated or inserted or the sequence from both sides of the deletion). In any case, the mismatched sequence 
mediates the further annealing of the products during the second PCR using flanking primers only. To be 
able to replace the mutated segment in the plasmid of interest, appropriate restriction sites are either retained 
within the segment or introduced with the flanking primers.            
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2.2.6 Reverse transcription and quantitative PCR (RT-qPCR) methods 
In all experiments efficiency of the HCV minus or plus strand synthesis initiation from a certain RNA 
construct was estimated using a reverse transcription and quantitative PCR approach. First, as a proof of 
principle, synthesis initiation was demonstrated by RT-PCR and then – for quantitative comparison – all 
measurements were carried out via RT-qPCR.   
2.2.6.1 Trizol-based cell lysis and total RNA isolation 
The first step in the analysis of newly synthesized HCV RNA strands is an isolation of total RNA from 
transfected cells. HuH-7.5 cells were seeded and transfected as described in 2.2.2.4 or 2.2.2.5. After a 
required time interval (usually, 48 h post transfection), the cells were rinsed once with PBS and lysed by 
Trizol (1 ml per well). Phenol and guanidine isothiocyanate – the major components of the Trizol reagent – 
enable disruption of cells and isolation of RNA of wide-scale molecular size. The lysates were transferred 
into tubes and mixed thoroughly with 200 µl of chloroform for RNA extraction. After an incubation for 
3 min at room temperature, the fractions were separated by centrifugation at maximum speed (13 000 rpm) 
for 15 min at 4°C. The RNA-containing upper aqueous fraction was collected into a clean tube; while DNA 
and proteins remain in the interphase and lower organic phases and discarded. Total RNA was precipitated 
by addition of 1 volume (500 µl) of isopropanol in the presence of 1 µl GlycoBlue reagent for at least 1 h at -
20°C. Next, the recovery of total RNA was conducted by centrifugation at maximum speed (13 000 rpm) for 
15 min at 4°C, followed by two subsequent washing steps (with 700 µl of 80 % ethanol) and reconstitution in 
50 µl of RNase-free water. Residual DNA removal was conducted with of DNase I with subsequent enzyme 
removal by the RNA Clean-up Kit according to the manufacturer’s instructions. Eventually, total RNA 
samples were eluted in equivalent amounts of RNase-free water. Final measurement of total RNA 
concentration usually was not conducted due to the downstream normalization strategy. 
2.2.6.2 Reverse transcription and PCR (RT-PCR) 
Reverse transcription and PCR were performed for only a limited amount of samples using a 
SuperScript III Reverse Transcriptase and the supplemented components following the manufacturer’s 
instructions. Later on, all reverse transcription reactions were performed using the qScript Flex cDNA Kit 
(Quanta Biosciences) according to the manufacturer’s instructions. For each RT reaction 1 µg of 
DNase I-treated total RNA from the step 2.2.6.1 was used in 8 µl mixture containing 2 µM of each 
gene-specific RT primer (see 2.1.8.2): NS5A/NS5B_minus_RT, Spinach_minus_RT or EMCV_plus_RT. 
Following incubation for 5 min at 65°C, 2 µl of reverse transcriptase reaction solution was supplemented and 
cDNA synthesis was performed for 30-60 min at 42°C, followed by the enzyme inactivation for 5 min at 
85°C. Distinct conditions were applied when a snap RT primer was utilized for cDNA synthesis of Spinach 
region to ensure the most specific primer annealing. In detail, after heating the mixture of total RNA and 
primers up to 70°C, temperature was decreased at a rate 1°C per minute until reached 60°C. After that 
samples were brought to room temperature and then a reverse transcriptase reaction solution was added; 
cDNA synthesis was shortened up to 20 min and enzyme inactivation was carried out at standard conditions. 
The downstream end-point PCR was performed by OneTaq DNA Polymerase using 1 µl of obtained 
cDNA together with a pair of gene-specific nested primers (for the detection of NS5A/NS5B/Spinach 
regions on minus strands or EMCV IRES region on plus strands). The general composition of a standard 
25 µl reaction was as described above (see 2.2.3.3) using 1 µl of obtained cDNA together with a pair of 
gene-specific primers (see 2.1.8.2). An optimal temperature profile was the following: initial denaturation for 
2 min at 95°C; 25 cycles of subsequent denaturation (for 15 s at 95°C), annealing (for 15 s at 60°C) and 
elongation (for 30 s at 68°C); final extension for 3 min at 68°C; hold is at 4°C. The PCR products were 
visualized by 1.5 % agarose gel-electrophoresis (see 2.2.4.1) or by 6 % PAGE (see 2.2.4.3). 
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2.2.6.3 Quantitative RT-PCR (RT-qPCR) 
Since RT-PCR is only a semi quantitative method, in order to discover and evaluate small differences 
in HCV RNA synthesis, a quantitative RT-PCR protocol was established. Reverse transcription was 
performed using the qScript Flex cDNA Kit according to 2.2.6.2. The qPCR was performed using the 
PerfeCTa SYBR Green FastMix according to the manufacturer’s instructions. In more detail, separate SYBR 
Green master mixes were prepared for each nested qPCR primer pair (2 µM each; for the detection of 
NS5A/NS5B/Spinach regions on minus strands or EMCV IRES region on plus strands) and distributed onto 
a colorless 96-well PCR plate. 2 µl of each cDNA sample produced with specific RT primers were applied 
into corresponding wells in 2 or 3 technical replicates (each final reaction volume is 20 µl). All 
measurements were conducted using Eppendorf Mastercycler ep Realplex
2
 S with the following temperature 
profile: initial denaturation for 2 min at 95°C; 40 cycles of subsequent denaturation (for 15 s at 95°C) and 
elongation (for 30 s at 60°C); melting curve for 20 min; hold is at 4°C. Specifically for quantification of 
cDNA obtained with a snap RT primer (for Spinach region only) annealing/elongation step was carried out at 
61°C in order to improve assay target-specificity. 
The values for the quantitative analysis were obtained from at least three independent experiments. 
Data was processed using the provided with the Realplex
2
 software to determine the threshold cycle (Ct) and 
analysis was performed according to Pfaffl (Pfaffl 2001) as described below.  
2.2.6.4 RT-qPCR data analysis 
To begin the analysis, amplification efficiencies were determined for each of the primer pairs used: for 
the NS5A/NS5B or Spinach regions on minus strands and EMCV IRES region on plus strands (also see 
Supplementary Materials 6.2.4). To accomplish this, a 10-fold dilution series of cDNA generated from the 
SL I-III construct transfected sample was amplified in qPCR. Measured Ct values were plotted against the 
common logarithm of the dilution factor, and the slope was derived from the plot. Amplification efficiency 
(E) was calculated using the following formula: E = 10
(-1/slope)
. Mock-transfected cells were used as a control 
of primers’ specificity in melting curves analysis (see 6.2.4). 
The value used to compare expression of certain RNA species (―target‖, t; corresponds to either 
NS5A, NS5B or Spinach region on minus strands) to an expression of a reference gene of choice 
(―reference‖, ref; corresponds to EMCV IRES region on input plus strands) is designated as a ―Relative 
Expression Ratio‖ (RER) and can be calculated in accordance to the formula:  
 
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Et and Eref are the respective amplification efficiencies; ΔCtt and ΔCtref are the Ct deviations of 
[control - sample] of the target or reference RNA, respectively.  
Calculations were made using Microsoft Excel 2010. Means and standard deviations (SD) were 
calculated from the relative expression ratios (RER). Data is represented as Mean +/- SD. Statistical 
significance was calculated by a two-tailed Student’s T-Test (* p < 0.05; ** p < 0.01; *** p < 0.001), with a 
p-value > 0.05 considered not significant. For all RT-qPCR reactions, abundance of detected minus strands 
was normalized to abundance of plus strand RNAs in the total RNA recovered from the cells. In the resulting 
figures, error bars show standard deviation between at least three independent experiments.  
2.2.7 Protein analysis methods: western blot 
For the detection of specific proteins, western blot analysis was applied. All experiments aimed to 
compare the HCV NS3 protein abundance in cell lysates at a certain time-point after transfection with RNA 
replication constructs. Detection of GAPDH was conducted in parallel and served as a loading control for 
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evaluation of HCV protein expression. Prior the analysis, cells transfected in a 12-well plate were lysed by 
NP-40 lysis buffer (150 µl per well) for 30 min at 4°C. Afterwards cell debris were pelleted by centrifugation 
at maximum speed (13 000 rpm) for 30 min at 4°C. Next, the supernatant was transferred into a clean tube 
for the analysis. Separation of the proteins was performed by SDS-PAGE (see 2.2.4.5) usually using 10 % of 
the obtained lysate. Directly after the gel run, proteins were transferred to a polyvinylidene difluoride 
(PVDF) membrane by semi-dry electroblotting. The order of layering is the following: first, three pieces of 
Whatman paper soaked in Anode buffer I, next, three pieces soaked in Anode buffer II, then a PVDF 
membrane (needs to be activated my immersion in methanol shortly before use), after that the gels are 
carefully placed on the membrane (a stacking gel is usually removed) and covered by three pieces of paper 
soaked in Cathode buffer. The size of a membrane and Whatman paper is chosen in accordance to the 
number of gels. After assembly protein transfer to the membrane is performed electrophoretically by 
application of 43 mA per gel for 1.5 h. When the transfer is completed, the membrane is blocked in a 
blocking 1 x TBS solution for 1 h at room temperature (or overnight at 4°C). At the next step, the membrane 
is to be incubated subsequently with primary antibodies (a mixture of anti-NS3 and anti-GAPDH antibodies) 
and then with the secondary (anti-mouse) HRP antibodies. All antibodies are diluted in a blocking TBST 
solution to their working concentrations (see 2.1.5). All incubations are carried out at room temperature 
under constant agitation and followed by three-step washing with 1 x TBST (each step takes 5 min). At last, 
the membrane is washed twice in 1 x TBS to remove detergent and incubated with a SuperSignal West 
Femto Chemiluminescent Substrate solution for 5 min at room temperature (1 ml of working solution per 
analyzed gel was applied). Eventually the membrane was thoroughly cleared from the solution and exposed 
to X-ray film for various time intervals (usually, 15 s to 15 min). 
2.2.8 Ribonuclease protection assay (RPA) 
Ribonuclease protection assay (RPA) is a sensitive technique that allows detection, quantification and 
mapping of specific RNAs within total cellular RNA pool. Principally, the assay is based on hybridization of 
a radioactively labeled target-specific single-stranded RNA probe to RNA species of interest and therefore 
on probe’s protection from degradation upon treatment with one or a mixture of endoribonucleases (RNases). 
In a classical procedure RNase A or a mixture of RNases A/T1 are applied: RNase A mediates specific 
cleavage within a single-stranded RNA at C and U residues, RNase T1 specifically hydrolyzes at G residues. 
Following hybridization, all remaining RNA species and unbound probe RNA are hydrolyzed and removed 
from a solution together with RNases by subsequent purification procedure including Proteinase K. In order 
to quantify protected fragments reflecting an amount of target RNA, the probe/target hybrids are precipitated 
and separated on a denaturing polyacrylamide gel. Denaturing conditions combined with detection by 
autoradiography visualize exclusively a radioactive probe RNA that remains intact proportionally to initial 
amount of RNA of interest in experimental total RNA sample.   
The initial step of the assay comprises a generation of α-32P-labeled RNA probe that is complementary 
to the target. Probe RNA is usually synthesized by in vitro transcription from a suitable template using a T7 
or SP6 promoter. When promoter is encoded within a plasmid DNA template, a linearized form of the latter 
is utilized directly as a transcription template (see 2.2.3.4). Alternatively, a promoter can be introduced 
within a PCR primer, and then a PCR product serves as a template for in vitro RNA synthesis. In vitro 
transcription from any of template types is conducted according to a standard protocol for radio-labeled RNA 
synthesis using a relevant - T7 or SP6 – RNA polymerase and followed by the DNA template removal with 
DNase I enzyme (see 2.2.3.4). The resulting probe is purified by phenol-chloroform extraction and ethanol 
precipitation (see 2.2.3.5 and 2.2.3.6), resuspended in an appropriate amount of RNase-free water and its 
integrity is verified by denaturing polyacrylamide gel electrophoresis (see 2.2.4.4).  
Preparation of experimental total RNA is conducted on the next step. Following transfection and 
incubation of cells as required for an experiment, cells are lysed using the NP-40 lysis buffer for 30 min at 
4°C with a subsequent centrifugation similarly to as described in 2.2.7. The supernatant is then transferred 
into a new tube and supplemented with 1 % SDS, 10 µg tRNA, CaCl2 (to a final concentration of 1 mM) and 
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30 μg of Proteinase K. To facilitate a Proteinase K digest, the samples are then incubated at 50°C for 1 h. 
Proteinase K is a subtilisin-related serine protease that hydrolyzes a variety of peptide bonds in a wide range 
of temperatures and buffers and serves to remove enzymes and proteins from enzymatic reactions or cell 
lysates, respectively. Isolated total RNA is eventually extracted with phenol-chloroform, precipitated with 
ethanol (see 2.2.3.5 and 2.2.3.6) and resuspended in RNA hybridization buffer.  
Hybridization of combined isolated experimental total RNA and radio-labeled probe RNA (in amounts 
equivalent between all samples) is initiated by rapid denaturation for 5 min at 85°C and subsequently 
performed on a heating block at 42°C for at least 16 h (usually overnight). Shortly before use, RNase A is 
diluted in RNase digestion buffer to working concentration of 40 μg/ml. At the end of hybridization, 10-fold 
amount of completed RNase digestion buffer is added to the samples; the final solutions is then carefully 
mixed and incubated for 90 min at 30°C. In order to terminate the RNase digest and to purify the remaining 
RNA, samples are supplemented with 0.5 % SDS, 10 µg tRNA, CaCl2 (to a final concentration of 1 mM) and 
100 μg of Proteinase K. The Proteinase K digest and a following purification procedure are conducted as 
described above (with an exception of RNA precipitation in the presence of NaCl instead of NaOAc).  
At the last step of the procedure remaining probe RNA protected by the target RNA is visualized after 
separation on a denaturing polyacrylamide gel (polyacrylamide concentration depends on the size of a probe) 
by autoradiography (see 2.2.4.4). 
2.2.9 RNA immunoprecipitation (RIP) 
RNA immunoprecipitation (RIP) is a standard approach applied in attempt to demonstrate 
RNA-protein interactions. In a simplified experimental setup the procedure can be conducted in vitro, 
however most commonly a cellular lysate is used as a source of protein: either containing the RNA-protein 
complex of interest or the complex is formed upon introduction of a target RNA by transfection. For the 
latter, the principle of the assay is based on visualization of radioactively labeled target RNA that is pulled 
down in a complex with its interaction partner - protein - due to binding by a specific antibody. In the current 
work HCV 3’UTR interaction with a number of aminoacyl-tRNA synthetases (ARS) was challenged. A role 
of a positive control was given to the PTB protein that is well-known to bind to polyU/C tract at the HCV 
3’-end. When the selected ARSs demonstrate an ability to stably bind to predicted sites within the HCV 
3’UTR, it can be detected and evaluated by autoradiography. 
At the initial step radio-labeled HCV 3’UTR RNA is generated by in vitro transcription (see 2.2.3.4), 
quantified and transfected into eukaryotic cells (HeLa cells) using Lipofectamine 2000 (see 2.2.2.4) for 4-6 
h. A fraction of the radioactive RNA transcript is saved to further serve as a size marker. Next, transfected 
cells are lysed by NP-40 lysis buffer (similar to as in 2.2.7). A portion of cell lysate at this step is also saved 
to serve as an input loading control. In the meanwhile, antibodies specific to candidate interaction proteins as 
well as to the PTB (positive control) and FLAG-epitope (negative control) are bound to protein G magnetic 
beads. In detail, 100 μl of protein G beads suspension is washed with 0.5 ml PBS using magnetic rack and 
eventually resuspended in 1 ml of PBS. Washed beads are combined with each antibody in a separate tube 
and incubated on a rotating wheel for at least 3 h (or overnight) at 4°C. This step allows binding of 
conservative Fc-regions of antibodies to the protein G and therefore mediates their immobilization at the 
beads surface. Importantly, an amount of each antibody applied for pull-down has to be optimized in 
advance based on the manufacture’s recommendations. Unbound antibodies are removed by washing with 
1 ml of IP washing buffer, the beads are again resuspended in 0.5 ml PBS. 
At the next step, beads coupled to various antibodies are combined with identical portions of cell 
lysate and incubated similarly on a rotating wheel for at least 3 h at 4°C. After that the beads are washed 
4 times using 1 ml of IP washing buffer to eliminate unspecific binding and resuspended in 1 ml of PBS. 
Subsequent Proteinase K treatment and purification procedures are carried out for all experimental samples 
and for RNA transcript and input cell lysate: Proteinase K is added to a final concentration of 20 mg/ml to 
release bound RNA during incubation for 15 min at 65°C. Further enzyme removal and target RNA isolation 
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is performed by phenol-chloroform extraction and ethanol precipitation (see 2.2.3.5 and 2.2.3.6), and 
resulting pellets are resuspended in appropriate amounts of formamide-containing loading buffer. Lastly, the 
results are analyzed by denaturing polyacrylamide gel electrophoresis (see 2.2.4.4), followed by 
autoradiography. Efficiency of target RNA recovery mediated by binding to a candidate protein interaction 
partner is evaluated when radioactive signals are compared to the ones in intact cell lysate (equivalent 
relative amounts loaded).  
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3. Results 
3.1 Design and establishment of the minus strand replication system 
The concept of a novel in vitro system that is able to bypass limitations of the current model systems 
was carefully considered in accordance to the existent information on the requirements for the HCV minus 
and plus RNA synthesis. Therefore, minimal constructs for separate initiation of both strands were designed 
in a way to be relatively easily modified (extended or diminished). As emphasized above, the roots of major 
limitations of the available in vitro systems – the replicon system and its derivatives as well as the full-length 
infectious system (Fig. 3.1.1, A) – are in simultaneous presence of both 5’- and 3’- genomic ends that enable 
HCV translation and full replication cycle. Since quantification of an output from a certain modification 
depends on the translation or/and replication performance, these systems yield no mechanistic insight when a 
mutation abrogates any of the processes. Even if a mutation is not ―lethal‖, it still remains challenging to 
define at which exact stage the affected cis-element performs its function. In order to clarify the uncertainties 
provided by the current replication models, the novel reduced replication system was developed in the 
present work. 
The separate minus and plus strand replication systems were designed to specifically uncouple minus 
strand synthesis from the plus strand replication and both from translation and other stages of the HCV life 
cycle. Each HCV RNA strand is to be initiated from an individual RNA template (Fig. 3.1.1, B and C) that 
contains the essential (according to the current knowledge) elements for a desired strand synthesis: the 
3’-end of the corresponding complementary strand and the HCV non-structural (NS) proteins encoded in cis. 
Since the present work predominantly focuses on the dissection of requirements for the HCV minus strand 
synthesis, this system (Fig. 3.1.1, B) is further featured in detail. 
The DNA elements for both systems were obtained by a commercial chemical synthesis and 
assembled into the minimal replication constructs, as thoroughly described and illustrated in the 
Supplementary material 6.2.1. Most of the functional elements are common for both systems. In the absence 
of a 5’-cap – as it is for the HCV genome – prevention of a rapid exonuclease degradation of experimental 
RNA construct is accomplished via a stable artificial stem-loop encoded directly downstream the T7 
promoter on the DNA template. The hairpin (hp) is followed by a Streptavidin S1 aptamer (not depicted) 
(Srisawat and Engelke 2001) included to enable isolation and analysis of replication complexes that 
assemble at the 3’-end of the replicating strand. Subsequent Spinach aptamer (Paige et al. 2011; Ouellet 
2016) encoded as a reverse complementary sequence surrounded by an appropriate scaffold to eliminate 
interference of neighboring sequences on the aptamer folding. Obtaining a functional secondary structure 
upon a complementary strand synthesis, this aptamer could be utilized for an intracellular visualization, 
localization and/or quantification of the newly produced HCV RNA strands. Additional information on 
structure and function of the Streptavidin and Spinach aptamers is given in the Supplementary material 6.2.2. 
The next vital component of the replication constructs is an Encephalomyocarditis Virus (EMCV) IRES that 
drives translation of the HCV non-structural proteins NS3 to NS5B independently of the HCV IRES. The 
replication module proteins are indispensable for the HCV replication in vitro and most of them are required 
in cis, however translation initiated by the HCV IRES situated on the same RNA substrate would largely 
disadvantage dissection of overlapping functions. The EMCV IRES in turn is not regulated by the same 
mechanisms as the HCV IRES, therefore performs a consistent and unbiased by unrelated mutations 
translation of the essential HCV proteins. The encoded NS3-NS5B gene cassette fully corresponds to the 
JFH1 isolate since it was derived from the Jc1 plasmid (for the plasmid map see 6.1.1) encoding full-length 
HCV J6/JFH1 chimeric genome (Pietschmann et al. 2006). Besides the wild-type NS3-NS5B sequence, a 
respective scrambled gene cassette was considered in the design. Scrambling of a protein coding region here 
stands for permutation of a nucleotide sequence in a way to disable genomic RNA cis-signals while retaining 
amino acid sequence, coding specificity, codon usage and codon pair bias. The resulting experimental 
constructs containing the scrambled NS3-NS5B sequence give raise to an unaffected replication complex, 
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but lack the cis-acting replication elements. Such version of the NS3-NS5B sequence was implemented to 
both constructs at the assembly step and required a synthetic production due to a complexity of mutations to 
be introduced. The computational procedure of scrambling was fully performed by Yutong Song and Steffen 
Mueller. The full-length sequences of the wild-type and scrambled NS3-NS5B cassettes are detailed in the 
Supplementary material 6.2.3. In order to maintain a wild-type sequence of the 5BSL3.2 element, which was  
reported to be essential for the HCV replication (Friebe et al. 2005; You and Rice 2008), and to optimize the 
complex assembly procedure, the scrambling was applied to the coding sequence between the BbvCI and 
AscI sites (also see Supplementary material 6.2.1). This retains 238 nt of the wild-type sequence upstream 
the BbvCI site and 152 nt downstream of the AscI site, which can be further mutated by conventional 
methods if required. Notably, in all scrambled constructs the NS5B miR-122 binding sites (5B.1, 5B.2 and 
5B.3) become inactivated. In both basic DNA templates (Fig. 3.1.1, B and C) the 3’-end of the ORF is 
directly merged to the HCV 3’UTR of a complementary strand followed by the Hepatitis Delta Virus (HDV) 
ribozyme (Shih and Been 2002). It is of a great importance to have the ribozyme fused to the very last 
3’-nucleotide of the functional sequence to obtain an RNA substrate with the exact HCV 3’-end after in vitro 
transcription. The HDV ribozyme acts in a self-cleavage manner and does not require any protein factors. As 
an additional measure, the ribozyme sequence was accompanied with the T7 Terminator (T7T) to prevent 
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continuous transcription and to ease a cleavage by the ribozyme. Additional information on structure and 
function of the HDV ribozyme is provided in the Supplementary material 6.2.2. 
In the basic construct for the plus strand synthesis (Fig. 3.1.1, C; for the plasmid map see 6.1.11) the 
3’-end of the template RNA comprises the complete reverse complementary sequence of the plus strand 
HCV 5’UTR and the first 325 nt of the HCV Core-coding sequence intending to maintain the folding of the 
3’-end of the minus strand as well as to include the cis-signals opposite to the coding region downstream the 
IRES. The minimal – designated as ―hp‖ - construct for the minus strand synthesis (Fig. 3.1.1, B; for the 
plasmid map see 6.1.7) harbors the 3’-end of the plus strand which is indispensable for the initiation with the 
HCV replication complex. Generated in wild-type or scrambled version (6.1.7 and 6.1.8) of the NS3-NS5B 
coding sequence, these constructs represent the basis for further modifications and mutations. The replicase-
deficient version of this construct (shortly, hp_GND; 6.1.23) was generated to serve as a negative control of 
minus strand synthesis initiation: the point mutation 318D→N within the NS5B RdRp gene completely 
inactivates the NS5B replicase (Lohmann et al. 1997).  
Prior to any modifications of the basic minus strand synthesis construct, preliminary tests were 
conducted to ensure functionality of the T7 promoter and of the EMCV IRES. Following the plasmid 
template linearization by EcoRI (the unique site located downstream the T7T), the in vitro transcription with 
a T7 RNA polymerase was established. Efficient and high-yield in vitro transcription of long RNAs required 
optimization of a standard protocol provided for the T7 polymerase; the conditions are detailed in 2.2.3.4. 
The in vitro transcribed RNA construct was visualized by 1 % agarose gel electrophoresis comparing the 
sample RNA before and after treatment with DNase I (Fig. 3.1.2, A). The polyprotein production (driven by 
the EMCV IRES) was challenged by a western blot detection of the HCV NS3 protein (Fig. 3.1.2, B). The 
HCV NS3 content was monitored in HuH-7.5 cell lysates derived at 6 h, 12 h and 24 h post transfection 
(h.p.t.) and compared on a gel to the lysate of mock-transfected cells (24 h.p.t. only). The rapid 
accumulationof the viral protein was observed already 6 hours post transfection followed by a steady decay 
of both thetranslation template and the viral protein, consistently to the research on half-lives of viral 
non-structural proteins shown to be 11–16 h (Pietschmann et al. 2001; Pause et al. 2003). Also in the
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infectious HCV system, large fraction of the NS proteins is eliminated after early translation rounds when the 
replications sites are established. However, the hp construct here lacks an ability to perform continuous 
replication, therefore new plus strands are not generated to serve as translation templates.  
After successful transfection of the HuH-7.5 cells with the in vitro generated HCV RNA replication 
template, the basic hp construct was challenged for ability for the HCV minus strand synthesis initiation.  
The minimal hp construct lacks any HCV 5’UTR sequences, therefore in the replication assay it 
wascompared to its extended version containing HCV SL I-II at the construct’s 5’-end (Fig. 3.1.3, A). The 
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latter RNA construct (designated as ―SL I-II‖) was generated from the linearized plasmid (for the plasmid 
map see 6.1.13) following the analogous procedure. The HCV SL I-II was reported to be the minimal 
essential 5’UTR sequence in a replicon system required for HCV replication (Friebe et al. 2001), in part due 
to the S1 and S2 miR-122 binding sites located at the single-stranded stretches of the SL I. For the primary 
replication assay, the replicase-deficient variants of both – the hp and the SL I-II constructs – were utilized as 
negative control of the minus strand synthesis initiation; generated from plasmids 6.1.23-24. The four RNA 
constructs were transfected to the HuH-7.5 cells via the Lipofectamine method (see 2.2.2.4); 48 hours post 
transfection the cell lysis with Trizol reagent was performed (2.2.6.1), followed by total RNA isolation and 
DNA removal. The total RNA after transfection is expected to contain the input RNA plus strand templates 
(Fig. 3.1.3, A) and, if the construct is capable of the minus strand synthesis initiation, also the newly 
synthesized minus strands. Detection of the plus and minus strands was accomplished by region specific 
RT-PCR targeting common for all experimental constructs: EMCV IRES and NS5A (reverse complementary 
of the coding sequence) regions, respectively (Fig. 3.1.3, B and C). The resulting PCR products (after 25 and 
30 cycles, respectively) were visualized by 8 % PAGE (Fig. 3.1.3, D and E). As a result, for all tested plus 
strand constructs – hp_wt/GND and SL I-II_wt/GND (wt stands for the intact replicase in contrast to the 
GND-mutant) – the input template RNA was still present and detectable in cellular total RNA fraction 2 days 
post transfection (Fig. 3.1.3, D). In the sample corresponding to the mock-transfected cells no PCR product 
was obtained underlining that the nested primer pair detecting EMCV IRES is specific to the HCV, but not 
cellular, RNA. Notably, PCR targeting the complementary (on the minus strand) sequence of the NS5A 
coding region resulted in a specific signal for the SL I-II_wt construct only (Fig. 3.1.3, E). Neither the 
replication-deficient constructs (hp_GND and SL I-II_GND) nor mock-transfected sample led to 
amplification of specific fragment of expected length. Since minus strands upon HCV infection are generally 
significantly less abundant than plus strands, the visualization of the minus strand synthesis required high 
amount of total RNA material and high amplification cycle number. This inevitably results in background 
bands which however appear for all experimental samples, including the mock control, and migrate 
unrelatedly to the expected product length. However, it is not clear from the electrophoretic image whether 
the minimal hp construct yields any minus strand synthesis or in absence of the HCV 5’UTR sequences 
becomes incapable of the synthesis initiation. Answering this question would require a more sensitive 
approach. Nevertheless, the present replication assay clearly demonstrates that SL I and II of the HCV 
5’UTR are sufficient for the minus strand synthesis initiation in accordance to the data obtained in replicon 
system. The RT-PCR was found to be a useful preliminary method to estimate minus strand replication 
ability of experimental RNA constructs, however some signals may appear beyond its detection level and/or 
overlaid by the background. In course of the project a detection of the HCV plus and minus strands was 
attempted using the ribonuclease protection assay (2.2.8), however a sensitivity of the method appeared 
insufficient for detection in the current experimental setup (for more details refer to Supplementary results 
6.3.1). Eventually a quantitative RT-PCR method (2.2.6.3) was utilized in the present study replacing the 
semi-quantitative RT-PCR. 
To conclude, the system attempting to separate HCV minus and plus strand synthesis from each other 
and from HCV translation was designed and proved to be functional. Mindfully generated RNA substrates 
are able to drive the HCV translation from heterologous IRES upon transfection into hepatoma cells and 
after certain sequence improvement – to serve as a template for the minus strand synthesis. Further sequence 
extensions and modifications and their effects on replication are to be presented in the following section.  
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3.2 Dissection of the HCV 5’UTR sequence requirements for minus strand 
synthesis initiation  
In agreement with the known requirements for the HCV replication, the minus strand synthesis 
initiation required a presence of the SL I-II sequence of the HCV 5’UTR within the replication template. 
However, due to multiple functions that those and other domains of the HCV 5’UTR serve in the viral life 
cycle, it is a challenge to define if these sequences actually are involved in minus strand initiation. While 
some sequences and structures only have an indirect effect on the antigenome synthesis, the others are 
essential for the replication complex activity at the genome’s 3’-end. This section provides an insight into the 
role of the HCV 5’UTR functional blocks in the initiation of the minus strand synthesis.  
The minimal construct for the minus strand synthesis initiation (Fig. 3.1.1, B) was extended by partial 
HCV 5’UTR sequences replacing the terminal hairpin at the template’s 5’-end (Fig. 3.2.1, A). The 
modification of the basic construct harboring SL I-II of the HCV 5’UTR was already featured above; it 
allows engaging of the two miR-122 binding sites at the 5’-end of the experimental construct that were 
reported to promote HCV translation (Henke et al. 2008) and replication (Jopling et al. 2005) and to protect 
the genomic RNA from Xrn1-mediated degradation (Shimakami et al. 2012a). The second modification
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comprises the entire SL I-III region (the construct is designated as ―SL I-III‖) of the HCV 5’UTR and 
therefore permits, in addition to the miR-122 binding, assembly of the 40S ribosomal subunit and of the 
translation initiation factor eIF3 at the 5’-end of the replication template (Spahn et al. 2001). Lacking the 
AUG start codon located within the SL IV, this construct is incapable of initiation of functional translation 
from the HCV IRES. The third modification represents an extension with the complete HCV 5’UTR 
followed by a short open reading frame (36 nt) confined by an UGA stop codon. Thus, in virtue of the 
in-frame truncated Core-coding region, the ―5’UTR‖ construct includes the complete and stable HCV IRES 
structure and an authentic AUG to fulfill a functional translation initiation event. Without interference with 
the downstream elements and their functions, the translation initiated at the template’s 5’-end enables 
studying an intricate translation versus replication balance.  
These replication constructs were generated by in vitro transcription from linearized DNA templates 
as previously (for plasmid maps see 6.1.7, 6.1.13, 6.1.15 and 6.1.18, respectively). The integrity of the 
full-length RNA was ensured by agarose gel electrophoresis (Fig. 3.2.2, A) and the functionality of the 
EMCV IRES, which mediates the HCV replication proteins production, was demonstrated by western blot 
(Fig. 3.2.2, B). Peculiarly, the effect of miR-122 binding on the stability of a replication template (SL I-II 
construct) was likely illustrated (Fig. 3.2.2, B, lane 2 vs. 3). Cellular lysates applied for the analysis were 
derived from HuH-7.5 cells transfected for 8 hours with each of the four described RNA templates either 
alone or together with a Miravirsen-like anti-miR-122 LNA/DNA mixmer, designated as ―LNA‖ from here 
on, (applied with the SL I-II construct only). This LNA functionally sequesters endogenous miR-122, 
therefore preventing its function on the HCV RNA or cellular mRNAs. As clearly reflected by western blot, 
the basic function of the EMCV IRES is not affected by introduction of various 5’-end sequence 
modifications (lanes 1, 3-5), however the removal of miR-122 does profoundly reduce the HCV NS3 content 
(lanes 2 and 3). Since the EMCV IRES function is miR-122 independent, the observed drop in NS3 
production is likely related to availability of a template after transfection, i.e. a template’s stability. 
Considering this effect is observed independently of the nature of the 5’-terminal sequence, other indirect 
functions of the miR-122 or its function at the 3’-end of the HCV genome could have had an impact. 
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Further on, the extended replication constructs were compared in a replication assay. As previously, 
preliminary analysis was conducted by RT-PCR, later on fully replaced by a quantitative PCR method. 
Universal primers targeting the input plus strands and newly produced minus strands were applied for both 
kinds of PCR analysis. The specific RT primers are indispensable for the synthesis of cDNAs corresponding 
to one or the other viral strand: due to the relatively low abundance of the HCV plus and especially minus 
strands (the ratio between HCV plus and minus strands is from 1:10 to 1:100) random primers failed to 
generate consistent amounts of cDNA in the reverse transcription reaction from cellular total RNA pool (data 
not shown). Notably, in order to reveal slight changes in minus strand synthesis efficiency from different 
RNA constructs, the reverse transcriptase requires RNase H activity to remove HCV strands that have 
fulfilled a template function. The input plus strands in the current and all the downstream replication assays 
are detected by RT-(q)PCR targeting the EMCV IRES region (Fig. 3.2.1, B), as previously; the same nested 
PCR primers are used for both kinds of PCR. The newly synthesized minus strands, if can be generated from 
an experimental RNA construct, are detected by RT-(q)PCR targeting a reverse complementary sequence of 
either the HCV NS5A/NS5B or the Spinach coding region (Fig. 3.2.1, C) using the same nested PCR primers 
for all constructs analyzed by both types of PCR. Quantification of minus strands by targeting either Spinach 
or NS5A/NS5B regions provides different information. While nascent minus strands detected via the 
Spinach region stand for nearly full-length construct’s complementary strands, the strands detected via the 
NS5A/NS5B region might not have resulted in the complete antigenome, if synthesis was abrogated for a 
certain reason. Therefore, the latter detection reflects to a higher extent the number of initiation events, 
whereas quantification of nearly full-length products represents a relative count of completed synthesis 
events.  
Initially, ability of the extended 5’-end constructs to initiate minus strand synthesis was assessed semi-
quantitatively by RT-PCR. Plus and minus RNA strands were detected in total RNA fraction isolated from 
HuH-7.5 cells transfected with each of the four RNA templates (Fig. 3.2.1, A) 2 days post transfection. The 
input plus strands were revealed for each experimental template (Fig. 3.2.3, A), while the newly synthesized 
minus strands were found only for the extended versions of the minimal hp construct (Fig. 3.2.3, B). Total 
RNA from mock-transfected cells sample does not provide any signals underlining the primers’ specificity to 
HCV sequences.  
Next, similarly derived cDNA samples were utilized for a quantitative analysis. Since the efficiency of 
minus strand synthesis initiation from a particular RNA construct is directly linked to its own abundance, the 
detected minus strand species were routinely normalized to the plus strand, i.e. input, content in the same 
total RNA sample. Thence, in spite of varying stability or potential ability to continuous replication 
(e.g. when both HCV genome ends are simultaneously present), minus strands count is relative to available 
plus strand templates. In the current section both – shorter and longer - elongation products are quantified via 
targeting a reverse complementary sequence of the NS5B and Spinach region (Fig. 3.2.1, B and C, 
respectively). The hp and SL I-II constructs harboring an inactivating GND mutation in the RNA-polymerase 
gene are regarded to as negative control, since any GND-mutant construct is incapable of antigenome 
synthesis. The values derived for this construct are indicated by dotted lines. In the present and most of the 
assays below, the mean relative expression ratio (RER) for the SL I-II construct was set to 1 to ease the 
comparison of the experimental constructs replication abilities. More aspects of the quantification approach 
are discussed in the Supplementary material 6.2.4. 
As evident from the graphs (Fig. 3.2.3, C and D), the results derived from targeting either NS5B or 
Spinach regions, respectively, appear to be largely in agreement. The RER value obtained for the basic hp 
RNA template appeared not to significantly differ from both analyzed replicase-deficient mutants (hp_GND 
and SL I-II_GND; indicated by dotted line), implying that the minus strand synthesis initiation is not 
possible in the absence of essential HCV 5’UTR sequences at the 5’-end of the experimental construct. The 
previously demonstrated ability of the 5’-end extended derivatives of the basic hp construct to synthesize 
minus strand (Fig. 3.2.3, B) was hereby quantified. Verified by targeting both, NS5B and Spinach regions,
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the relative minus strand abundance increases with the addition of SL III sequence, but surprisingly drops, 
relatively to SL I-II and SL I-III constructs, with the inclusion of the complete HCV 5’UTR followed by a 
short ORF. As tested only in the Spinach region (Fig. 3.2.3, D), the GND mutants corresponding to SL I-III 
and 5’UTR constructs are unable of progeny genome synthesis. Expectedly, co-transfection of the SL I-II 
construct with anti-miR-122 LNA leads to dramatic reduction of minus strand synthesis, which is in 
correspondence with the observed above HCV NS3 protein drop (Fig. 3.2.2, B), and related to vital functions 
of the miR-122 on the HCV genome such as genome stabilization and replication stimulation. Interestingly, 
the ratio between minus strands generated from SL I-II or SL I-III constructs differs upon targeting either 
NS5B or Spinach regions. It can only be speculated if this inclines on elevated initiation capacity from the 
SL I-III template and in more similar full-length antigenome production ability, when compared to the 
SL I-II template. As a nearly full-length antigenome synthesis ability is a more important measure, in most of 
the experiments below only the Spinach region is targeted in RT-qPCR assays. 
Taken together, the visual and quantitative representation provided evidence that the HCV minus 
strand synthesis is initiated in the developed minus strand replication system when the essential 5’UTR 
SL I-II sequence is present. Further extensions of the 5’-end with the HCV 5’UTR sequences were expected 
to demonstrate either a simulative or no effect on the antigenome synthesis. An inclusion of the SL I-III 
sequence permits, in addition to functional miR-122 binding, the proposed long-range interactions with the 
cis-elements at the genome 3’-end as well as the assembly of the translation complex. Indeed, the replication 
assay results indicate significant increase of the relative minus strand abundance, disclosing a positive role of 
those interactions in minus strand synthesis initiation. The direct and indirect premises are to be further 
dissected by additional mutational approaches. Remarkably, a further extension of the replication template 
with the complete HCV 5’UTR sequence followed by a short ORF results in a significant drop of minus 
strand synthesis comparing to both SL I-II and SL I-III constructs. In fact, the 5’UTR construct resembles a 
full-length or replicon situation when both genomic ends are present simultaneously and the functional 
translation from the HCV IRES takes place: the shortage can be compensated by a thoughtful mutational 
approach disabling selectively one or more functions of the construct. The controversy of the observed 
results may serve as an illustration of a balance between mutually exclusive HCV translation and replication: 
once permitted, the functional translation slows down the overall replication rate. A closer insight into this 
observation is provided in the following section.       
3.3 Analysis of the HCV translation impact on the minus strand synthesis 
Although the HCV translation initiation is entirely dependent on the cellular machinery, its mechanism 
is remarkably different from the one for eukaryotes and engages fewer canonical factors. The intact HCV 
IRES element directs and positions the 40S ribosomal subunit without a need for an initial recognition and 
scanning. The HCV IRES SL III domain represents a binding platform for the small ribosomal subunit, while 
the domains II and IV contribute to this interaction and its regulation (Fig. 3.3.1, A, in yellow). These 
domains are sensitive to mutations affecting both sequence and structure, however the apical loop of the 
domain IIId was found to be indispensable for the recruitment of the ribosome: a 266–268GGG to CCC 
mutation reduces 40S binding affinity by 25-fold (Kieft et al. 2001; Ji et al. 2004). Following the 40S 
association, the eukaryotic initiation factor 3 (eIF3) mediates attachment of the tertiary complex and 
positioning of tRNA in the P site. Thereby, the correct recruitment and function of the eIF3 is crucial for the 
functional translation initiation. The eIF3 binding platform on the HCV IRES is comprised by the 4-way 
helical junction IIIabc (Fig. 3.3.1, B, in red). The translation initiation can be disrupted at the IRES-40S 
complex stage by the removal of the stem-loop domain IIIb (Otto and Piglisi 2004; Ji et al. 2004). This 
knowledge was applied in the present study to dissect a stage of the HCV translation initiation impeding the 
minus strand RNA synthesis.  
The HCV translation and replication are indefeasibly linked together and essentially vital for each 
other. However, since regulated by the similar set of viral and cellular determinants, these processes need to 
be uncoupled in time and space. Thus, the above observed relative interference of the HCV translation 
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initiation with the minus strand RNA synthesis was not entirely unexpected. The minus strand replication 
system appeared to be helpful in shedding the light on a possible mechanism. The original SL I-III and 
5’UTR replication templates (Fig. 3.3.2, A and B, E) are capable of the HCV minus strand synthesis 
initiation at its 3’-end (Fig. 3.2.3) as well as of an assembly of the translation initiation complex at the 
5’-end. Moreover, the 5’UTR construct is additionally competent to drive a functional translation of a short 
open reading frame from the HCV IRES. In order to dissect the functions overlapping in this configuration, 
disruptive mutations were introduced in both constructs.  
 
Disabling of translation initiation from the HCV IRES was achieved by a deletion of the domain IIIb 
that abolishes attachment of the eIF3, without seriously affecting the 40S subunit binding affinity. This 
modification was applied to both wild-type constructs (∆IIIb variants; Fig. 3.3.2, C and F), although the 
translation initiation is not possible in SL I-III construct by default. The binding of the 40S ribosomal subunit 
alone may affect the replication initiation (through altering the HCV 5’- and 3’- end long-range interactions) 
either negatively, by interfering with the proposed genomic ends’ hybridization (Fricke et al. 2015), or 
positively by bringing the HCV genome ends together (Bai et al. 2013). Its affinity to both ends leads to their 
accommodation in a close proximity that may impede the replication complex assembly at the 3’-terminus. 
Additionally, the 40S competes with the 5BSL3.2 for binding to the IRES domain IIId permitting an 
interaction between 5BSL3.2 and SL9110. Thus, in both experimental constructs the 40S attachment was 
restricted by the GGG to CCC mutation in the apical loop of the IIId (IIId* variants; Fig. 3.3.2, D and G). 
The replication templates harboring the described modifications in SL I-III or 5’UTR context were 
generated by in vitro transcription, as previously. Verification of experimental RNA integrity was 
accomplished by agarose gel electrophoresis (Fig. 3.3.3, A). The HCV replication proteins expression in 
transfected cells was demonstrated by western blot detection of the NS3 protein (Fig. 3.3.3, B). For the latter 
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test, the HCV NS3 protein was targeted in HuH-7.5 cells lysate 2 days post transfection with each of the 
constructs. The wild-type SL I-III and 5’UTR constructs (Fig. 3.3.3, B; lanes 1 and 5) were additionally 
co-transfected with anti-miR-122 LNA (lanes 2 and 6). The similar effect, as for the SL I-II transfected 
sample (Fig. 3.2.2, B), was observed: sequestration of endogenous miR-122 from the transfected hepatoma 
cells seems to reduce stability or/and replication ability of the input plus strand templates, therefore less 
target protein can be produced from the EMCV IRES (at later time-points) due to a lack of templates. 
Providing that deterioration of the translation function from the HCV IRES should only improve the 
replication rate, the direct positive impact of miR-122 on RNA synthesis was presumably affected. In both 
the SL I-III and the 5’UTR experimental constructs all annotated miR-122 target sites are present: S1 and S2 
sites are located within the SL I sequence at the 5’-end and the 5B.1-3 and S3 sites – at the 3’-end of plus 
strands (the precise impact of miR-122 binding to either of these sites is the main issue of the next section). 
Impairment of miR-122 binding to these sites by sequestering LNA reduces the efficiency of minus and plus 
strand synthesis from the SL I-III and 5’UTR replication templates, therefore limiting genomic RNA 
amounts remaining by 2 days post transfection that could serve as a template for the HCV protein synthesis. 
In turn, the modifications - ∆IIIb and IIId* - both did not impair the HCV NS protein expression (lanes 3, 4 
and 7, 8), even resulting in more intense signals comparing to their wild-type replication templates. The 
possible explanation here may again refer to an alteration of the input RNA stability: the formation of the 
translation initiation complex at the HCV IRES, and in particular a performance of active translation, may be 
linked to elevated activity of cellular exonucleases at the template’s 5’-end. 
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Since the expression of the HCV replication proteins appeared not to be negatively affected for the 
mutated templates, the further quantitative analysis of the minus strand synthesis efficiency was conducted. 
The varying stability of input replication RNA templates does not bias the data obtained by RT-qPCR, since 
in each sample the newly generated minus strand count is always normalized to abundance of the plus strand 
templates. Hence, although less stable plus strand species result in fewer minus strands in absolute count, the 
relative efficiency of the particular RNA construct to serve as a temple remains solid. A similar adjustment 
principle is useful when a construct is capable of continuous replication: although the template plus strands 
are amplified over the time post transfection, the count of progeny minus strands per one template RNA is 
unaffected.    
In the replication assay the original SL I-III and 5’UTR constructs were compared to their 
corresponding mutant variants and the effect on minus strand synthesis efficiency was evaluated by 
RT-qPCR targeting the NS5B and Spinach regions on newly generated minus strands (Fig. 3.3.3, C and D, 
respectively). The ∆IIIb and IIId* modifications aimed to dissect the overlapping functions exerted by the 
SL I-III or the complete HCV 5’UTR sequence in scope of translation from the HCV IRES versus 
antigenome synthesis. The outcome of the introduced mutations was evaluated for each context (SL I-III or 
5’UTR) contrasted to a wild-type SL I-III construct (the RER values were set to 1). In the described assay 
the basic hp construct with a GND mutation (hp_GND) serves as a negative control of the minus strand 
synthesis: the signals obtained for this construct are indicated by a dotted line on the graphic representation. 
Contrasting results were acquired for the series of the SL I-III and the 5’UTR experimental constructs 
(Fig. 3.3.3, C and D, left). In the SL I-III context deletion of the SL IIIb that prevents an association of the 
eIF3 did not have an effect on the minus strand synthesis efficiency. On the other hand, restriction of the 40S 
binding to the HCV IRES significantly lowered the relative minus strand abundance. Indeed, incapable of a 
functional translation initiation, the SL I-III construct is not affected by arrest of the eIF3 binding. However 
the mutation in IIId loop sequence leads to a lack of the 40S subunit association and/or a number of 
suggested long-range interactions. On the contrary, in the context of the 5’UTR construct, an elevation of a 
relative minus strand production was observed when translation initiation from the HCV IRES was 
prevented: both by the IIId* mutation and more profoundly – by ∆IIIb deletion (Fig. 3.3.3, C and D, right). 
The latter modification disrupting an interaction with the eIF3 demonstrated the more pronounced effect than 
the inhibition of the 40S binding, which underlines the impact of an actual translation initiation event in 
negative regulation of the minus strand synthesis initiation. Indeed, according to published literature, the 
5’UTR_∆IIIb completely disables translation initiation, whereas the IIId* mutation within the same RNA 
template only reduces the efficiency of the 40S binding by 25-fold (Ji et al. 2004). It can be hypothesized 
that some initiation events in the context of 5’UTR_IIId* construct may still take place that slightly 
disadvantages the replication. Nevertheless, the difference between the 5’UTR construct mutants was 
missing a statistical significance.   
The complex interplay between distant cis-elements at the 3’-end of the HCV genome and the 5’UTR, 
together with assembly of the translation complex, drives a switch between translation and replication. The 
long-range contact between the domain IIId and the bulge of 5BSL3.2 cis-element is thought to bring the 
genome ends into a close proximity and therefore facilitate replication (Shetty et al. 2013). The latter 
structural element thereby normally has to compete with the ribosome, in particular with the 40S subunit, 
that in turn favors a translation event. Taking these into account, the GGG to CCC mutation in the apical 
loop of the IIId is to impair both – translation and replication. For this reason, in the SL I-III series, where 
translation cannot play a role as an inhibitory factor, disruption of the IIId-5BSL3.2(bulge) interaction 
plainly interferes with a formation of an open 5BSL3.2 element conformation and genome circularization 
(Romero-López et al. 2012; Romero-López and Berzal-Herranz 2017). Additionally, binding of the 40S 
ribosome itself was described to promote the ends communication due to its interaction of non-competing 
nature with both 5’UTR and poly(U/C) track in the 3’UTR via different sites on the 40S (Bai et al. 2013). 
Either of the two mechanisms or both may result in the observed decrease in the efficiency of the
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SL I-III_IIId* antigenome production. Contrariwise, the SL IIId* and the ∆IIIb mutations led to an elevation 
of the 5’UTR replication potency. The principal explanation here is a relief of the inhibition mediated by 
enabled functional translation initiation. Since the 40S subunit has a higher affinity to the HCV IRES than 
the 5BSL3.2(bulge), the 5BSL3.2 pseudoknot will preferably be in a closed conformation and the RNA 
template undergoes translation. Therefore, a more prominent elevation of minus strand synthesis is observed 
for the 5’UTR_∆IIIb due to a total arrest of translation, and a lesser – for the 5’UTR_IIId* construct that 
occasionally is capable of translation initiation. Disruption of the long-range SLIIId-5BSL3.2(bulge) 
interaction and genome circularization also might contribute to the latter effect.  
Overall, the conducted experiments provide only a slight glance at the entangled interplay between the 
HCV translation and genome synthesis. Impairing action of the functional HCV translation on the 5’UTR 
construct indicates that the HCV translation impedes the replication at the stage of ongoing protein synthesis. 
Evidently, when the interaction of the eIF3 with the HCV 5’-end is disabled, a higher potency of the minus 
strand production from the 3’-end is displayed. On the contrary, disruption of the SL IIId may have a dual 
effect: preventing a translation initiation, it also detunes essential communication between the genome ends. 
Further in-depth investigation should be attempted in order to resolve this duality. One possibility to 
distinguish between the effects of either a physical binding of the 40S or of long-range interactions is to 
introduce modifications in the IIIe tetraloop, retaining the SL III intact. Disruptions within the IIIe prohibit 
the 40S subunit binding as well as reduce overall translational activity (Psaridi et al. 1999). A combination of 
double SL IIId* and the ∆IIIb mutations may appear useful to reveal any unexpected replication inhibitory 
factors or events when comparing such mutant in the 5’UTR context with the wild-type SL I-III construct. 
Eventually, the other less investigated cis-elements, i.e. the SL 588 within the Core-coding region 
(Pirakitikulr et al. 2016), should be incorporated into experimental constructs to complete the state-of-the-art 
5’-end cis-signals engaged in long-range interactions with the 3’-end elements with a proposed impact on the 
HCV replication.  
3.4 Effects of miR-122 acting at the HCV 5’- and 3’- UTRs on the HCV 
minus strand replication 
The vital role of liver-specific miR-122 on HCV replication (Jopling et al. 2005), translation (Henke 
et al. 2008) and RNA stability (Shimakami et al. 2012a) has been proposed for a long period of time. The 
mechanism of miR-122 action on the HCV RNA is well-described for the 5’UTR target sites S1 and S2, 
however its function at the 3’-end candidate binding sites (5B.1-3 and S3) remains unclear. Moreover, a 
transition from serving one function to another upon miR-122 binding is largely elusive. The main limitation 
originates from the multiple functions of those 5’UTR sites in the HCV life cycle that are challenging to 
dissect. Therefore, in the current research it was attempted to unravel the miR-122 impact on the HCV minus 
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strand synthesis efficiency upon binding to the target sites at either of the HCV genomic ends and to 
determine the requirements for the antigenome production using the minus strand replication system.  
In order to uncouple the miR-122 functions in the HCV translation, the SL I-II construct containing all 
– the 5’- and 3’- ends’ binding sites – was utilized for the analysis (Fig. 3.4.1, A). Role of the miR-122 
binding sites at either HCV genomic end in minus strand synthesis were investigated separately bymutational 
approach disabling binding of the miR-122, but retaining an original secondary structure of the HCV RNA. 
The mutations within the 5’UTR S1 and S2 miR-122 binding sites were originally designed and generated by 
Anika Nieder-Röhrmann, as described in her doctoral dissertation (also in Nieder-Röhrmann et al. 2017) 
(Fig. 3.4.1, B and C). The details on the mutated sequence are specified in the Appendix together with 
plasmid maps corresponding to the wild-type and its S1/S2-mutated version (designated as SL I-II_S1mS2m; 
see 6.1.13-14). In the scope of the present work only a double – S1mS2m – mutant (Fig. 3.4.1, C) in the 
context of the SL I-II construct was generated; the in-depth analysis of each of the two HCV 5’UTR 
miR-122 binding sites is not included. Apart from a complexity reason, these sites function cooperatively 
and play a more profound role when addressed simultaneously (Nieder-Röhrmann et al. 2017), which 
justifies application of a double mutant in the proof-of-principle experiment.  
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With regard to the HCV 3’-end target sites – 5B.1-3 and S3 – mutations (Fig. 3.4.1, A) sufficient to 
disable the miR-122 binding and function were introduced into the same wild-type replication construct, and 
were presented in the doctoral work of Nadia Dünnes (also in Gerresheim et al. 2017). The detailed 
representation of mutated 3’-end sites’ sequences in the context of the SL I-II construct (designated as 
SL I-II_5B.2m, SL I-II_5B.3m and SL I-II_S3m) is provided in the Appendix (see 6.1.25-27). In the present 
work the potential miR-122 site 5B.1 located within the HCV NS5B coding region was inactivated in all 
generated constructs since this site is not conserved among HCV isolates (only in 26 out of 106 selected 
HCV isolates; Fricke et al. 2015). In contrast, the 5B.2, 5B.3 and the S3 miR-122 target sites located 
downstream the 5B.1 in the HCV NS5B coding region and the 3’UTR were found to be highly conserved 
(99/106, 106/106 and 106/106 among selected HCV isolates respectively; Fricke et al. 2015), therefore 
included in the mutational analysis. The mutations were introduced within seed site regions separately for 
each of the binding sites resulting in single mutants. Similarly, the analogous mutations were generated 
within the SL I-II_S1mS2m construct (designated as SL I-II_S1mS2m_5B.2m, SL I-II_S1mS2m_5B.3m and 
SL I-II_S1mS2m_S3m; see 6.1.28-30).  
Generated by in vitro transcription, replication template RNAs corresponding to the above described 
SL I-II construct and its 5’- and/or 3’- UTR miR-122 binding mutants (Fig. 3.4.2, A) were tested upon 
transfection into HuH-7.5 cells. Here, the cells were lysed 2 days post transfection and the HCV NS3 protein 
detection was conducted by western blot (Fig. 3.4.2, B). Visualization of the viral protein at this time-point 
only for few of the transfected RNA templates indicates that the introduced mutations crucially affect
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replication driven from these constructs. At the later time-points post transfection, i.e. 2 days, an availability 
of templates for translation rather than templates’ stability appears critical for the HCV protein accumulation. 
Indeed, only the constructs that are capable of continuous replication may still retain in a cell 2 days post 
transfection and serve as a template for protein synthesis. Clearly, apart from the wild-type SL I-II template 
RNA, only its 5B.2 and to a lesser extent 5B.3 mutants remain viable in terms of ongoing rounds of 
replication (lanes 1, 3 and 4).  
As illustrated in the above sections, co-transfection of sequestering anti-miR-122 LNA reduces the 
HCV NS proteins expression already at the 8 h post transfection, most likely due to a negative impact on 
RNA stability. On the long run, such LNA rather affects the efficiency of replication from transfected RNA 
construct since miR-122 binding is abolished to all 5’- and 3’- UTR binding sites (Fig. 3.2.3, C and D). 
Therefore, any replication template co-transfected with the anti-miR-122 LNA resembles its mutant with all 
five sites disabled from miR-122 binding perspective, but remains wild-type regarding the primary HCV 
sequence. None of the SL I-II_S1mS2m derivatives (lanes 7; 9-11) results in continuous replication, 
suggesting that the S1 and S2 sites are important for the HCV replication at the first place. The 5B.2 and 
5B.3 single mutants of the SL I-II construct maintain a capacity for ongoing replication, since a template for 
translation of the HCV NS proteins is still available 2 days post transfection, thus the 5B.2 and 5B.3 
miR-122 target sites are not essential for the HCV replication, whereas the S3 site appears to be evidently 
required. Whether this effect is mediated by the miR-122 binding or/and is a consequence of the primary 
sequence alteration requires clarification by a miR-122 complementation approach.  
To elucidate the role of miR-122 binding to the above-mentioned sites along the HCV genome, the 
replication assay was carried out. The wild-type SL I-II construct and its SL I-II_S1mS2m derivative were 
transfected in series in parallel with the corresponding miR-122 binding mutants at the 3’-end (5B.2m, 
5B.3m and S3m). The efficiency of the HCV minus strand synthesis was evaluated by RT-qPCR (targeting 
only Spinach region) using the total RNA isolated from the cells 2 days post transfection. Transfection with 
the SL I-II construct harboring the GND mutation in the replicase coding-region served as a negative control 
of minus strand synthesis initiation; the signals derived for SL I-II_GND are indicated with a dotted line at 
the presented schematics. The mean RER value for the wild-type SL I-II construct was set to 1 to enable 
visual comparison to all generated – single and multiple – miR-122 binding mutants (Fig. 3.4.3, A). Results 
of this replication assay to a high extent resemble the HCV NS3 protein detection by western blot 
(Fig. 3.4.2, B). Relative minus strand synthesis efficiency of the intact SL I-II construct is significantly 
higher than of all the mutants, except for the SL I-II_5B.2m. Already in wild-type S1/S2 context, disabling 
of miR-122 binding to the 5B.3 or S3 sites severely impairs replication. A similar negative effect is displayed 
when the 5’UTR miR-122 target sites are disabled (SL I-II_S1mS2m). Further mutations of the 3’-end target 
sites – 5B.2, 5B.3 and S3 – do not significantly impair antigenome synthesis further on. This observation 
emphasizes the primary importance of the miR-122 binding to the S1 and S2 sites for efficient HCV 
replication. However, a fundamental reason for this importance may be either direct physical consequences 
of the binding, i.e. in Ago2 complex formation and stabilization of RNA templates (Shimakami et al. 2012a; 
Li et al. 2013), or/and in indirect effects on cis-elements’ communication due to primary structure 
alterations.  
This uncertainty can be addressed by a compensation approach. In the current experimental situation, 
either application of miR-122 variants harboring compensatory substitutions to restore its binding to mutated 
sites or introduction of corresponding mutations within cis-elements that are proposed to engage in 
RNA-RNA interactions. The latter – genetic approach – is to a large degree more challenging, not only due 
to substantial mutagenesis required, but most importantly due to involvement of the other known (and 
unknown) functions of cis-elements along the HCV genome. Particularly, the SL I primary sequence, 
containing both 5’UTR miR-122 binding sites, is highly conserved among HCV isolates and was predicted 
to engage in long-range interactions with the 3’-end region (also remarkably conserved) potentially resulting 
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in the HCV genome circularization (Fricke et al. 2015). Any attempts of genetic alterations at the conserved 
and indispensable 3’-end are expected to result in, by default, unviable genomes.  
Thence, compensation by correspondingly mutated synthetic miR-122 variants was carried out. At 
first, to challenge the importance of miR-122 binding to the 5’UTR, wild-type and S1mS2m SL I-II 
constructs were transfected either alone or with a respective miR-122 (wild-type or a composition of 
mutated) or withanti-miR-122 LNA (Fig. 3.4.3, B). The compensatory mutations in the miR-122 ―guide‖ 
strand were designed in accordance to introduced S1m and S2m mutations within the S1 and S2 sites 
(see 6.1.13-14) to restore the binding. These miR-122 variants were demonstrated to bind to their 
corresponding mutated target sites and to rescue the miR-122 binding at the HCV 5’UTR (dissertation of 
Anika Nieder-Röhrmann). An equimolar mixture of the modified miR-122_S1m and miR-122_S2m 
duplexes was used in the current work for the co-transfection with the SL I-II_S1mS2m replication 
construct. In the replication assay additional wild-type miR-122 did not significantly increase the relative 
minus strand abundance displayed by the SL I-II construct, most likely due to a saturated effect of miR-122 
on the HCV genome, however sequestration of endogenous miR-122 from HuH-7.5 cells by LNA resulted in 
a dramatic drop of synthesis efficiency (Fig. 3.4.3, B). As shown above, the minus strand production was 
drastically affected when the S1mS2m version of the SL I-II construct was used. Remarkably, compensatory 
mutated miR-122 S1m and S2m variants applied together with the SL I-II_S1mS2m replication construct 
could not improve antigenome production. Resulting in a similarly low minus strand synthesis efficiency 
upon application of compensatory miR-122 variants, this experiment proves the importance of the primary 
sequence constituting the S1 and S2 target sites in the SL I region. Actual binding of miR-122 to those sites, 
if contributes at all, seems to play a secondary role in regulation of the HCV minus strand synthesis 
initiation. Indeed, the engagement of the SL I into the long-range interaction with the genomic 3’-end 
(initiated between the apical regions of the SL II and the DLS and extended up to 62 nt) and a subsequent 
genome ends hybridization was proposed to result in the HCV genome circularization (Fricke et al. 2015), 
which is known to facilitate replication in other members of the Flaviviridae family, i.e. in Dengue virus 
(Alvarez et al. 2005). 
The role of miR-122 binding to the HCV 3’-end sites 5B.2, 5B.3 and S3 was analyzed challenging the 
single site mutants in replication assay upon application of compensatory miR-122 variants. These miR-122 
variants were designed in accordance to introduced mutations within the 5B.2, 5B.3 and S3 sites (see 
6.1.28-30) during the doctoral work of Nadia Dünnes and their binding to the corresponding mutated target 
sites was validated (dissertation of Nadia Dünnes). Since all constructs from the SL I-II_S1mS2m series 
displayed very low functionality in terms of minus strand synthesis (Fig. 3.4.3, A), most likely resulting 
already from mutations in the 5’UTR, these constructs were not subjected to a compensation assay. For the 
series of the SL I-II construct with original S1 and S2 sites, minus strand abundance was quantified in total 
RNA fraction from HuH-7.5 cells 2 days post transfection via RT-qPCR targeting the Spinach region 
(Fig. 3.4.3, C). As was shown above, 5B.3m and S3m mutants of the original SL I-II replication template 
demonstrate significantly lower relative abundance of nascent minus strands. Co-transfection of individually 
mutated constructs with their corresponding compensatory miR-122 variants failed to rescue the antigenome 
synthesis rate in all mutants. Resulting effects of application of a compensatory miR-122 were comprised by 
either insignificant change in the replication efficiency (for 5B.3m and S3m mutants) or by a surprising (and 
significant) impairment – as for the 5B.2m mutant. The latter anomaly could hypothetically originate from 
less effective transfection of the input RNA templates or more likely by dilution of the cellular pool of the 
wild-type miR-122 molecules leading to its decreased activity at the functional S1 and S2 sites. To sum up, 
in a manner similar to compensation of the miR-122 binding at the 5’-end, physical binding of miR-122 
variants and Ago2 complex assembly at the 3’-end target sites were found insufficient for effective rescue of 
minus strand synthesis initiation. Further research is required to unravel genuine roles of these – yet under 
investigated – miR-122 target sites. Their importance in HCV replication was confirmed using the full-length 
HCV culture system and contrasting degree of contribution of each individual binding site was demonstrated 
(Gerresheim et al. 2017). Supposedly, the miR-122 binding and Ago2 recruitment to the 3’-end sites of the 
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HCV genome (especially the more downstream) may contribute to conformational changes at the genome 
terminus in order to facilitate replication initiation. However, the obtained results in turn imply the 
significance of the primary RNA sequence, which can be utilized as a scaffold for surrounding structural 
elements or to play a direct role.  
In conclusion, miR-122 is one of the most influential host factors in HCV life cycle. Its contribution at 
various stages directly and indirectly complicates the dissection of its functions and mechanisms of action. 
Its activity at the HCV 3’-end remains poorly understood, although the high degree of conserved target sites 
in this region is striking. The developed minus strand replication system is applied in the present work to 
gain knowledge on the miR-122 role in the HCV minus strand synthesis initiation upon binding to the 
5’- and 3’- end target sequences. Importantly, it provided evidence on the positive role of miR-122 binding at 
either of the HCV ends on antigenome production. A more comprehensive complementation analysis is 
required to clarify the mechanism of the promoting effect at both ends, since compensatory miR-122 binding 
was found to be insufficient for efficient replication in contrast to the primary sequence of this vital region. 
In analogy to the observed importance for the S1 and S2 miR-122 binding sites and their possible role in 
genome circularization, high sequence conservation of certain regions along the HCV genome (and in 
particular of the miR-122 binding sites) point out their functional role in the viral life cycle. Further insight 
on potential of the minus strand replication system in unraveling of functions of other HCV cis-elements is 
presented in the following section.       
3.5 A glance over the role of cis-elements located in the HCV coding region 
in minus strand synthesis initiation 
An importance of the cis-elements contained at the HCV 5’- and 3’- UTRs in plus and minus strand 
synthesis had been recognized for long time (You et al. 2004, Friebe et al. 2005). In addition, the cis-acting 
replication element 5BSL3.2 was identified in the NS5B coding region. The complex tertiary structure of the 
5BSL3.2 element was found to engage in several alternating long-range RNA-RNA interactions and 
proposed to serve as a molecular switch between translation and replication (Diviney et al. 2008; 
Tuplin et al. 2012; Shetty et al. 2013). Later on, more signals that are essential for the HCV replication were 
identified within the NS5B coding region (Chu et al. 2013; Mauger et al. 2015), however they still require 
further investigation. Moreover, even fewer information is available concerning other potential cis-elements 
located along the rest of the HCV polyprotein coding sequence. Identification and validation of cis-elements 
is a meticulous process, which is often complicated by overlapping functions of an element in the viral life 
cycle. 
In the present work the developed minus strand replication system was adapted for an assessment of 
possible roles of other cis-acting replication elements within the HCV coding region in minus strand 
synthesis initiation. In the designed replication templates the most downstream 152 nt of the NS5B coding 
region were not mutated to retain the 5BSL3.2 element unaffected, as long as it is known to be essential for 
the HCV replication. When required, further mutagenesis can be conducted within this unmodified sequence. 
The rest of the HCV NS3-NS5B coding sequence was scrambled in silico (conducted by Yutong Song and 
Steffen Mueller) and produced by commercial chemical synthesis. The scrambling procedure aims to disable 
all possible RNA cis-signals that may act at the input RNA template, but retaining the amino acid sequence 
to obtain operative replication machinery, as well as codon usage and codon pair bias to prevent local 
differences in translation speed, which might have impact on protein folding and by that on activity and 
functionality of the HCV proteins. As a basis for analysis, the hp (as a part of cloning and assembly 
procedure) and SL I-II constructs were modified accordingly resulting in pairs of wild-type and scrambled 
(SCR) replication templates (Fig. 3.5.1, A), designated as SL I-II (when wild-type) and SL I-II_SCR (for 
plasmid maps see 6.1.13 and 6.1.21). Additionally, the nearly fully scrambled NS3-NS5B cassette was 
incorporated into the SL I-II construct containing mutated miR-122 binding sites at the 5’UTR 
(SL I-II_S1mS2m_SCR; see 6.1.22). 
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This series of SL I-II constructs - in wild-type or scrambled context - was challenged in the replication 
assay, where, as before, the SL I-II RNA template harboring inactivating replication GND mutation was 
utilized as a negative control of the HCV minus strand synthesis initiation (indicated as a dotted line on the 
graphic representation). The HuH-7.5 cells, as in the experiments above, were transfected with each 
construct and total cellular RNA was isolated 2 days post transfection. Results provided by the RT-qPCR 
quantification of relative minus strand abundance targeting the Spinach region (Fig. 3.5.1, B) demonstrated a 
significant abrogation of the nascent HCV minus strand RNA production after non-directed scrambling. 
Apparently, potentially occurring cis-elements within the SL I-II_SCR construct (excluding the vital 
5BSL3.2 element) were inactivated. Thus, an importance of cis-elements located upstream the 5BSL3.2 
element in the HCV minus strand synthesis initiation can be recognized from this experiment; however, 
in-depth identification of the essential sequences and structures is necessary.  
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In the fashion of the 5BSL3.2, it can be speculated that the remaining cis-signals are also engaged in 
intramolecular RNA communication with the sequences at the HCV 5’- and 3’- ends to regulate minus strand 
synthesis. Since scrambling of the entire NS3-NS5B sequence (excluding the very last 152 nt in the NS5B 
coding region) results in drastic reduction of minus strand synthesis efficiency, next step requires addressing 
of cis-elements mutations separately. A comprechensive approach would implement division of the entire 
scrambled sequience into several parts and analysis of each part mutated independently of the others. This is 
inevitable in a course of very preliminary screeening of essential cis-elements. However, a reasonable 
number of publications on the HCV cis-acting replication elements suggested candidate target sequences. 
Two cis-elements within the HCV NS5B coding regions, which had been shown to be involved in overall 
HCV replication in the published literature, were selected for mutational analysis. The first element, known 
as J8640 (Mauger et al. 2015) or SL8647 (Chu et al. 2013), is located in the NS5B-coding region at position 
8680 of the JFH-1 HCV isolate. This cis-element represents an apical loop within a stem-loop that is 
involved in genome replication and virus particle production (Chu et al. 2013). Another characterized 
cis-element, known as SL9110 or Alt-sequence (Diviney et al. 2008), is located within the NS5B sequence at 
position 9170 in the JFH-1 genome. The apical loop of the SL9110 resides upstream of the 5BSL3.2 and 
engages in the long-range interaction with the bulge of the latter. This SL9110-5BSL3.2(bulge) contact was 
reported to be critically involved in replication and virus production (Diviney et al. 2008).  
Therefore, these mutations were introduced only into the SL I-II construct (designated as 
SL I-II_8680mut and SL I-II_9170mut; see 6.1.33-34) in order to be compared with the wild-type SL I-II 
construct and its entirely scrambled version. Challenged in a replication assay, the RNA templates containing 
individual mutations of the 8680 and 9170 cis-elements displayed a drastic drop in relative minus strand 
abundance, similar to the fully-scrambled SL I-II_SCR construct (Fig. 3.5.1, B). No significant difference in 
replication ability was observed between all three cis-element mutants - SL I-II_8680mut/9170mut or 
SL I-II_SCR. Additionally tested 5’UTR miR-122 binding mutant (SL I-II_S1mS2m; in wild-type or 
scrambled contex) also presented similarly low replication capabilities: likely the major inactivating effect in 
this case originated from mutation of the essential 5’UTR sequence.  
To sum up, the 5BSL3.2 element appears to be not the only crucially important cis-element within the 
HCV polyprotein coding region for the efficient minus strand synthesis initiation. Comprehensive 
non-specific scrambling of the coding region upstream the 5BSL3.2 element as well as individual directed 
distraction of known vital elements 8680 and 9170 (in the JFH-1 HCV isolate) resulted in severely reduced 
replication activity of the characterized SL I-II constructs. Indeed, disabling hybridization of the 9170 
element’s loop to a bulge of the 5BSL3.2 unbalances the dynamic conformational rearragement in the 
5BSL3.2 element and formation of essential long-range interractions; however, the exact mechanistic details 
still remain to be disclosed. In turn, modifications introducted within an apical loop of the 8680 element are 
thought to disrupt its communication with the SL2/DLS in the X-tail (Fricke and Marz 2016). While the 
latter is not known to have a direct effect on replication efficiency, retaning the complex interplay between 
RNA cis-elements may be the key. Several previously characterized structural RNA elements remain 
candidates for further analysis. Among them, for example, are so-called SL6038 element located in the 
NS4B region (Pirakitikulr et al. 2016) as well as the J7880 and J8880 elements distributed along the HCV 
NS5B coding region (Mauger et al. 2015). All these elemnents are described to a certain extent to play a role 
in replication. A prominent cis-element designated as SL 588 is located downstream the HCV IRES and was 
also suggested to act as a cis-acting replication element (Pirakitikulr et al. 2016). Further research on these 
cis-elements may definitely take advantage of using the minus strand replication system that uncouples the 
major HCV life cycle events from the HCV RNA synthesis.      
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3.6 Dynamics of experimental HCV RNA constructs: synthesis and decay  
The above chapters have illustrated broad applications of the developed minus strand replication 
system in dissecting determinants and essential components for the HCV replication. Plasticity of the system, 
in terms of enabling effortless modifications of functional elements, suggests a broad range of future 
applications, i.e. further unraveling of the miR-122 function on the HCV genome, a trial of non-structural 
proteins’ mutants as well as partial provision of replication proteins in trans, screening for cis-elements 
within the structural proteins (especially, in Core) coding regions, and many others. However, so far the 
system was utilized within a time period post transfection of RNA templates (around 48 h) that implies the 
active HCV plus and minus strand replication. It was shown in several studies on highly infectious virus 
variants, such as the JFH1, that minus strand production peaks at 24-48 h post transfection/infection and 
followed by plus strands ascent (Targett-Adams et al. 2008, Keum et al. 2012). Indeed, in the context of the 
developed system, only highly variable and low singnals were derived in attempt to detect minus strand 
production 24 h post transfection, likely due to various degrees of sequence and/or functional elements 
deficiency within the experimental HCV RNAs that to a certain extent postpones a replication uprise. 
Moreover, given that only a few of the developed replication RNAs contain sufficient sequence elements to 
undergo continuous replication (meaning that they use newly synthesized minus strands as templates for 
nascent plus strand production), the dynamics of HCV RNA supplied by the minus strand replication system 
should differ from the one of a wild-type viral RNA. The current chapter attempts to elucidate the dynanic 
changes after transfection into cells of the main RNA replication templates presented in this research.  
The importance of unraveling of the HCV RNA dynamics can not be underrated. A rise and a decay of 
minus and/or plus HCV RNA provided by transfection of a certain RNA template are directly linked to their 
possible applications and limitations. Every of the main replication RNAs used in the above sections – hp, 
SL I-II, SL I-III and 5’UTR (Fig. 3.2.1, A) – was subjected to transfection in a time-course manner together 
with the corresponding replication-deficient GND mutants. An additonal construct was introduced in this 
analysis: the so-called 5’UTR-Core construct (for the plasmid map see 6.1.35) that resembles the 
characterized 5’UTR replication template, with an exception that its open reading frame is represented by the 
complete HCV Core-coding sequence in contrast to the short upstream fragment provided in the 5’UTR 
construct. This construct was developed to allow the possible effector functions of the structural elements 
contained within the Core-coding sequence as well as of the Core protein itself.  
To minimize bias, transfection reactions related to different time-points originated from a master-mix 
and the normalization procedure was conducted as following. Plus strand abundance was measured by 
RT-qPCR targeting the EMCV region at the plus strand (universal for all contructs) (Fig. 3.2.1, B) and, 
instead of being normalized to a certain cellular mRNA abundance, was normalized to input plus strand 
(i.e. transfected RNA template) abundance individually within each construct’s series; in other words, per 
well of cells. This approach allowes to avoid serious bias rising from amplification of cells during a 
prolonged time-course as well as from the quality and relative amounts of input RNAs. Instead, it provides a 
fraction of remaining input RNA originated from the same master-mix. Therefore, the plus strand abundance 
for each construct at the time-point 0 is set to 1. Normalization of minus strand content derived by targeting 
the Spinach region by RT-qPCR (Fig. 3.2.1, C) was performed, as previously, to plus strand abundance, 
resulting in a comparison of each construct’s ability to give rise to minus strands. All transfections in the 
current section were achieved by electroporation in order to ensure that all detected RNA had entered the cell 
and did not reside at the cellular surface or within endosomes, as for Lipofectamine-based transfection. The 
cells transfected with each of the tested constructs were lysed directly after transfection and further at 6-8 h, 
16 h, 24 h, 36-48 h and 96 h post transfection (full time-course data available for most of the below-
mentioned constructs).  
A summary of several time-course experiments (n = 3-6) is illustrated on Fig. 3.6.1. Regardless exact 
starting amounts of input plus strand templates (that may differ from experiment to experiment depending on 
integrity of in vitro transcribed RNA, efficiency of transfection and cell passage), a stable gradual decay of 
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plus strand RNAs is observed within the first 16 h post transfection for all studied constructs: in both 
wild-type or GND context (Fig. 3.6.1, A). The minimum of the plus strand content is found to reside at 24 h 
time-point for most constructs; however no detailed time-course was conducted between 24 h and 48 h time-
points to investigate it in more detail. Then, the plus strand abundance for some of the constructs elevates by 
the 48 h post transfection: significantly – for the SL I-III construct (starting at 24 h), slightly and variably – 
for the SL I-II, 5’UTR and 5’UTR-Core constructs. This observation strongly supports the capability of these 
constructs (especially of the SL I-III) to utilize newly synthesized minus strands (detected in the sections 
above) as templates for nascent plus strands synthesis. Importantly, no significant difference in plus strand 
accumulation was observed upon addition of the HCV Core-coding sequence to the 5’UTR constructs, 
emphasizing an inhibitory effect of functional translation from the HCV IRES on the construct’s replication. 
Insignificant or no increase in plus strand abundance followed by the further decline was demonstrated by 
the rest of the constructs (hp and all GND mutants), verifying their inability to produce neither of the HCV 
genomic strands. Nevertheless, eventual decline of plus strand abundance for all experimental constructs by 
96 h time-point takes place and is in agreement with descent of overall replication displayed in full-length 
viral systems. No further information on the fate of transfected RNA was obtained in scope of the current 
research.  
Relative abundance of minus strands in corresponding total RNA samples is illustrated by 
Fig. 3.6.1, B. Unlike transfected plus strands, which are at their maximum at time-point 0, minus strands 
remain below detection level until 24 h post transfection, inclusively. As the graph clearly illustrates, relative 
minus strand abundance rises for the SL I-II, SL I-III, 5’UTR and 5’UTR-Core constructs at time-points 48 h 
and 96 h only. The replication-incapable GND mutants and the hp construct result only in background 
signals. The derivative of the SL I-II construct, harboring the mutated miR-122 binding sites at the 5’-end, 
demonstrates no accumulation of either of the strands, consistently with the results from section 3.4. 
Interestingly, the peak does not reside at 48 h time-point, as for corresponding plus strands’ quantification, 
neither for relative minus strand abundance nor for raw minus strand signals prior normalization 
(Fig. 3.6.1, C). Likely, it originates from the combination of general decrease of replication rates after 48 h 
and of postponed synthesis dynamics of the studied constructs. When the replication slows down, plus 
strands are no longer synthesized in high excess over minus strands and all available minus strands are 
retained in double-stranded form. It would be of high interest to investigate the fate of both strands in a 
longer time-course; however it is largely complicated by viability of transfected cells at late time-points.  
In order to monitor dynamic changes in HCV protein levels along a similar time-course, the HCV NS3 
protein was monitored up to 96 h post transfection of replication RNA templates. Since all non-structural 
HCV proteins encoded in replication templates (except for the HCV Core in the 5’UTR-Core construct) are 
translated from the EMCV IRES independently of the constructs’ nature and the HCV IRES sequence, ratios 
between detected NS3 protein should resemble availability of plus strand templates – input or nascent – that 
serve as templates for translation. Therefore, given transfection of equimolar amounts of RNA and identical 
transfection efficiency, protein levels detected at early time-points (as the first rounds of HCV protein 
translation start 4 h post transfection when driven from HCV IRES) should be similar for all constructs, 
including replication-deficient GND mutants. Considering a half-life of the HCV NS3 protein in vivo to be 
11–16 h (Pietschmann et al. 2001; Pause et al. 2003) and decay of input plus strands within a similar time 
period (Fig. 3.6.1, A), relative increase in the HCV protein content should originate from translation from 
decreasing amount of input plus strands and emerging, when possible, nascent genomic strands.  
As illustrated by the Fig. 3.6.2, A, at the time-point 16 h post transfection (upper panel), levels of 
detected HCV NS3 protein appear rather variable and systematic difference between wild-type and GND 
constructs is not observed. Additionally, the presented western blot illustrates emergence of background 
bands after longer exposure time, also in mock-transfected lane, which reside at the same level as the HCV 
NS3 protein and complicate the interpretation. However, corresponding transfection reactions result in fewer 
background and indicates profoundly different levels of the NS3 protein 36 h post transfection (Fig. 3.6.2, A, 
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lower panel). Evidently, a strong increase can be observed for the SL I-III construct, which is in agreement 
with the plus strand abundance time-course. Thus, pronounced elevation of plus strands in the SL I-III 
construct transfected sample supplies new templates for translation, whereas lesser represented plus strands 
in the SL I-II and 5’UTR samples seem to only maintain, but not increase viral protein content in cells at 
later time-points. Agreed to steadily lowering levels of input plus strands in GND samples (Fig. 3.6.1, A), 
these cannot keep the previous levels of the NS3 protein, and both – input template and newly synthesized 
protein – are subjected to consecutive degradation.  
In an extended up to 96 h time-course similar fate of the HCV NS3 protein was observed 
(Fig. 3.6.2, B). At the early time-point – 8 h post transfection – low and variable levels of the HCV protein 
were detected (upper panel). At 48 h time-point the NS3 levels elevated dramatically for the similar set of 
constructs (SL I-II, SL I-III and 5’UTR) and remained unchanged by 96 h (exposure to one X-ray film). A 
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decrease of the HCV NS3 protein to background level by 48 h time-point supports the previously shown (at 
plus and minus strand RNA level) incapability of selected constructs (hp, SL I-II_S1mS2m and a scrambled 
version of the SL I-II) to undergo efficient minus and plus strand replication.  
Another time-course aimed at direct comparison of the HCV protein abundance at time-points most 
relevant for the minus and plus strand RNA quantification upon transfection with the main set of functional 
constructs, including the 5’UTR-Core (Fig. 3.6.2, C). As evident from the RNA constructs dynamics 
(Fig. 3.6.1), already at 24 h time-point input template RNA becomes limiting, unless the RNA construct is 
capable of plus strand production. Limitation in templates for the HCV non-structural proteins translation 
from the EMCV IRES reflects dissimilar amounts of detected HCV NS3 protein. Neither of the replication 
constrcuts that were shown incapable of plus strand synthesis, such as all tested GND variants and also the 
hp construct, display detectable amounts of the NS3 protein (Fig. 3.6.2, C). The direct correlation between 
the number of genomic RNAs and protein synthesis is reflected by the highest NS3 protein content displayed 
for the SL I-III construct and the lowest – for the SL I-II. Importantly, the production of the HCV Core 
protein from the HCV IRES is demonstrated in amounts comparable to the HCV NS3 that is synthesised 
from the EMCV IRES, as the whole gene cassette. A decrease of both the NS3 and the Core protein amounts 
along the time-course imply that an addition of a vital Core-coding sequence at the constructs 5’-end 
nevertheless does not permit a persistence of the construct, which undergoes a subsequent decay 
(Fig. 3.6.1, A). 
These illustrations may underline how tightly the processes of protein synthesis and replication of 
genomic and antigenome RNA strands are linked. Affecting either of the steps often completely disables the 
others process resulting in no readout. This emphasizes an importance of development of experimental 
systems, in which as few functions as possible are linked to each other. Uncoupling HCV replication from 
translation and minus strand synthesis from plus strand production (in many, but not all, of the constructs), 
the minus strand replication system allows determining the roles of selected elements through an 
introduction of one at a time mutations and tracking their effects on minus strand synthesis and overall HCV 
RNA and protein dynamics. One indispensable characteristic that should be taken into account when 
comparing various constructs and their derivatives is an overall stability of replication template RNAs. Since 
the abundance of minus strands in the current work is routinely normalized to plus strand abundance, 
stability appears a vital characteristic of experimental construct to account for. Indeed, results can be 
misinterpreted when the stability of examined templates, especially of the ones that are incapable of 
continuous replication, are drastically different. Based on the published data, certain modifications are 
already expected to affect stability of the HCV genome strand, such as mutations within the miR-122 binding 
sites at the 5’UTR that are well-known to serve in protection of the HCV genome from 5’-exonucleolytic 
degradation (Shimakami et al. 2012a). In this context, normalization of minus strand abundance to plus 
strands count still provides a more unbiased picture than normalization to cellular house-keeping gene, in 
particular for the constructs with high plus strand replication rates. Nevertheless, the need to account for 
3. Results 
 
89 
 
3. Results 
90 
 
 various stabilities of experimental constructs, in general, remains debatable in the field.  
Characterization of the stability of the main RNA templates applied in the work was performed via a 
time-course experiment. As it was acquired in the above experiments (Fig. 3.6.1, A), input plus strand RNAs 
largely decay within the first 24 h post transfection. It can be approximated from the graphs that for the most 
of the constructs a half-life value is in a range between 8 and 16 h. Therefore, a detailed time-course was 
conducted to track input plus strands abundance at 0, 6, 16, 24 and 36 h post electroporation. As before, plus 
strand abundance was quantified by RT-qPCR targeting the EMCV region at the input RNA template.  
Normalization was conducted individually for each construct to the plus strand signal derived for the 
time-point 0 (set to 1). Such normalization, i.e. to a well of transfected cells, results in fractions of remaining 
plus strand RNA that enable an approximation to an exponential decay function (conducted using OriginPro8 
software and a ExpDec1 function) and subsequent calculation of half-life values. Cellular GAPDH mRNA 
was in parallel quantified in the same RNA samples to verify a comparable efficiency of total RNA isolation 
from cells (data not shown). Comparison of decay rates of the replication constructs hp, SL I-II, SL I-III and 
5’UTR with their GND mutants and a number of miR-122 binding mutants (derivatives of the SL I-II 
construct) provided interesting results. The half-life time values for the hairpin (hp) constructs – both 
wild-type and GND version – demonstrate one of the lowest stability values among the investigated RNAs: 
9.4±0.3 and 10.3±0.5 h, respectively (Fig. 3.6.3, A and F). For the pairs of the SL I-II and 5’UTR (wild-type 
and GND) constructs, the tendency of each replication-deficient construct to display a slightly lower half-life 
time was observed: 13.4±0.9 and 11.9±0.5 h for the SL I-II series and 14.8±1.8 h and 10.6±1.9 h – for the 
5’UTR (Fig. 3.6.3, B, D and F). A fundamentally analogous situation is observed for the pair of the SL I-III 
(wild-type and GND) constructs (Fig. 3.6.3, C): as already shown in Fig. 3.6.1, A, the replication-competent 
SL I-III construct efficiently generates new plus strands and therefore cannot be fitted to a decay curve, 
however its GND version decays in a similar manner like other GND mutants and displays a comparable 
half-life time - 12.4±0.9 h (Fig. 3.6.3, F). Virtually, taking standard deviations into account, half-lives of all 
GND mutants vary around 10-12 h, with the lowest value for the hp_GND construct. As for the wild-type 
SL I-II, SL I-III and 5’UTR constructs, which are able to produce new progeny plus strands (Fig. 3.6.1, A), 
the calculated half-lives do not represent a true decay rate, unlike the ones for GND mutants, and can only be 
used to ensure a plus strand dynamics’ difference when compaired to their replication-deficient versions. To 
sum up, concerning the above-mentioned constructs, exclusively their GND mutants should be utilized to 
elucidate possible alterations of RNA stability originating from sequence extensions.  
Another group of RNA constructs subjected to stability assay was composed of the derivatives of the 
SL I-II construct with mutations affecting miR-122 binding to the HCV 5’UTR S1 and S2 sites (S1mS2m) as 
well as to the 3’-end binding sites (5B.2m, 5B.3m and S3m) (as in section 3.4). Providing that miR-122 
functions on the HCV RNA in association with Ago2, it is expected to protect the original SL I-II construct 
from degradation at the 5’-end. Indeed, stability of the S1mS2m variant is slightly lower than of the 
SL I-II_GND RNA (10.4±0.3 and 11.9±0.5 h, respectively) (Fig. 3.6.3, E and F). The mutants of miR-122 
binding to the two most downstream target sites - 5B.3m and S3m – do not demonstrate any significant 
difference in half-life time values when compared to the SL I-II_GND RNA (11.7±0.7 and 12.3±0.7 h), 
whereas the 5B.2m construct displays a substantial decrease in stability (Fig. 3.6.3, E and F): 8.9±0.7 h. 
Surprisingly, the 5B.2m mutant was the only miR-122 binding mutant that did not demonstrate any 
significant reduction of minus strand synthesis efficiency when compared to the wild-type SL I-II construct 
(Fig. 3.4.3, A). Nevertheless, the difference in stabilities of the studied constructs are not substantial enough 
(not exceeding 25 %) to affect the conclusions made from comparison of relative minus strand abundance in 
the above experiments. On the other hand, RNA half-life values need to be always minded – in experiments 
with reduced and full-length systems.   
In summary, the replication-competent constructs featured in the current study unambiguously 
illustrate the tight association of the HCV protein and RNA synthesis: translation of substantial amounts of 
protein requires a sufficient amount of translation templates, whereas the HCV non-structural proteins are 
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essential for an arrangement of the HCV replication sites in transfected cells. Stability of RNA replication 
constructs is an important characteristic, which upon its increase may enable a more efficient overall 
replication rate. Dynamic at different stages of the HCV life cycle, the HCV genome stability depends on the 
current conformation of the plus strand RNA and on occupation of binding platforms on the RNA by various 
cellular factors. Thus, evaluation of half-life time of experimental RNA templates comes with a high degree 
of variation. The following can be summarized and hypothesized from the performed time-courses. The 
hairpin construct, protected from degradation at the 5’-end only by an artificial stem-loop, lacks the HCV 
SLs I and II and miR-122/Ago2 recruitment; hence has the lowest half-life time. Relatively low stability is 
demonstrated by the replication-deficient 5’UTR_GND construct; since this construct is capable of 
functional translation initiation from the HCV IRES, it may undergo transformational rearrangements 
coupled with translation, in turn exposing the RNA to degradation. This aspect should be addressed using 
another translation-competent construct – the 5’UTR-Core – as well as its translation mutants. A study on 
plus and minus strand RNA and HCV protein dynamics of constructs harboring translation abrogating 
mutations (∆IIIb and IIId* in the SL III) remains to be performed. Comparison of stability of the wild-type 
translation-deficient 5’UTR RNA constructs can assist in unraveling the mechanistic aspects of switching 
between translation and replication. At last, the 5’- and 3’-end miR-122 binding mutants displayed the most 
variable half-lives among the studied RNA templates. While the decreased stability of the 5’-terminal 
miR-122 binding mutant is expected from published literature, the role of miR-122 binding at 3’-end 
requires further in-depth investigation.  
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4. Discussion 
In this study an innovative reduced replication system for specific analysis of the HCV minus strand 
synthesis initiation was developed and applied for revisiting some of the vital requirements for the HCV 
replication and translation. A vast number of former studies focusing on mechanisms and regulation of the 
HCV life cycle events have been performed using a replicon or full-length HCV systems. These have 
provided indispensable insight into essential viral and cellular determinants for the HCV entry, translation, 
genome replication and assembly; however since harboring both genomic ends, the obtained results were 
often missing a precise assignment of each individual element to a specific function.  
The current work was predominantly focused on uncoupling of the antigenome synthesis prerequisites 
from the ones for the genome strand synthesis and/or for translation, known to be all together engaged in an 
intricate interplay. The developed minus strand replication system applied in the study reveals that sequences 
present at the 5’-end of the plus strand HCV RNA are indeed positively involved in the regulation of the 
minus strand synthesis initiation at the 3’-end of the genome. The system enables a revision of functions of 
well-studied liver-specific miR-122 in HCV replication and provides a novel insight into its function upon 
binding to the 3’-end target sites. A vital contribution to the substantially controversial aspect of a switch 
between HCV translation and replication has been made. An importance of selected cis-acting RNA 
elements located within the protein coding region is reviewed and underlined for efficient antigenome 
synthesis. Nevertheless, it remains debatable whether the HCV RNA undergoes major genome 
rearrangements, i.e. circularization and/or dimerization, in analogy to other members of the Flaviviridae 
family.    
4.1 RNA cis-signals requirements for the HCV genome replication 
In the course of molecular evolution RNA virus genomes acquire optimal primary and secondary 
structures essential to fulfill their lifecycle in a particular cell type of a particular host organism. The primary 
RNA sequence is tightly linked to its structure, they co-evolve and advantageous combinations are retained 
and conserved within virus generations. For decades, members of the Flaviviridae family are known to 
contain the vital conserved cis-elements involved in virus translation, RNA replication and encapsidation 
within the 5’- and 3’- untranslated regions. A primary role assigned for the 5’UTR is a cap-dependent (genus 
Flavivirus) or cap-independent (genera Hepacivirus and Pestivirus) translation initiation. Notably, sequences 
that are not directly involved in translation are frequently found to be essential for overall virus production 
and characterized by high degree of conservation among virus isolates. 5’UTR elements on a genomic strand 
may contribute to a switch from translation to initiation of antigenome synthesis or to packaging. Moreover, 
complementary sequences located at the 3’-end of the minus strand are directly involved in the initiation of 
plus strand synthesis.  
Taking advantage of a bicistronic replicon system (Lohmann et al. 1999; Fig. 1.1.4), comprehensive 
mapping of the HCV 5’UTR previously revealed that SL I and II constitute a region that is not essential for 
the HCV translation, but rather for RNA replication: up to 125 nt were found essential and the complete 
5’UTR - required for efficient colony formation by replicons (Friebe et al. 2001; Kim et al. 2002). Such read-
out enabled an uncoupling of the investigated sequences’ role in translation from possibly overlapping 
functions in replication: in replicon systems the HCV non-structural gene cassette is driven from a 
heterologous IRES element, whereas a reporter gene is dependent on the HCV 5’UTR sequences. A related 
concept was applied in design of the replication system in the current study; however, in contrast to 
replicons, our system also attempts uncoupling of minus and plus strand synthesis, which is crucial since a 
number of elements were found to execute their functions on both genomic and antigenomic strands. The 
minimal hairpin (hp) construct appeared incapable of minus strand synthesis initiation, whereas the RNA 
construct containing the HCV SL I-II displayed ability for antigenome synthesis (Fig. 3.1.3, E), in agreement 
with the above mentioned studies. Nevertheless, requirement for the SL I-II sequence remains to be further 
challenged in order to determine the exact sequence and/or structure that are indispensable for fulfillment of 
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replication. A glance at an aspect of primary sequence requirements is discussed below in the context of 
miR-122 binding sites.  
The SL I-II virtually represents the minimal 5’UTR sequence requirements for RNA replication 
initiation from the landmark publications, albeit contrasting results on the role of the downstream sequence 
have been obtained. Unlike in a replicon system (that cannot discriminate between minus and plus strand 
replication), our results demonstrate a strong enhancement of the minus strand synthesis in presence of the 
SL I-III sequences and a subsequent impairment with an addition of further downstream 5’UTR and protein-
coding elements, i.e. SL IV harboring a translation initiation codon followed by only a short open reading 
frame or by the complete HCV Core-coding sequence (Fig. 3.2.3, Fig. 3.6.1, B). Neither of the two sequence 
extension variants following the SL I-III (5’UTR and 5’UTR-Core constructs) managed to restore the 
replication efficiency of the SL I-III construct, unless the translation function was impaired 
(Fig. 3.3.3, C and D). Notably, a role of a number of other reported candidate cis-acting RNA elements 
within the 5’-end on minus strand synthesis was not displayed in the context of our system. Mutational 
disruption of the structural integrity of the SL V and IV was shown to affect viral replication to various 
extents (McMullan et al. 2007; Vassilaki et al. 2008); however, the nature of the experimental systems used 
does not allow drawing a definite conclusion, at which step of the HCV replication cycle these elements 
actually are involved. Advantages of SHAPE analysis, enabling identification of novel conserved and 
biologically functional RNA elements, suggested a clustering of RNA regulatory elements within the Core 
and NS5B coding regions positively involved in HCV replication (Mauger et al. 2015; Pirakitikulr et al. 
2016) (Fig. 4.1). Although a directed mutational analysis of these elements in the context of the minus and 
plus strand synthesis assay is still to be performed, it can already be concluded that the structural elements 
downstream the annotated SL III sequence are not essential for the HCV minus or plus strand synthesis and 
may rather play a role in translation. Whilst efficient translation elevates overall virus production (when 
analyzed coupled to replication as in the presented publications), when uncoupled from replication it appears 
to have an inhibitory impact on RNA synthesis. 
A slight advantage of the 5’UTR-Core construct over the 5’UTR construct, encoding only for 36 nt of 
the Core-coding region, was observed in our replication assays (Fig. 3.6.1). Giving the similar ability for 
functional translation initiation of both RNA templates, they however differ in a number of above-mentioned 
cis-elements. Enhancement of RNA replication may originate from either a direct positive effect of structural 
regulatory elements or alternatively from an inhibitory effect of a region within the SL IV on translation 
(Wang et al. 2000; Kim et al. 2003). The latter is mediated by a long-range RNA-RNA interaction between a 
sequence flanked by the two miR-122 binding sites (position 24-38) and a stretch within the SL VI stem in 
the Core-coding region. Notably, the inhibitory effect on translation remains after frame-shift mutations, but 
not mutations of the primary sequence (Honda et al. 1999). An answer is to be obtained by follow-up 
experiments upon a relief of a proposed inhibitory effect of active translation from the HCV IRES: both 
constructs should be challenged in a replication assay when contain the mutations disabling the translation 
function (i.e. ∆SL IIIb; Ji et al. 2004; Otto and Piglisi 2004).  
With regard to contribution of the genomic 3’UTR to the HCV minus strand synthesis, its crucial 
importance has been understood and thoroughly studied. Various requirements were proposed for different 
regions with an emphasis on the very 3’-terminal X-tail sequence conservation and its essential role in 
replication (Friebe and Bartenschlager 2002; Yi and Lemon 2003a,b). In our replication system the intact 
HCV 3’UTR sequence was retained (Fig. 3.2.1, A). On the other hand, an increasing number of reports on 
functional roles of cis-elements within the protein coding region in replication, prevalently NS5B, were 
found intriguing. Yet many of the proposed regulatory signals (Fig. 4.2) require revisiting, since their exact 
function and mechanism of action remain elusive. Relatively early reports on a group of highly conserved 
and stable stem-loop structures at the C-terminal NS5B coding region – 5BSL1-3 (alternatively named SL-
VII to SL-V) – suggested their role in replication (Lee et al. 2004; You et al. 2004). Both a bulge and an 
apical loop within the cis-replication element 5BSL3.2 were proclaimed essential for the HCV replication
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due to formation of a ―kissing-loop‖ interaction with the SL2 at the 3’UTR (Friebe et al. 2005). Moreover, 
both sequence and structure conservation is crucial in this element, suggesting multiple overlapping 
functions of the 5BSL3.2 (You and Rice 2008) (Fig. 4.2). Later, an importance of the other long-range RNA 
interactions engaging the 5BSL3.2 was understood: the subterminal bulge-loop interaction with a loop of an 
upstream cis-element SL9110 (named ―9170‖ in Fig. 4.2) was also found crucial for the HCV replication 
(Diviney et al. 2009). A significance of the latter and other cis-replication elements was challenged using the 
developed minus strand replication system (Fig. 3.5.1). The 5BSL3.2 element was so far always retained 
unmodified due to a genetic proof of its utmost importance (Friebe et al. 2005). Notably, mutations affecting 
the interaction between the 5BSL3.2(bulge) and the SL9110 resulted in a reduction of minus strand synthesis 
efficiency, but not a complete abrogation of replication (Fig. 3.5.1, B; the SL9110 is designated as SL9170 
according to its position in the JFH-1 isolate sequence). Another proposed long-range interaction established 
between the bulge of the 5BSL3.2 and an apical loop of subdomain IIId of the IRES (Shetty et al. 2013), 
when affected by mutations within the IIId loop sequence (266–268GGG to CCC), resulted in an attenuated 
minus strand production (Fig. 3.3.3, C and D). The latter mutation is known to impair another interaction at 
the HCV RNA: the integrity of the subdomain IIId apical loop sequence was found critical for the 
recruitment of the 40S small ribosomal subunit (Kieft et al. 2001; Ji et al. 2004) (Fig. 4.3). In agreement with 
a proposed function of the 5BSL3.2 as a molecular switch between viral translation and replication 
(Tuplin et al. 2015; Romero-López and Berzal-Herranz 2017), the mutation of the SL IIId prevents a long-
range interaction that aims bringing the genomic ends together and therefore impair a switch to replication.  
4. Discussion 
96 
 
The above-mentioned interaction of the 5BSL3.2 with the SL2 (Fig. 4.2) that was reported to be 
required for overall viral replication in infectious HCV system (You and Rice 2008) was not challenged in 
scope of this work and can be addressed in further investigations. Controversial conclusions had been made 
on the exact role of this interaction in the HCV life cycle. Utilization of the full-length viral system 
complicates a dissection of a role in translation and/or replication by mutational analysis. An increase in 
observed viral replication efficiency when the 5BSL3.2(loop)-SL2 interaction is either intact or restored by 
compensatory mutations (You and Rice 2008) can indeed be due to the direct function of this LRI in 
replication or can be a result of impaired translation (Romero-López et al. 2012) that, in turn, indirectly shifts 
the balance to RNA synthesis. The latter observation is supported by the fact that an inhibitory effect on 
translation was relieved when the 5BSL3.2 or the 3’UTR regions alone were provided (Lourenço et al. 2008; 
Romero-López et al. 2012). Other studies, however, demonstrated either no 5BSL3.2-dependent effect on 
translation (Lee et al. 2004) or a contrasting positive effect (Tuplin et al. 2015); thus, further clarifications of 
the 5BSL3.2 function are required. 
 Findings on the role of RNA regulatory elements located within the protein coding region on the 
HCV genome postulate tuning of the overall virus production at different stages of the life cycle, however 
exact mechanisms are largely speculative. A majority of the cis-element candidates discovered recently by a 
combination of chemical probing, RNA structure modeling and functional assays (Mauger et al. 2015; 
Pirakitikulr et al. 2016) (Fig. 4.2) was not possible to challenge in scope of the present study. Some of them 
are claimed to engage only at late stages of virus production; another, such as SL8001, although predicted to 
limit the initial steps of replication, displays an indifferent effect in the cell culture model (Pirakitikulr et al. 
2016). One of the elements, annotated as SL8647 (Chu et al. 2013) and claimed to be required for efficient 
genome replication, for de novo infectivity (Chu et al. 2013) and for production of infectious virus (Mauger 
et al. 2015), has especially drawn our attention. A sequence located in an apical loop of the stem-loop 
structure was predicted to interact with the 3’UTR dimerization linkage sequence (DLS) (Fricke and Marz 
2016). Therefore, this sequence may play a role in conformational rearrangements during switching between 
replication and packaging and/or in genome dimerization and encapsidation (Ivanyi-Nagy et al. 2006; Shetty 
et al. 2010; Romero-López et al. 2014) (Fig. 4.2). In our experiments a construct harboring a mutated apical 
loop sequence within the element (designated as SL8680 according to its position in the JFH-1 isolate 
sequence) displayed a significantly lowered minus strand synthesis efficiency (Fig. 3.5.1, B), supporting the 
importance of this cis-element at the earlier stages of replication independently from packaging. Our 
replication system in further experiments can be applied for characterization of the other structural elements 
– J7880 and J8880 – predicted to positively affect HCV replication (Mauger et al. 2015) (Fig. 4.2); however 
possible interactions of these elements with the other RNA elements or cellular factors have not yet been 
determined.  
A comprehensive screening for novel potential cis-replication elements has been initiated in the 
current study. RNA sequences with a regulatory function on various stages of the viral life cycle are 
predominantly highly conserved among virus isolates and frequently exhibited as single-stranded stretches 
on highly-ordered structures. So far a relatively highly-structured NS5B coding region was a target for a 
screening for cis-elements (Fig. 4.2). Additionally, a replication-suppressive function was assigned to the 
SL6038 element within the NS4B coding sequence (Pirakitikulr et al. 2016), and a few functional RNA 
elements were discovered within the HCV Core-coding sequence (Fig. 4.1), as mentioned above. 
Nonetheless, other genomic regions largely stayed out of focus. In the present work, in the context of the 
minimal replication-competent SL I-II construct (Fig. 3.5.1, A), most of the HCV NS3 to NS5B protein 
coding sequence was permutated to essentially disable all potential RNA cis-elements, while retaining amino 
acid coding specificity, codon usage and codon pair bias (in analogy to Song et al. 2012), though retaining 
the known to be essential for replication 5BSL3.2 and downstream signals unaffected. Recoding of the ORF 
upstream the 5BSL3.2 element led to a pronounced reduction in replication efficiency (Fig. 3.5.1, B) 
emphasizing the need for more detailed research. In follow-up experiments the entire scrambled sequence 
should be subdivided and separately analyzed as chimeras with wild-type sequences in order to narrow down 
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prominent regions. Although of an immense effort, these experiments will assist a discovery of novel 
regulatory elements and likely a validation of the recently published ones. Additionally, the scrambled RNA 
template can also appear useful in follow-up trans-complementation experiments: such construct when 
providing intact replication proteins, but only selected cis-elements, may restore a function of a reduced 
reporter RNA construct.        
 
A discovery of novel cis-replication elements requires further investigation into their mechanism of 
action. Evolution of viral genomes maintains such elements conserved in sequence and structure, often as 
loops or internal bulges. The RNA regulatory elements on viral genomes serve for fine-tuning of molecular 
processes during a course of infection as well as to minimize requirements for proteins. Among the 
regulatory RNA elements some depend in their function on both sequence and structure, for others – 
structure plays a primary role and functionality of such elements can be rescued in mutational analysis by 
compensatory changes within a sequence of their interaction partner. RNA secondary structures may interact 
when located on a genome in close proximity or give rise to long-range interactions (LRI) that may bridge 
distances between a few hundred to several thousands of nucleotides. LRIs and their ultimate form – genome 
circularization – are well-understood to assist viral replication and other stages of life cycle, e.g. packaging. 
Genome circularization is proposed for many members of the Flaviviridae family, including HCV 
(Romero-López et al. 2009), some picornaviruses and retroviruses. Advantages of bioinformatic analysis 
nowadays enable computational prediction of novel RNA-RNA interactions, which however require 
meticulous validation. Potential LRIs occurring in the HCV genome were recently revisited by bioinformatic 
analysis using the ―LRIscan‖ program, which has largely confirmed the existing knowledge as well as 
proposed new possible interactions (Fricke and Marz 2016). The replication system presented in the current 
study can represent a useful tool for verification of long-range RNA interactions in the HCV context.   
Up to date only few RNA-RNA interactions were experimentally addressed by the system, such as 
interactions of the SL IIId and of RNA elements within the Core-coding region (see above). An attempt to 
experimentally demonstrate a circularization of the HCV genome has been undertaken. Generally, 
circularization of a viral genome is known to be mediated by RNA cis-elements and recruitment of 
trans-acting proteins; however protein-independent bridging of 5’- and 3’- genomic ends was reported for 
Dengue virus (Alvarez et al. 2005). For HCV, cellular and viral proteins are thought to assist a process of 
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genome circularization; although it remains unclear what is established first - the ends’ communication via 
RNA-RNA hybridization - or their approximation by proteins interacting with both ends. Fulfillment of 
sequence prerequisites for circularization of the HCV genome has been bioinformatically demonstrated 
(Fricke et al. 2015). Formation of an alternative stem-loop within the 3’UTR X-tail and exposure of the DLS 
sequence (Ivanyi-Nagy et al. 2006; Shetty et al. 2010) allow hybridization to the complementary sequence 
within the apical loop of the SL II in the 5’UTR. This primary contact was predicted to extend up to 62 nt 
leading to hybridization of the HCV 5’- and 3’- ends (Fricke et al. 2015). Mutational approaches to validate 
this interaction remain challenging due to the crucial importance of primary sequence conservation at the 
HCV 3’-end; one such attempt to prove circularization failed, most likely due to the fact that any changes in 
the extremely conserved 3’UTR renders the genome inactive and cannot be rescued by any compensatory 
mutations at the other genome end (Fricke et al. 2015). 
Indirect conclusions supporting the functional importance of the described interaction have been made 
from our experiments. Mutations introduced within a single-stranded stretch between SL I and II in the 
5’UTR, aiming to disable miR-122 binding at this region, abrogated the minus strand synthesis 
(Fig. 3.4.3, A), as expected due to the known function of miR-122 binding for the HCV replication (Jangra 
and Lemon 2010). However, application of correspondingly mutated miR-122 variants that restore 
miR-122/Ago complexes assembly at the RNA template could not rescue HCV replication (Fig. 3.4.3, B) 
that evidently implies a critical importance of primary sequence conservation for the minus strand synthesis 
in our experimental system. Taking together that, firstly, a utilization of an RNA construct lacking the HCV 
IRES uncouples HCV replication and translation, secondly, that an impact of mutations on functions of the 
3’-end of the minus strand in replication was minimized - the wild-type SL I-II construct does not support 
efficient plus strand synthesis (Fig. 3.6.1, A), and, lastly, that the miR-122 function in RNA stability was 
recovered due to Ago2 recruitment by mutated miR-122, the primary sequence itself must be concluded to be 
essential for replication. Several studies on miR-122 independent propagation support this assumption. An 
adaptation of the full-length HCV to mutations within the 5’UTR affecting miR-122 binding does not result 
in compensatory mutations to restore the miR-122 binding, but rather in alternative mutations that, 
nevertheless, reverted high replication rates (Hopcraft et al. 2016). Specific nucleotide changes introduced 
into the annotated very 5’-terminal HCV 5’UTR sequence (without altering the IRES activity) resulted in 
reduction of plus strand RNA synthesis on the minus strand 3’-end RNA template to various extents 
(Masante et al. 2008). Thus, apart from physical binding of miR-122 at the 5’UTR, efficient HCV replication 
appears to depend on RNA-RNA and/or RNA/protein interactions mediated by the 5’-end primary sequence 
of the annotated genome. A hypothesis that the primary sequence directly contributes to genome ends’ 
contacts initiated either by long-range RNA interactions or by RNA-binding proteins requires experimental 
evidence. Attempts to facilitate replication by artificial bridging of the HCV RNA constructs’ ends using 
complementary oligonucleotides did not provide any conclusive results likely due to rather subtle nature of 
genome rearrangements assisted by many different factors.       
Notably, a computational prediction of long-range interactions for HCV and other members of the 
Flaviviridae family underlined their dissimilar distribution along viral genomes. The HCV genome was 
characterized by abundance of LRIs at the 5’- and 3’- UTRs, whereas for Flavivirus genomes LRIs are 
presented at the 3’-end as well as in the protein coding sequence. Nevertheless, interactions between the very 
genomic ends are predicted for both Hepacivirus and Flavivirus RNA (Fricke and Marz 2016). Such 
differences in LRI distribution may suggest different strategies applied by these viruses for genome 
circularization. Flaviviruses, such as Dengue virus (DENV), West Nile Virus (WNV) and Yellow Fever 
Virus (YFV), are known to circularize via the 8 nt motifs (that can be extended) located within the ORF at 
the 5’-end and at the very terminus of the 3’-end, and the degree of base pairing rather than exact sequence 
affects replication efficiency (Khromykh et al. 2001). The Human Immunodeficiency Virus type 1 (HIV-1) 
was found to be dependent on the viral nucleic acid chaperone protein NC and the cellular poly(A)-binding 
protein (PABP) for genome circularization and rearrangements. For HIV, spontaneous protein assembly 
facilitates the bridging between the 5’- and 3’- ends (Beerens and Kjems 2010). In Luteovirus and 
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Tombusvirus direct base-pairing of genomic ends and formation of specific kissing complexes regulate 
multiple processes including the switch between translation and RNA replication (Edgil and Harris 2006). At 
last, undertaking of a circular conformation by cellular mRNAs is essential for efficient translation, for 
which it is promoted by a PABP interacting with 5’-cap binding proteins (Mazumder et al. 2003). While 
indispensable for mRNA, protein bridges often play a secondary role in circularization of viral genomic 
RNA. Given the contrast between organization of the Flavivirus and HCV genomic ends as well as distinct 
mechanisms of translation initiation, the HCV genome circularization is thought to be primed by 
RNA-binding proteins.  
Functions of selected cis-elements have been also extrapolated for the trans genomic RNA 
interactions. Existence of two alternative conformations of the 3’UTR X-tail (Fig. 4.2) had been shown both 
in vitro (Ivanyi-Nagy et al. 2006, Shetty et al. 2010) and bioinformatically (Fricke et al. 2015). The 
stem-loop originating from combination of SLs 2 and 3 exposes a short palindromic DLS motif (CUAG) in 
its apical loop that enables formation of RNA homodimers, leading to the speculation that HCV RNA 
genomes may dimerize. A validated kissing-loop interaction of the preceding SL2 with the apical loop of the 
5BSL3.2 (Fig. 4.2) implies dynamic rearrangements of the X-tail depending on a state of the viral genome. 
Interplay between either of the RNA elements shifts equilibrium to one of the processes with a dimerized 
genome being an intermediate form. Essential functional regions 5BSL3.2 and the HCV IRES were found to 
exert contrary control over RNA dimer formation (Romero-López and Berzal-Herranz 2017). Our reduced 
replication system can represent a tool for clarification of HCV genome dimerization requirements for the 
minus strand RNA synthesis. A possibility to uncouple the HCV antigenome synthesis from translation, 
while retaining essential RNA regulatory elements, may assist dissection of primary switch determinants. It 
has been clearly demonstrated in our experimental system that enabling of translation from the HCV IRES 
has a negative impact on the efficiency of viral RNA synthesis (Fig. 3.3.3, C and D). Solely disabling the 
translation event without affecting RNA-RNA interactions largely, but not entirely, restored the replication 
rates, underlining that translation and replication are mutually exclusive processes. Mechanistic aspects of a 
switch between HCV translation and replication are discussed below. 
Although specific aspects of the HCV plus strand synthesis initiation were out of focus of this work, 
extension of functional elements in RNA constructs enabled nascent plus strands production. All unmodified 
successors of the SL I-II construct (Fig. 3.2.1, A) displayed a various degree of genome RNA synthesis 
efficiency at the late time-points (Fig. 3.6.1, A). Largely controversial information had been published on 
RNA-element requirements for the HCV plus strand synthesis (Fig. 1.3.4). The studies utilizing in vitro 
system in the presence of the HCV RdRp (Astier-Gin et al. 2005; Masante et al. 2008) or replicon system 
(Friebe and Bartenschlager 2009) agree that SL I’ is indispensable for RNA synthesis initiation at the 3’-end 
of the HCV minus strand. However, reports on a role of the following SL IIz’ element are conflicting: the 
biochemical studies reveal an inhibitory impact (Astier-Gin et al. 2005), whereas in replicon system this 
sequence together with the third structural element SL IIy’ were found to contribute to efficient replication 
(Friebe and Bartenschlager 2009). Lastly, unlike genetic studies, the in vitro experiments emphasize the role 
of the SL IIIb’ structure in plus strand synthesis. Our data on a follow-up plus strand production indirectly 
points out the importance of the elements complementary to SL I and II. Indeed, the SL I-II construct 
demonstrated, although very low, ability for continuous replication (Fig. 3.6.1, A). It would be of a high 
interest to challenge a further truncated version of this RNA containing only the SL I at the 5’-end in order to 
rule out whether the basic levels of plus strand synthesis from it are due to inhibitory effect of the SL IIz’ 
sequence or a requirement for more downstream elements. Nevertheless, the SL I-III construct in our 
experiments displayed an utmost ability for ongoing replication even comparing to the 5’UTR and 
5’UTR-Core constructs capable of functional translation from the HCV IRES (Fig. 3.6.1, A). It is likely that 
determinants of the efficient minus strand RNA synthesis indirectly impact on abundance of plus strands, 
thus plus strand replication still remains to be dissected from the minus strand production. By the date 
translation is found to generally interfere with RNA synthesis: both versions of the 5’UTR containing 
constructs result in lowered plus strand synthesis rates. Although it remains to be confirmed by additional 
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experiments, the 5’UTR-Core construct displays a slightly higher abundance of both minus and plus strands, 
likely due to the presence of additional cis-elements (i.e. SL VI and SL 588) (Fig. 4.1) and therefore their 
complementary analogs on the minus strand, as well as due to an expression of the HCV Core protein. These 
aspects should be challenged by subsequent mutational analysis and assessed by tracking of the strands’ 
dynamics.  
Overall, the constructed replication system displays a high potential for investigation and clarification 
of debated aspects of HCV biology. In the setup presented in the current study the experimental system was 
not limited in viral (non-structural) and cellular protein determinants to focus on regulation of viral RNA 
synthesis. In particularly, with an emphasis on cis-replication RNA element prerequisites for antigenome 
synthesis, the following conclusions have been made. Uncoupled from other stages of the HCV life cycle, 
synthesis of the HCV minus strand RNA depends on certain 5’UTR sequences. Previously utilized replicon 
or full-length genome systems, although demonstrating strict requirements for these sequences, contained 
both HCV genomic ends and therefore could not clearly assign their role to minus or plus strand synthesis, or 
both. Our experiments evidently confirm that the initiation of the HCV antigenome synthesis from the 3’-end 
requires the SL I and II sequence at the 5’UTR. Moreover, minimal requirements for the HCV minus strand 
synthesis include a conservation of primary sequence within these elements, possibly to enable a genome 
circularization. The RNA replication template, lacking the HCV 5’UTR sequences, was confirmed to be 
incapable of minus strand synthesis, which was not possible to address in former systems due to a readout 
via overall replication and/or virus production, since HCV plus strand synthesis has to be initiated from the 
complementary sequences on the opposite strand. The more detailed investigation into the requirements 
within the SL I and II can be attempted in the future. Next, our replication system distinctly shows how 
further addition of the SL III significantly stimulates minus strand synthesis and enables a robust nascent 
plus strand production. The HCV SL I-III sequence not only allows an experimental construct for miR-122 
binding at the 5’UTR and for possible genome circularization, but also for interaction with a number of HCV 
RNA-binding proteins including the 40S small ribosomal subunit. Partial addressing these factors and 
mutations of known regulatory sequences within these SLs is key for the dissection of exact determinants for 
the HCV minus and plus strand synthesis. A 3-nt mutation in the subdomain IIId seriously impaired the 
minus strand replication that, regarding the absence of the HCV IRES directed translation, underlines an 
importance of the HCV genomic ends communication and approximation driven by the long-range 
interaction 5BSL3.2-SLIIId and/or the 40S subunit binding at both ends. An even more severe effect on 
replication is observed when functional translation from the HCV IRES is permitted. Notably, impairment of 
the genomic ends communication by the same mutation in the apical loop of the SL IIId, which primarily 
restricts translation, then improves RNA synthesis, pointing out a strong inhibitory effect of translation on 
replication. Overall, plus strand synthesis within the translation-competent construct is also comparably 
lower than of the translation-deficient construct. So far, mostly hypothetical models are available to illustrate 
a balance between the HCV translation and RNA synthesis. Lastly, in the context of minimal required 5’-end 
sequences the role of selected cis-elements located within a protein coding sequence on minus strand 
synthesis efficiency was demonstrated. RNA elements SL8680 and SL9170, which were previously 
annotated to be vital for overall replication efficiency, are suggested to exert their positive effects via 
interactions with the DLS and the 5BSL3.2(bulge), respectively. The latter, when enabled, may play a role in 
stabilization of genome conformation that favors RNA synthesis rather than translation. More yet 
undiscovered regulatory RNA elements may reside within the HCV coding sequence, as was demonstrated 
after non-directed scrambling of the HCV NS3-NS5B ORF. Nonetheless, an impact of a number of 
cis-elements on HCV replication is still to be clarified in future studies using the developed replication 
system.  
The concept of the system specifically focusing on minus strand synthesis – yet with a possibility to 
enable plus strand replication – can be potent for applications in context of the other plus strand RNA virus 
genomes. The minus strand replication system could serve to refine and analyze in-depth the information 
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obtained by full-length studies on such specific molecular step in viral life cycle as antigenome RNA 
synthesis. 
4.2 Role of miR-122 in HCV replication  
With discovery of the vast – and still expanding – variety of cellular microRNAs, enslavement of host 
miRNAs by viruses had been reported as one of the strategies for efficient virus propagation. Apart from a 
direct binding to the viral genome, miRNAs were found to exert their function via complex regulatory 
pathways. Viruses in turn can suppress an expression of antiviral and induce an expression of proviral 
cellular miRNAs. Moreover, many DNA viruses (e.g. HSV, HCMV and EBV) and some RNA viruses 
(e.g. WNV, HIV-1) even encode their own miRNAs to shape the virus-host interaction (Kincaid and Sullivan 
et al. 2012).  
There are several limiting factors, such as insufficient abundance of miRNAs in a particular cell type, 
that prevent its utilization by viruses. Among RNA viruses, HCV and its homologs (e.g. the GB virus B, 
GBV-B, the equine Non-Primate Hepacivirus, NPHV) take advantage of the highly abundant and 
liver-specific miR-122 that itself is virtually the major regulator of lipid metabolism and lipoprotein 
assembly in hepatocytes (Tsai et al. 2012), which is exploited by the HCV on site for lipoviral particle 
formation (Andre et al. 2005). MiR-122 appears to be the most influential host factor in the HCV life cycle 
that (together with receptor specificity and a dependence on lipid metabolism) determines a tropism of the 
HCV to hepatocytes (Yu et al. 2018). It can only be speculated, which of these factors have predetermined 
the tropism, however, the exploitation of miR-122 was most likely a secondary adaptation to enhance 
exploitation of the liver environment: the related Hepaciviruses that are only partly dependent on miR-122 
display a broader tissue tropism (Yu et al. 2018).  
Along with providing a favorable environment, miR-122 promotes the HCV life cycle via a direct 
function on the HCV RNA during translation and replication. Only few other RNA viruses are characterized 
by direct functions of cellular miRNAs on their genomes. An efficient replication of the Hepacivirus called 
NPHV (related to HCV) requires miR-122 binding to a single site at the genome 5’UTR (Kapoor et al. 
2011). For Bovine Viral Diarrhea Virus (BVDV), interaction of miR-17 and let-7 with the genomic 3’UTR 
was found critical for translation and viral RNA synthesis (Scheel et al. 2016). The miR-10a-3p was found to 
exert post-transcriptional regulation of Coxsackievirus B3 (CSB3) RNA via direct targeting of the 3D-coding 
sequence (Tong et al. 2013). Lastly, Poliovirus was recently reported to be dependent on miR-134 
(Orr-Burks et al. 2017). 
Its most well-known effects miR-122 exerts at the two adjacent conserved target sites S1 and S2 
(Fig. 3.4.1; Fig. 4.1) in the HCV 5’UTR (Jopling et al. 2005), which is in agreement with the strongest Ago 
binding mapped to these sites by CLIP (Luna et al. 2015). Since miR-122 was found to enhance overall HCV 
RNA accumulation via a modulation of translation (Henke et al. 2008), replication (Jopling et al. 2008) and 
RNA stability (Shimakami et al. 2012a,b), it remains a challenge to designate precise mechanisms of each of 
the miR-122 actions. The current study focuses on re-evaluation of the requirements for miR-122 binding to 
the HCV RNA in fulfillment of virus minus strand RNA synthesis. The developed system allowed 
uncoupling of the HCV minus strand synthesis from translation and largely from the plus strand synthesis. 
Mutations affecting miR-122 binding were generated within the experimental construct (Fig. 3.4.1, A), 
which contains all annotated target sites both at the 5’- and 3’- ends of the HCV genome, and provided an 
information on requirements for each of the sites in the HCV minus strand production.  
In agreement with published results, binding of miR-122 to the S1 and S2 binding sites at the 5’UTR 
was found essential for efficient antigenome synthesis (Fig. 3.4.3, A). Moreover, a weak ability for nascent 
plus strand synthesis, expressed by the wild-type SL I-II construct, was completely abrogated (Fig. 3.6.1, A). 
A confidently lower stability of the RNA replication template harboring the S1m and S2m sites in 
comparison to a replication-deficient GND construct in turn confirms the importance of these sites in 
protection of the viral RNA from exonucleolytic degradation (Fig. 3.6.3, F). However, the observed 
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difference in stability is not profound enough to be the only cause of impaired replication in our system. 
Indeed, a knockdown of the Xrn1 – the major 5’-exonuclease responsible for the HCV RNA degradation – 
fails to rescue a replication of HCV mutant defective in miR-122 binding to the 5’UTR (Li et al. 2013; 
Masaki et al. 2015). When an increased susceptibility to decay was compensated by application of 
correspondingly mutated miR-122 variants, replication was not restored (Fig. 3.4.3, B). This fact points out 
that, apart from physical binding of miR-122, the primary nucleotide sequence of the binding sites appears 
vital for efficient minus strand synthesis. This observation provides an indirect, but strong, argument for a 
role of SL I-II sequence in replication enhancement though genome circularization, as thoroughly discussed 
above. The latter can be primed by RNA-RNA long-range interactions (Fricke et al. 2015) and/or protein 
bridges, e.g. via PCBP2 protein that binds both to the SL I in the HCV 5’UTR and to the poly(U/C) tract in 
the 3’UTR (Wang et al. 2011). Notably, alternating occupation of the HCV 5’UTR by PCPB2 protein and 
miR-122 is proposed to mediate a switch between translation and replication (Masaki et al. 2015) that also 
underlines a critical role of primary sequence in regulation of the HCV replication by the SL I-II region.  
Although the S1 and S2 miR-122 binding sites have been hypothesized to unevenly contribute to each 
of the proposed functions in the HCV life cycle upon binding of miR-122 (Thibault et al. 2015), in the 
present study they were so far addressed only simultaneously. Taking into account that the two sites are 
located in highly conserved proximity from each other (Fricke et al. 2015) and that miR-122 binding occurs 
cooperatively (Thibault et al. 2015; Nieder-Röhrmann et al. 2017), separate addressing of the S1 and S2 sites 
may lead to misinterpretation of their individual functions due to generally weaker binding when only one of 
the two sites is mutated. Both of the 5’UTR sites were shown to equally and cooperatively contribute to 
HCV replication in the replicon system (Thibault et al. 2015); however it would be interesting to revisit this 
statement in the context of minus strand synthesis using our experimental system. Controversial results 
obtained by the replicon system (Thibault et al. 2015) suggested that miR-122 binding to the S1 site (and 
therefore the effect on replication) is not saturated in HuH-7.5 cells. In our experiments, using the wild-type 
SL I-II construct transfected into the same cell system, an ectopic supplementation with additional miR-122 
resulted in a highly variable, however insignificant, increase of replication efficiency (Fig. 3.4.3, B). This is 
an intriguing and under-investigated in the context of HCV replication matter that requires a further insight, 
when S1 and S2 miR-122 target sites are addressed separately.         
An importance of another cluster of miR-122 binding sites located at the 3’-end of the HCV genome 
(Fig. 4.1) was recognized relatively recently. These sites demonstrate an exceptional degree of conservation 
among the HCV isolates (Fricke et al. 2015) and mediate recruitment of miR-122/Ago2 complexes in a 
similar manner to the 5’UTR sites (Luna et al. 2015), implying their functional roles. Up to date 
contradictory results have been published regarding the roles of the 5B.2, 5B.3 and the 3’UTR S3 miR-122 
binding sites. There were indirect evidences of their functions in HCV translation and replication exerted 
independently of the miR-122 interaction with the 5’UTR target sites (Henke et al. 2008; Jangra and Lemon 
2010). Another study in replicon system (Nasheri et al. 2011) assigns an inhibitory role to the 5B.2 and S3 
target sites and mechanistically links it to slowing down actively translated ribosomes leading to negative 
modulation of the overall HCV production aiming at suppression of viral titers for purposes of escaping 
immune response evasion (Mahajan et al. 2009). A more recent study using the full-length HCV system 
demonstrated an overall stimulatory impact of the 5B.2 and - to a smaller extent - 5B.3 sites, but not S3, on 
total HCV RNA and protein levels (Gerresheim et al. 2017). In the present work roles of each individual 
miR-122 binding site at the HCV 3’-end in minus strand synthesis were challenged by mutational analysis. 
Mutations within each of the conserved sites (the non-conserved 5B.1 site was inactivated) were generated in 
the context of the replication construct harboring only SL I-II 5’UTR sequence (Fig. 3.4.1, A). In contrast to 
any of the previous studies, the 5B.3 and S3 site were found to be essential for antigenome synthesis, 
whereas the 5B.2 site was not found to contribute (Fig. 3.4.3, A and C). Strictly, this result is a unique 
finding and cannot be reviewed in the context of previous studies that were accounting for overall HCV 
production and incapable of dissection of virus antigenome synthesis from other steps of the life cycle.   
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Interestingly, an opposing effect on replication RNA constructs’ stability was observed upon these 
mutations: a mutation in the 5B.2 site significantly decreased the half-live time of the SL I-II construct, 
whereas mutations within the 5B.3 and S3 sites had no effect on RNA stability when compared to a 
corresponding replication-deficient GND construct (Fig. 3.6.3, F). Until the more in-depth research on the 
function of these sites is conducted, we can only hypothesize that the interactions at the 5B.2 site somehow 
mediate preservation of viral RNA, and at the 5B.3 and S3 sites – a direct modulation of minus strand 
replication. When evaluating a role of a selected miR-122 target site, it is also crucial to take into 
consideration that effector functions of miR-122 binding sites were reported to be dependent on the sites’ 
accessibility (Sagan et al. 2010; Gerresheim et al. 2017). Under the circumstances of highly ordered RNA 
structure of the NS5B coding region and the 3’UTR, a function of the 5B.1-5B.3 and S3 binding sites at a 
certain step of the viral life cycle may be determined by an actual conformation of the genome permitting or 
not an interaction of miR-122 with required sites. The RNA-RNA long-range interactions and RNA-protein 
interactions that reshape a genome conformation in favor of a particular process may play a key role in 
engaging miR-122 to its target sites, when needed. This fact can help an explanation why application of 
compensatory miR-122 variants (mutated in correspondence to each of the miR-122 binding sites) appeared 
insufficient to rescue an efficient minus strand synthesis (Fig. 3.4.3, C). Although the binding in vitro of 
mutated miR-122/Ago2 complexes to the targets was restored, the mutations may unpredictably affect the 
neighboring cis-elements’ communication.  
A dilemma whether miR-122 exerts its function via a physical interaction with a selected target site or 
indirectly by affecting the formation of RNA secondary structures and long-range interactions, or both, 
should be addressed in the future studies. It is not always possible to dissect functions of certain miR-122 
site(s) when the other(s) are mutated, as it was demonstrated for a series of the SL I-II_S1mS2m construct, 
since the mutations within the S1 and S2 sites already completely abrogate the RNA synthesis and moreover 
could not be rescued by compensatory miR-122 variants (Fig. 3.4.3, A). However, a combination of 
mutational analysis and application of antisense LNA oligonucleotides can offer a possible solution. In such 
an approach individual miR-122 sites can be obstructed without affecting the primary sequence by genome-
specific LNAs; or the anti-miR-122 LNA in combination with target sites’ mutations and compensatory 
miR-122 can be applied. The latter approach may recreate conditions of limiting miR-122 and point at 
prioritized targets of miR-122 binding and their functions. So far, the anti-miR-122 LNA/DNA mixmer was 
only utilized together with unmodified SL I-II construct and resulted in abolishment of the HCV replication 
and protein synthesis from the construct. Such effect of sequestering of cellular miR-122 by this LNA in the 
context of wild-type RNA primary sequence underlines an importance of physical binding of miR-122 for 
efficient minus strand synthesis (Fig. 3.4.3, B) and robust HCV production (Gerresheim et al. 2017).  
A more fundamental role of the miR-122 binding at the HCV genome 3’-end can be proposed. Often 
miRNAs target a 3’UTR of mRNAs, in part to prevent collusion of miR/Ago2 complexes with scanning or 
translating ribosomes. In contrast, an array of 3’-terminal miR-122 binding sites at the HCV genome is 
located just at the very end of a protein open reading frame. This suggests an inviting mechanism of 
functional ribosomes deceleration mediated by three to four miR-122/Ago2 complexes. A high degree of 
conservation of the 5B.2, 5B.3 and S3 binding sites among the HCV isolates as well as of distances between 
them (Fricke et al. 2015) strongly supports this assumption. Ribosome pausing is reported to occur during 
elongation or termination of translation and serve a quality control purpose in both pro- and eukaryotes 
(Buskirk and Green 2017). In HCV such elongation deceleration may serve to facilitate the nearly 
full-length, but still held at its C-terminus, NS5B RNA polymerase to find the 3’-end of an apparently intact 
genomic RNA target. Whence, the C-terminus of the HCV RdRp does not exert the enzymatic activity 
(Moradpour et al. 2004; Bartenschlager et al. 2010), the initiation of antigenome synthesis can be enabled 
even before completion of the NS5B protein assembly. This intriguing and yet to be confirmed function of 
the adjacent miR-122 binding sites in HCV replication is indirectly supported by our results. Indeed, 
dissimilar requirements for each of the 3’-end target sites suggest that the most upstream of the investigated 
sites 5B.2 is not required for minus strand synthesis initiation, whereas the 5B.3 and S3 site were found 
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indispensable for antigenome synthesis as well as for maintenance of continuous replication (Fig. 3.4.2, B). 
Controversially, in the full-length HCV system requirements for each of the 3’-end miR-122 binding sites on 
overall virus production were found to be right the opposite (Gerresheim et al. 2017). It has to be noted that 
our replication system provides an insight on the function of these sites selectively on minus strand synthesis 
uncoupled from other stages of the HCV life cycle. It can only be speculated whether the full-length virus 
possesses certain compensatory mechanisms to support efficient antigenome synthesis and which other yet 
undiscovered function do these binding sites implement during the HCV life cycle.  
At last, only little is known about possible roles of other miRNAs associated with the HCV infection. 
Several cellular miRNAs, such as miR-199a, let-7b, miR-181c, miR-448 and miR-196, were reported to bind 
at the genome 5’UTR and at the 3’-end (within the coding sequence and 3’UTR) and be implicated in 
suppression of the HCV RNA replication (Ojha et al. 2016). A negative impact on HCV propagation of these 
miRNAs suggests a therapeutic potential alternative to miR-122 sequestration (Lanford et al. 2010; Janssen 
et al. 2013), which requires unraveling of mechanistic details of action of these miRNAs. The replication 
system presented in the current study may assist in understanding of the roles of these as well as the other 
host factors acting on the HCV RNA in virus replication and representing a possible target for anti-HCV 
therapy.   
In conclusion, the developed replication system has succeeded to provide novel insights into such 
controversial aspects as a role of miR-122 in HCV replication, in particular in the minus strand synthesis. 
With regard to the influence of miR-122 on such aspects of the HCV life cycle as translation and stability, 
although thoroughly revised by the scientific community, open questions still remain. The current work 
confirms a positive role of miR-122 binding to the sites located at the 5’UTR, in addition underlining a 
requirement for intact 5’UTR SL I and II primary sequence for the HCV antigenome synthesis. Similar 
effects on efficiency of the HCV minus strand replication were observed when the downstream 3’-end 
miR-122 binding sites 5B.3 and S3 were challenged by mutational analysis. Principally, an action of 
miR-122 at both genome ends was demonstrated to modulate the HCV minus strand synthesis uncoupled 
from other molecular processes. On the one hand, this way of action is dependent on actual recruitment of 
miR-122/Ago2 complexes, as confirmed by sequestration of endogenous miR-122 by LNA. On the other 
hand, it depends on integrity of the primary sequence, as evident from the failure of rescue experiments 
using miR-122 variants with compensating mutations. Interestingly, supplementation of the experimental cell 
system with additional miR-122 did not result in a confident increase of replication rates. This points out that 
the amounts of miR-122 in HuH-7.5 cells are sufficient for its activities on the RNA replication constructs. 
Overall, a number of hypotheses require more detailed investigation empowered by further mutational 
analysis in the context of the developed system. One of them is an apparent significance of overlapping 
and/or adjacent RNA regulatory sequences and structures in a complex interplay between major molecular 
processes engaging viral RNA. Additional non-canonical roles of miR-122 binding to the HCV genome, 
such as ribosome pausing or switching the balance between translation and replication, require further 
studies. 
4.3 A balance between translation and replication  
A tight association and mutual dependence of all intracellular stages of the HCV life cycle together 
with a need for separating them in time and/or space suggest an existence of a strictly regulated balance 
between the processes. Early rounds of virus translation take place in the cytoplasm in association with the 
ER-membrane; however membrane compartments’ refinement is subsequently induced by viral proteins to 
form an optimal and enclosed environment for the HCV RNA synthesis. In these compartments – double-
membrane vesicles – antigenome synthesis followed by progeny plus strands replication take place. The 
latter induce new rounds of viral translation and replication and the switch between the two mutually 
exclusive processes is ought to be mindfully governed. Globally driven by shortage or excess of products of 
the HCV life cycle, the balance between translation and replication (and at the late stages – packaging) is 
currently thought to be regulated by an intricate interplay between structural RNA elements and host and 
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viral proteins simultaneously acting at one or two copies of the HCV genome. These cis-acting replication 
elements (as discussed above) and trans-acting factors (as described below) are generally entangled in 
multiple alternating interactions that profoundly complicate analysis of their individual function as well as of 
exact molecular prerequisites for each step of virus propagation. In the present study analysis of 
requirements for HCV minus strand synthesis enables a contribution to the state-of-the-art mechanism 
concerning a balance between translation and replication upon HCV infection.      
According to the current model, the HCV genome assumes a circular conformation at various stages of 
the life cycle to facilitate viral protein and RNA synthesis, as it is common for other members of the 
Flaviviridae family, which is supported by multiple experimental and computational studies. The HCV 
IRES, 5BSL3.2 and X-tail are thought to be the major elements establishing the RNA-RNA and 
RNA-protein communication and subsequent structural rearrangements of the genome. Following entry of 
the HCV genome into the cytoplasm, the viral RNA instantly engages in interaction with cellular proteins. 
The HCV 5’UTR serves as a binding platform for recruitment of the host translation machinery, in which the 
GGG sequence within subdomain SL IIId plays a key role in efficient and stable 40S ribosomal subunit 
binding, whereas the domain SL IIIabc is critical for the functional translation complex assembly (Kieft et al. 
2001). When the SL IIId is occupied by bound ribosomes and therefore is not available for long-range 
RNA-RNA interactions, the 5BSL3.2 is present in a closed conformation (i.e. interactions 5BSL3.2(loop)-
SL2 and 5BSL3.2(bulge)-SL9110) (Diviney et al. 2008; Tuplin et al. 2012; Shetty et al. 2013; 
Romero-López et al. 2014); and a potential interaction site with the RNA polymerase is likely occupied by 
hnRNP A1 protein (Ríos-Marco et al. 2016). The poly(U/C) tract at the 3’-end is occupied by PTB protein 
(Ito et al. 1998) that can in turn bridge the genome ends via an interaction with hnRNP L protein residing at 
the 5’UTR (Kim et al. 2000). The ends’ communication at the stage of translation is strongly supported by 
enhancement of translation in presence of the HCV 3’UTR (Song et al. 2006) and by a non-competing 
binding of the 40S subunit to both genomic ends (Bai et al. 2013). PCBP2 is another cellular protein that 
binds to both genomic ends at sites partially overlapping with miR-122 binding. All these RNA-protein 
interactions facilitate viral translation through protection of genome ends and recycling of ribosomes on a 
circular template (Fig. 4.3).  
 
Accumulation of viral proteins after several rounds of translation is thought to initiate genome 
rearrangements. The viral NS3 protease acts to cleave the polyprotein and to disintegrate the translation-
stimulating protein bridges (Fontanes et al. 2009; Wang et al. 2011). The latter is assisted by miR-122 
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displacing PCBP2 from the viral genome and freeing the 3’-end for purposes of replication complex 
formation (Masaki et al. 2015). Accumulating HCV Core protein displaces the 40S ribosomal subunit 
(Shimoike et al. 2006) freeing the subdomain IIId for a long-range interaction with the 5BSL3.2(bulge), 
thereby the 5BSL3.2 is present in an open conformation and restores the HCV genome circularization. This 
interaction in turn shifts equilibrium between 3’-X-tail conformations to the two stem-loops form with an 
exposure of the DLS region as well as of the three overhang nucleotides at the 3’-terminus of the HCV 
genome - the form that strongly favors RNA synthesis initiation (Romero-López et al. 2014). Originating 
from an interaction between inverted repeats within the DLS motifs, the homodimeric form of the 3’UTR 
was shown to be a preferential template for the NS5B replicase activity (Masante et al. 2015). Interestingly, 
biophysical studies indicate that in the absence of other interaction partners, the 5BSL3.2(loop)-SL2 is a 
preferred contact, in contrast to genomes’ dimerization (Cantero-Camacho and Gallego 2015). Therefore, 
maintenance of the actively replicating genome form requires a structural disruption of the three stem-loops 
conformation and stabilization of the two-stem loops form through RNA-RNA and RNA-protein 
interactions. Ultimately, an efficient switch to the latter has an impact on the genotype-dependent virulence 
(Tuplin et al. 2012). Nonetheless, at this step interaction of the 5BSL3.2(bulge) with either SL IIId or 
SL9110 are thermodynamically equal and alternate during antigenome synthesis, which occurs from 
dimerized or isolated genomic RNA templates. Under conditions of gradually accumulating plus strands, the 
two-stem loop conformation of the 3’-end is even further promoted and stabilized through formation of 
genome dimers interacting via the DLS. The following events additionally shift a balance during active 
replication. The 5BSL3.2(bulge)-SLIIId interaction itself modifies the three-dimensional organization of the 
HCV IRES altering its functionality; therefore an impairment of the 40S and eIF3 recruitment leads to a 
translationally-repressed state (Collier et al. 2002; Romero-López et al. 2012). Furthermore, the apical loop 
of the 5BSL3.2 recruits the viral RdRp (Zhang et al. 2005) that again interferes with the interaction 
5BSL3.2(loop)-SL2 and most importantly places the RNA polymerase in a close proximity to the 
3’-overhang.  
Undoubtedly, the recapitulated mechanism of a switch between translation and replication is an 
exceptionally entangled process, which is triggered by few key elements, but regulated and stabilized by a 
wide range of factors. Following early rounds of translation and replication sites’ formation, it can only be 
speculated how many rounds of translation/replication each individual viral RNA undergoes before the 
equilibrium is shifted towards one of the molecular processes. Apparently, the whole range of different 
functional conformational states can be found in the cell at a selected time-point and even subtle changes in 
local concentration of a certain product can promote a change of the genome’s function. As a substantial part 
of this work, an initiation of the HCV minus strand synthesis was dissected from translation and largely – 
from plus strand synthesis. Additionally, replication of the constructs containing various fragments of the 
HCV 5’UTR - and ultimately the complete 5’UTR followed by the Core-coding sequence – was 
investigated. The constructs including the HCV 5’UTR sequence SL I-III and further, although permitting 
both genomic and antigenomic strands production, shed light on the complex interplay between the 
functional elements balancing HCV RNA and protein synthesis.  
An assessment of various cis-acting replication elements in the context of the SL I-II construct enabled 
narrowing down the HCV RNA synthesis requirements independently of translation driven from the HCV 
IRES, as discussed in detail above. Notably, an ability of this construct for minus strand and even weak plus 
strand production (Fig. 3.6.1, A and B) is in agreement with the knowledge that replication of Flaviviruses 
does not require ongoing translation when non-structural viral proteins are provided (Westaway et al. 1999).  
However, a number of reports underline apparently non-overlapping, but overall positive, impact of 
translation on replication and vice versa. For instance, replication stimulation by miR-122 was shown to be 
dependent on active protein translation (Masaki et al. 2015). On the other hand, IRES-mediated translation 
initiation at the HCV 5’UTR is promoted in presence of the 3’UTR (Song et al. 2006). As a matter of fact, 
the mutual dependence of the HCV translation and replication most likely occurs as a result of engagement 
of the same set of cis-elements and/or host factors and from using the overall virus production as an 
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experimental readout. The latter represents the major limitation of the HCV full-length or replicon systems 
that was attempted to overcome in the present study.  
Our results demonstrate a substantial improvement of minus strand synthesis efficiency as well as 
establishment of robust plus strand synthesis solely upon addition of the SL III downstream the SL I-II 
sequence at the constructs’ 5’-end (Fig. 3.2.3, C and D). The HCV SL I-III sequence at the 5’UTR represents 
an incomplete IRES and alone is not sufficient for functional translation initiation. In turn, SL III plays an 
essential role in the 40S subunit binding at the HCV 5’UTR (Spahn et al. 2001) as well as in binding of the 
translation initiation factor eIF3 (Kieft et al. 2001). Importantly, the affinity of eIF3 is largely enhanced 
when preceded by the 40S recruitment (Siridechadilok et al. 2005). Therefore, the high replication rates 
displayed by the SL I-III construct in our study (Fig. 3.6.1, A and B) most likely originate from increased 
ability for the genome ends to communicate via protein bridges. Indeed, the experimental constructs SL I-II 
and SL I-III harbor identical cis-replication elements at the genome’s 3’-end, but the effector function of 
those may differ drastically depending on a dimensional conformation of the RNA template. Although the 
SL I-II construct provides sufficient sequences and structures for RNA synthesis initiation at the 5’- and 3’- 
ends, the protein binding platform at its 5’-end is largely reduced in comparison to the SL I-III construct. 
Such a strong requirement specifically for the SL III presence suggests the role of several cellular proteins in 
protein-mediated bridging of the RNA ends. As already mentioned above, the 40S small ribosomal subunit 
was found to bind in a non-overlapping manner to both 5’- and 3’- genome ends via SL III and poly(U/C) 
tract, respectively. In a situation when translation from the HCV IRES is permitted, such interaction would 
serve circularization of the RNA template for purposes of efficient translation. Conversely, in context of the 
translation-incompetent SL I-III construct the closed RNA form can facilitate the long-range interactions that 
are beneficial for replication, however omitting a competition with translation for the same template. The 
PCBP2 is another protein that can bind to both HCV genomic ends and potentially promote replication via a 
protein bridge formation. Notably, PCBP2 is characterized by two binding platforms at each of the genome 
ends; within the HCV 5’UTR these are the SL I and the SL III pseudoknot (Spangberg and Schwartz 1999; 
Wang et al. 2011). The first of these two platforms at the very 5’-end may mediate a circularization of the 
SL I-II replication template, although less efficiently as for the SL I-III construct. Thus, the PCBP2-mediated 
circularization of the SL I-II construct may contribute to replication rates observed for this RNA. 
Importantly, as for the 40S ribosomal subunit, the PCBP2 protein is known to stimulate translation in 
non-reduced systems, however in our experimental setup they appear beneficial for RNA synthesis due to an 
absence of competition for a template between translation and replication. Lastly, in presence of SL I-III 
sequence at the construct’s 5’-end, the cellular RNA chaperones NF90/NF45 (Isken et al. 2007) can facilitate 
genomic RNA circularization via binding to the SL III pseudoknot and to SL3 at the 5’- and 3’- genome 
ends, respectively. The presence of the 5BSL3.2 was demonstrated to be required for replication stimulation 
by these chaperons (Schmidt et al. 2017) that additionally testifies for a role of protein bridges in the genome 
ends’ approximation for purposes of establishment of beneficial long-range RNA-RNA interactions. The key 
LRI occurring between the 5’- and 3’- end in circularization is the 5BSL3.2(bulge)-SLIIId interaction. This 
interaction, established in the full-length HCV genome after displacement of the translating ribosome, is 
thought to be involved in genome’s reshaping that represses translation and favors minus strand synthesis 
initiation. 
Despite the fact that all described RNA-protein and RNA-RNA interactions are possible in context of 
the 5’UTR construct, it displays a seriously impaired ability for minus and plus strand synthesis (Fig. 3.3.3, 
C and D; Fig. 3.6.1, A and B). Besides, overall lower translation efficiency was observed at later time-points 
for this RNA template, which reflects the reduced amount of available templates for protein synthesis due to 
inefficient replication (Fig. 3.3.3, B; Fig. 3.6.2, C). The nature of these differences between the SL I-III and 
5’UTR constructs lays in enabling of functional translation initiation from the HCV IRES. This translation 
virtually does not result in any useful protein product and the ORF sequence (36 nt) does not contribute with 
any vital RNA regulatory elements. Furthermore, when the vital elements contained within the Core-coding 
sequence and functions fulfilled by the Core protein itself are provided by the 5’UTR-Core replication 
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construct, the efficiency of RNA synthesis remains virtually the same (3.6.1, A and B). The comparison of 
the replication rates from the SL I-III and 5’UTR/5’UTR-Core constructs evidently demonstrates a 
repressive effect of translation from HCV IRES on antigenome and genome RNA synthesis. Apparently, the 
above-mentioned RNA-protein interactions, e.g. with the 40S subunit or the PCBP2, in presence of a 
complete HCV IRES followed by an ORF prioritize HCV translation over replication. The cellular and viral 
determinants essential for RNA synthesis initiation are now insufficient to override active translation, and the 
overall rates of replication decrease due to the need to compete for an RNA template.  
In an attempt to shift a balance from the HCV translation to replication, two principal sites within the 
HCV IRES were targeted by mutational analysis. The three point mutations within the apical loop of the 
subdomain IIId (IIId*) had been found crucial for both long-range interaction with the 5BSL3.2(bulge) 
(Shetty et al. 2013) and for efficient binding of the 40S ribosomal subunit (Kieft et al. 2001; Ji et al. 2004). A 
deletion of the subdomain IIIb (ΔIIIb) was demonstrated to be sufficient for abrogation of the eIF3 binding, 
importantly without affecting the 40S subunit recruitment (Kieft et al. 2001; Ji et al. 2004). Despite an 
incomplete reduction of the affinity of the 40S binding by the IIId* mutation; it subsequently impairs the 
eIF3 attachment (Siridechadilok et al. 2005) that makes translation from the mutated IRES highly 
improbable. Strikingly, a deterioration of translation initiation by prevention of the eIF3 binding to the HCV 
IRES led to the most pronounced increase in replication rates of the 5’UTR_ΔIIIb construct (Fig. 3.3.3, 
C and D). A smaller positive effect acquired by the IIId* mutation is in agreement with an importance of the 
IIId loop for RNA-RNA communication. Indeed, for the SL I-III construct, whose replication is not slowed 
down by functional translation, this mutation resulted in a significant reduction of minus strand synthesis 
(Fig. 3.3.3, C and D), suggesting both the 40S subunit and LRIs to play an important, but not essential, role 
in RNA synthesis. Nevertheless, despite a negative impact of abrogation of these interactions in the context 
of the 5’UTR construct, disallowance of active translation overrides the converse effect and results in 
elevated replication.  
An alternative explanation for the reduction of replication efficiency after inclusion of additional 
annotated 5’UTR sequences may include events taking place at the 3’-end of the antigenome minus strand. 
Inclusion of more sequences upstream of the 3’-end of the minus strand, compared to those sequences in the 
minus strand 3’-end provided by the SL I-III construct, may result in inhibition of initiation of plus strand 
synthesis at the minus strand 3’-end. However, in our opinion this explanation appears less likely, in 
particular since very distinct mutations (deletion of the SL IIIb sequences or mutation of only three 
nucleotides in the SL IIId) have profound effects on enhancing minus strand synthesis in the 5’UTR 
construct but not in the SL I-III construct. 
The next degree of complexity to this interplay was added with the full-length Core-coding sequence 
included downstream the HCV IRES. The Core protein itself is known to shift equilibrium from translation 
to replication via a negative feedback mechanism: accumulating Core protein signals for sufficient protein 
synthesis by competing with the 40S subunit and eventually displacing it and promoting the cis-elements 
contacts and genome dimensional rearrangements in favor of RNA replication. Moreover, the Core-coding 
sequence contains cis-elements (Fig. 4.1) with various impact on the HCV replication (McMullan et al. 
2007; Vassilaki et al. 2008), as discussed above. The similarly decreased minus strand synthesis efficiency 
displayed by the 5’UTR-Core, as for the 5’UTR constructs, indicates that the beneficial function of the Core-
coding sequence and the protein itself are not sufficient to override the inhibiting effect of translation 
initiated from the HCV IRES. The mutational analysis in context of the 5’UTR-Core construct yet remains to 
be performed in follow-up experiments. Functions of additional cis-elements within the Core-coding 
sequence on antigenome synthesis and overall replication is to be evaluated in the absence of suppressive 
effect from functional translation initiation. Ultimately, effects of double-mutants IIId*/ΔIIIb should be 
assessed in comparison to single mutated variants for all developed SL III-containing constructs in order to 
challenge a contribution of the subdomain IIId when translation from the HCV IRES is restricted.  
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In conclusion, uncoupling of RNA and protein synthesis in scope of the designed experimental system 
allowed isolating the requirements for the HCV replication. It was evidently demonstrated upon extension of 
the 5’-end sequence – up to the full-length HCV IRES followed by an open reading frame – that a functional 
translation initiation event inhibits minus strand synthesis initiation at the 3’-end, likely due to corresponding 
genome rearrangements and template limitations. Indeed, the molecular processes of the HCV translation 
and antigenome RNA synthesis use the same genome RNA template for initiation. In order to avoid 
collusions of the HCV RNA polymerase with translating ribosomes, the regulatory RNA elements with 
assistance of trans-acting proteins reshape the genome to a conformation favoring one of the processes and 
repressing another. Both efficient HCV translation and replication appear to rely on genome template 
circularization mediated however by distinct RNA-RNA and RNA-protein interactions. Since the subsequent 
addition of the HCV 5’UTR sequences results in robust plus strand replication, future attempts to dissect this 
process from minus strand production in the presence and absence of active translation should be made. This 
would imply perspective dissection of requirements for the HCV genome synthesis independently of the 
antigenome synthesis, which is a general challenge for plus strand RNA viruses.   
4.4 Conclusions and open questions   
In scope of the present work vital aspects of the HCV minus strand synthesis uncoupled from plus 
strand synthesis and HCV translation were revisited using the minus strand replication system. This system 
attempts to overcome limitations of the full-length genome or replicon systems containing both genome ends 
and therefore being unable to assign the overlapping effects of cis-elements to distinct steps of RNA 
replication. Up to date the special focus on the cis-elements engaged in minus strand RNA synthesis 
provided evidence that sequences at the 5’-end of the HCV genome are required for minus strand synthesis 
initiation at the 3’-end. This process, when uncoupled from other steps of the HCV life cycle, appears to 
depend on liver-specific miR-122 and on several previously annotated RNA regulatory elements within the 
NS5B-coding region as well as on certain yet unknown cis-elements in the HCV polyprotein coding 
sequence. Enabling of functional translation initiation from the HCV IRES was demonstrated to have a 
strong suppressive effect on antigenome synthesis. Although this research has provided an insight into major 
debatable aspects of the HCV minus strand synthesis regulation, it raises a number of succeeding questions. 
Among the questions that are to be answered by subsequent experiments is a more detailed 
investigation into the 5’UTR sequence requirements for efficient HCV minus strand synthesis, for which a 
comprehensive mutational analysis can be conducted. Moreover, this direction of the study would indirectly 
assist a determination of the requirements for a follow-up plus strand synthesis initiation, displayed by some 
of the experimental constructs. In this context the constructs characterized by robust continuous replication 
are ultimate targets for mutagenesis. Thereby, the separate analysis of minus and plus strand synthesis may 
be improved by a further increase in specificity and sensitivity, in particular of minus strand detection. 
Further insight into protein-mediated regulation of observed competition between translation initiation and 
RNA synthesis needs to be acquired, perhaps by knockdown approach to confirm the roles of potential 
trans-acting factors in this balance. The role of the proteins functioning on the HCV RNA in genome 
circularization is also a vital point for further investigation. Despite the fact that mutational analysis within 
essential cis-replication elements does not always yield results due to distraction of vital RNA-RNA 
interactions, targeting of the host factors acting on these elements may provide a solution. Roles of under-
investigated cellular determinants of the HCV minus and plus strand synthesis, such as miRNAs, long 
non-coding RNAs and RNA-binding proteins, in particular tissue-specific host factors, can be addressed in 
long-term studies by the system developed in this work. Furthermore, the system offers a potential for in situ 
localization of replication complexes. Any defects upon application of reduced genome RNA template 
and/or provision of replication determinants in trans can be identified using a fluorescent Spinach aptamer. 
Controversial aspects of the HCV-induced autophagy and subsequent suppression of host immune response 
and their effects on virus replication can be addressed in cell culture using the reduced, but robustly 
replicating RNA constructs. Ultimately a panel of replication constructs addressing distinct points of RNA 
4. Discussion 
110 
 
synthesis is to be established to make its concept easily adjustable for the analysis in other plus strand RNA 
virus genomes. 
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6. Appendix 
6.1 Plasmid maps 
6.1.1 pFK-JFH1-J6 C-846_dg (JC1)_12961 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
5’UTR HCV 5’UTR untranslated region 18-357 
Core HCV Core-coding sequence 358-930 
E1 HCV E1 glycoprotein coding sequence 931-1506 
E2 HCV E2 glycoprotein coding sequence 1507-2607 
p7 HCV p7 polypeptide coding sequence 2608-2796 
NS2 HCV NS2 protein coding sequence 2797-3447 
NS3 HCV NS3 protein coding sequence 3448-5340 
NS4A HCV NS4A protein coding sequence 5341-5502 
NS4B HCV NS4B protein coding sequence 5503-6285 
NS5A HCV NS5A protein coding sequence 6286-7683 
NS5B HCV NS5B protein coding sequence 7684-9459 
3’UTR HCV 3’-untranslated region 9460-9695 
HDV Hepatitis D Virus genomic ribozyme 9696-9779 
T7T T7 RNA Polymerase terminator 9845-9891 
T3  T3 RNA Polymerase promoter (RC) 9931-9950 
pBR322 ori pBR322 origin of replication 9954-12945 
Amp R Ampicillin resistance gene (RC) 10162-11019 
2000
4000
6000
8000
10000
12000
BsiWI
NotI
AflII
BbvCI
BlnI
SanDI
RsrII
BsrGI
HindIII
SnaBI
SexAI
SfiI
SrfI
EcoRV
AscI
SgrAI
MluI
SspI
PvuI
AseI
Eco47III
FspAI
SbfI
5´UTR
Core
E1
E2
p7
NS2
NS3
NS4A
NS4BNS5A
NS5B
3´UTR
HDV 
T7T
T3
pBR322 ori
AmpR
T7 
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6.1.2 pUC18_Plus_strand_backbone_4374 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
Stem-loop  40 nt GC-rich stem-loop sequence 25-64 
S1 Aptamer S1 Streptavidin aptamer sequence 72-116 
Spinach aptamer_RC Reverse complement of Spinach RNA 
aptamer sequence  
163-260 
EMCV IRES Encephalomyocarditis Virus Internal 
Ribosome Entry Site 
300-855 
NS3*_238 nt Partial wild-type NS3 sequence (238 nt) 862-1099 
Linker40 A random 40 nt linker sequence 1100-1139 
NS5B*_209 nt Partial wild-type NS5B sequence (209 nt) 1140-1348 
3’UTR HCV 3’-untranslated region 1349-1584 
HDV Hepatitis D Virus genomic ribozyme 1585-1671 
T7T T7 RNA Polymerase terminator 1672-1718 
Amp R Ampicillin resistance gene (RC) 2895-3755 
 
 
 
 
1000
2000
3000
4000
AflII
FseI
MluI
XbaI
NotI
BbvCI
AscI
EcoRI
SbfI
T7 
Stem-loop
S1 Aptamer
Spinach aptamer_RC
EMCV IRES
NS3*_238 nt 
Linker40
NS5B*_209 nt
3´UTR
HDV
T7T
AmpR
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6.1.3 pUC18_Minus_strand_backbone_4685 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
Stem-loop  40 nt GC-rich stem-loop sequence 25-64 
S1 Aptamer S1 Streptavidin aptamer sequence 72-116 
Spinach aptamer_RC Reverse complement of Spinach RNA aptamer 
sequence  
163-260 
EMCV IRES Encephalomyocarditis Virus Internal Ribosome 
Entry Site 
300-855 
Linker50-1 A random 50 nt linker sequence 864-913 
Linker50-2 A random 50 nt linker sequence 920-969 
Linker40 A random 40 nt linker sequence 976-1015 
NS5B*_SCR_55 nt Partial scrambled NS5B sequence (55 nt) 1016-1070 
NS5B*_WT_154 nt Partial wild-type NS5B sequence (154 nt) 1071-1224 
IRES+Core*_RC Reverse complement of HCV Internal Ribosome 
Entry Site followed by a partial HCV Core-coding 
sequence (325 nt)  
1231-1895 
HDV Hepatitis D Virus genomic ribozyme 1896-1982 
T7T T7 RNA Polymerase terminator 1983-2029 
Amp R Ampicillin resistance gene (RC) 3206-4066 
1000
2000
3000
4000
AflII
FseI
MluI
XbaI
NotI
NsiI
BsrGI
AscI
EcoRI
SbfI
T7 
Stem-loop
S1 aptamer
Spinach aptamer_RC
EMCV IRES 
Linker50-1
Linker50-2
Linker40
NS5B*_SCR_55 nt
NS5B*_WT_154 nt
IRES+core*_RC
HDV
T7T
AmpR
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6.1.4 pUC18_Fragment 1_NS5B_SCR_4157 
 
Feature Description Start – Stop (nt) 
NS5B*_SCR_1516 nt Partial scrambled NS5B sequence (1516 nt) 1-1516 
Amp R Ampicillin resistance gene (RC) 2693-3553 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1000
2000
3000
4000
BsrGI
AscI
NS5B* _SCR_1516 nt
AmpR
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6.1.5 pUC18_Fragment 2_NS3-NS5B_SCR_5148 
 
Feature Description Start – Stop (nt) 
NS3*_SCR_31 nt Partial scrambled NS3 sequence (31 nt) 1-31 
NS4A_SCR Scrambled NS4A coding sequence  32-193 
NS4B_SCR Scrambled NS54B coding sequence  194-976 
NS5A_SCR Scrambled NS5A coding sequence  977-2374 
NS5B*_SCR_120 nt Partial scrambled NS5B sequence (120 nt) 2375-2494 
Amp R Ampicillin resistance gene (RC) 3671-4531 
 
 
 
 
 
 
 
 
 
 
 
 
1000
2000
3000
4000
5000
NsiI
BsrGI
NS3*_SCR_31 nt
NS4A_SCR
NS4B_SCR
NS5A_SCR
NS5B*_SCR_120 nt
AmpR
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6.1.6 pUC18_Fragment 3_NS3_SCR_4515 
 
Feature Description Start – Stop (nt) 
NS3*_SCR_1868 nt Partial scrambled NS3 sequence (1868 nt) 1-1868 
Amp R Ampicillin resistance gene (RC) 3045-3905 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1000
2000
3000
4000
NsiI
NotI
NS3*_SCR_1868 nt
AmpR
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6.1.7 pUC18_P.s_WT_hp_9899 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
Stem-loop  40 nt GC-rich stem-loop sequence 25-64 
S1 Aptamer S1 Streptavidin aptamer sequence 72-116 
Spinach aptamer_RC Reverse complement of Spinach RNA aptamer 
sequence 
163-260 
EMCV IRES Encephalomyocarditis Virus Internal Ribosome 
Entry Site 
300-855 
NS3 Wild-type NS3 coding sequence 862-2754 
NS4A Wild-type NS4A coding sequence 2755-2916 
NS4B Wild-type NS4B coding sequence 2917-3699 
NS5A Wild-type NS5A coding sequence 3700-5097 
NS5B Wild-type NS5B coding sequence 5098-6873 
3’UTR HCV 3’-untranslated region 6874-7109 
HDV Hepatitis D Virus genomic ribozyme 7110-7196 
T7T T7 RNA Polymerase terminator 7197-7243 
Amp R Ampicillin resistance gene (RC) 8420-9280 
 
2000
40006000
8000
AflII
FseI
MluI
XbaI
NotI
BbvCI
BsrGI
AscI
EcoRI
SbfI
T7 
Stem-loop
S1 Aptamer
Spinach aptamer_RC
EMCV IRES
NS3
NS4A
NS4B
NS5A
NS5B
3´UTR
HDV
T7T
AmpR
6. Appendix 
134 
 
6.1.8 pUC18_P.s _SCR_hp_9899 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
Stem-loop  40 nt GC-rich stem-loop sequence 25-64 
S1 Aptamer S1 Streptavidin aptamer sequence 72-116 
Spinach aptamer_RC Reverse complement of Spinach RNA 
aptamer sequence  
163-260 
EMCV IRES Encephalomyocarditis Virus Internal 
Ribosome Entry Site 
300-855 
NS3_SCR Scrambled NS3 coding sequence 862-2754 
NS4A_SCR Scrambled NS4A coding sequence 2755-2916 
NS4B_SCR Scrambled NS4B coding sequence 2917-3699 
NS5A_SCR Scrambled NS5A coding sequence 3700-5097 
NS5B*_SCR_1636 nt Partial scrambled NS5B sequence (1636 nt) 5098-6721 
NS5B*_WT_152 nt Partial wild-type NS5B sequence (152 nt) 6722-6873 
3’UTR HCV 3’-untranslated region 6874-7109 
HDV Hepatitis D Virus genomic ribozyme 7110-7196 
T7T T7 RNA Polymerase terminator 7197-7243 
Amp R Ampicillin resistance gene (RC) 8420-9280 
 
2000
40006000
8000
AflII
FseI
MluI
XbaI
NotI
BbvCI
NsiI
XbaI
AscI
EcoRI
SbfI
T7 
Stem-loop
S1 Aptamer
Spinach aptamer_RC
EMCV IRES
NS3_SCR
NS4A_SCR
NS4B_SCR
NS5A_SCR
NS5B*_SCR_1636 nt
NS5B*_WT_152 nt
3´UTR
HDV
T7T
AmpR
6. Appendix 
 
135 
 
6.1.9 pUC18_Minus_strand_F1_6092 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
Stem-loop  40 nt GC-rich stem-loop sequence 25-64 
S1 Aptamer S1 Streptavidin aptamer sequence 72-116 
Spinach aptamer_RC Reverse complement of Spinach RNA aptamer 
sequence  
163-260 
EMCV IRES Encephalomyocarditis Virus Internal Ribosome 
Entry Site 
300-855 
Linker50-1 A random 50 nt linker sequence 864-913 
Linker50-2 A random 50 nt linker sequence 920-969 
NS5B*_SCR_1516 nt Partial scrambled NS5B sequence (1516 nt) 971-2479 
NS5B*_WT_152 nt Partial wild-type NS5B sequence (152 nt) 2480-2631 
IRES+Core*_RC Reverse complement of HCV Internal Ribosome 
Entry Site followed by a partial HCV Core-coding 
sequence (325 nt) 
2638-3302 
HDV Hepatitis D Virus genomic ribozyme 3303-3389 
T7T T7 RNA Polymerase terminator 3390-3436 
Amp R Ampicillin resistance gene (RC) 5515-5473 
1000
2000
3000
4000
5000
6000
AflII
FseI
MluI
XbaI
NotI
NsiI
BsrGI
XbaI
AscI
EcoRI
SbfI
T7
Stem-loop
S1 aptamer
Spinach aptamer_RC
EMCV IRES 
Linker50-1
Linker50-2
NS5B* _SCR_1516 nt
NS5B*_WT_152 nt
IRES+core*_RCHDV
T7T
AmpR
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6.1.10 pUC18_Minus_strand_F1_F2_8524 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
Stem-loop  40 nt GC-rich stem-loop sequence 25-64 
S1 Aptamer S1 Streptavidin aptamer sequence 72-116 
Spinach aptamer_RC Reverse complement of Spinach RNA 
aptamer sequence 
163-260 
EMCV IRES Encephalomyocarditis Virus Internal 
Ribosome Entry Site 
300-855 
Linker50-1 A random 50 nt linker sequence 864-913 
NS3*_SCR_31 nt Partial scrambled NS3 sequence (31 nt) 919-944 
NS4A_SCR Scrambled NS4A coding sequence  945-1106 
NS4B_SCR Scrambled NS54B coding sequence  1107-1889 
NS5A_SCR Scrambled NS5A coding sequence  1890-3287 
NS5B*_SCR_1636 nt Partial scrambled NS5B sequence (1516 nt) 3288-4911 
NS5B*_WT_152 nt Partial wild-type NS5B sequence (152 nt) 4912-5063 
IRES+Core*_RC Reverse complement of HCV Internal 
Ribosome Entry Site followed by a partial 
HCV Core-coding sequence (325 nt) 
5070-5734 
HDV Hepatitis D Virus genomic ribozyme 5735-5821 
T7T T7 RNA Polymerase terminator 5822-5868 
Amp R Ampicillin resistance gene (RC) 7045-7905 
2000
4000
6000
8000
AflII
FseI
MluI
XbaI
NotI
NsiI
BsrGI
XbaI
AscI
EcoRI
SbfI
T7
Stem-loop
S1 aptamer
Spinach aptamer_RC
EMCV IRES 
Linker50-1
'NS3*_SCR_31 nt
NS4A_SCR
NS4B_SCR
NS5A_SCR
NS5B*_SCR_1636 nt
NS5B*_WT_152 nt
IRES+core*_RC
HDV
T7T
AmpR
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6.1.11 pUC18_M.s_WT_hp_10334 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
Stem-loop  40 nt GC-rich stem-loop sequence 25-64 
S1 Aptamer S1 Streptavidin aptamer sequence 72-116 
Spinach aptamer_RC Reverse complement of Spinach RNA aptamer 
sequence  
163-260 
EMCV IRES Encephalomyocarditis Virus Internal Ribosome 
Entry Site 
300-855 
NS3 Wild-type NS3 coding sequence 862-2754 
NS4A Wild-type NS4A coding sequence 2755-2916 
NS4B Wild-type NS4B coding sequence 2917-3699 
NS5A Wild-type NS5A coding sequence 3700-5097 
NS5B Wild-type NS5B coding sequence 5098-6873 
IRES+Core*_RC Reverse complement of HCV Internal Ribosome 
Entry Site followed by a partial HCV Core-coding 
sequence (325 nt) 
6880-7544 
HDV Hepatitis D Virus genomic ribozyme 7545-7631 
T7T T7 RNA Polymerase terminator 7632-7678 
Amp R Ampicillin resistance gene (RC) 8855-9715 
 
2000
4000
6000
8000
10000
AflII
FseI
MluI
XbaI
NotI
NsiI
BsrGI
AscI
EcoRI
SbfI
T7 
Stem-loop
S1 aptamer
Spinach aptamer_RC
EMCV IRES 
NS3
NS4A
NS4B
NS5ANS5B
IRES+core*_RC
HDV
T7T
AmpR
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6.1.12 pUC18_M.s_SCR_hp_10334 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
Stem-loop  40 nt GC-rich stem-loop sequence 25-64 
S1 Aptamer S1 Streptavidin aptamer sequence 72-116 
Spinach aptamer_RC Reverse complement of Spinach RNA 
aptamer sequence  
163-260 
EMCV IRES Encephalomyocarditis Virus Internal 
Ribosome Entry Site 
300-855 
NS3_SCR Scrambled NS3 coding sequence 862-2754 
NS4A_SCR Scrambled NS4A coding sequence  2755-2916 
NS4B_SCR Scrambled NS54B coding sequence  2917-3699 
NS5A_SCR Scrambled NS5A coding sequence  3700-5097 
NS5B*_SCR_1636 nt Partial scrambled NS5B sequence (1636 nt) 5098-6721 
NS5B*_WT_152 nt Partial wild-type NS5B sequence (152 nt) 6722-6873 
IRES+Core*_RC Reverse complement of HCV Internal 
Ribosome Entry Site followed by a partial 
HCV Core-coding sequence (325 nt) 
6880-7544 
HDV Hepatitis D Virus genomic ribozyme 7545-7631 
T7T T7 RNA Polymerase terminator 7632-7678 
Amp R Ampicillin resistance gene (RC) 8855-9715 
2000
4000
6000
8000
10000
AflII
FseI
MluI
XbaI
NotI
NsiI
BsrGI
AscI
EcoRI
SbfI
T7
Stem-loop
S1 aptamer
Spinach aptamer_RC
EMCV IRES 
NS3_SCR
NS4A_SCR
NS4B_SCR
NS5A_SCR
NS5B*_SCR_1636 nt
NS5B*_WT_152 nt
IRES+core*_RC
HDV
T7T
AmpR
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6.1.13-14 pUC18_P.s_WT_SL I-II_wt_9968 / pUC18_P.s_WT_SL I-II_S1mS2m_9968 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
SL I (wt or S1mS2m  
miR-122 sites) 
HCV SL I sequence (with wild-type or mutated  
miR-122 binding sites S1 and S2) 
18-59  
(38-44 and 54-59) 
SL II HCV SL II sequence 60-134 
S1 Aptamer S1 Streptavidin aptamer sequence 141-185 
Spinach aptamer_RC Reverse complement of Spinach RNA aptamer 
sequence  
232-329 
EMCV IRES Encephalomyocarditis Virus Internal Ribosome 
Entry Site 
369-924 
NS3 Wild-type NS3 coding sequence 931-2823 
NS4A Wild-type NS4A coding sequence 2824-2985 
NS4B Wild-type NS4B coding sequence 2986-3768 
NS5A Wild-type NS5A coding sequence 3769-5166 
NS5B Wild-type NS5B coding sequence 5167-6942 
3’UTR HCV 3’-untranslated region 6943-7178 
HDV Hepatitis D Virus genomic ribozyme 7179-7265 
T7T T7 RNA Polymerase terminator 7266-7312 
Amp R Ampicillin resistance gene (RC) 8489-9349 
miR-122 binding site S1: 
GCCTGCCCCTAATAGGGGCGACACTCCGCCATGAATCACTCCCCT… mutated to S1m: 
GACTGCCCCTAATAGGGGCGAGACTACGCCATGAATCACTCCCCT… 
miR-122 binding site S2: 
GCCTGCCCCTAATAGGGGCGACACTCCGCCATGAATCACTCCCCT… mutated to S2m: 
GACTGCCCCTAATAGGGGCGAGACTACGCAGTGAATCTATCCCCT… 
2000
40006000
8000
FseI
MluI
XbaI
NotI
BbvCI
BsrGI
AscI
EcoRI
SbfI
T7 
SL I
SL I-II
S1 Aptamer
Spinach aptamer_RC
EMCV IRES
NS3
NS4A
NS4B
NS5A
NS5B
3´UTR
HDV
T7T
AmpR
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6.1.15-16 pUC18_P.s_WT_SL I-III_10182 / pUC18_P.s_WT_SL I-III_IIId mut_10182 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
SL I (wt miR-122 sites) HCV SL I sequence (with wild-type miR-122 
binding sites 1 and 2) 
18-59 (38-44 and 54-
59) 
SL II HCV SL II sequence 60-134 
SL III (wt or SL IIId mut) HCV SL III sequence (with wild-type or 
GGG→CCC mutation in SL IIId) 
135-346 (282-284) 
S1 Aptamer S1 Streptavidin aptamer sequence 355-399 
Spinach aptamer_RC Reverse complement of Spinach RNA 
aptamer sequence  
446-543 
EMCV IRES Encephalomyocarditis Virus Internal 
Ribosome Entry Site 
583-1138 
NS3 Wild-type NS3 coding sequence 1145-3037 
NS4A Wild-type NS4A coding sequence 3038-3199 
NS4B Wild-type NS4B coding sequence 3200-3982 
NS5A Wild-type NS5A coding sequence 3983-5380 
NS5B Wild-type NS5B coding sequence 5381-7156 
3’UTR HCV 3’-untranslated region 7157-7392 
HDV Hepatitis D Virus genomic ribozyme 7393-7479 
T7T T7 RNA Polymerase terminator 7480-7526 
Amp R Ampicillin resistance gene (RC) 8703-9563 
2000
4000
6000
8000
10000
FseI
MluI
XbaI
NotI
BbvCI
BsrGI
AscI
EcoRI
SbfI
T7 
SL I-III
SL II
SL III
S1 Aptamer
Spinach aptamer_RC
EMCV IRES
NS3
NS4A
NS4B
NS5A
NS5B
3´UTR
HDV
T7T
AmpR
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6.1.17 pUC18_P.s_WT_SL I-III_IIIb del_10136 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
SL I (wt miR-122 sites) HCV SL I sequence (with wild-type miR-122 
binding sites S1 and S2) 
18-59  
(38-44 and 54-59) 
SL II HCV SL II sequence 60-134 
SL III_IIIb del HCV SL III sequence a deletion of SL IIIb (46 nt; 
193-238 in wt) 
135-300  
S1 Aptamer S1 Streptavidin aptamer sequence 309-353 
Spinach aptamer_RC Reverse complement of Spinach RNA aptamer 
sequence  
400-497 
EMCV IRES Encephalomyocarditis Virus Internal Ribosome 
Entry Site 
537-1092 
NS3 Wild-type NS3 coding sequence 1099-2991 
NS4A Wild-type NS4A coding sequence 2992-3153 
NS4B Wild-type NS4B coding sequence 3154-3936 
NS5A Wild-type NS5A coding sequence 3937-5334 
NS5B Wild-type NS5B coding sequence 5335-7110 
3’UTR HCV 3’-untranslated region 7111-7346 
HDV Hepatitis D Virus genomic ribozyme 7347-7433 
T7T T7 RNA Polymerase terminator 7434-7480 
Amp R Ampicillin resistance gene (RC) 8657-9517 
2000
4000
6000
8000
10000
FseI
MluI
XbaI
NotI
BbvCI
BsrGI
AscI
EcoRI
SbfI
T7 
SL I-III
SL II
SL III
S1 Aptamer
Spinach aptamer_RC
EMCV IRES
NS3
NS4A
NS4B
NS5A
NS5B
3´UTR
HDV
T7T
AmpR
∆SLIIIb 
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6.1.18-19 pUC18_P.s_WT_5’UTR_sinfr_stop_10242 and 
pUC18_P.s_WT_5’UTR_sinfr_stop_IIId mut_10242 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
SL I (wt miR-122 sites) HCV SL I sequence (with wild-type miR-122 
binding sites S1 and S2) 
18-59 (38-44 and 54-
59) 
SL II HCV SL II sequence 60-134 
SL III (wt or SL IIId mut) HCV SL III sequence (with wild-type or 
GGG→CCC mutation in SL IIId) 
135-346 (282-284) 
SL IV HCV SL IV sequence 347-370 
sinfr_36 nt Short in-frame HCV Core-coding sequence 
(36 nt) followed by UGA stop codon 
358-393  
S1 Aptamer S1 Streptavidin aptamer sequence 415-459 
Spinach aptamer_RC Reverse complement of Spinach RNA 
aptamer sequence  
506-603 
EMCV IRES Encephalomyocarditis Virus Internal 
Ribosome Entry Site 
643-1198 
NS3 Wild-type NS3 coding sequence 1205-3097 
NS4A Wild-type NS4A coding sequence 3098-3259 
NS4B Wild-type NS4B coding sequence 3260-4042 
NS5A Wild-type NS5A coding sequence 4043-5440 
NS5B Wild-type NS5B coding sequence 5441-7216 
3’UTR HCV 3’-untranslated region 7217-7452 
HDV Hepatitis D Virus genomic ribozyme 7453-7539 
T7T T7 RNA Polymerase terminator 7540-7586 
Amp R Ampicillin resistance gene (RC) 8763-9623 
 
2000
4000
6000
8000
10000
FseI
MluI
XbaI
NotI
BbvCI
BsrGI
AscI
EcoRI
SbfI
T7 
SL I
5´UTR 
SL II
SL III
SL IV
sinfr_36 nt
S1 Aptamer
Spinach aptamer_RC
EMCV IRES
NS3
NS4A
NS4B
NS5A
NS5B
3´UTR
HDV
T7T
AmpR
6. Appendix 
 
143 
 
6.1.20 pUC18_P.s_WT_5’UTR_sinfr_stop_IIIb del_10196 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
SL I (wt miR-122 sites) HCV SL I sequence (with wild-type miR-122 
binding sites S1 and S2) 
18-59  
(38-44 and 54-59) 
SL II HCV SL II sequence 60-134 
SL III_IIIb del HCV SL III sequence a deletion of SL IIIb (46 nt; 
193-238 in wt) 
135-300  
SL IV HCV SL IV sequence 301-324 
sinfr_36 nt Short in-frame HCV Core-coding sequence (36 nt) 
followed by UGA stop codon 
312-347 
S1 Aptamer S1 Streptavidin aptamer sequence 369-413 
Spinach aptamer_RC Reverse complement of Spinach RNA aptamer 
sequence  
460-557 
EMCV IRES Encephalomyocarditis Virus Internal Ribosome 
Entry Site 
597-1152 
NS3 Wild-type NS3 coding sequence 1159-3051 
NS4A Wild-type NS4A coding sequence 3052-3213 
NS4B Wild-type NS4B coding sequence 3214-3996 
NS5A Wild-type NS5A coding sequence 3997-5394 
NS5B Wild-type NS5B coding sequence 5395-7170 
3’UTR HCV 3’-untranslated region 7171-7406 
HDV Hepatitis D Virus genomic ribozyme 7407-7493 
T7T T7 RNA Polymerase terminator 7494-7540 
Amp R Ampicillin resistance gene (RC) 8717-9577 
 
2000
4000
6000
8000
10000
FseI
MluI
XbaI
NotI
BbvCI
BsrGI
AscI
EcoRI
SbfI
T7 
SL I
5´UTR 
SL II
SL III
SL IV
sinfr_36 nt
S1 Aptamer
Spinach aptamer_RC
EMCV IRES
NS3
NS4A
NS4B
NS5A
NS5B
3´UTR
HDV
T7T
AmpR
∆SLIIIb 
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6.1.21-22 pUC18_P.s_SCR_SL I-II_wt_9968 and pUC18_P.s_SCR_SL I-II_ 
S1mS2m_9968 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
SL I (wt or S1mS2m 
miR-122 sites) 
HCV SL I sequence (with wild-type or mutated 
miR-122 binding sites S1 and S2) 
18-59  
(38-44 and 54-59) 
SL II HCV SL II sequence 60-134 
S1 Aptamer S1 Streptavidin aptamer sequence 141-185 
Spinach aptamer_RC Reverse complement of Spinach RNA aptamer 
sequence  
232-329 
EMCV IRES Encephalomyocarditis Virus Internal 
Ribosome Entry Site 
369-924 
NS3_SCR Scrambled NS3 coding sequence 931-2823 
NS4A_SCR Scrambled NS4A coding sequence  2824-2985 
NS4B_SCR Scrambled NS54B coding sequence  2986-3768 
NS5A_SCR Scrambled NS5A coding sequence  3769-5166 
NS5B*_SCR_1636 nt Partial scrambled NS5B sequence (1636 nt) 5167-6790 
NS5B*_WT_152 nt Partial wild-type NS5B sequence (152 nt) 6791-6942 
3’UTR HCV 3’-untranslated region 6943-7178 
HDV Hepatitis D Virus genomic ribozyme 7179-7265 
T7T T7 RNA Polymerase terminator 7266-7312 
Amp R Ampicillin resistance gene (RC) 8489-9349 
 
2000
40006000
8000
FseI
MluI
XbaI
NotI
BbvCI
MluI
NsiI
BsrGI
XbaI
AscI
EcoRI
SbfI
T7
SL I-II
SL II
S1 Aptamer
Spinach aptamer_RC
EMCV IRES
NS3_SCR
NS4A_SCR
NS4B_SCR
NS5A_SCR
NS5B*_SCR_1636 nt
NS5B*_WT_152 nt
3´UTR
HDV
T7T
AmpR
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6.1.23 pUC18_P.s_WT_hp_GND_9899 
For a plasmid map see 6.1.7. 
A replicase-deficient plasmid variant of pUC18_P.s_WT_hp_9899 (6.1.7) harboring a GND mutation 
(318D→N; Lohmann et al. 1997) within the NS5B RdRp gene (6049G→A).  
6.1.24 pUC18_P.s_WT_SL I-II_wt_GND_9968 
For a plasmid map see 6.1.13. 
A replicase-deficient plasmid variant of pUC18_P.s_WT_SL I-II_wt_9968 (6.1.13) harboring a GND 
mutation (318D→N; Lohmann et al. 1997) within the NS5B RdRp gene (6118G→A). 
6.1.25-27 pUC18_P.s_WT_SL I-II_wt_5B.2m_9968, pUC18_P.s_WT_SL I-II_ 
wt_5B.3m_9968 and pUC18_P.s_WT_SL I-II_wt_S3m_9968  
For a plasmid map see 6.1.13. The plasmids are generated by Nadia Dünnes. 
miR-122 binding site 5B.2: ACACTCC (6369-6375) mutated to 5B.2m: ACACAGC (6373-6374 
TC→AG); 
miR-122 binding site 5B.3: CACTCC (6774-6779) mutated to 5B.3m: GACACC (6774C→G and 
6777T→A); 
miR-122 binding site S3: ACACTCC (6960-6966) mutated to S3m: ACTCTGC (6962A→T and 
6965C→G). 
6.1.28-30 pUC18_P.s_WT_SL I-II_S1mS2m_5B.2m_9968, pUC18_P.s_WT_SL I-II_ 
S1mS2m_5B.3m_9968 and pUC18_P.s_WT_SL I-II_S1mS2m_S3m_9968  
For a plasmid map see 6.1.14. The plasmids are generated by Nadia Dünnes. 
miR-122 binding site 5B.2: ACACTCC (6369-6375) mutated to 5B.2m: ACACAGC (6373-6374 
TC→AG); 
miR-122 binding site 5B.3: CACTCC (6774-6779) mutated to 5B.3m: GACACC (6774C→G and 
6777T→A); 
miR-122 binding site S3: ACACTCC (6960-6966) mutated to S3m: ACTCTGC (6962A→T and 
6965C→G). 
6.1.31 pUC18_P.s_WT_SL I-III_GND_10182 
For a plasmid map see 6.1.15. 
A replicase-deficient plasmid variant of pUC18_P.s_WT_SL I-III_GND_10182 (6.1.15) harboring a 
GND mutation (318D→N; Lohmann et al. 1997) within the NS5B RdRp gene (6332G→A).  
6.1.32 pUC18_P.s_WT_5’UTR_sinfr_stop_10242 
For a plasmid map see 6.1.18. 
A replicase-deficient plasmid variant of pUC18_P.s_WT_5’UTR_sinfr_stop_10242 (6.1.18) harboring 
a GND mutation (318D→N; Lohmann et al. 1997) within the NS5B RdRp gene (6392G→A). 
6.1.33-34 pUC18_P.s_WT_SL I-II_wt_8680mut_9968 and pUC18_P.s_WT_SL I-II_ 
wt_9170mut_9968 
For a plasmid map see 6.1.13.  
Positions 6180-6187 in the apical loop of the NS5B cis-acting RNA element 8680 (in JFH-1 sequence; 
designated as J8640 in Mauger et al. 2015) in 6.1.13: 
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…CTTCACGG… mutated to 8680mut: …ATTTACCG… 
Positions 6670-6677 for the cis-acting RNA element 9170 (in JFH-1 sequence; designated as ―9110‖ 
in Diviney et al. 2008) in 6.1.13: 
…AGTCGGGC… mutated to 9170mut: … UCCAGAGC… 
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6.1.35 pUC18_P.s_WT_5’UTR_Core_10779 
 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
SL I (wt miR-122 sites) HCV SL I sequence (with wild-type miR-122 
binding sites S1 and S2) 
18-59  
(38-44 and 54-59) 
SL II HCV SL II sequence 60-134 
SL III  HCV SL III sequence  135-346  
SL IV HCV SL IV sequence 347-370 
HCV Core_stop HCV Core-coding sequence followed by a stop 
codon 
358-930 
S1 Aptamer S1 Streptavidin aptamer sequence 952-996 
Spinach aptamer_RC Reverse complement of Spinach RNA aptamer 
sequence  
1043-1140 
EMCV IRES Encephalomyocarditis Virus Internal Ribosome 
Entry Site 
1180-1735 
NS3 Wild-type NS3 coding sequence 1742-3634 
NS4A Wild-type NS4A coding sequence 3635-3796 
NS4B Wild-type NS4B coding sequence 3797-4579 
NS5A Wild-type NS5A coding sequence 4580-5977 
NS5B Wild-type NS5B coding sequence 5978-7753 
3’UTR HCV 3’-untranslated region 7754-7989 
HDV Hepatitis D Virus genomic ribozyme 7990-8076 
T7T T7 RNA Polymerase terminator 8077-8123 
Amp R Ampicillin resistance gene (RC) 9300-10160 
The plasmid and its derivatives 6.1.36-37 are generated by a Gesche Gerresheim. 
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6.1.36 pUC18_P.s_WT_5’UTR_Core_GND_10779 
For a plasmid map see 6.1.35. 
A replicase-deficient plasmid variant of pUC18_P.s_WT_5’UTR_Core_10779 (6.1.35) harboring a 
GND mutation (318D→N; Lohmann et al. 1997) within the NS5B RdRp gene (6929G→A). 
6.1.37 pUC18_P.s_WT_5’UTR_Core_IIIb del _10733 
For a plasmid map see 6.1.35. 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 1-18 
SL I (wt miR-122 sites) HCV SL I sequence (with wild-type miR-122 
binding sites S1 and S2) 
18-59  
(38-44 and 54-59) 
SL II HCV SL II sequence 60-134 
SL III_IIIb del HCV SL III sequence a deletion of SL IIIb 
(46 nt; 193-238 in wt) 
135-300  
SL IV HCV SL IV sequence 301-324 
Core HCV Core-coding sequence 312-884 
HCV Core_stop HCV Core-coding sequence followed by a stop 
codon 
906-950 
Spinach aptamer_RC Reverse complement of Spinach RNA 
aptamer sequence  
997-1094 
EMCV IRES Encephalomyocarditis Virus Internal 
Ribosome Entry Site 
1134-1689 
NS3 Wild-type NS3 coding sequence 1696-3588 
NS4A Wild-type NS4A coding sequence 3589-3750 
NS4B Wild-type NS4B coding sequence 3751-4533 
NS5A Wild-type NS5A coding sequence 4534-5931 
NS5B Wild-type NS5B coding sequence 5932-7707 
3’UTR HCV 3’-untranslated region 7708-7943 
HDV Hepatitis D Virus genomic ribozyme 7944-8030 
T7T T7 RNA Polymerase terminator 8031-8077 
Amp R Ampicillin resistance gene (RC) 9254-10114 
 
 
 
 
 
6. Appendix 
 
149 
 
6.1.38 pHCV-SIN_3235 
Feature Description Start – Stop (nt) 
T7  T7 RNA Polymerase promoter 3219-3235 
5’UTR HCV 5’-untranslated region 1-341 
Core Partial HCV Core-coding sequence (61 nt) 342-402 
Linker Partial firefly luciferase ORF 403-437 
3’UTR HCV 3’-untranslated region 438-658 
Amp R Ampicillin resistance gene (RC) 1877-2737 
 
6.1.39 pHCV-3’UTR only_3571 
Feature Description Start – Stop (nt) 
Sp6 SP6 RNA Polymerase promoter 1-21 
Linker Partial firefly luciferase ORF 22-62 
3’UTR HCV 3’-untranslated region 63-283 
Amp R Ampicillin resistance gene (RC) 1510-2370 
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6.2 Supplementary materials  
6.2.1 Assembly of DNA templates for minus and plus strand synthesis initiation    
The underlying concept for design of the reduced systems for HCV minus and plus strand replication 
initiation is described in detail in 4.1. This section illustrates the routine cloning procedures that were carried 
out for the system assembly. The products of each decisive restriction digest are depicted elucidating all the 
subsequent cloning steps. 
Suppl. Fig. 6.1 provides an overview on the assembly of a DNA template for the synthesis of the HCV 
minus strands. A backbone construct that mimics plus strand HCV RNA – plasmid 
pUC18_Plus_strand_backbone_4374 (plasmid map 6.1.2) – was chemically synthesized and inserted into 
pUC18 vector. It was designed to contain a short random linker sequence flanked by unique restriction sites - 
BbvCI and AscI. Short stretches of the HCV coding sequences were retained upstream and downstream the 
linker according to the cloning strategy. However, the majority of HCV NS3-NS5B coding sequence was 
derived from the plasmid pFK-JFH1-J6 C-846_dg_12961 (plasmid map 6.1.1) that encodes full-length HCV 
genome. Therefore, following the restriction digest of both plasmids by BbvCI/AscI endonucleases, the 
NS3-NS5B cassette was transferred into the backbone plasmid, resulting in the complete construct for minus 
strand synthesis initiation - pUC18_P.s_WT_hp_9899 – minimal ―hp‖ construct (plasmid map 6.1.7).       
An assembly of a DNA template for the HCV plus strand synthesis initiation required three cloning 
steps that are illustrated by Suppl. Fig. 6.2-6.4. In analogy to the construct described above, the backbone of 
the system was chemically synthesized. Similarly, this backbone was incorporated into a pUC18 vector, 
resulting in pUC18_Minus_strand_backbone_4685 (plasmid map 6.1.3), and designed to harbor three linkers 
separated by unique restriction sites: NotI, NsiI, BsrGI and AscI. To minimize costs, the plasmid was 
destined to contain scrambled NS3-NS5B cassette, in contrast to pUC18_P.s_WT_hp_9899 (plasmid map 
6.1.7), and an exchange of the cassettes between the backbones eventually allowed deriving the basic 
constructs in all four combinations. Only downstream 152 nt region of the NS5B coding sequence was 
maintained wild-type in both types of the cassette. Since the scrambled NS3-NS5B sequence was developed 
specifically for the project, it had to be newly synthesized. The length of the cassette required devision of the 
sequence into three parts that were subsequently inserted into the backbone. The first cloning step is depicted 
in Suppl. Fig. 6.2 and was accomplished via substitution of Linker40 with the Fragment 1 (restriction sites 
used are BsrGI and AscI) (plasmid map 6.1.4), resulting in an intermediate plasmid 
pUC18_Minus_strand_F1_6092 (plasmid map 6.1.9). Next, after the digest with BsrGI and NsiI, the 
Fragment 2 (plasmid map 6.1.5) was introduced into the intermediate plasmid replacing Linker50-2, and the 
second intermediate plasmid - pUC18_Minus_strand_F1_F2_8524 (plasmid map 6.1.10) - was obtained 
(Suppl. Fig. 6.3). The final cloning step completed assembly of the minus strand mimicking template: the 
last linker replacement with the Fragment 3 (plasmid map 6.1.6) was mediated by a digest with NotI and NsiI 
endonucleases, resulting in pUC18_M.s_SCR_hp_10334 (plasmid map 6.1.12) (Suppl. Fig. 6.4). Each DNA 
template – for minus and plus strand replication – was finally derived in two variants: encoding either 
wild-type or scrambled NS3-NS5B cassette. The initial design allowed an exchange of the cassettes between 
the backbones due to unique NotI/AscI restriction sites flanking the NS3-NS5B sequences. Suppl. Fig. 6.5 
illustrates a production of plasmids pUC18_P.s_SCR_hp_9899 (plasmid map 6.1.8) and 
pUC18_M.s_WT_hp_10334 (plasmid map 6.1.11).     
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Supplementary Figure 6.1: Assembly of a DNA template for minus strand synthesis initiation.    
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Supplementary Figure 6.2: Assembly of an intermediate plasmid pUC18_Minus_strand_F1.                                                                                                                                                                                                                                                                                                                                 
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Supplementary Figure 6.3: Assembly of an intermediate plasmid pUC18_Minus_strand_F1_F2.                                                                                                                                                                                                                                                                                                                                              
6. Appendix 
154 
 
 
 
 
Supplementary Figure 6.4: Assembly of a DNA template for plus strand synthesis initiation.                                                                                                                                                    
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Supplementary Figure 6.5: A scheme of the backbones/cassettes exchange. 
6. Appendix 
156 
 
6.2.2 Structural elements of the replication system 
The design of the replication system in the current work required introduction of several complex 
structural elements serving functional purposes for the constructs production and detection. Both – the 
template for minus and plus strand synthesis initiation – share the same functional units (Fig. 3.1.1, B and C).  
The Streptavidin aptamer (Suppl. Fig. 6.6, A) was included in the system design to allow isolation and 
analysis of the HCV replication complex acting at the functional replication template. This RNA affinity tag 
enables a selective recovery of an input construct together with all associated proteins under nondenaturing 
conditions: the aptamer binds specifically to streptavidin and can be gently eluted by competition with biotin. 
Using streptavidin as a target of the RNA affinity tag is very advantageous due its availability and 
extraordinary high affinity to biotin. The optimal sequence of the Streptavidin aptamer was derived via a 
SELEX approach and the corresponding aptamers were easily removable from streptavidin with biotin 
(Srisawat and Engelke 2001). The aptamers are classified in accordance to their consensus sequence, and in 
the current work the full-length S1 aptamer (group 1) was included for the system construction. 
Following the Streptavidin aptamer, the antisense Spinach aptamer sequence is incorporated in the 
designed constructs (―as-spinach‖; Fig. 3.1.1, B and C). This aptamer is provided on input replication 
templates as a reverse complementary in order to express its functional secondary structure at the newly 
synthesized RNA strand and to enable a detection of the synthesis initiation event. The unique spatial 
configuration of this RNA aptamer was developed to bind fluorophores and emit a green fluorescence 
demonstrating a GFP-like functionality (Suppl. Fig. 6.6, B and D) (Paige et al. 2011). The Spinach aptamer 
allows a protein-free direct post-transcriptional live-cell imaging that, in contrast to the GFP fluorescence, is 
resistant to photobleaching. To enhance fluorescence provided with the use of 4-hydroxybenzlidene 
imidazolinone (HBI; fluorogen in GFP system) its derivative – DMHBI (3,5-dimethoxy-4-
hydroxybenzylidene imidazolinone) – is applied to induce fluorescence when combined with the Spinach 
aptamer (Suppl. Fig. 6.6, C). DMHBI appeared to be the most suitable due to the lack of nonspecific cellular 
fluorescence as well as cyto- and photo- toxicity. The role of the aptamer itself is to stabilize the planar 
structure of the fluorogen directing dissipation of its energy predominantly through radiative decay pathways 
(Ouellet 2016) (Suppl. Fig. 6.6, D). Although both aptamers have not been in use in the present work, they 
will certainly advantage further applications of the developed replication system.  
A structural component of the system that plays a vital role in replication RNA template production is 
a Hepatitis Delta Virus (HDV) ribozyme (Fig. 3.1.1, B and C). Insertion of a ribozyme downstream the HCV 
coding sequence aims at processing of in vitro transcribed RNA to generate the exact HCV 3’-end. The very 
same nucleotide at the 3’-end of replication templates is an indispensable prerequisite for the function of the 
HCV replication complex in the first place, in addition to valid comparison of synthesis initiation efficiency 
from different templates. The HDV ribozyme undertakes non-enzyme-catalyzed RNA cleavage mechanism 
in which making and breaking of phosphorus-oxygen bonds take place: the adjacent 2’-hydroxyl group is the 
attacking nucleophile in the transesterification reaction and a 2’,3’-cyclic phosphate group is generated upon 
cleavage (Suppl. Fig. 6.6, E). The genomic and antigenomic HDV ribozyme sequences form a similar 
secondary structure of a nested double pseudoknot containing base-paired regions (P1-4), joining sequences, 
and hairpin loops. The folding into two helical stacks composed of the duplex regions stabilizes the 
ribozyme’s structure and brings the catalytic residue (cytosine C75) to a proximity of the cleavage site 
(Suppl. Fig. 6.6, F) (Shih and Been 2002). 
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6.2.3 HCV NS3-NS5B wild-type and scrambled sequence 
Comparison of the nucleotide HCV NS3-NS5B coding sequences within wild-type (WT) and 
scrambled (SCR) RNA constructs’ versions. The last 152 nt of the NS5B coding-sequence were retained 
unmodified during cloning process to maintain a wild-type sequence of the 5BSL3.2 element. The alignment 
is CLUSTAL multiple sequence alignment by MUSCLE (3.8). 
NS3-NS5B_WT       GCTCCCATCACTGCTTATGCCCAGCAAACACGAGGCCTCCTGGGCGCCATAGTGGTGAGT 
NS3-NS5B_SCR      GCTCCTATCACGGCCTACGCACAACAGACGAGGGGACTTCTTGGGGCTATAGTTGTCTCC 
                  ***** ***** ** ** ** ** ** **  * ** ** ** ** ** ***** **     
 
NS3-NS5B_WT       ATGACGGGGCGTGACAGGACAGAACAGGCCGGGGAAGTCCAAATCCTGTCCACAGTCTCT 
NS3-NS5B_SCR      ATGACAGGAAGAGACCGAACTGAGCAGGCTGGCGAAGTCCAAATCTTATCGACCGTGAGC 
                  ***** **  * *** * ** ** ***** ** ************ * ** ** **     
 
NS3-NS5B_WT       CAGTCCTTCCTCGGAACAACCATCTCGGGGGTTTTGTGGACTGTTTACCACGGAGCTGGC 
NS3-NS5B_SCR      CAATCCTTTCTGGGCACCACCATCTCCGGTGTCTTGTGGACAGTCTACCATGGGGCGGGG 
                  ** ***** ** ** ** ******** ** ** ******** ** ***** ** ** **  
 
NS3-NS5B_WT       AACAAGACTCTAGCCGGCTTACGGGGTCCGGTCACGCAGATGTACTCGAGTGCTGAGGGG 
NS3-NS5B_SCR      AATAAGACCCTGGCGGGGCTCAGAGGTCCGGTCACCCAAATGTATTCGTCAGCTGAGGGG 
                  ** ***** ** ** **  *  * *********** ** ***** ***   ********* 
 
NS3-NS5B_WT       GACTTGGTAGGCTGGCCCAGCCCCCCTGGGACCAAGTCTTTGGAGCCGTGCAAGTGTGGA 
NS3-NS5B_SCR      GACCTCGTTGGGTGGCCCTCCCCGCCCGGGACCAAAAGTCTGGAACCCTGCAAGTGCGGA 
                  *** * ** ** ******  *** ** ********   * **** ** ******** *** 
 
NS3-NS5B_WT       GCCGTCGACCTATATCTGGTCACGCGGAACGCTGATGTCATCCCGGCTCGGAGACGCGGG 
NS3-NS5B_SCR      GCCGTGGATCTGTATCTCGTCACCCGCAATGCCGATGTGATCCCAGCCCGCCGGCGTGGT 
                  ***** ** ** ***** ***** ** ** ** ***** ***** ** **  * ** **  
 
NS3-NS5B_WT       GACAAGCGGGGAGCATTGCTCTCCCCGAGACCCATTTCGACCTTGAAGGGGTCCTCGGGG 
NS3-NS5B_SCR      GACAAACGGGGGGCTCTTCTCTCGCCCAGACCTATTTCAACACTAAAAGGGAGCTCAGGT 
                  ***** ***** **  * ***** ** ***** ***** **  * ** ***  *** **  
 
NS3-NS5B_WT       GGGCCGGTGCTCTGCCCTAGGGGCCACGTCGTTGGGCTCTTCCGAGCAGCTGTGTGCTCT 
NS3-NS5B_SCR      GGCCCAGTGCTTTGCCCCCGAGGGCATGTGGTGGGCTTGTTCAGGGCTGCGGTCTGCAGC 
                  ** ** ***** *****  * ** ** ** ** **  * *** * ** ** ** ***    
 
NS3-NS5B_WT       CGGGGCGTGGCCAAATCCATCGATTTCATCCCCGTTGAGACACTCGACGTTGTTACAAGG 
NS3-NS5B_SCR      CGCGGCGTAGCAAAGTCTATCGATTTTATCCCCGTGGAGACCTTGGATGTGGTGACTCGG 
                  ** ***** ** ** ** ******** ******** *****  * ** ** ** **  ** 
 
NS3-NS5B_WT       TCTCCCACTTTCAGTGACAACAGCACGCCACCGGCTGTGCCCCAGACCTATCAGGTCGGG 
NS3-NS5B_SCR      TCTCCCACTTTCAGCGATAACTCCACACCTCCCGCAGTTCCCCAAACTTACCAAGTAGGC 
                  ************** ** ***  *** ** ** ** ** ***** ** ** ** ** **  
 
NS3-NS5B_WT       TACTTGCATGCTCCAACTGGCAGTGGAAAGAGCACCAAGGTCCCTGTCGCGTATGCCGCC 
NS3-NS5B_SCR      TATCTCCACGCGCCGACGGGGAGCGGTAAGTCGACAAAAGTTCCAGTCGCTTATGCGGCT 
                  **  * ** ** ** ** ** ** ** ***   ** ** ** ** ***** ***** **  
 
NS3-NS5B_WT       CAGGGGTACAAAGTACTAGTGCTTAACCCCTCGGTAGCTGCCACCCTGGGGTTTGGGGCG 
NS3-NS5B_SCR      CAGGGCTACAAGGTCTTGGTTCTAAACCCCTCTGTCGCGGCGACGCTGGGGTTCGGGGCC 
                  ***** ***** **  * ** ** ******** ** ** ** ** ******** *****  
 
NS3-NS5B_WT       TACCTATCCAAGGCACATGGCATCAATCCCAACATTAGGACTGGAGTCAGGACCGTGATG 
NS3-NS5B_SCR      TATTTGAGCAAAGCCCACGGGATCAACCCGAATATTAGGACCGGTGTTCGCACAGTCATG 
                  **  *   *** ** ** ** ***** ** ** ******** ** **  * ** ** *** 
 
NS3-NS5B_WT       ACCGGGGAGGCCATCACGTACTCCACATATGGCAAATTTCTCGCCGATGGGGGCTGCGCT 
NS3-NS5B_SCR      ACCGGCGAAGCAATTACCTACTCAACCTACGGGAAGTTCCTAGCCGACGGCGGCTGCGCC 
                  ***** ** ** ** ** ***** ** ** ** ** ** ** ***** ** ********  
 
NS3-NS5B_WT       AGCGGCGCCTATGACATCATCATATGCGATGAATGCCACGCTGTGGATGCTACCTCCATT 
NS3-NS5B_SCR      TCAGGGGCCTACGACATCATCATCTGCGACGAGTGTCATGCCGTCGACGCCACGTCCATC 
                     ** ***** *********** ***** ** ** ** ** ** ** ** ** *****  
 
NS3-NS5B_WT       CTCGGCATCGGAACGGTCCTTGATCAAGCAGAGACAGCCGGGGTCAGACTAACTGTGCTG 
NS3-NS5B_SCR      CTCGGGATCGGCACTGTCCTCGACCAGGCGGAGACAGCGGGCGTCCGGCTCACCGTCCTT 
                  ***** ***** ** ***** ** ** ** ******** ** *** * ** ** ** **  
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NS3-NS5B_WT       GCTACGGCCACACCCCCCGGGTCAGTGACAACCCCCCATCCCGATATAGAAGAGGTAGGC 
NS3-NS5B_SCR      GCCACAGCCACTCCCCCCGGCAGCGTCACCACGCCCCACCCAGACATCGAGGAGGTGGGT 
                  ** ** ***** ********    ** ** ** ***** ** ** ** ** ***** **  
 
NS3-NS5B_WT       CTCGGGCGGGAGGGTGAGATCCCCTTCTATGGGAGGGCGATTCCCCTATCCTGCATCAAG 
NS3-NS5B_SCR      TTGGGCAGAGAAGGAGAAATCCCTTTTTATGGACGCGCAATCCCTCTCAGCTGCATCAAA 
                   * **  * ** ** ** ***** ** *****  * ** ** ** **   *********  
 
NS3-NS5B_WT       GGAGGGAGACACCTGATTTTCTGCCACTCAAAGAAAAAGTGTGACGAGCTCGCGGCGGCC 
NS3-NS5B_SCR      GGGGGCAGGCACCTCATTTTCTGCCACTCTAAGAAGAAGTGCGACGAGTTGGCTGCCGCT 
                  ** ** ** ***** ************** ***** ***** ****** * ** ** **  
 
NS3-NS5B_WT       CTTCGGGGCATGGGCTTGAATGCCGTGGCATACTATAGAGGGTTGGACGTCTCCATAATA 
NS3-NS5B_SCR      CTAAGGGGAATGGGACTCAATGCGGTAGCTTATTACCGGGGACTGGACGTTTCGATAATA 
                  **  **** *****  * ***** ** ** ** **  * **  ******* ** ****** 
 
NS3-NS5B_WT       CCAGCTCAGGGAGATGTGGTGGTCGTCGCCACCGACGCCCTCATGACGGGGTACACTGGA 
NS3-NS5B_SCR      CCAGCCCAGGGGGATGTGGTCGTGGTGGCCACGGACGCGTTAATGACTGGATATACGGGG 
                  ***** ***** ******** ** ** ***** *****  * ***** ** ** ** **  
 
NS3-NS5B_WT       GACTTTGACTCCGTGATCGACTGCAATGTAGCGGTCACCCAAGCTGTCGACTTCAGCCTG 
NS3-NS5B_SCR      GACTTCGACTCCGTCATCGACTGCAACGTGGCCGTGACCCAGGCCGTGGACTTTTCCCTA 
                  ***** ******** *********** ** ** ** ***** ** ** *****   ***  
 
NS3-NS5B_WT       GACCCCACCTTCACTATAACCACACAGACTGTCCCACAAGACGCTGTCTCACGCAGT 
NS3-NS5B_SCR      GATCCTACATTCACAATAACAACCCAAACGGTGCCGCAGGACGCCGTCAGCAGGTCT 
                  ** ** ** ***** ***** ** ** ** ** ** ** ***** ***    *   * 
 
NS3-NS5B_WT       CAGCGCCGCGGGCGCACAGGTAGAGGAAGACAGGGCACTTATAGGTATGTTTCCACTGGT 
NS3-NS5B_SCR      CAGAGAAGAGGGAGAACTGGCAGAGGCCGGCAAGGGACCTATCGCTACGTGTCCACGGGT 
                  *** *  * *** * ** ** *****  * ** ** ** *** * ** ** ***** *** 
 
NS3-NS5B_WT       GAACGAGCCTCAGGAATGTTTGACAGTGTAGTGCTTTGTGAGTGCTACGACGCAGGGGCT 
NS3-NS5B_SCR      GAGAGGGCGTCAGGCATGTTCGACTCCGTGGTCCTGTGCGAGTGCTACGATGCCGGCGCT 
                  **  * ** ***** ***** ***   ** ** ** ** *********** ** ** *** 
 
NS3-NS5B_WT       GCGTGGTACGATCTCACACCAGCGGAGACCACCGTCAGGCTTAGAGCGTATTTCAACACG 
NS3-NS5B_SCR      GCCTGGTACGACTTGACTCCGGCTGAGACCACGGTGAGGCTGCGGGCCTACTTCAACACC 
                  ** ********  * ** ** ** ******** ** *****  * ** ** ********  
 
NS3-NS5B_WT       CCCGGCCTACCCGTGTGTCAAGACCATCTTGAATTTTGGGAGGCAGTTTTCACCGGCCTC 
NS3-NS5B_SCR      CCCGGGCTGCCCGTGTGCCAGGACCACCTAGAGTTCTGGGAGGCCGTCTTCACTGGCCTG 
                  ***** ** ******** ** ***** ** ** ** ******** ** ***** *****  
 
NS3-NS5B_WT       ACACACATAGACGCCCACTTCCTCTCCCAAACAAAGCAAGCGGGGGAGAACTTCGCGTAC 
NS3-NS5B_SCR      ACCCACATTGATGCTCATTTTCTGTCACAGACGAAGCAGGCTGGAGAAAATTTTGCCTAC 
                  ** ***** ** ** ** ** ** ** ** ** ***** ** ** ** ** ** ** *** 
 
NS3-NS5B_WT       CTAGTAGCCTACCAAGCTACGGTGTGCGCCAGAGCCAAGGCCCCTCCCCCGTCCTGGGAC 
NS3-NS5B_SCR      CTTGTGGCCTACCAGGCCACCGTCTGCGCGCGGGCCAAGGCGCCTCCACCATCGTGGGAT 
                  ** ** ******** ** ** ** *****  * ******** ***** ** ** *****  
 
NS3-NS5B_WT       GCCATGTGGAAGTGCCTGGCCCGACTCAAGCCTACGCTTGCGGGCCCCACACCTCTCCTG 
NS3-NS5B_SCR      GCAATGTGGAAGTGCCTGGCCAGGCTGAAACCTACCCTGGCCGGGCCCACCCCGCTTCTC 
                  ** ****************** * ** ** ***** ** ** ** ***** ** ** **  
 
NS3-NS5B_WT       TACCGTTTGGGCCCTATTACCAATGAGGTCACCCTCACACACCCTGGGACGAAGTACATC 
NS3-NS5B_SCR      TACAGGCTCGGGCCCATCACAAACGAGGTAACGTTGACTCACCCTGGCACCAAGTATATC 
                  *** *  * ** ** ** ** ** ***** **  * ** ******** ** ***** *** 
 
NS3-NS5B_WT       GCCACATGCATGCAAGCTGACCTTGAGGTCATGACCAGCACGTGGGTCCTAGCTGGAGGA 
NS3-NS5B_SCR      GCTACATGCATGCAGGCAGACTTGGAGGTGATGACATCGACCTGGGTGCTGGCTGGGGGA 
                  ** *********** ** *** * ***** *****    ** ***** ** ***** *** 
 
NS3-NS5B_WT       GTCCTGGCAGCCGTCGCCGCATATTGCCTGGCGACTGGATGCGTTTCCATCATCGGCCGC 
NS3-NS5B_SCR      GTTCTGGCTGCTGTGGCGGCTTACTGCCTGGCCACAGGATGCGTATCCATCATCGGACGG 
                  ** ***** ** ** ** ** ** ******** ** ******** *********** ** 
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NS3-NS5B_WT       TTGCACGTCAACCAGCGAGTCGTCGTTGCGCCGGATAAGGAGGTCCTGTATGAGGCTTTT 
NS3-NS5B_SCR      CTTCATGTGAATCAAAGGGTCGTCGTTGCCCCGGACAAGGAGGTGCTCTACGAGGCCTTC 
                   * ** ** ** **  * *********** ***** ******** ** ** ***** **  
 
NS3-NS5B_WT       GATGAGATGGAGGAATGCGCCTCTAGGGCGGCTCTCATCGAAGAGGGGCAGCGGATAGCC 
NS3-NS5B_SCR      GACGAGATGGAGGAGTGTGCTTCGCGTGCCGCCTTGATCGAGGAGGGGCAGAGAATCGCG 
                  ** *********** ** ** **  * ** **  * ***** ********* * ** **  
 
NS3-NS5B_WT       GAGATGTTGAAGTCCAAGATCCAAGGCTTGCTGCAGCAGGCCTCTAAGCAGGCCCAGGAC 
NS3-NS5B_SCR      GAAATGTTGAAGTCTAAGATACAGGGGCTACTACAGCAAGCTTCGAAGCAGGCTCAAGAC 
                  ** *********** ***** ** **  * ** ***** ** ** ******** ** *** 
 
NS3-NS5B_WT       ATACAACCCGCTATGCAGGCTTCATGGCCCAAAGTGGAACAATTTTGGGCCAGACACATG 
NS3-NS5B_SCR      ATACAACCCGCCATGCAAGCCAGCTGGCCGAAGGTCGAGCAGTTCTGGGCGCGGCACATG 
                  *********** ***** **    ***** ** ** ** ** ** *****  * ****** 
 
NS3-NS5B_WT       TGGAACTTCATTAGCGGCATCCAATACCTCGCAGGATTGTCAACACTGCCAGGGAACCCC 
NS3-NS5B_SCR      TGGAACTTTATTTCAGGGATACAATATTTGGCTGGTCTCTCCACCCTCCCAGGAAACCCC 
                  ******** ***   ** ** *****  * ** **  * ** ** ** ***** ****** 
 
NS3-NS5B_WT       GCGGTGGCTTCCATGATGGCATTCAGTGCCGCCCTCACCAGTCCGTTGTCGACCAGTACC 
NS3-NS5B_SCR      GCTGTGGCGTCTATGATGGCCTTCAGTGCGGCTCTTACGTCCCCACTATCCACATCGACT 
                  ** ***** ** ******** ******** ** ** **    **  * ** **    **  
 
NS3-NS5B_WT       ACCATCCTTCTCAACATCATGGGAGGCTGGTTAGCGTCCCAGATCGCACCACCCGCGGGG 
NS3-NS5B_SCR      ACTATCTTGCTAAATATCATGGGGGGCTGGCTGGCCTCCCAAATCGCCCCTCCTGCTGGA 
                  ** *** * ** ** ******** ****** * ** ***** ***** ** ** ** **  
 
NS3-NS5B_WT       GCCACCGGCTTTGTCGTCAGTGGCCTGGTGGGGGCTGCCGTGGGCAGCATAGGCCTGGGT 
NS3-NS5B_SCR      GCAACCGGATTTGTTGTATCAGGGCTCGTTGGCGCGGCCGTTGGTTCCATCGGTCTCGGC 
                  ** ***** ***** **    ** ** ** ** ** ***** **   *** ** ** **  
 
NS3-NS5B_WT       AAGGTGCTGGTGGACATCCTGGCAGGATATGGTGCGGGCATTTCGGGGGCCCTCGTCGCA 
NS3-NS5B_SCR      AAAGTTTTAGTAGATATACTGGCTGGGTACGGAGCTGGAATCTCGGGAGCTCTCGTGGCC 
                  ** **  * ** ** ** ***** ** ** ** ** ** ** ***** ** ***** **  
 
NS3-NS5B_WT       TTCAAGATCATGTCTGGCGAGAAGCCCTCTATGGAAGATGTCATCAATCTACTGCCTGGG 
NS3-NS5B_SCR      TTTAAAATTATGAGCGGGGAGAAACCCTCTATGGAGGACGTCATTAACCTGCTCCCGGGC 
                  ** ** ** ***   ** ***** *********** ** ***** ** ** ** ** **  
 
NS3-NS5B_WT       ATCCTGTCTCCGGGAGCCCTGGTGGTGGGGGTCATCTGCGCGGCCATTCTGCGCCGCCAC 
NS3-NS5B_SCR      ATTCTCTCTCCTGGGGCACTTGTGGTTGGTGTCATATGTGCAGCCATTCTGAGGAGGCAT 
                  ** ** ***** ** ** ** ***** ** ***** ** ** ********* *  * **  
 
NS3-NS5B_WT       GTGGGACCGGGGGAGGGCGCGGTCCAATGGATGAACAGGCTTATTGCCTTTGCTTCCAGA 
NS3-NS5B_SCR      GTGGGTCCAGGAGAGGGAGCTGTTCAGTGGATGAACCGCCTGATAGCTTTCGCCTCGCGG 
                  ***** ** ** ***** ** ** ** ********* * ** ** ** ** ** **  *  
 
NS3-NS5B_WT       GGAAACCACGTCGCCCCTACTCACTACGTGACGGAGTCGGATGCGTCGCAGCGTGTGACC 
NS3-NS5B_SCR      GGCAACCACGTGGCGCCCACCCACTATGTCACCGAATCAGATGCCTCCCAAAGGGTCACT 
                  ** ******** ** ** ** ***** ** ** ** ** ***** ** **  * ** **  
 
NS3-NS5B_WT       CAACTACTTGGCTCTCTTACTATAACCAGCCTACTCAGAAGACTCCACAATTGGATAACT 
NS3-NS5B_SCR      CAGCTGCTAGGGTCCCTCACCATCACTTCTCTCCTGAGACGGCTTCACAACTGGATAACA 
                  ** ** ** ** ** ** ** ** **    ** ** *** * ** ***** ********  
 
NS3-NS5B_WT       GAGGACTGCCCCATCCCATGCTCCGGATCCTGGCTCCGCGACGTGTGGGACTGGGTTTGC 
NS3-NS5B_SCR      GAGGACTGCCCAATTCCTTGCAGTGGGAGCTGGCTAAGAGATGTCTGGGACTGGGTCTGC 
                  *********** ** ** ***   **   ******  * ** ** *********** *** 
 
NS3-NS5B_WT       ACCATCTTGACAGACTTCAAAAATTGGCTGACCTCTAAATTGTTCCCCAAGCTGCCCGGC 
NS3-NS5B_SCR      ACCATCCTCACGGACTTCAAAAACTGGCTGACCAGTAAGCTCTTCCCCAAACTCCCGGGG 
                  ****** * ** *********** *********  ***  * ******** ** ** **  
 
NS3-NS5B_WT       CTCCCCTTCATCTCTTGTCAAAAGGGGTACAAGGGTGTGTGGGCCGGCACTGGCATCATG 
NS3-NS5B_SCR      CTTCCCTTTATCTCTTGTCAGAAGGGCTATAAAGGGGTGTGGGCGGGGACAGGTATCATG 
                  ** ***** *********** ***** ** ** ** ******** ** ** ** ****** 
 
NS3-NS5B_WT       ACCACGCGCTGCCCTTGCGGCGCCAACATCTCTGGCAATGTCCGCCTGGGCTCTATGAGG 
NS3-NS5B_SCR      ACAACCCGGTGCCCCTGTGGGGCGAACATCTCTGGGAACGTGAGGCTGGGGAGCATGCGA 
                  ** ** ** ***** ** ** ** *********** ** **  * *****    *** *  
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NS3-NS5B_WT       ATCACAGGGCCTAAAACCTGCATGAACACCTGGCAGGGGACCTTTCCTATCAATTGCTAC 
NS3-NS5B_SCR      ATTACTGGCCCTAAGACTTGCATGAACACGTGGCAAGGCACGTTCCCAATCAACTGCTAC 
                  ** ** ** ***** ** *********** ***** ** ** ** ** ***** ****** 
 
NS3-NS5B_WT       ACGGAGGGCCAGTGCGCGCCGAAACCCCCCACGAACTACAAGACCGCCATCTGGAGGGTG 
NS3-NS5B_SCR      ACCGAAGGCCAATGCGCCCCCAAGCCTCCCACCAACTACAAAACCGCAATATGGCGAGTA 
                  ** ** ***** ***** ** ** ** ***** ******** ***** ** *** * **  
 
NS3-NS5B_WT       GCGGCCTCGGAGTACGCGGAGGTGACGCAGCATGGGTCGTACTCCTATGTAACAGGACTG 
NS3-NS5B_SCR      GCAGCTTCAGAATATGCAGAGGTGACCCAGCACGGCTCATATTCCTACGTTACGGGCTTG 
                  ** ** ** ** ** ** ******** ***** ** ** ** ***** ** ** **  ** 
 
NS3-NS5B_WT       ACCACTGACAATCTGAAAATTCCTTGCCAACTACCTTCTCCAGAGTTTTTCTCCTGGGTG 
NS3-NS5B_SCR      ACAACCGACAACCTAAAGATCCCCTGCCAACTGCCCTCGCCCGAGTTTTTCTCCTGGGTA 
                  ** ** ***** ** ** ** ** ******** ** ** ** *****************  
 
NS3-NS5B_WT       GACGGTGTGCAGATCCATAGGTTTGCACCCACACCAAAGCCGTTTTTCCGGGATGAGGTC 
NS3-NS5B_SCR      GATGGCGTGCAAATACACCGCTTCGCGCCCACGCCCAAGCCTTTCTTTAGAGACGAGGTG 
                  ** ** ***** ** **  * ** ** ***** ** ***** ** **  * ** *****  
 
NS3-NS5B_WT       TCGTTCTGCGTTGGGCTTAATTCCTATGCTGTCGGGTCCCAGCTTCCCTGTGAACCTGAG 
NS3-NS5B_SCR      TCTTTCTGCGTCGGCCTCAATTCCTACGCGGTAGGCAGTCAGCTCCCATGCGAGCCCGAG 
                  ** ******** ** ** ******** ** ** **    ***** ** ** ** ** *** 
 
NS3-NS5B_WT       CCCGACGCAGACGTATTGAGGTCCATGCTAACAGATCCGCCCCACATCACGGCGGAGACT 
NS3-NS5B_SCR      CCCGACGCCGACGTGCTGCGATCCATGCTGACCGACCCCCCGCACATAACAGCAGAGACA 
                  ******** *****  ** * ******** ** ** ** ** ***** ** ** *****  
 
NS3-NS5B_WT       GCGGCGCGGCGCTTGGCACGGGGATCACCTCCATCTGAGGCGAGCTCCTCAGTGAGCCAG 
NS3-NS5B_SCR      GCAGCGCGCAGACTAGCGAGAGGCTCCCCTCCCTCCGAGGCCAGTAGCTCAGTCTCTCAA 
                  ** *****  *  * **  * ** ** ***** ** ***** **   ******    **  
 
NS3-NS5B_WT       CTATCAGCACCGTCGCTGCGGGCCACCTGCACCACCCACAGCAACACCTATGACGTGGAC 
NS3-NS5B_SCR      TTGTCAGCACCGTCTCTCAGAGCCACGTGCACAACCCATTCTAATACATACGACGTCGAT 
                   * *********** **  * ***** ***** *****    ** ** ** ***** **  
 
NS3-NS5B_WT       ATGGTCGATGCCAACCTGCTCATGGAGGGCGGTGTGGCTCAGACAGAGCCTGAGTCCAGG 
NS3-NS5B_SCR      ATGGTCGACGCTAACCTCCTTATGGAAGGAGGAGTTGCCCAAACTGAACCAGAATCTCGG 
                  ******** ** ***** ** ***** ** ** ** ** ** ** ** ** ** **  ** 
 
NS3-NS5B_WT       GTGCCCGTTCTGGACTTTCTCGAGCCAATGGCCGAGGAAGAGAGCGACCTTGAGCCCTCA 
NS3-NS5B_SCR      GTCCCCGTCCTAGACTTTCTCGAGCCAATGGCAGAGGAGGAGTCAGACCTGGAGCCTTCC 
                  ** ***** ** ******************** ***** ***   ***** ***** **  
 
NS3-NS5B_WT       ATACCATCGGAGTGCATGCTCCCCAGGAGCGGGTTTCCACGGGCCTTACCGGCTTGGGCA 
NS3-NS5B_SCR      ATCCCTAGTGAGTGCATGTTGCCGCGCTCAGGCTTCCCCAGAGCACTTCCCGCTTGGGCC 
                  ** **    ********* * **  *    ** ** **  * **  * ** ********  
 
NS3-NS5B_WT       CGGCCTGACTACAACCCGCCGCTCGTGGAATCGTGGAGGAGGCCAGATTACCAACCGCCC 
NS3-NS5B_SCR      AGACCGGATTATAACCCCCCTCTGGTCGAGTCCTGGCGCCGCCCAGACTACCAGCCTCCC 
                   * ** ** ** ***** ** ** ** ** ** *** *  * ***** ***** ** *** 
 
NS3-NS5B_WT       ACCGTTGCTGGTTGTGCTCTCCCCCCCCCCAAGAAGGCCCCGACGCCTCCCCCAAGGAGA 
NS3-NS5B_SCR      ACTGTGGCGGGCTGCGCCCTGCCCCCGCCTAAGAAGGCGCCTACCCCGCCACCTCGCCGG 
                  ** ** ** ** ** ** ** ***** ** *******      ***** * **  *  * 
 
NS3-NS5B_WT       CGCCGGACAGTGGGTCTGAGCGAGAGCACCATATCAGAAGCCCTCCAGCAACTG 
NS3-NS5B_SCR      AGGAGAACTGTGGGGCTGTCAGAAAGCACCATATCCGAGGCGCTGCAACAGCTT 
                   *  * ** ***** ***   ** *********** ** ** ** ** ** **  
 
NS3-NS5B_WT       GCCATCAAGACCTTTGGCCAGCCCCCCTCGAGCGGTGATGCAGGCTCGTCCACGGGGGCG 
NS3-NS5B_SCR      GCAATAAAAACATTTGGCCAACCTCCCTCCAGTGGGGATGCGGGCTCCTCCACAGGAGCT 
                  ** ** ** ** ******** ** ***** ** ** ***** ***** ***** ** **  
 
NS3-NS5B_WT       GGCGCCGCCGAATCCGGCGGTCCGACGTCCCCTGGTGAGCCGGCCCCCTCAGAGACAGGT 
NS3-NS5B_SCR      GGCGCGGCCGAATCCGGCGGTCCGACGTCCCCGGGGGAGCCCGCACCTTCCGAGACTGGT 
                  ***** ************************** ** ***** ** ** ** ***** *** 
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NS3-NS5B_WT       TCCGCCTCCTCTATGCCCCCCCTCGAGGGGGAGCCTGGAGATCCGGACCTGGAGTCTGAT 
NS3-NS5B_SCR      TCCGCCTCGTCCATGCCGCCACTGGAAGGTGAGCCAGGCGACCCAGATTTAGAATCGGAC 
                  ******** ** ***** ** ** ** ** ***** ** ** ** **  * ** ** **  
 
NS3-NS5B_WT       CAGGTAGAGCTTCAACCTCCCCCCCAGGGGGGGGGGGTAGCTCCCGGTTCGGGCTCGGGG 
NS3-NS5B_SCR      CAAGTGGAGCTGCAGCCTCCACCTCAGGGTGGTGGTGTCGCCCCCGGGTCCGGGAGCGGC 
                  ** ** ***** ** ***** ** ***** ** ** ** ** ***** ** **    **  
 
NS3-NS5B_WT       TCTTGGTCTACTTGCTCCGAGGAGGACGATACCACCGTGTGCTGCTCCATGTCATACTCC 
NS3-NS5B_SCR      TCATGGTCTACTTGCTCGGAGGAAGACGACACAACCGTCTGCTGCAGCATGTCTTACTCC 
                  ** ************** ***** ***** ** ***** ******  ****** ****** 
 
NS3-NS5B_WT       TGGACCGGGGCTCTAATAACTCCCTGTAGCCCCGAAGAGGAAAAGTTGCCAATCAACCCT 
NS3-NS5B_SCR      TGGACCGGTGCCCTTATCACCCCATGCTCTCCTGAGGAGGAGAAATTGCCGATCAACCCG 
                  ******** ** ** ** ** ** **    ** ** ***** ** ***** ********  
 
NS3-NS5B_WT       TTGAGTAACTCGCTGTTGCGATACCATAACAAGGTGTACTGTACAACATCAAAGAGCGCC 
NS3-NS5B_SCR      CTCTCCAACTCGCTCCTCAGGTATCACAATAAGGTGTATTGTACAACCTCCAAGTCCGCG 
                   *    ********  *  * ** ** ** ******** ******** ** ***  ***  
 
NS3-NS5B_WT       TCACAGAGGGCTAAAAAGGTAACTTTTGACAGGACGCAAGTGCTCGACGCCCATTATGAC 
NS3-NS5B_SCR      TCCCAGCGGGCCAAGAAGGTCACCTTCGACCGTACCCAGGTCTTGGACGCTCACTACGAC 
                  ** *** **** ** ***** ** ** *** * ** ** **  * ***** ** ** *** 
 
NS3-NS5B_WT       TCAGTCTTAAAGGACATCAAGCTAGCGGCTTCCAAGGTCAGCGCAAGGCTCCTCACCTTG 
NS3-NS5B_SCR      AGCGTGTTGAAGGACATAAAGCTGGCCGCCTCTAAGGTGTCCGCCCGCCTACTTACTCTC 
                     ** ** ******** ***** ** ** ** *****   ***  * ** ** **  *  
 
NS3-NS5B_WT       GAGGAGGCGTGCCAGTTGACTCCACCCCATTCTGCAAGATCCAAGTATGGATTCGGGGCC 
NS3-NS5B_SCR      GAGGAGGCCTGCCAGCTCACTCCACCCCACTCCGCCCGGTCGAAGTACGGATTTGGAGCG 
                  ******** ****** * *********** ** **  * ** ***** ***** ** **  
 
NS3-NS5B_WT       AAGGAGGTCCGCAGCTTGTCCGGGAGGGCCGTTAACCACATCAAGTCCGTGTGGAAGG 
NS3-NS5B_SCR      AAGGAGGTGAGGTCACTTAGTGGCCGCGCCGTCAACCATATCAAATCGGTCTGGAAGG 
                  ********  *     *    **  * ***** ***** ***** ** ** ******* 
 
NS3-NS5B_WT       ACCTCCTGGAAGACCCACAAACACCAATTCCCACAACCATCATGGCCAAAAATGAGGTGT 
NS3-NS5B_SCR      ACTTGTTGGAGGACCCCCAGACCCCCATCCCGACTACAATCATGGCAAAGAATGAGGTAT 
                  ** *  **** ***** ** ** ** ** ** ** ** ******** ** ******** * 
 
NS3-NS5B_WT       TCTGCGTGGACCCCGCCAAGGGGGGTAAGAAACCAGCTCGCCTCATCGTTTACCCTGACC 
NS3-NS5B_SCR      TCTGCGTAGATCCGGCTAAGGGAGGCAAGAAGCCCGCGAGGCTAATCGTGTATCCCGATT 
                  ******* ** ** ** ***** ** ***** ** **  * ** ***** ** ** **   
 
NS3-NS5B_WT       TCGGCGTCCGGGTCTGCGAGAAAATGGCCCTCTATGACATTACACAAAAGCTTCCTCAGG 
NS3-NS5B_SCR      TGGGGGTAAGAGTCTGTGAGAAGATGGCATTGTATGACATCACCCAGAAGCTCCCCCAGG 
                  * ** **  * ***** ***** *****  * ******** ** ** ***** ** **** 
 
NS3-NS5B_WT       CGGTAATGGGAGCTTCCTATGGCTTCCAGTACTCCCCTGCCCAACGGGTGGAGTATCTCT 
NS3-NS5B_SCR      CCGTCATGGGGGCCTCGTATGGATTTCAGTATTCTCCCGCCCAGAGAGTGGAATACCTCT 
                  * ** ***** ** ** ***** ** ***** ** ** *****  * ***** ** **** 
 
NS3-NS5B_WT       TGAAAGCATGGGCGGAAAAGAAGGACCCCATGGGTTTTTCGTATGATACCCGATGCTTCG 
NS3-NS5B_SCR      TGAAGGCCTGGGCCGAGAAGAAGGACCCCATGGGCTTTAGTTACGACACAAGGTGCTTTG 
                  **** ** ***** ** ***************** ***   ** ** **  * ***** * 
 
NS3-NS5B_WT       ACTCAACCGTCACTGAGAGAGACATCAGGACCGAGGAGTCCATATACCAGGCCTGCTCCC 
NS3-NS5B_SCR      ACAGCACGGTAACTGAGCGGGACATACGTACGGAGGAGTCTATATATCAAGCCTGCTCCC 
                  **   ** ** ****** * *****  * ** ******** ***** ** ********** 
 
NS3-NS5B_WT       TGCCCGAGGAGGCCCGCACTGCCATACACTCGCTGACTGAGAGACTTTACGTAGGAGGGC 
NS3-NS5B_SCR      TACCCGAGGAGGCTCGCACAGCCATTCACTCCCTCACAGAGAGGCTCTATGTGGGGGGGC 
                  * *********** ***** ***** ***** ** ** ***** ** ** ** ** **** 
 
NS3-NS5B_WT       CCATGTTCAACAGCAAGGGTCAAACCTGCGGTTACAGACGTTGCCGCGCCAGCGGGGTGC 
NS3-NS5B_SCR      CCATGTTTAATTCCAAAGGCCAGACGTGTGGCTACCGACGTTGCAGGGCTAGCGGGGTGC 
                  ******* **   *** ** ** ** ** ** *** ******** * ** ********** 
 
NS3-NS5B_WT       TAACCACTAGCATGGGTAACACCATCACATGCTATGTGAAAGCCCTAGCGGCCTGCAAGG 
NS3-NS5B_SCR      TCACCACTAGCATGGGGAACACAATTACCTGTTACGTGAAGGCGCTGGCCGCCTGCAAAG 
                  * ************** ***** ** ** ** ** ***** ** ** ** ******** * 
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NS3-NS5B_WT       CTGCGGGGATAGTTGCGCCCACAATGCTGGTATGCGGCGATGACCTAGTAGTCATCTCAG 
NS3-NS5B_SCR      CCGCGGGAATCGTTGCCCCAACGATGCTAGTCTGTGGGGACGACCTCGTGGTAATCTCTG 
                  * ***** ** ***** ** ** ***** ** ** ** ** ***** ** ** ***** * 
 
NS3-NS5B_WT       AAAGCCAGGGGACTGAGGAGGACGAGCGGAACCTGAGAGCCTTCACGGAGGCCATGACCA 
NS3-NS5B_SCR      AGTCCCAAGGAACAGAAGAAGATGAAAGAAATCTCCGGGCCTTCACAGAAGCGATGACTC 
                  *   *** ** ** ** ** ** **  * ** **  * ******** ** ** *****   
 
NS3-NS5B_WT       GGTACTCTGCCCCTCCTGGTGATCCCCCCAGACCGGAATATGACCTGGAGCTAATAACAT 
NS3-NS5B_SCR      GCTACTCCGCCCCACCCGGGGACCCCCCCAGGCCTGAGTACGATTTGGAGCTGATCACCT 
                  * ***** ***** ** ** ** ******** ** ** ** **  ******* ** ** * 
 
NS3-NS5B_WT       CCTGTTCCTCAAATGTGTCTGTGGCGTTGGGCCCGCGGGGCCGCCGCAGATACTACCTGA 
NS3-NS5B_SCR      CATGCTCATCTAACGTTTCGGTAGCCCTGGGGCCTAGAGGACGGAGGCGCTATTATTTAA 
                  * ** ** ** ** ** ** ** **  **** **  * ** **  *  * ** **  * * 
 
NS3-NS5B_WT       CCAGAGACCCAACCACTCCACTCGCCCGGGCTGCCTGGGAAACAGTTAGACACTCCCCTA 
NS3-NS5B_SCR      CACGGGACCCGACCACTCCACTGGCACGCGCGGCGTGGGAGACCGTCCGGCATAGCCCCA 
                  *  * ***** *********** ** ** ** ** ***** ** **  * **   *** * 
 
NS3-NS5B_WT       TCAATTCATGGCTGGGAAACATCATCCAGTATGCTCCAACCATATGGGTTCGCATGGTCC 
NS3-NS5B_SCR      TCAACAGCTGGCTAGGGAATATAATCCAGTACGCGCCGACCATCTGGGTGAGGATGGTGC 
                  ****    ***** ** ** ** ******** ** ** ***** *****  * ***** * 
 
NS3-NS5B_WT       TAATGACACACTTCTTCTCCATTCTCATGGTCCAAGACACCCTGGACCAGAACCTCAACT 
NS3-NS5B_SCR      TCATGACCCACTTCTTTTCAATTCTGATGGTACAGGACACTCTAGATCAGAACCTCAATT 
                  * ***** ******** ** ***** ***** ** ***** ** ** *********** * 
 
NS3-NS5B_WT       TTGAGATGTATGGATCAGTATACTCCGTGAATCCTTTGGACCTTCCAGCCATAATTGAGA 
NS3-NS5B_SCR      TCGAGATGTACGGCTCGGTCTACTCCGTGAACCCCCTTGATCTCCCAGCCATCATAGAGC 
                  * ******** ** ** ** *********** **  * ** ** ******** ** ***  
 
NS3-NS5B_WT       GGTTACACGGGCTTGACGCCTTTTCTATGCACACATACTCTCACCACGAACTGACGCGGG 
NS3-NS5B_SCR      GCCTTCACGGCTTGGACGCCTTCAGCATGCACACCTATTCCCACCACGAGCTCACCAGAG 
                  *  * *****  * ********    ******** ** ** ******** ** **  * * 
 
NS3-NS5B_WT       TGGCTTCAGCCCTCAGAAAACTTGGGGCGCCACCCCTCAGGGTGTGGAAGAGTCGGGCTC 
NS3-NS5B_SCR      TTGCGAGTGCTCTGCGCAAGCTCGGTGCCCCCCCCCTGAGGGTCTGGAAGTCCAGAGCTA 
                  * **    ** **  * ** ** ** ** ** ***** ***** ******    * ***  
 
NS3-NS5B_WT       GCGCAGTCAGGGCGTCCCTCATCTCCCGTGGAGGGAAAGCGGCCGTTTGCGGCCGATATC 
NS3-NS5B_SCR      GGGCTGTCCGAGCCAGCCTCATCAGTAGGGGGGGCAAGGCAGCTGTGTGCGGGCGATATC 
                  * ** *** * **   *******    * ** ** ** ** ** ** ***** ******* 
 
NS3-NS5B_WT       TCTTCAATTGGGCGGTGAAGACCAAGCTCAAACTCACTCCATTGCCGGAGGCGCGCCTAC 
NS3-NS5B_SCR      TCTTCAATTGGGCCGTGAAGACAAAGTTGAAGCTAACACCCCTTCCCGAGGCGCGCCTAC 
                  ************* ******** *** * ** ** ** **  * ** ************* 
 
NS3-NS5B_WT       TGGACTTATCCAGTTGGTTCACCGTCGGCGCCGGCGGGGGCGACATTTTTCACAGCGTGT 
NS3-NS5B_SCR      TGGACTTATCCAGTTGGTTCACCGTCGGCGCCGGCGGGGGCGACATTTTTCACAGCGTGT 
                  ************************************************************ 
 
NS3-NS5B_WT       CGCGCGCCCGACCCCGCTCATTACTCTTCGGCCTACTCCTACTTTTCGTAGGGGTAGGCC 
NS3-NS5B_SCR      CGCGCGCCCGACCCCGCTCATTACTCTTCGGCCTACTCCTACTTTTCGTAGGGGTAGGCC 
                  ************************************************************ 
 
NS3-NS5B_WT       TCTTCCTACTCCCCGCTCGGTAG 
NS3-NS5B_SCR      TCTTCCTACTCCCCGCTCGGTAG 
                  *********************** 
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6.2.4 Establishment of RT-qPCR for HCV plus and minus strand detection 
Canonical end-point PCR method appears poorly quantitative since nucleotides and primers are 
gradually becoming limited providing a nonlinear correlation between the starting copy number and the final 
yield of the amplified product. Recently developed approaches for simultaneous DNA amplification and 
concentration tracking enabled a reliable and reproducible quantification of nucleic acids. Quantitative PCR 
(qPCR) method is based on detection and quantification of a fluorescent reported signal which linearly 
increases in relation to the amount of DNA in the PCR reaction. Using a fluorescence detecting 
thermocycler, fluorescence emission is monitored at each cycle during the exponential phase when none of 
the components are limited and initial amounts of template correlate with an increase of the PCR product 
amounts. Moreover, advantageous high sensitivity of fluorescent detection empowers DNA quantification in 
a wide dynamic range (up to nine orders of magnitude). Combined with reverse transcription, qPCR is 
applied for quantification of mRNA for evaluation of gene expression and even for microRNA. The 
detection in qPCR may exploit different chemistries: using DNA-binding dyes, probe-based chemistry or 
quenched dye primers. In the present work all assays were conducted using DNA-binding SYBR Green I 
dye.  
 All fluorogenic DNA-binding dyes bind to any double-stranded DNA in reaction mixture in a 
sequence-independent manner. Unbound dye demonstrates little fluorescence (1000-fold less) when in a 
solution and the emission intensity increases proportionally to the amplified DNA. SYBR Green I is 
currently one of the most optimal DNA-binding dyes due to its high sensitivity and reliability as well as 
relatively low cost that allows large number of samples. The lack of specificity to a target sequence provides 
some shortcomings such as detection of nonspecific reaction products or primer dimers. For this reason at the 
end of amplification a melting curve of the amplified DNA is generated to determine the melting temperature 
of product(s). Melting curves provide the information on homogeneity of the product and allows validating it 
by the specific melting temperature (Tm) (from Sambrook, vol. 2, fourth edition). 
Fluorescence detection during amplification is represented by a sigmoidal amplification plot where for 
the first 10-20 cycles the curve is flat until the fluorescent signal becomes detectable; then the curve becomes 
linear for several cycles representing exponential phase of the reaction. Eventually, reagents become limited 
and the curve plateaus. The initial concentration of a target is expressed as a cycle number required to reach 
a certain threshold of amplification (Ct). The threshold reflects a statistically significant level of fluorescence 
over the background and usually automatically programmed. Two methods are available for the analysis of 
derived Ct values: the ΔΔCt method and the standard curve method (used in the present work).  
For the standard curve method the amounts of target and reference genes in the calibrator and 
experimental sample are first determined using a standard curve, followed by the target gene normalization 
to the reference gene in both samples. When only the relative quantification is conducted, the target amount 
in the experimental sample is compared to that in the calibrator sample; while for the absolute quantification 
the Ct value of the test is compared to values of standards with known concentration plotted on a standard 
curve. Each target/reference gene requires construction of a separate standard curve. To ensure reliability of 
quantification, the standard curve should be constructed in a dynamic range wider than the range of expected 
concentrations.  
The present research deals only with relative quantification; therefore the plot of a standard curve is 
represented by Ct value versus log of a dilution factor. The standard curves were generated for each of the 
primer pairs targeting HCV minus strand (Spinach_minus, Spinach2_minus, NS5A_minus and 
NS5B_minus) as well as for the HCV plus strand (EMCV_plus) (Suppl. Fig. 6.7). According to the main 
focus of the work on the HCV minus strand synthesis initiation, input plus strands during transfection served 
as a reference to normalize the relative abundance of minus strands targeted at either of the above mentioned 
regions. Normalization to the plus strand content is more reasonable than to one of the cellular genes since it 
permits to eliminate discrepancies related to lipofection efficiency in individual samples and to an ability of 
selected replication templates to undergo continuous replication. The standard curves for each
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target/reference gene provide important information on amplification efficiency (E) for each of the qPCR 
primer pairs, which is calculated according to the equation: E = 10
(-1/slope)
. All derived curves (Suppl. Fig. 6.7, 
A-E) were generated using a total RNA sample from HuH-7.5 cells transfected with the SL I-III construct (2 
days post transfection). In scope of the current work this construct displayed the highest ability for minus 
strand synthesis. Serial 10-fold dilutions of this total RNA sample were subjected to reverse transcription and 
qPCR in a manner similar to all experimental samples. Importantly, following a dilution of the total RNA 
sample, cellular (mock-transfected) total RNA was utilized to equalize total RNA content in each 
downstream dilution sample. The linearity of plots within the present dynamic range indicates the reliable 
quantification of all targets with designed primers and enables determination of corresponding amplification 
efficiencies: 
EMCV_plus: ≈ 1.97 (dynamic range 15.48 to 25.66); 
Spinach_minus: ≈ 2.10 (dynamic range 17.57 to 26.8); 
Spinach2_minus: ≈ 1.99 (dynamic range 22.72 to 32.71); 
NS5A_minus: ≈ 1.99 (dynamic range 16.92 to 26.84); 
NS5B_minus: ≈ 2.10 (dynamic range 14.41 to 23.56). 
An illustration of amplification plots derived in a course of standard curves generation is presented on 
Suppl. Fig. 6.8. Serial 10-fold dilutions (up to (-6)) of experimental total RNA, as well as the mock-
transfected total RNA in equal amounts, were subjected to RT-qPCR targeting the EMCV region on the 
genome strand (EMCV_plus; Suppl. Fig. 6.8, A) and the Spinach region on the complementary minus strand 
(Spinach2_minus; Suppl. Fig. 6.8, E). As evident from the plots, linearity of standard curves becomes 
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inaccurate for undiluted total RNA (corresponds to around 1000 ng total RNA per RT, which is an amount 
recommended by the manufacturer), and is not mediated by generally high total RNA content, since it was 
maintained for all dilutions by cellular total RNA. For both target regions, starting from (-1) dilutions 
(corresponds to around 100 ng target-containing total RNA per RT) the linearity is fulfilled. On the other 
hand, (-6) (and to a smaller extent (-5)) dilution does not contain enough target HCV RNAs: the Ct values 
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reach the ones for cellular total RNA indicating the background level, which represents the border of a 
dynamic range. The latter can in turn be visualized by a melting curve analysis: high specificity is indicated 
by the presence of one single, sharp peak. Indeed, for the two lowest dilutions – (-5) and (-6) – profiles of 
melting curves significantly alter and point out an absence of a specific target for both, EMCV and Spinach, 
regions (Suppl. Fig. 6.8, B and F, respectively). Separated comparison of melting curves, derived for the (-1) 
dilution of experimental RNA sample with its (-6) dilution (Suppl. Fig. 6.8, C and G) and with a mock-
transfected cellular total RNA (Suppl. Fig. 6.8, D and H) verifies the unspecific nature of Ct values 
originating from samples with no or very low content of target molecules.  
Selection of the primers for RT-qPCR with optimal target-specificity is generally a challenge in 
establishing quantitative PCR protocols. Newly-designed primers should be characterized by low specificity 
to cellular genome and transcriptome and especially to a viral RNA strand complementary to a target strand. 
The latter ensures the strand-specificity of RT-qPCR assays aiming to distinguish between genome and 
antigenome strand synthesis initiation. All primers for detection of either of HCV strands lack targets on 
opposite strands (Suppl. Fig. 6.9): each primer has minimum 5 mismatches and for most of the primers – 8 to 
10 mismatches (analysis was conducted in Clustal Omega). In turn, BlastN searches against the human 
genome and transcriptome using the primer sequences and their reverse complements yielded smaller 
amount of mismatches (minimum 3 to 4). However, in all assays mock-transfected cellular total RNA 
exclusively resulted in very high Ct values and melting curve plots implicating the absence of any cross-
reactivity (Suppl. Fig. 6.8, D and H).  
Notably, the background signals in minus strand quantification often appear higher within samples 
corresponding to early time-points (up to 24 h) than at later time-points (around 96 h) (Fig. 3.6.1, B and C). 
This phenomenon is likely explained by an aberrant activity of the T7 RNA polymerase in initiation of 
transcription from a promoter-less end of template DNA (Mu et al. 2018). Such activity results in production 
of an antisense complementary RNA that, unlike another potential source of background signals – DNA 
transcription templates, is insensitive to DNase treatment. Upon transfection of in vitro transcribed RNA 
constructs this small fraction of antigenome strands is detected by minus strand specific primers. An 
elimination of these artifacts is related to subsequent degradation of ―transfected‖ minus strands and 
detection of genuine minus strands, if they can be synthesized from a construct. Another possibility – a 
cross-reactivity with HCV genomic RNA, which is 10-100 times more abundant than minus strands, unlikely 
to take place, since for replicating constructs dynamics of plus strands at later time-points does not correlate 
with dynamics of minus strands; on the contrary, plus and minus strands peak at dissimilar time during 
time-courses.    
An attempt to further improve a strand-specificity of primers targeting HCV minus strands was made 
concerning the Spinach primers, as the most often utilized. In a fashion of ―molecular beacon‖ a new RT 
primer was designed to self-hybridize at its 5’- and 3’- ends to form a short stem (see 2.1.8.2). The basic idea 
was to exploit this self-hybridization of the primer’s ends at temperatures lower than Tm in order to impair 
the primers’ hybridization to off-target sequences. Once this primer binds to a genuine target, the stem is 
distracted and a cDNA product is synthesized. Additional changes were introduced at a step of total 
RNA/primers hybridization (prior an addition of reverse transcriptase). Incubation under condition of gradual 
decrease from temperatures higher to temperatures slightly lower than Tm aimed at hybridization to the most 
sequence-specific targets. This approach enabled a reduction of background signals up to 10 times (data not 
shown).  
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6.3 Supplementary results 
6.3.1 Detection of HCV plus and minus strands by Ribonuclease Protection Assay 
Prior an establishment of quantitative RT-PCR (see 6.2.4) for detection of HCV plus and minus 
strands upon transfection of studied replication RNA templates, a possibility of utilization of a classic 
ribonuclease protection assay (RPA) was challenged. RPA is a sensitive and target-specific technique for 
visualization and quantification of RNA of interest that allows detection of a target in a total cellular RNA 
pool (see 2.2.8). Principally, the technique is based on a hybridization of radioactively labeled probe to a 
target RNA and therefore on protection of a duplex from hydrolytic activity of single-strand specific 
ribonucleases (RNase), whereas all non-target RNA is being degraded. Visualization of the protected dsRNA 
fragment is conducted via a denaturing polyacrylamide gel electrophoresis followed by autoradiography. 
Commonly, a probe is designed to be not completely complementary to its target, providing a ssRNA stretch 
at one of the ends. The latter facilitates discrimination of genuine probe-target hybrids when compared to 
initial probe and prevents a misinterpretation of signals originating from possible probe self-hybridization or 
hybridization to other targets.  
In scope of the presented in the current work experimental setup, it was initially attempted to develop 
a set of probes – specific to either of the HCV constructs’ strands – that would be universal for all 
investigated constructs. Taking into consideration a series of constructs for minus strand synthesis initiation 
where most of an NS3-NS5B open reading frame was scrambled, probes targeting the reverse 
complementary (RC) of HCV 3’UTR were considered. Following a primary goal of the project in detection 
of the HCV minus strand synthesis from designed minimal (hp) and extended RNA constructs (e.g. 5’UTR), 
several probes were examined, at first, using control in vitro transcribed templates (as positive control) and 
then using total RNA isolated from cells transfected with experimental constructs (see below). Two 
approaches of targeting the HCV 3’UTR in RPA were considered. Regarding the presence of a long polyU/C 
tract within the HCV 3’UTR it was thought to potentially give rise to problems in full-length probe synthesis 
and therefore target-hybridization. Hence, two strategies were applied: a production of shorter probes that 
hybridize up- or down- stream the antisense 3’UTR sequence (Suppl. Fig. 6.10, A) and a utilization of a long 
3’UTR-containing probe (Suppl. Fig. 6.10, B). All shorter probes, as well as control templates applied in 
preliminary RPA experiments, were in vitro transcribed from PCR templates generated using SP6 promoter 
provided at one of the primers (Suppl. Fig. 6.10, A and B). The long probe was generated from a plasmid 
encoding only the HCV 3’UTR from T7 promoter. In all pairs of probe/target RNA a part of the probe’s 
sequence had no complementarity to a control template. Concerning input plus strands detection, a probe 
complementary to the sense HCV 5’UTR was designed (generated from using SP6 promoter) and a control 
template was in vitro transcribed from T7 promoter providing a sense HCV 5’UTR sequence (Suppl. Fig. 
6.10, C). However, a detection of input RNA templates in minus strand initiation assays requires a distinct 
probe universal for all investigated constructs, since the complete HCV 5’UTR is not present in most of 
experimental constructs. 
Applicability of designed probes for HCV minus and plus strand detection was challenged in RPA 
using a suitable (antisense or sense, respectively) in vitro generated RNA transcripts. In order to estimate a 
sensitivity of an assay for each of the probes, serial 10-fold dilutions of template RNAs were subjected to 
detection. In more detail, in an assay utilizing the shorter sense-3’UTR probes (Suppl. Fig. 6.10, A), dilutions 
of in vitro transcribed antisense HCV 3’UTR control template - 5000 ng to 50 ng – were applied (Suppl. Fig. 
6.11, A). The probe hybridizing upstream the polyU/C tract appeared sensitive up to 50 ng of target RNA, 
whereas the probe hybridizing downstream the polyU/C tract remained sensitive even at 50 ng of control 
target. The latter probe also demonstrated preferable specificity resulting in a single protected RNA signal 
that corresponded to predicted length of shared by probe/target sequence; this probe was further applied in 
downstream assays. On the contrary, utilization of the long sense-3’UTR probe (Suppl. Fig. 6.10, B) did not 
result in specific binding and protection when combined with the control antisense HCV 3’UTR template 
(Suppl. Fig. 6.11, B). It can be speculated, that in vitro transcription across the polyU/C tract in HCV 3’UTR 
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results in imprecise transcripts of both probe and control template. This fact in turn does not affect detection 
by shorter probes, avoiding the 3’UTR and protected by the control template either up- or down- stream. At 
last, challenging of the antisense HCV 5’UTR probe in RPA with serial dilutions of a control sense 5’UTR 
template (Suppl. Fig. 6.11, C) confirmed specificity and sensitivity of the probe. It allowed detection of up to 
1 ng of target, inclusively, however was not quantitative in a range 100-1000 ng of target RNA, possibly due 
to limiting probe molecules. It is virtually important to predetermine a protected RNA fragment to be shorter 
than a probe, since residual amounts of probe RNA may remain undigested after RNAses treatment 
(Suppl. Fig. 6.11, C) and result in false-positive results. This artifact may originate from retention of DNA 
transcription template during a probe synthesis and can be eliminated by usage of longer enough templates to 
be further reliably separated from a probe by gel-electrophoresis followed by probe RNA purification from a 
gel. Another possible origin of ssRNase resistant products in a ―probe only‖ experimental sample is self-
hybridization of probe RNA. Here, the assay for sense HCV 5’UTR detection (Suppl. Fig. 6.10, C) can be 
improved by a careful isolation of a probe RNA from its in vitro transcription reaction by extraction from a 
preparative gel.  
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Providing that one of the shorter probes for HCV minus strand detection was functional in a 
preliminary assay with in vitro transcribed control template (Suppl. Fig. 6.11, B, right), it was utilized in 
attempt to detect HCV minus strand synthesis initiation in a replication assay. As in the majority of 
experiments presented in the current research, HuH-7.5 cells were transfected for two days with either a 
minimal ―hp‖ replication template or with one of its extended versions, harboring a complete HCV 5’UTR at 
the construct’s 5’-end (see Fig. 3.2.1, A). Additionally, each of the experimental constructs was alternatively 
supplemented with miR-122 in order to potentially facilitate RNA constructs’ functions (Suppl. Fig. 6.12, A 
and B). An in vitro synthesized control template RNA used at the step of assay establishment 
(Suppl. Fig. 6.10, A) served as a positive control to indicate an expected length of the protected fragment. 
The Suppl. Fig. 6.12 illustrates two representative experiments, as described above. In contrast to the control 
template, experimental total RNA from transfected cells did not give rise to a protected fragment, indicating 
an absence of target RNA – reverse complementary HCV 3’UTR sequence – at a detection limit ensured by 
the assay. Taking into consideration that an increase of sample total RNA leads to elevation of background 
and also that HCV minus strands (unlike plus strands) are generally present in cells at very low abundance, 
the ribonuclease protection assay was found insufficiently sensitive for this application. As an alternative to 
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RPA, quantitative RT-PCR (see 6.2.4) was established for evaluation of minus strand synthesis efficiency 
from different templates as well as of input plus strand construct RNA. Indeed, providing relatively small 
variations in minus strand abundance from replication-competent templates, it would have been challenging 
to obtain quantity data, similarly to another possible detection method – northern blot.   
6.3.2 Aminoacyl-tRNA synthetases binding at the HCV 3’UTR 
RNA viruses widely exploit host cell proteins in regulation of their translation and replication. Such 
proteins, when acting directly at the viral RNA, contain multiple RNA-binding motifs and commonly 
interact at highly structured 5’- and/or 3’- UTR of the genome. Some cellular proteins, e.g. La protein 
(Spangberg et al. 1999), PCPB2 (Spangberg and Schwartz 1999; Wang et al. 2011), PTB and hnRNP C 
(Gontarek et al. 1999), were proven to fulfill key functions at the HCV UTRs, however, other potential 
factors may remain undiscovered. Several proteomic studies provide extensive data collections on cellular 
proteins that can associate with certain regions of the HCV RNA and potentially play a functional role. In the 
recent study applying a specific affinity capture system in combination with LC/MS/MS, 83 cellular factors 
were identified to associate with the HCV genome (Upadhyay et al. 2013). Another study based on 
biotinylated RNA pull-down assay followed by 2DE/MALDI-TOF MS and 1DE/LC/MS methods, revealed 
10 proteins binding particularly at the HCV 3’UTR (Tingting et al. 2006). Apart from well-investigated 
factors, both studies demonstrated the binding of selected cellular aminoacyl-tRNA synthetases (ARSs). A 
peculiar phenomenon of the ARS acting at viral genome was illustrated for Poliovirus: recruitment of 
glycyl-tRNA synthetase (GARS) to the apical part of the IRES domain V facilitates a correct positioning of 
the 40S ribosomal subunit at the initiation region of the Poliovirus IRES therefore elevating the translation 
initiation. Remarkably, an association of GARS is promoted by the anticodon stem-loop mimicry of tRNA
Gly
 
(anticodon ACC) in the apical part of the IRES domain V (Andreev et al. 2012).  
The above mentioned allowed to put forward a hypothesis on a possible function of ARSs at the HCV 
RNA. Taken together, the proteomics studies suggested a direct interaction of the Arginyl-, Aspartyl-, 
Glutaminyl- and Lysyl- tRNA synthetases (RARS, DARS, QARS and KARS, respectively) with the HCV 
RNA (Tingting et al. 2006; Upadhyay et al. 2013); notably, all these are also parts of multi-tRNA synthetase 
complex (Norcum and Warrington 1998). Most of the complex-forming ARS are known to have 
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non-canonical activities in cell apart from the protein synthesis, therefore may assumingly act at viral RNA. 
The multi-tRNA synthetase complex is formed by nine different ARSs and three non-enzymatic factors, 
associated within 3 subdomains (DARS and QARS are included in domain 1, KARS and RARS – in 
domain 2) (Park et al. 2010).   
Following the fashion of GARS binding to the Poliovirus IRES, anticodon stem-loop mimicry was 
hypothesized to represent the mechanism of the ARSs binding to the HCV 3’UTR. Since the HCV 3’UTR 
variable region reflects a low degree of conservation and the polyU/C stretch is not structured, the X-tail was 
found to be the most promising platform for the binding. Primary sequence of the X-tail is nearly invariant 
(Suppl. Fig. 6.13, A), and its secondary structure has three stable stem-loops (SL1-3) harboring 6, 10 and 7 
nucleotides within their apical loops, respectively (Suppl. Fig. 6.13, B). An alignment of X-tail sequences 
from different HCV isolates illustrates the presence of the anticodon sequences corresponding to the ARSs 
with proposed binding to the 3’UTR located within loop sequences of the SL2 and SL3 (Suppl. Fig. 6.13, B). 
The following ―anticodon‖ nucleotides are absolutely conserved among studied HCV subtypes: DARS 
―anticodon‖ 5’-AUC-3’ (codons are GAPy), RARS ―anticodon‖ 5’-UCU-3’ (codons are CGN, AGPu), 
QARS ―anticodon‖ 5’-CUG-3’ (codons are CAPu) (Suppl. Fig. 6.13, A, blue, red and green labeling, 
respectively). The ―anticodon‖ for KARS - 5’-PyUU-3’ (codons are AAPu) was not found within single-
stranded sequences of the X-tail. Thus, it was hypothesized that the SL2 and SL3 may mimic anticodon 
stem-loops for the Arginyl-, Aspartyl- and Glutaminyl- tRNA synthetases (RARS, DARS and QARS, 
respectively) mediating their recruitment to the HCV 3’UTR.    
Prior investigation of the RARS/DARS/QARS functions at the HCV 3’UTR, the binding of these 
ARSs was challenged in RNA immunoprecipitation (RIP) assay. Following validation of antibodies specific 
for the studied ARSs (data not shown) immunoprecipitation of the HCV RNA was performed with each of 
the ARSs separately and in combination. As a positive control of binding to the HCV 3’UTR, the PTB 
protein was pulled down. Radioactively labeled RNA construct harboring HCV 5’UTR, Core-coding 
sequence and the 3’UTR (Suppl. Fig. 6.14, A) was transfected into HeLa cells. After 6 hours, cell lysates 
were prepared and combined with the protein A magnetic beads hybridized to an antibody or a combination 
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of antibodies specific to selected proteins (RARS, DARS, QARS or PTB). Following the binding for 6 hours 
(at 4°C under a constant mixing), the RNA was eluted from beads and visualized by PAGE. In multiple 
assays binding of neither of studied ARSs was demonstrated in contrast to the binding of PTB (Suppl. Fig. 
6.14, B) that has a strong affinity to the HCV 3’UTR. Once altering of the pull-down conditions did not 
affect the result, it was concluded that the binding of the ARSs may be temporal occurring with a low 
affinity and/or relaying on other unknown components.  
6.3.3 Generation of Poliovirus IRES domain V mutants 
As already briefly discussed in 6.3.2, Poliovirus (PV) sets an example of exceptional adaptation to the 
host cell environment and of its exploitation for fulfillment of the viral life cycle. The Poliovirus IRES 
element is located at the genomic 5’UTR and is known to recruit a variety of cellular RNA-binding proteins 
that modulate its activity and mediate cap-independent translation initiation (Belsham and Jackson 2000). 
The Poliovirus IRES is classified as a Type 1 (according to its secondary structure; see 1.2.1 and Fig. 1.2.2) 
and unlike Type 3 and 4 IRESes utilizes some auxiliary proteins in addition to certain canonical initiation 
factors. Many of these non-canonical factors (IRES Trans-Acting Factors, ITAFs) are also known to 
stimulate translation from the HCV IRES (Type 3 IRES), for instance, La protein, PTB or PCPB2 
(Niepmann 1999). Domain V of the Poliovirus IRES appears to be the most important structural element, it 
binds the complex of eIF4G/eIF4A (that mediates the entry of the 40S ribosomal subunit on the IRES) as 
well as eIF4B factor and almost all mutations affecting its structure abrogate the IRES activity (Ochs et al. 
2003). In particular, several single point mutations within this domain are presented in well-known 
attenuated Sabin vaccine strains (Minor 1993). These are A(480)→G, G(481)→A and C(472)→U mutations 
in Sabin 1, 2 and 3 vaccine strains, respectively (Suppl. Fig. 6.15).  
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Moreover, an unexpected ITAF - cellular glycyl-tRNA synthetase (GARS) - was discovered to be an 
essential player in PV translation initiation (Andreev et al. 2012). It was demonstrated that GARS 
specifically binds to the apical part of the IRES domain V and mediates a correct positioning of the 40S 
ribosomal subunit at the PV IRES. Strikingly, the structure and sequence of the apical stem-loop at the 
domain V mimics the anticodon stem-loop of tRNAGly (anticodon ACC) and ensures an exceptional 
specificity of GARS binding. Mutations affecting the anticodon and therefore preventing GARS recruitment 
were shown to results in a dramatic drop of the Poliovirus IRES activity. In a fashion of tRNAGly 
recognition by GARS, the two C residues appeared to be essential for GARS binding to the domain V, 
whereas the first residue A is redundant. Peculiarly, Poliovirus appears to evolve a specific mechanism to 
exploit a cytoplasmic house-keeping enzyme, probably shared with other representatives of Type 1 IRES 
elements (Belsham and Jackson 2000).  
As a side project, we aimed to investigate an impact of the above-mentioned mutations within the PV 
IRES domain V on the viral life cycle. Any of the Sabin mutations are well-known to crucially impair 
Poliovirus infectivity and neurovirulence due to significant impairment of the translation initiation factors 
eIF4B and eIF4G binding to the domain V and therefore of an association of ribosomes at the viral genome. 
In contrast, the effect of mutations within the apical loop of the domain V, which is proposed to be 
responsible for binding of GARS, on Poliovirus translation and/or life cycle has not been tested in vivo. 
Hence, Gly-anticodon mutation (ACC→TAG), which fully abrogates tRNAGly binding by GARS, was 
introduced into full-length Poliovirus genome by site-directed mutagenesis approach. In order to control a 
degree of attenuation of Poliovirus propagation by the latter, a Sabin 1 mutation was introduced into a 
plasmid encoding a wild-type PV genomic RNA; additionally, a double mutant was generated (Suppl. Fig. 
6.15). Transfection of in vitro transcribed Poliovirus genomic RNA (derived in the same fashion as presented 
for HCV in the current work) into HeLa cells and isolation and characterization of virus stock still remains to 
be done. Upon titration of the virus stock on susceptible cells, a multiplicity of infection (MOI) is to be 
determined. At last, a growth kinetics of the wild-type and mutated Poliovirus is to be characterized via 
infection of HeLa cells with either of the virus type at a high MOI, followed by a plaque assay.  
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The described experiment aims to support the data obtained in vitro and to provide vital information on 
attenuating ability of GARS binding impairment and on its potential application for vaccine strains 
generation. An additive attenuating effect, if demonstrated by the double mutant, may be applied for creation 
of safer vaccines without affecting a degree of immune response.  
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6.4 Functional sequestration of microRNA-122 from Hepatitis C Virus by 
circular RNA sponges 
 
 
 
Recent advantages in deep sequencing technologies enabled a discovery of non-conventional splicing 
of primary transcripts in human genome. A substantial number of RNAs were identified with circularly 
permuted exon orders and hypothesized to result from head-to-tail splicing of exons (also known as 
back-splicing), when a donor splice site splicing to an upstream instead of a downstream acceptor site 
(Salzman et al. 2012). In the following years thousands of circular RNAs (circRNAs) were identified in 
different species, leading to a creation of a database ―circBase‖ (Glažar et al. 2014). Biological functions of 
eukaryotic exonic circRNAs, however, largely remain to be understood.  
One of the well-investigated examples of circRNA function in human is CDR1as (also known as 
ciRS-7 in Hansen et al. 2013), an antisense to the cerebellar degeneration-related protein 1 transcript. 
Containing 73 conserved binding sites for miR-7, CDR1as functionally suppresses miR-7 and miR-671 
activity in neuronal tissues and de-represses their direct targets, which appears critical for normal brain 
function (Memczak et al. 2013, Hansen et al. 2013, Piwecka et al. 2017). Such way of action was defined as 
miRNA sponge.   
In the published research (Jost et al. 2018), conducted prevalently by Isabelle Jost, an artificial miRNA 
sponge was designed, synthesized and validated. Developed in analogy to natural circRNA sponge, as a 
proof-of-principle, an anti-miR-122 sponge was created and applied to HCV cell culture system. The latter 
enabled verification of a functional sequestration of miRNA-122 by the engineered circular RNA sponge. 
Upon efficient binding of cellular miR-122 by the sponge, HCV protein production was dramatically 
reduced, comparable to an effect of the antimiR-122 drug Miravirsen (Janssen et al. 2013). The study 
provides a detailed protocol for engineering and generation in vitro of circRNA sponges, also harboring 
sequence of repetitive nature. Importantly, the circRNA sponges were testified to be more stable than their 
linear counterparts, suggesting an extended sequestration during a possible application.  
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The majority of the work was performed by Isabelle Jost and detailed in the completed PhD thesis. 
During my PhD thesis, in parallel with the main project, I have conducted the part that required work with an 
infectious HCV full-length system under BSL3** conditions, since it was unavailable for Isabelle. 
Additionally, with a help of Gesche Gerresheim, I performed all experiments requested during further 
revision process. Exclusively these results are summarized below. 
6.4.1 Design and biogenesis of circular miR-122 sponge RNAs  
Development and optimization of artificial anti-miR-122 sponge production procedure comprises a 
substantial part of the PhD thesis of Isabelle Jost. In the development of sponges, high-affinity miRNA 
binding sites were designed and experimentally validated in vitro, since the binding affinity of artificial 
miR-122 binding sites needs to be comparable of the ones situated on HCV RNA. 
Hereby an application of the optimized protocol illustrates the key steps and intermediates of circRNA 
in vitro synthesis (Suppl. Fig. 6.16). An RNA template for circularization is derived by in vitro transcription 
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from a linearized DNA plasmid encoding corresponding tandem binding sites as well as shared by all 
constructs’ sequences (Suppl. Fig. 6.16, A). Due to the repetitive nature of these tandem binding sites, 
theirnumber was limited to 8 in the course of optimization preventing dramatic impairment in the efficiency 
of major biochemical techniques. Three types of miR-122 binding sites were evaluated in the study: a bulged 
binding site with a mismatch at nucleotides 10-12, a perfectly complementary binding site and a shuffled 
sequence serving as a negative control (Suppl. Fig. 6.16, B and C). Linear RNA transcripts harboring a 
monophosphate at the 5’-end can be circularized by RNA ligase 1 or form linear dimers (Suppl. Fig. 
6.16, C). The ratio between products varies in accordance to a degree of sequence repetitiveness, resulting in 
the highest outcome for the shuffled circRNA construct. Omitting linear dimer forms, both monomeric forms 
– linear and circular – were separated on a gel in order to gel-purify and concentrate the resulting constructs. 
A simple diagnostic approach allows distinguishing between circular and linear forms by differential 
electrophoretic mobility of circular molecules in polyacrylamide gels of different acrylamide concentration 
(Tabak et al. 1988; Suppl. Fig. 6.16, D). To sum up, three types of circular and linear sponges containing 
miR-122 or control binding sites can be generated by in vitro approaches; for more details and optimizations 
see the PhD thesis of Isabelle Jost. 
6.4.2 Stability of circRNA sponges  
As a part of my contribution to the study, stability of the presented sponge RNAs was evaluated. 
Formerly, Isabelle Jost had performed time-course experiments aiming to quantify half-life times of the three 
circRNA constructs and their linear counterparts in HuH-7.5 cells that are routinely used for the functional 
assays. However, the former analyses were biased due to the use of Lipofectamine transfection reagent, 
which can artificially alter an uptake of circular versus linear RNAs and/or shield RNAs from degradation on
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the outer cellular surface. Therefore, to gain more reliable comparison of stability of circular and linear 
constructs, electroporation method of RNA transfection was applied on HuH-7.5 cells, followed by isolation 
of total cellular RNA according to a selected time-course (input, 8, 24, 48 and 72 hours post electroporation; 
three biological replicates). Once equal amounts of circRNA sponges or their linear counterparts are 
transfected, fractions of intact RNAs remaining in the course of an experiment allow mathematical prediction 
of each construct’s half-life time. For each RNA species, mean fractions of remaining RNA were normalized 
to 8 h values. Decay curves for the analyzed constructs were derived by plotting to an exponential decay 
function (ExpDec1) using OriginPro8 software. CircRNA constructs were characterized by stability of either 
a circular form alone or summed up with a corresponding linearized fraction (an opened cycle) that still 
functions as a sponge.  
Visualization of intact fractions of circular and linear forms was fulfilled by ³²P-northern blot analysis 
using identical probes in the constant region for all constructs and U1 snRNA as a loading control. The 
representative images (Suppl. Fig. 6.17, A) testify for an increased stability of circular RNA sponges over 
their linear counterparts, which originate from both inaccessibility for exonucleolytic degradation and from 
the two-step decay. For the downstream calculations (Suppl. Fig. 6.17, B), the autoradiography bands’ 
intensity was quantified using ImageQuantTL software. Taking results for bulge, perfect and shuffle 
constructs together, half-life values varied from 11.3 to 13.2 h for linear RNAs and from 14.1 to 19.1 h – for 
a circular form, whereas the overall value for ―circular + linearized‖ forms varied from 18.7 to 22.7 h. Thus, 
the analyzed circular constructs appear to be functional nearly twice as long as the linear constructs 
providing an advantageous feature for potential therapeutic applications.     
6.4.3 Application of circRNA sponges to infectious HCV system 
The major part of my contribution to the study was a validation of the designed miR-122 sponges’ 
functionality using the full-length HCV cell culture system. Prior referring to their effects on infectious virus, 
meticulous selection and verification of binding sites was conducted by Isabelle Jost utilizing two different 
HCV-reporter systems. As long as the artificial circRNAs demonstrated a comparable or even a higher 
activity as of Miravirsen-like antisense oligonucleotide in impairment of the miR-122 dependent reporter 
gene translation, the sponges’ functionality was trialed in HCV infection model.  
MiR-122 is beyond doubt one of the most vital host factors for HCV propagation. It acts directly on 
the viral genomic RNA and modulates almost every step of the HCV life cycle. One well-investigated 
mechanism of miR-122 action is fulfilled through its binding to two tandem binding sites at the very 5’-end 
of the HCV genome. In association with Ago2 miR-122 was demonstrated to increase HCV RNA stability as 
well as to promote its replication and translation (for more details see 1.3.4.3). In a full-length HCV system, 
in contrast to HCV reporter systems, miR-122 may also contribute via binding to an array of binding sites 
located at the 3’-end of genomic RNA and additionally affecting the stages downstream of 
translation/replication. Although the use of a full-length HCV system does not reveal which exact stage of 
the viral life cycle is primarily inhibited upon sponging of miR-122 from HCV by the designed constructs, it 
provides an insight into their overall effect on viral propagation in cell culture (schematically illustrated by 
Suppl. Fig. 6.18, A).  
Taking advantage of the developed fully permissive HuH-7.5 cell culture system (Lindenbach et al. 
2005; Wakita et al. 2005; Zhong et al. 2005), the effect of the circRNA miR-122 sponges was compared to 
as of linear constricts and of Miravirsen upon co-transfection together with in vitro transcribed Jc1 HCV 
RNA. It should be noted that the introduction of equal absolute mass quantities of all sponge RNAs and 
Miravirsen in the experiments below reflects a three-fold higher molarity of miRNA-122 binding sites for the 
transfection of Miravirsen. Following the co-transfection, HuH-7.5 cells were incubated for 5 days to allow a 
full-blown HCV infection and further harvested to isolate total protein extract and total RNA. Usually 50 ng 
of a sequestration construct was used for co-transfection in 12-well format and resulted in a reduction of 
HCV proteins translation to undetectable level for both circular bulge and perfect constructs as well as for 
the Miravirsen-like antisense oligonucleotide (Suppl. Fig. 6.18, B). Reproduced multiple times such
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experimental setup only rarely demonstrated noticeable differences in sponging efficiencies of circular 
constructs and their linear counterparts. The latter are characterized by nearly two times lower stability in 
HuH-7.5 cells, as presented above, and are expected to be less efficient than circRNAs. Indeed, when 10 ng 
of each sponge was applied in the similar format, significant advantages in circular constructs’ functionality, 
especially for bulge circRNA, were demonstrated over their linear counterparts (Suppl. Fig. 6.18, C). 
Ultimately, the bulge circRNA sponge manifested the more profound functional sequestration of miR-122 
than bulge linear RNA or the construct containing perfectly complementary binding sites, or Miravirsen. As 
expected, shuffle linear and circular sponges had no effect on HCV translation: viral infection development 
was as in control experiment (HCV RNA only transfected). Moreover, efficient interference with production 
of both non-structural (NS3) and structural (Core) HCV proteins indirectly implies that both - intracellular 
stages of the HCV life cycle (e.g. polyprotein processing, RNA replication) and budding – would be 
impaired by functional RNA sponges.  
In order to provide a prove that observed effects on HCV production are indeed mediated by sponging 
of miR-122, the total intracellular level of miR-122 was compared to amount of unbound, accessible 
molecules. While northern blot detection of miR-122 content reveals all molecules in the cell (including 
those sequestered by sponges or situated on its cellular target and/or HCV RNA), reverse transcription 
followed by TaqMan qPCR quantifies only functionally available molecules. Carried out under denaturing 
conditions, quantification of miR-122 by northern blot within the samples corresponding to Suppl. Fig. 
6.18, B, indicated identical total levels of the targeted microRNA (data not shown here). In contrast, 
quantification of miR-122 by TaqMan RT-qPCR resulted in remarkable reduction of accessible molecules, 
supposedly upon sponging (Suppl. Fig. 6.18, D). Interestingly, the degree of reduction was in agreement with 
the stability of circular versus linear RNA forms and with observed effects on HCV translation. Aiming to 
support an assumption that TaqMan RT-qPCR approach virtually quantifies only unbound microRNAs, 
recreation of denaturing conditions prior reverse transcription was attempted. Pre-heating of analyzed total 
RNA together with RT primers to 95°C for 2 minutes denatures secondary structures liberating bound 
miR-122 molecules for hybridization to primers. As expected, a reversion to quantification of the total pool 
of miR-122 was observed (Suppl. Fig. 6.18, E).   
In summary, circRNA sponges appeared to be more efficient for miR-122 sequestration than their 
linear analogs suggesting the more prominent potential for clinical applications. Due to their extended 
stability alone and functionality both as circular and linearized sponges, they were shown to sequester more 
miR-122 molecules than linear RNA in scope of the presented experiments. Unlike Miravirsen, the 
developed circRNA sponges are metabolized when applied in vivo, arguing against side effects mediated by 
accumulation of a therapeutic agent (Swayze et al. 2006). This proof-of-principle study has demonstrated 
how an efficient targeting of pathogens’ essential factor by artificial circular RNA sponges can effectively 
inhibit pathogens’ production opening a wide range of possible applications in molecular therapy and 
medicine.  
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6.5 List of abbreviations and symbols 
3D - three-dimensional 
AA - acrylamide 
Ago2 - Argonaute protein 2 
APS - ammonium persulfate 
ARS - aminoacyl-tRNA synthetase  
ATP - adenosine triphosphate 
bp - base pair 
BR - broad range 
BVDV - Bovine Viral Diarrhea Virus 
C - Cytidine 
CD - cluster of differentiation 
cDNA - complementary DNA 
circRNA – circular RNA 
CLDN1 - Claudin-1 
cm
2
 - square centimeter 
CRE - cis-acting replication element 
CrPV - Cricket Paralysis Virus 
CSB3 - Coxsackievirus B3 
Ct - threshold cycle 
CTP - cytosine triphosphate 
CypA - Cyclophilin A 
DAA - direct-acting antiviral 
DARS – Aspartyl-tRNA synthetase 
DENV - Dengue Virus  
DLS - dimerization linkage sequence 
DMEM - Dulbecco’s Modified Eagle’s Medium 
DMHBI - 3,5-dimethoxy-4-hydroxybenzylidene imidazolinone 
DMSO - dimethyl sulfoxide 
DMV/MMV - double/multi membrane vesicle 
DNA - deoxyribonucleic acid 
DNase - deoxyribonuclease 
dsRNA - double-stranded RNA 
DTT - dithiothreitol 
E - amplification efficiency 
EBV - Epstein-Barr Virus 
E. coli - Escherichia coli 
EDTA - ethylenediaminetetraacetic acid 
EGTA - ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid 
eIF - eukaryotic initiation factor 
EMCV - Encephalomyocarditis Virus 
ER - endoplasmic reticulum 
FBS - fetal bovine serum 
FMDV - Foot-and-Mouth Disease Virus 
for - forward 
g - gram 
G - Guanine 
G-418 - Geneticin 418 
GAPDH - glyceraldehyde-3-phosphate dehydrogenase 
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GARS - Glycyl-tRNA synthetase 
GBV-B - GB Virus B 
GDP - guanosine diphosphate 
GFP - green fluorescent protein 
Gly – Glycine 
GSH - glutathione 
GTP - guanosine triphosphate 
h - hour 
HAV - Hepatitis A Virus 
HBI - 4-hydroxybenzlidene imidazolinone 
HCMV - Human Cytomegalovirus 
HCV - Hepatitis C Virus 
HDV - Hepatitis Delta Virus 
HF - high fidelity 
HIV-1 - Human Immunodeficiency Virus type 1 
hnRNP - heterogeneous nuclear ribonucleoprotein 
hp - hairpin 
h.p.t. - hours post transfection 
HRP - horseradish peroxidase 
HSPG - heparan sulfate proteoglycan 
HSV - Herpes Simplex Virus 
IFN(-α) - Interferon(-alpha) 
Ile - Isoleucine 
IRES - internal ribosome entry site 
IRF3 - interferon regulatory factor 3 
ISG - IFN-stimulated gene 
ITAF - IRES trans-acting factor 
JFH - Japanese fulminant hepatitis 
kb - kilobase 
kDa - kilodalton 
l - liter 
La - Lupus antigen 
LB - Luria-Bertani 
LD - lipid droplet 
LDL - low-density lipoprotein 
LDLR - LDL receptor 
LNA - locked nucleic acid 
Met - Methionine 
mg - milligram 
min - minute 
min. - minimum 
miR(NA) - microRNA 
miRISC - miRNA-induced silencing complex 
ml - milliliter 
mM - millimolar  
mm - millimeter 
mm
2
 - square millimeter 
MOPS - 3-(N-morpholino) propanesulfonic acid 
mRNA - messenger RNA 
ms - millisecond 
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M.s - minus strand 
MS – mass-spectrometry 
mut - mutated 
NANB(H) - non-A/non-B (hepatitis) 
NEB - New England Biolabs 
neo - neomycin 
nm - nanometer 
NPHV - Non-Primate Hepacivirus 
NS - non-structural 
NTP - nucleoside triphosphate 
nt - nucleotide(s) 
ORF - open reading frame 
PABP - poly(A)-binding protein 
PAGE - polyacrylamide gel electrophoresis 
PBS - phosphate buffered saline 
PCBP2 - Poly(rC) binding protein 2 
PCR - polymerase chain reaction 
p.e.p – post electroporation 
PI4KIIIα - phosphatidylinositol-4-kinase IIIα 
PI4P - phosphatidylinositol-4-phosphate 
PNA - peptide nucleic acid  
RER - relative expression ratio 
RPA - ribonuclease protection assay 
pp - pseudoparticle 
pre-miRNA - precursor miRNA 
pri-miRNA - primary miRNA 
P.s - plus strand 
PTB - polypyrimidine tract-binding protein 
Pu - purine 
PV - Poliovirus 
PVDF - polyvinylidene difluoride  
Py – pyrimidine 
QARS - Glutaminyl-tRNA synthetase 
qPCR - quantitative PCR 
RARS - Arginyl-tRNA synthetase 
RC - reverse complement(ary) 
RdRp - RNA-dependent RNA polymerase 
REM - replication-enhancing mutation 
rev - reverse 
RIG-I - Retinoic Acid Inducible Gene I 
RIP - RNA immunoprecipitation 
RNA - ribonucleic acid 
RNAi - RNA interference 
RNase - ribonuclease 
rpm - revolutions per minute 
RT - reverse transcription 
RT-qPCR - quantitative RT-PCR  
Rxn - reaction 
s – second 
scr - scrambled 
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SD - standard deviation 
SDS - sodium dodecyl disulfate 
Ser - Serine 
SELEX - systematic evolution of ligands by exponential enrichment 
siRNA - small interfering RNA 
SHAPE - selective 2’-hydroxyl acylation and primer extension 
SL - stem-loop 
SPP - signal peptide peptidase 
SR-BI - scavenger receptor class B type I  
ssRNA – single-stranded RNA 
T7T - T7 Terminator  
TAP1 - tocopherol-associated protein 1 
TEMED - N,N,N’,N’-tetramethylethylenediamine 
Tm - melting temperature 
tRNA - transfer RNA 
U - Uridine 
U - unit 
UTP - uridine triphosphate 
UTR - untranslated region 
VAPA/VAPB - vesicle-associated membrane proteins A/B 
VLDL - very low-density lipoprotein 
WB - western blot 
WHO - World Health Organization 
WNV - West Nile Virus 
wt - wild-type 
Xrn - exoribonuclease 
YFV - Yellow Fever Virus 
µg - microgram 
µl - microliter 
µM - micromolar 
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